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Sphingomyelin	as	a	danger	signal	in	cell-autonomous	immunity		
Individual	 cells	 employ	 mechanisms	 of	 cell-autonomous	 immunity	 to	 defend	 their	cytosol	 against	 bacterial	 invasion.	 One	 such	mechanism	 involves	 indirect	 detection	 of	the	 pathogen	 through	 recognition	 of	 pathogen-induced	 disturbances	 causing	 the	appearance	 of	 specific	 host	molecules	 in	 an	 abnormal	 location.	 For	 example,	 glycans,	which	 are	 located	 on	 the	 extracellular	 leaflet	 of	 the	 plasma	 membrane	 under	homeostatic	 conditions,	 become	 hidden	 inside	 bacteria-containing	 vacuoles	 (BCVs)	during	bacterial	entry	 into	 the	cell.	Upon	BCV	rupture,	glycans	become	exposed	to	 the	cytosol	 where	 they	 act	 as	 a	 danger	 signal	 and	 are	 detected	 by	 the	 cytosolic	 danger	receptor,	Galectin	8.		My	 research	 reveals	 that	 sphingomyelin,	 a	 host	 lipid	 predominantly	 located	 on	the	outer	leaflet	of	the	plasma	membrane,	is	exposed	to	the	cytosol	on	damaged	BCVs.	I	visualised	 the	 appearance	 of	 intracellular	 sphingomyelin	 by	 utilising	 Lysenin	 -	 a	sphingomyelin-specific	toxin	from	earthworms	–	as	a	cytosolic	sphingomyelin	reporter.	Lysenin	is	recruited	to	BCVs	in	a	sphingomyelin-dependent	manner	upon	cytosolic	entry	of	both	Gram-negative	and	Gram-positive	bacteria.		Lysenin	 co-localises	 with	 Galectin	 8	 on	 a	 proportion	 of	 BCVs,	 indicating	 that	sphingomyelin	 exposure	 occurs	 upon	membrane	 damage.	Moreover,	 I	 elucidated	 that	sphingomyelin	 exposure	 occurs	 before	 glycan	 exposure	 on	 damaged	 BCVs	 indicating	that	 BCV	 rupture	 may	 proceed	 through	 two	 stages:	 ‘minor’	 and	 ‘major’	 damage.	 My	investigations	into	possible	causes	of	vacuole	rupture	are	on	going.		To	 identify	 endogenous	 cellular	 receptors	 for	 cytosol-exposed	 sphingomyelin,	 I	established	 and	 executed	 an	 assay	 to	 compare	 enrichment	 of	 mammalian	 cell	 lysate	proteins	 on	 liposomes	 containing	 or	 lacking	 sphingomyelin.	 Following	 mass	spectrometry	analysis,	49	candidate	proteins	were	tested	for	recruitment	to	Salmonella.	Twelve	candidates	were	recruited	to	BCVs	upon	infection.	Of	these	twelve,	I	pursued	five	candidates	in	greater	detail	due	to	their	recruitment	to	Salmonella	being	either	entirely	unknown,	or	known,	but	via	a	non-sphingomyelin	mechanism.	Further	analysis	of	one	candidate	in	particular,	TECPR1,	elucidated	that	TECPR1	is	recruited	to	Salmonella	in	a	sphingomyelin-dependent	 manner	 and	 possesses	 sphingomyelin-specific	 binding	properties	 in	vitro.	Therefore,	my	 thesis	 research	 identifies	TECPR1	as	an	endogenous	sphingomyelin-binding	protein.	
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Summary	
Individual	 cells	 employ	 mechanisms	 of	 cell-autonomous	 immunity	 to	 defend	 their	cytosol	 against	 bacterial	 invasion.	 One	 such	mechanism	 involves	 indirect	 detection	 of	the	 pathogen	 through	 recognition	 of	 pathogen-induced	 disturbances	 causing	 the	appearance	 of	 specific	 host	molecules	 in	 an	 abnormal	 location.	 For	 example,	 glycans,	which	 are	 located	 on	 the	 extracellular	 leaflet	 of	 the	 plasma	 membrane	 under	homeostatic	 conditions,	 become	 hidden	 inside	 bacteria-containing	 vacuoles	 (BCVs)	during	bacterial	entry	 into	 the	cell.	Upon	BCV	rupture,	glycans	become	exposed	to	 the	cytosol	 where	 they	 act	 as	 a	 danger	 signal	 and	 are	 detected	 by	 the	 cytosolic	 danger	receptor,	Galectin	8.		My	 research	 reveals	 that	 sphingomyelin,	 a	 host	 lipid	 predominantly	 located	 on	the	outer	leaflet	of	the	plasma	membrane,	is	exposed	to	the	cytosol	on	damaged	BCVs.	I	visualised	 the	 appearance	 of	 intracellular	 sphingomyelin	 by	 utilising	 Lysenin	 -	 a	sphingomyelin-specific	toxin	from	earthworms	–	as	a	cytosolic	sphingomyelin	reporter.	Lysenin	is	recruited	to	BCVs	in	a	sphingomyelin-dependent	manner	upon	cytosolic	entry	of	both	Gram-negative	and	Gram-positive	bacteria.		Lysenin	 co-localises	 with	 Galectin	 8	 on	 a	 proportion	 of	 BCVs,	 indicating	 that	sphingomyelin	 exposure	 occurs	 upon	membrane	 damage.	Moreover,	 I	 elucidated	 that	sphingomyelin	 exposure	 occurs	 before	 glycan	 exposure	 on	 damaged	 BCVs	 indicating	that	 BCV	 rupture	 may	 proceed	 through	 two	 stages:	 ‘minor’	 and	 ‘major’	 damage.	 My	investigations	into	possible	causes	of	vacuole	rupture	are	on	going.		To	 identify	 endogenous	 cellular	 receptors	 for	 cytosol-exposed	 sphingomyelin,	 I	established	 and	 executed	 an	 assay	 to	 compare	 enrichment	 of	 mammalian	 cell	 lysate	proteins	 on	 liposomes	 containing	 or	 lacking	 sphingomyelin.	 Following	 mass	spectrometry	analysis,	49	candidate	proteins	were	tested	for	recruitment	to	Salmonella.	Twelve	candidates	were	recruited	to	BCVs	upon	infection.	Of	these	twelve,	I	pursued	five	candidates	in	greater	detail	due	to	their	recruitment	to	Salmonella	being	either	entirely	unknown,	or	known,	but	via	a	non-sphingomyelin	mechanism.	Further	analysis	of	one	candidate	in	particular,	TECPR1,	elucidated	that	TECPR1	is	recruited	to	Salmonella	in	a	sphingomyelin-dependent	 manner	 and	 possesses	 sphingomyelin-specific	 binding	properties	 in	vitro.	Therefore,	my	 thesis	 research	 identifies	TECPR1	as	an	endogenous	sphingomyelin-binding	protein.		
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Chapter	1:	Introduction	
The	 immune	 system	 is	 a	 highly	 complex	 network	 of	 specialised	 cells	 functioning	together	to	orchestrate	an	appropriate	response	to	a	pathogen.	The	vertebrate	immune	system	is	composed	of	two	branches,	both	of	which	are	essential	for	survival:	the	innate	immune	 system	 is	 responsible	 for	 rapid	 pathogen	 detection	 and	 often	 initiates	 the	second	 branch,	 the	 adaptive	 immune	 system,	 which	 is	 responsible	 for	 a	 longer-term	response	and	establishment	of	immunological	memory.		In	 addition	 to	 pathogen	 detection	 through	 this	 specialised	 cell	 network,	individual	 non-specialised	 cells,	 cells	 that	 are	 not	 part	 of	 the	 immune	 system,	 also	rapidly	detect	pathogen	invasion	of	the	cell	cytosol	and	defend	themselves	accordingly.	Such	 cells	 achieve	 this	 pathogen	 resistance	 through	 cell-autonomous	 defence	mechanisms,	 which	 have	 been	 evolutionarily	 conserved	 from	 single-celled	 organisms	(Randow	et	al,	2013).			 The	 effectiveness	 of	 cell-autonomous	 immunity	 in	 protecting	 the	 cell	 cytosol	against	bacteria	 is	evident	from	the	intracellular	 location	that	bacteria	 inhabit.	Despite	the	 abundance	 of	 nutrients	 within	 the	 cytosol,	 the	 majority	 of	 bacteria,	 such	 as	
Salmonella,	Legionella	and	Brucella	reside	within	a	vacuole,	thus	suggesting	a	powerful	cytosolic	 anti-bacterial	 mechanism	 exists.	 Vacuole-dwelling	 bacteria	 can	 become	exposed	to	the	cytosol,	primarily	through	accidental	vacuole	rupture,	and	are	destroyed	through	 the	 cytosolic	 defence	mechanism	of	 xenophagy,	 also	 known	 as	 anti-microbial	autophagy.	In	order	for	efficient	anti-microbial	autophagy	to	occur,	the	cell	must	first	rapidly	detect	the	pathogen	invading	the	cytosol.	The	cell	can	either	directly	detect	the	pathogen,	through	recognition	of	specific	pathogen	 features,	or	 indirectly,	 through	recognition	of	pathogen-induced	disturbances	of	 cellular	homeostasis,	 causing	appearance	of	 specific	host	molecules	 in	abnormal	 compartments.	 Such	host	molecules	are	known	as	danger	signals.	The	host	danger	signal	is	detected	by	specific	cytosolic	danger	receptors,	which	trigger	 the	 clearance	of	 the	pathogen,	 ultimately	defending	 the	 cytosol	 from	pathogen	invasion.	The	focus	of	my	research	has	been	to	identify	and	investigate	new	danger	signals	involved	 in	 anti-bacterial	 cytosolic	 defence.	 The	 following	 sections	 introduce	 the	background	to	my	research.	
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1.1 Innate	detection	of	pathogens	A	crucial	mechanism	by	which	cells	directly	detect	pathogens	is	through	recognition	of	Pathogen	Associated	Molecular	Patterns	(PAMPs)	(Janeway	&	Medzhitov,	2002).	PAMPs	are	 evolutionarily	 conserved	 parts	 of	 the	 pathogen	 that	 are	 essential	 for	 pathogen	survival	and	are	invariant	among	particular	classes	of	pathogen.	PAMPs	are	detected	by	a	set	of	host	receptors,	known	as	pattern	recognition	receptors	(PRRs),	each	specific	for	a	 particular	 PAMP.	 Four	 main	 families	 of	 PAMP	 receptors	 are	 known:	 1.	 Toll-like	receptors	(TLRs);	2.	RIG-I-like	receptors	(RLRs);	3.	NOD-like	receptors	(NLRs)	and	4.	C-type	lectin	receptors	(CLRs).	
1.1.1 Toll-like	receptors	(TLRs)	Human	 TLRs	 comprise	 a	 family	 of	 single-pass	 transmembrane	 proteins	 with	 an	extracellular	 N-terminal	 ligand-binding	 region	 composed	 of	 multiple	 leucine-rich	repeats	 (LRRs)	 and	 a	 Toll-IL-1	 receptor	 (TIR)	 signalling	 domain	 in	 their	 C	 terminus.	TLRs	detect	a	wide	range	of	PAMPs	(Table	1.1)	and	are	mainly	expressed	on	particular	cell	types	of	the	immune	system	(Iwasaki	&	Medzhitov,	2004),	although	certain	TLRs	are	expressed	on	epithelial	cells	(Cario	&	Podolsky,	2000).		
TLR	 PAMP	detected	 Cell	expression	
TLR1:2	
heterodimer	
Triacyl	lipopeptides	(Gram-negative	bacteria)	Cell	wall	β-glucans	(bacteria	and	fungi)	Zymosan	(fungi)	 Monocytes,	DCs,	mast	cells,	eosinophils,	basophils	
TLR2:6	
heterodimer	
Diacyl	lipopeptides	(Mycobacteria)	Lipoteichoic	acid	(Gram-positive	bacteria)	Cell	wall	β-glucans	(bacteria	and	fungi)	Zymosan	(fungi)	
TLR3	 dsRNA	(viruses)	 NK	cells	
TLR4	
Lipopolysaccharide	(Gram-negative	bacteria)	Lipoteichoic	acids	(Gram-positive	bacteria)	 Macrophages,	DCs,	mast	cells,	eosinophils	
TLR5	 Flagellin	(bacteria)	 Intestinal	epithelium	
TLR7	 ssRNA	(RNA	viruses)	 DCs,	NK	cells,	eosinophils,	B	cells	
TLR8	 ssRNA	(RNA	viruses)	 NK	cells	
TLR9	
Unmethylated	CpG	DNA	(bacteria	and	herpesviruses)	 DCs,	eosinophils,	B	cells,	basophils	
TLR10	 unknown	 DCs,	eosinophils,	B	cells,	basophils	
Table	1.1:	PAMP	specificity	and	cell	type	expression	of	the	human	TLR	family.			DC	(dendritic	cell);	NK	(natural	killer	cell).	
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The	 particular	 cellular	 location	 of	 TLRs	 also	 varies,	 as	 TLR	1,	 2,	 4,	 5,	 6,	 10	 are	located	 on	 the	 plasma	 membrane	 whilst	 TLR	 3,	 7,	 8,	 9	 are	 located	 in	 endosomes.	Therefore,	TLRs	survey	the	extracellular	environment	and	endosomal	compartments.	Upon	PAMP	binding,	TLR	oligomerisation	occurs	forming	homodimers	or,	in	the	case	 of	 TLR2,	 heterodimers	 of	 TLR1:2	 or	 TLR2:6.	 Oligomerisation	 brings	 the	 TIR	cytoplasmic	domains	into	close	proximity	forming	a	platform	for	recruitment	of	adaptor	molecules	 and	 kinases	 culminating	 in	 activation	 of	 the	 transcription	 factors	 NFκB	(Nuclear	 factor-κB),	 AP-1	 (activator	 protein-1)	 and	 IRF3	 and	 7	 (interferon	 regulatory	factor	3	and	7).		The	five	main	adaptor	proteins	involved	in	regulating	the	TLR	signal	are	MyD88	(Myeloid	 differentiation	 factor	 88),	 Mal	 (MyD88	 adaptor-like),	 TRIF	 (TIR	 domain-containing	adaptor-inducing	IFN-B),	TRAM	(TRIF-related	adaptor	molecule)	and	SARM	(sterile	α–and	 armadillo-repeat-containing	 protein)	 (O'Neill	&	Bowie,	 2007).	 By	 using	different	 adaptor	 proteins,	 the	 TLRs	 stimulate	 different	 transcription	 factors,	 thereby	initiating	 a	 different	 cellular	 response	 (Mogensen,	 2009).	 	 Signalling	 via	 MyD88/Mal	results	 in	NFκB	 and	AP-1	 activation	with	 subsequent	 production	 of	 pro-inflammatory	cytokines,	such	as	TNF-α,	IL-1	and	IL-12.	Signalling	via	TRIF/TRAM,	however,	activates	the	 IRF3	 transcription	 factor	 resulting	 in	 production	 of	 type	 I	 interferons	 (IFN-α	 and	IFN-β),	 important	 in	 the	 anti-viral	 response.	 Figure	 1.1	 depicts	 the	 TLR4	 signalling	cascade	with	subsequent	activation	of	NFκB,	AP-1	and	IRF.					
Figure	1.1:	The	TLR	signalling	pathway.		Upon	TLR-ligand	binding,	TLR	oligomerisation	occurs,	recruiting	adaptor	proteins,	such	as	Mal	and	MyD88.	 These	 adaptors	 activate	 kinases	 such	 as	 IRAK4	 and	 IRAK1/2,	which	 activate,	 via	phosphorylation,	 the	E3	 ligase,	 TRAF6.	 In	 turn,	 TRAF6	ubiquitinates,	 and	 activates,	 the	TAB1-TAB2/3-TAK1	 complex.	 This	 complex	phosphorylates	 IKKα	 and	β	which	phosphorylate	 IκB,	 a	negative	regulator	of	NFκB,	resulting	in	IκB	dissociation	from	NFκB.	NFκB	then	translocates	into	the	 nucleus	 to	 initiate	 pro-inflammatory	 cytokine	 gene	 transcription.	 TAB1-TAB2/3-TAK1	complex	can	also	activate	AP-1	transcription	factor	via	a	MAPK-dependent	pathway	(MKK).	AP-1	activity	also	upregulates	pro-inflammatory	cytokine	gene	transcription.		
Figure	1.1	legend	continues	on	the	following	page.	
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Figure	1.1	legend	continued:	If	the	TRAM	and	TRIF	adaptor	proteins	are	employed	upon	TLR	activation,	a	different	signalling	cascade	 is	 initiated	 involving	 TBK1	 activation	 and	 subsequent	 phosphorylation	 of	 the	 IRF3	transcription	factor.	 IRF3	then	translocates	 into	the	nucleus	and	upregulates	Type	I	 Interferon	(IFN)	gene	transcription.	TLR	4,	7,	8,	and	9	activate	both	signalling	cascades,	TLR	1,	2,	5	and	6	only	 activate	 pro-inflammatory	 cytokine	 production	 and	 TLR3	 only	 activates	 Type	 I	 IFN	production.		
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1.1.2 RIG-I	like	receptors	Whilst	 TLRs	 detect	 extracellular	 or	 endosomal	 pathogens,	 RIG-I	 like	 receptors	 (RLRs)	RIG-I	(retinoic	acid	inducible	gene	1)	and	MDA-5	(Melanoma	differentiation-associated	5)	detect	cytosolic	viruses.		RLRs	 detect	 cytoplasmic	 RNA	 in	 an	 ATP-dependent	 manner	 (Yoneyama	 et	 al,	2015).	RIG-I	detects	short	dsRNA	(up	to	1kb)	and	detection	is	further	increased	by	a	5’-triphosphate	on	the	dsRNA,	whilst	MDA5	detects	long	dsRNA,	greater	than	2kb	(Kato	et	
al,	 2008).	 Both	 RIG-I	 and	 MDA-5	 are	 IFN-inducible	 and	 are	 important	 in	 immune	responses	to	viruses	such	as	hepatitis	C	and	norovirus	(Sumpter	et	al,	2005;	McCartney	
et	al,	2008;	Loo	et	al,	2008).		 RLRs	are	composed	of	a	central	DExD/H	box	RNA-helicase/ATPase	domain	and	two	N-terminal	CARD	domains	(caspase	recruitment	domain).	Upon	viral	RNA	binding	to	the	RNA	helicase-domain	of	the	RLR,	the	N-terminal	CARD	domain	interacts	with	the	CARD	domain	in	the	adaptor	protein,	MAVS	(mitochondrial	antiviral-signalling	protein),	present	 in	 the	 outer	 mitochondrial	 membrane.	 MAVS	 activates	 TRAF3	 and	 TRADD	(Michallet	et	al,	2008)		initiating	two	signalling	pathways	that	respectively	culminate	in	IRF3	activation	with	 type	 I	 IFN	production,	or	NFκB	activation	with	pro-inflammatory	cytokine	production.	Whilst	 RLRs	 detect	 cytosolic	 RNA,	 cytosolic	 DNA	 is	 detected	 by	 other	 cellular	sensors,	 including:	 DAI	 (DNA-dependent	 activator	 of	 IFN-regulatory	 factors),	 cGAS	(cyclic	 GMP-AMP	 synthase)	 and	AIM2	 (Absent	 in	melanoma	 2)	 (Takaoka	 et	al,	 2007).	DAI	 and	 cGAS	 signalling	 result	 in	 type	 1	 IFN	 production,	 the	 latter	 via	 the	 adaptor	protein	STING.	AIM2	signalling	results	in	pro-inflammatory	cytokine	production.	
1.1.3 NOD-like	receptors	Another	 cytosolic	 PRR	 family	 is	 the	 NOD-like	 receptor	 family	 (NLRs).	 Twenty-two	human	 NLR	 genes	 have	 been	 identified	 and	 each	 family	 member	 is	 composed	 of	 a	central	nucleotide-binding	oligomerisation	(NOD)	domain	and	a	C-terminal	LRR	domain	to	which	 the	 PAMP	 binds.	 The	NLR	 family	 can	 be	 subdivided	 depending	 upon	 the	 N-terminal	 protein-interacting	 domain	 present:	 the	 NOD	 family	members	 contain	 an	 N-terminal	 CARD	 domain	 whilst	 other	 NLRs	 contain	 either	 a	 Pyrin	 domain	 or	 a	 BIR	(baculovirus	inhibitor	of	apoptosis	protein	repeat)	domain	(Inohara	&	Núñez,	2003)			 Two	 important	 NOD	 family	 members	 are	 NOD1	 and	 NOD2.	 NOD1	 detects	 γ-glutamyl	diaminopimelic	acid	(iE-DAP)	(Chamaillard	et	al,	2003),	mainly	produced	from	
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Gram-negative	 bacterial	 peptidoglycan	 degradation,	 and	 NOD2	 detects	 muramyl	dipeptide,	 present	 in	 a	 wide	 range	 of	 bacterial	 peptidoglycan	 (Girardin	 et	 al,	 2003;	Tanabe	et	al,	2004).	Upon	ligand	detection,	NOD1	and	2	recruit	the	kinase	RIPK2,	in	turn	activating	 TAK1	 and	 resulting	 in	 NFκB	 activation	 and	 pro-inflammatory	 cytokine	production.	 Several	 inflammatory	diseases	 result	 from	aberrant	NOD2	signalling,	 such	as	Crohn’s	disease	(Inohara	et	al,	2003;	van	Heel	et	al,	2005).	The	sub-family	of	NLRs	containing	a	Pyrin	or	BIR	domain	can	be	activated	by	a	vast	 range	 of	 bacterial	 and	 viral	 PAMPs	 and,	 upon	 activation,	 these	 NLRs	 form	 an	inflammasome,	 a	 large	 macromolecular	 proteolytic	 complex,	 via	 self-association	 and	oligomerisation	with	the	adaptor	protein	ASC	(Apoptosis-associated	speck-like	protein	containing	 a	 CARD).	 Inflammasome	 formation	 is	 not	 exclusively	 achieved	 by	 NLR	proteins	containing	an	N-terminal	Pyrin	or	BIR	domain:	NLR	proteins	containing	an	N-terminal	CARD	domain,	such	as	NLRC4,	and	non-NLR	proteins,	such	as	the	DNA	sensor	AIM2	discussed	in	Chapter	1.1.2,	also	form	inflammasomes.	Inflammasome	formation	culminates	 in	production	of	IL-1β.	This	 is	achieved	by	recruitment	 of	 inflammatory	 caspases,	 such	 as	 caspase	 1,	 to	 the	 inflammasome	 via	CARD-CARD	interactions	with	ASC	(Martinon	et	al,	2002).	Cleavage	of	pro-IL-1β	to	IL-1β	then	 occurs	 through	 caspase	 1	 activity.	 Cellular	 levels	 of	 pro-IL-1β	 can	 be	 increased	through	 pro-inflammatory	 TLR	 signalling	 (Schroder	 &	 Tschopp,	 2010).	 Therefore,	although	PRR	families	have	distinct	signalling	mechanisms,	the	overall	cellular	response	to	the	pathogen	can	depend	upon	integration	of	different	PRR	signalling	pathways.	
1.1.4 C-type	lectins	C-type	 lectins	 are	 calcium-dependent	 carbohydrate-binding	proteins	 that	 are	 essential	for	 an	 anti-fungal	 immune	 response.	 Each	 receptor	 contains	 two	 carbohydrate-recognition	 domains	 (CRDs)	 and	 some	 of	 the	 most	 well-studied	 CLRs	 are	 Dectin-1,	Dectin-2,	Mincle	and	DC-SIGN	(Dambuza	&	Brown,	2015;	Hardison	&	Brown,	2012).	CLRs	detect	a	range	of	ligands	from	carbohydrates	such	as	β-glucan	and	mannan,	to	lipids.	Dectin-1	specifically	binds	β-glucan	(Brown	et	al,	2002),	but	other	CLRs	such	as	Dectin-2,	 Mincle	 and	 DC-SIGN,	 recognise	 mannan	 (McGreal	 et	 al,	 2006).	 Different	signalling	cascades	are	 initiated	upon	activation	of	different	CLRs,	each	culminating	 in	inflammatory	 cytokine	 gene	 transcription.	 Additionally,	 CLRs	 and	 TLRs,	 in	 particular	Dectin-1	and	TLR2,	have	been	 found	 to	 function	 together	 to	produce	crucial	cytokines	for	 an	 anti-fungal	 immune	 response	 (Brown	 &	 Gordon,	 2003;	 Gantner	 et	 al,	 2003),	
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further	indicating	the	importance	of	PRR	signalling	pathway	integration,	as	described	at	the	end	of	the	previous	section.	
1.1.5 Danger	Signals	and	Damage-Associated	Molecular	Patterns		In	 addition	 to	 direct	 detection	 of	 pathogens	 through	PAMP	 recognition	 by	 PRRs,	 cells	can	 also	 indirectly	 detect	 pathogens	 through	 sensing	 pathogen-induced	 membrane	damage.	 This	 is	 achieved	 by	 detecting	 the	 increased	 concentration	 of	 particular	 self	molecules	in	abnormal	locations	that	results	from	this	membrane	damage	(Randow	et	al,	2013).	 Such	 self	 molecules	 act	 as	 danger	 signals	 and	 are	 detected	 by	 specific	 danger	receptors.	Cells	utilise	their	compartmentalised	nature	to	physically	separate	the	danger	signal	from	the	danger	receptor	under	resting	conditions	(Figure	1.2A).			 Glycans,	a	type	of	carbohydrate,	are	one	type	of	danger	signal.	Glycans	are	located	on	the	outer	leaflet	of	the	plasma	membrane	and	therefore	on	the	intraluminal	leaflet	of	plasma	 membrane-derived	 vesicles.	 Upon	 vesicle	 damage,	 previously	 hidden	 glycans	become	exposed	to	the	cytosol	where	they	are	detected	by	a	family	of	proteins	known	as	Galectins.	 Galectins	 are	 cytosolic	 lectins	 that	 specifically	 recognise	 glycans	 containing	
β(1-4)-linked	 galactosides	 via	 carbohydrate-recognition	 domains	 (CRD)	 (Yang	 et	 al,	2008).	 The	 Galectin	 family	 is	 composed	 of	 15	 members,	 12	 of	 which	 are	 found	 in	humans	(Houzelstein	et	al,	2004;	Rabinovich	&	Toscano,	2009).	However,	only	Galectin	1,	3,	8	and	9	detect	glycans	exposed	on	damaged	vesicles	(Paz	et	al,	2010;	Dupont	et	al,	2009;	 Thurston	 et	 al,	 2012).	 Galectin	 8	 detection	 of	 exposed	 glycans	 on	 damaged	bacteria-containing	vacuoles	has	been	identified	as	an	important	anti-bacterial	defence	mechanism,	 as	 will	 be	 discussed	 in	 Chapter	 1.3.2.1,	 illustrating	 the	 crucial	 role	 of	danger	 signals	 in	 membrane	 damage	 detection	 and	 in	 the	 indirect	 detection	 of	pathogens.	Certain	 host	 lipids	 can	 also	 act	 as	 danger	 signals,	 although	 these	 lipid	 danger	signals	have	not	been	described	in	the	context	of	pathogen	detection.	For	example,	the	lipid	 cardiolipin	 becomes	 exposed	 on	 damaged	 mitochondria,	 alerting	 the	 cell	 to	organelle	 damage.	 The	 role	 of	 lipids	 as	 danger	 signals	 will	 be	 discussed	 further	 in	
Chapter	1.6.2.	Conversely	 to	danger	signals	being	detected	 intracellularly,	 intracellular	proteins	can	be	detected	in	an	extracellular	environment	upon	loss	of	integrity	of	the	whole	cell,	which	 occurs	 during	 cell	 damage	 or	 death	 (Figure	 1.2B).	 Such	 proteins	 are	 termed	damage-associated	molecular	patterns	(DAMPs)	(Matzinger,	2002;	Kono	&	Rock,	2008;	
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Rosin	 &	 Okusa,	 2011).	 DAMPs	 include	 the	 calcium-binding	 protein	 family	 S100,	 High	mobility	 Group	 Box	 1	 protein	 (HMGB1),	 heat	 shock	 proteins,	 uric	 acid,	 ATP	 and	adenosine.	 However,	 other	 DAMPs	 are	 produced	 by	 cleavage	 of	 extracellular	 matrix	components	by	proteins	released	from	dying	cells.	For	example,	 fibrinogen,	hyaluronic	acid,	collagen,	laminin	and	elastin	can	become	cleaved	into	DAMPs.			 DAMPs	are	detected	by	a	spectrum	of	receptors	including	TLRs,	NLRs	and	RAGE	(receptor	for	advanced	glycation	end-products),	the	latter	of	which	detects	HMGB1	and	S100	 proteins	 (Hofmann	 et	al,	 1999).	 DAMP	 activation	 of	 these	 receptors	 initiates	 an	inflammatory	 response	 through	 signalling	 cascades	 culminating	 in	 pro-inflammatory	cytokine	production,	as	previously	discussed.		
	
Figure	1.2:	The	recognition	of	self	molecules	as	danger.		
(A)	 Certain	 host	 molecules	 act	 as	 danger	 signals	 when	 exposed	 to	 an	 abnormal	 intracellular	compartment.	Under	homeostatic	conditions,	the	danger	signal	 is	physically	separated	from	its	receptor.	Upon	compartment	damage,	which	can	be	mediated	by	a	pathogen,	the	danger	signal	becomes	 exposed	 and	 subsequently	 interacts	 with	 its	 specific	 receptor,	 alerting	 the	 cell	 to	danger.	
(B)	Intracellular	molecules	are	released	from	damaged	or	dying	cells	and	are	detected	as	DAMPs	by	specialised	cells,	such	as	dendritic	cells,	initiating	an	inflammatory	response.					
Cara	J.	Ellison		 	 Chapter	1:	Introduction	
	 11	
1.2 Autophagy	With	the	exception	of	danger	signals,	 the	mechanisms	of	pathogen	detection	discussed	so	 far	 are	mainly	 employed	 in	 specialised	 cells	 of	 the	 immune	 system.	However,	 non-specialised	 cells	 are	 also	 protected	 against	 pathogen	 invasion	 via	 the	 process	 of	 cell-autonomous	 immunity.	 Xenophagy,	 autophagy	 of	 pathogens,	 is	 one	 such	 cell-autonomous	process	employed	 for	pathogen	destruction	 in	 individual,	non-specialised	cells.	Before	discussing	xenophagy,	the	molecular	details	of	general	autophagy	will	first	be	described.			Macroautophagy	(often	referred	to	as	autophagy)	is	an	evolutionarily	conserved	recycling	pathway	in	which	parts	of	the	cytosol	and	organelles	become	surrounded	by	a	double	 membrane,	 the	 autophagosome,	 and	 fuse	 with	 a	 lysosome	 resulting	 in	degradation	 of	 the	 auto-lysosomal	 contents	 (Figure	 1.3).	 The	breakdown	products	 of	this	 degradation	 process	 are	 subsequently	 released	 into	 the	 cytosol	 where	 they	 are	utilised	in	cellular	processes.		
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Figure	1.3:	The	canonical	pathway	of	autophagy.	
(A)	 Autophagy	 progresses	 through	 the	 formation	 of	 an	 isolation	membrane,	 also	 known	 as	 a	phagophore,	 originating	 from	 membranes,	 such	 as	 the	 endoplasmic	 reticulum	 (ER).	 The	phagophore	expands	to	 form	a	double	membrane	structure,	known	as	an	autophagosome,	and	fuses	 with	 a	 lysosome	 forming	 an	 auto-lysosome.	 The	 autophagosome	 and	 contents	 are	subsequently	 degraded	 and	 the	 breakdown	 products	 are	 released	 into	 the	 cytosol.	 (B)	 Upon	activation	 of	 the	 mammalian	 canonical	 autophagy	 pathway,	 the	 ULK1-Atg13-FIP200-Atg101	complex	is	released	from	inhibitory	association	with	mTORC1	(mammalian	target	of	rapamycin	complex	 1)	 and	 is	 recruited	 to	 the	 phagophore	 assembly	 site	 where	 it	 activates	 the	Phosphatidylinositol-3-Kinase	(PI3Kinase)	complex	to	form	the	second	messenger	PI(3)P	on	the	membrane.	 PI(3)P	 binding	 proteins	 such	 as	 WIPI	 1	 and	 2	 are	 subsequently	 recruited.	Phagophore	expansion	 into	an	autophagosome	 is	achieved	 through	activity	of	 the	Atg12-Atg5-Atg16L	 complex,	 which	 attaches	 phosphatidylethanolamine	 (PE)	 to	 LC3,	 thereby	 covalently	attaching	LC3	to	the	autophagosome	membrane.		
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Autophagy	can	be	a	non-selective	process,	which	is	induced	by	numerous	extra-	and	intracellular	stimuli	 including	starvation	and	TLR	signalling	(He	&	Klionsky,	2009;	Kroemer	et	al,	2010;	Abada	&	Elazar,	2014),	or	a	selective	process	 in	which	particular	substrates	 are	 marked	 with	 ‘eat-me’	 signals	 (Boyle	 &	 Randow,	 2013).	 Such	 signals	interact	 with	 cargo	 receptors,	 which	 in	 turn	 interact	 directly	 with	 the	 autophagy	machinery.	 A	 range	 of	 different	 substrates	 can	 be	 selectively	 autophagised	 including	mitochondria	 (mitophagy),	 endoplasmic	 reticulum	 (ERphagy),	 aggregated	 particles	(aggrephagy)	and	pathogens	(xenophagy),	with	the	latter	being	of	most	relevance	to	the	research	 presented	 within	 this	 thesis.	 However,	 despite	 the	 substrate	 differing,	 non-selective	and	selective	autophagy	progress	through	the	same	mechanistic	pathway.		Autophagy	 is	 essential	 for	 cell	 homeostasis,	 survival	 and	 development	(Mizushima	 &	 Komatsu,	 2011).	 This	 importance	 of	 autophagy	 is	 illustrated	 further	through	 aberrant	 autophagy	 manifesting	 in	 disease.	 For	 example,	 loss	 of	 function	mutations	 in	 components	 of	 mitophagy	 contribute	 to	 Parkinson’s	 disease	 (Youle	 &	Narendra,	2011);	and	 loss	of	 function	mutations	 in	NOD2	and	Atg16L1	impairs	NOD2-dependent	 Atg16L1	 recruitment	 to	 the	 plasma	 membrane	 for	 xenophagy	 and	contributes	 to	 Crohn’s	 Disease	 (Henderson	 &	 Stevens,	 2012;	 Deretic	 et	 al,	 2013;	Mizushima	et	al,	2008).	The	 autophagy	pathway	 involves	 three	main	 stages	 as	 indicated	 in	Figure	 1.3:	initiation	of	phagophore	formation,	phagophore	elongation	forming	an	autophagosome	and	finally,	autophagosome	maturation	and	degradation	through	lysosomal	fusion.	The	main	 family	of	proteins	 involved	 in	autophagy	 is	 the	Atg	 (AuTophaGy-related)	protein	family,	 of	 which	 35	members	 have	 been	 discovered	 in	 yeast	 (Mizushima	 et	 al,	 2011)	with	 homologous	 proteins	 identified	 in	 mammals	 and	 other	 organisms	 (Farré	 &	Subramani,	2016).	Several	Atg	proteins	 form	complexes	 that	are	crucial	 for	autophagy	progression	 and	 will	 be	 discussed	 in	 the	 following	 sections	 in	 the	 context	 of	 non-selective	autophagy.		
1.2.1 Initiation	of	phagophore	formation	In	 yeast,	 phagophore	 formation	 occurs	 at	 a	 single,	 distinct	 location	 within	 the	 cell	termed	 the	 Phagophore	 Assembly	 Site	 (PAS).	 Within	 mammalian	 cells,	 multiple	 sites	exist	and	several	membranes	have	been	identified	as	a	site	of	initiation,	including	the	ER,	Golgi,	 mitochondria	 and	 ER-mitochondria	 contact	 sites	 (Tooze	 &	 Yoshimori,	 2010;	Hamasaki	et	al,	2013).		
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The	core	machineries	 involved	in	phagophore	formation	are	the	ULK1	(Unc-51-like	kinase	1)	complex	and	the	class	III	Phosphatidylinositol-3-kinase	(PI(3)K)	complex.	The	mammalian	ULK1	complex	(Atg1	in	yeast),	composed	of	ULK1,	Atg13,	FIP200	(FAK	family	 kinase-interacting	 protein	 of	 200kDa)	 (Atg17	 in	 yeast)	 and	 Atg101	 is	constitutively	 assembled	within	 cells	 and	 is,	 under	 resting	 conditions,	 associated	with	the	 regulator	 of	 starvation-induced	 autophagy,	 mTORC1	 (mammalian	 target	 of	rapamycin	 complex	1)	 (Mizushima,	 2010).	Upon	nutrient	 starvation,	ULK1	dissociates	from	 mTORC1	 and	 is	 activated	 through	 autophosphorylation.	 Activated	 ULK1	subsequently	phosphorylates	Atg13	and	FIP200,	thereby	activating	the	complex	(Jung	et	
al,	2009;	Ganley	et	al,	2009).	The	ULK1	complex	 is	recruited	to	the	site	of	phagophore	initiation	where	it	recruits	and	regulates	the	class	III	PI(3)Kinase	complex	(Russell	et	al,	2013).		The	mammalian	class	III	PI(3)K	complex	is	composed	of	hVps34,	Beclin	1	(Atg6	in	 yeast),	 Atg14L	 and	 p150	 (Vps15	 in	 yeast).	 Once	 activated	 by	 the	 ULK1	 complex,	VPS34,	the	kinase	component	of	the	complex,	phosphorylates	phosphatidylinositol	(PI),	forming	 the	 second	 messenger	 molecule,	 PI(3)P.	 PI(3)P-binding	 proteins	 are	 in	 turn	recruited,	 such	 as	WIPI-1	 and	 2	 (WD-repeat	 domain	 phosphoinositide-interacting	 1),	ALFY	 and	 DFCP1	 (Proikas-Cezanne	 et	 al,	 2004;	 Dooley	 et	 al,	 2014;	 Axe	 et	 al,	 2008)	contributing	to	formation,	and	maturation,	of	the	autophagosome.		
1.2.2 Autophagosome	expansion		Two	 ubiquitin-like	 conjugation	 systems	 are	 the	 main	 components	 of	 phagophore	expansion	and	elongation:	the	Atg12-Atg5-Atg16L	and	LC3-PE	(Microtubule-associated	protein	 1	 light	 chain	 3	 –	 Phosphatidylethanolamine)	 conjugation	 systems.	 LC3	 is	 a	mammalian	 homologue	 of	 yeast	 Atg8.	 In	 humans,	 eight	 Atg8	 homologues	 are	 present	and	 are	 divided	 into	 two	 sub-families:	 LC3	 and	 GABARAP	 (Gamma-aminobutyric	 acid	receptor-associated	protein)	families	(Shpilka	et	al,	2011)	.	In	 the	 Atg12-Atg5-Atg16L	 system,	 Atg12	 becomes	 conjugated	 to	 Atg5	 through	interactions	 with	 Atg7	 and	 Atg10	 (Mizushima	 et	 al,	 1998).	 The	 Atg12-Atg5	 complex	subsequently	 interacts	 with	 Atg16L	 (Kuma	 et	 al,	 2002).	 The	 resulting	 Atg12-Atg5-Atg16L	 complex	 localises	 to	 the	 phagophore	 membrane	 through	 Atg5-membrane	binding	(Romanov	et	al,	2012)	and	in	an	Atg16L-dependent	manner	(Suzuki	et	al,	2001).	The	 Atg16L	 complex	 is	 crucially	 involved	 in	 autophagosome	 elongation	 through	mediating	PE	conjugation	onto	LC3-I	forming	LC3-PE	(also	known	as	LC3-II)	(Hanada	et	
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al,	 2007).	LC3-PE	 thereby	becomes	 covalently	attached	 to	 the	phagophore	membrane.	PE	conjugation	is	achieved	through	Atg7	(LC3	activating)	and	Atg3	(transfers	LC3	to	PE).	Atg3	 interacts	with	 the	membrane	 in	 a	 curvature-dependent	manner	 involving	 the	N-terminal	 amphipathic	 helix.	 If	 these	 residues	 are	mutated	 such	 that	 hydrophobicity	 is	increased,	 Atg3-targeting	 to	 membranes	 is	 increased	 and	 even	 occurs	 on	 flat	membranes	(Nath	et	al,	2014;	Dancourt	&	Melia,	2014).		
1.2.3 Autophagosome	maturation		Autophagosome	 maturation	 involves	 autophagosome	 closure	 and	 lysosomal	 fusion,	forming	 an	 autolysosome,	 resulting	 in	 degradation	 and	 permease-mediated	 release	 of	cellular	building	blocks	back	 into	 the	 cytosol.	 Certain	Atg	proteins,	 such	 as	Atg22,	 are	thought	to	possess	permease	activity	and	be	involved	in	the	release	of	the	autolysosomal	degradation	products	(Yang	et	al,	2006).		Whilst	mechanisms	by	which	autophagosome	closure	occurs	are	not	completely	understood,	various	protein	families,	including	Rabs,	Syntaxins	and	SNAREs,	have	been	implicated	 in	 this	 process	 (Ao	 et	 al,	 2014;	 Lu	 et	 al,	 2013;	 Itakura	 et	 al,	 2012).	Additionally,	TECPR1	(tectonin	β–propeller	repeat-containing	protein	1)	is	required	for	autophagosome	fusion,	as	a	decrease	in	cellular	levels	of	TECPR1	increases	the	number	of	unfused	autophagosomes	(Chen	et	al,	2012).		TECPR1	is	of	particular	relevance	for	the	research	detailed	in	this	thesis	and	investigations	into	its	activity	as	a	danger	receptor	will	be	presented	in	Chapter	5.		
1.3 Selective	autophagy	
1.3.1 Cargo	receptors	Selective	 autophagy	 is	 achieved	 through	 recognition	 of	 substrate-associated	 ‘eat-me’	signals	 by	 cargo	 receptors	 that	 subsequently	 interact	 with	 LC3	 and	 GABARAP	 family	members	 thereby	 targeting	 the	 cargo	 to	 the	 autophagosome	 (Boyle	&	Randow,	 2013;	Johansen	 &	 Lamark,	 2011).	 Six	 cargo	 receptors	 are	 known	 to	 exist:	 p62;	 NBR1	(Neighbour	of	BRCA1	gene	1),	a	paralog	of	p62;	NDP52	(Nuclear	Dot	Protein	52);	T6BP	(TRAF6-binding	protein),	a	paralog	of	NDP52;	Optineurin	and	Nix.	Each	cargo	receptor	contains	an	LC3-Interacting-Region	(LIR)	containing	the	conserved	amino	acid	motif	of	(W/F)XX(I/L/V)	(Figure	1.4)	and	the	cargo	receptor-LC3	interaction	can	be	regulated	through	phosphorylation	of	residues	adjacent	to	the	LIR	(Wild	et	al,	2011).	Each	cargo	
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receptor,	 apart	 from	NDP52,	 interacts	 non-specifically	with	 LC3	 and	GABARAP	 family	members.	However,	NDP52	interacts	specifically	with	LC3C	(Muhlinen	et	al,	2012).			 Cargo	receptors	are	involved	in	several	types	of	selective	autophagy.	However,	of	most	relevance	to	my	thesis	is	their	role	in	selective	anti-bacterial	autophagy,	a	type	of	Xenophagy.	 For	 example,	 p62,	 NDP52	 and	 optineurin	 are	 involved	 in	 autophagy	 of	
Salmonella	Typhimurium	(Zheng	et	al,	2009;	Thurston	et	al,	2009;	Wild	et	al,	2011).			
		
Figure	1.4:	Cargo	receptors	in	selective	autophagy.		The	domain	architecture	of	 cargo	adaptors	 involved	 in	autophagy:	p62,	NBR1	(Next	 to	BRCA1	gene	protein),	NDP52	(nuclear	dot	protein	52),	OPTN	(optineurin)	and	Nix	(NIP3-like	protein	X).	CC,	 coiled-coil;	 Gal8IR,	 Galectin	 8	 interacting	 region;	 GBR,	 GABARAP	 proteins;	 LIR,	 LC3-interacting	region;	CLIR,	LC3C-specific	interacting	region;	PB1,	Phox	and	Bem1P;	SKICH,	skeletal	muscle	and	kidney	enriched	inositol	phosphatase	carboxyl	homology;	UBA,	ubiquitin-associated	domain;	 UBAN,	 ubiquitin	 binding	 in	 ABIN	 and	 NEMO	 domain.	 Green	 triangles	 represent	ubiquitin.	Amino	acid	length	of	the	protein	is	indicated	at	the	C	terminus.			 	
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1.3.2 Xenophagy	Xenophagy	is	a	crucial	defence	mechanism	in	the	cell-autonomous	response	to	a	range	of	 pathogens	 (Orvedahl	 &	 Levine,	 2009).	 Xenophagy	 has	 protective	 roles	 against	bacteria	 such	 as	 Streptococcus	 pyogenes,	Mycobacterium	 tuberculosis,	 Salmonella	 and	
Vibrio	 cholera	 	 (Nakagawa	 et	al,	 2004;	 Gutierrez	 et	al,	 2004;	 Birmingham	 et	al,	 2006;	Gutierrez	et	al,	2007)	and	viruses,	such	as	Herpes	Simplex	virus	(Tallóczy	et	al,	2006).	Furthermore,	inhibition	of	xenophagy	enables	viral	and	bacterial	survival,	manifesting	in	disease	 such	 as	 lethal	 encephalitis	 and	 Crohn’s	 disease	 (Orvedahl	 &	 Levine,	 2008;	Deretic	et	al,	2013).		
1.3.2.1 ‘Eat-me’	signals	in	xenophagy	Cytosolic	 machinery	 tags	 cytosol-invading	 pathogens	 with	 specific	 host	 molecules,	known	 as	 ‘eat-me’	 signals,	 marking	 them	 for	 autophagosomal	 destruction	 through	recognition	by	cargo	receptors.	The	involvement	of	‘eat-me’	signals	in	cytosolic	defence	against	vacuole-dwelling	bacteria,	such	as	Salmonella,	is	depicted	in	Figure	1.5.		One	 type	 of	 ‘eat-me’	 signal	 is	 ubiquitin,	 which	 is	 deposited	 on	 cytosol-invading	bacteria	 by	 cellular	 E3	 ligases	 (Perrin	 et	 al,	 2004;	 Fujita	 et	 al,	 2013).	 The	 resulting	ubiquitin	 coat	 is	 comprised	 of	 several	 different	 linkage	 types	 (Collins	 et	 al,	 2009;	Manzanillo	 et	 al,	 2013;	 van	Wijk	 et	 al,	 2012)	 and	 is	 detected	 by	 the	 cargo	 receptors	NDP52,	 p62	 and	 Optineurin	 via	 dedicated	 ubiquitin	 binding	 domains.	 Each	 of	 these	three	ubiquitin-cargo	receptor	interactions	is	crucial	for	bacterial	restriction	(Mostowy	
et	al,	2011;	Zheng	et	al,	2009;	Wild	et	al,	2011)	in	a	non-redundant	manner.	Several	E3	ubiquitin	 ligases	 responsible	 for	 the	 bacterial	 ubiquitin	 coat	 have	 been	 identified	 and	are	required	for	bacterial	restriction.	These	include	Leucine-rich	repeat	and	sterile	alpha	motif-containing	protein	1	(LRSAM1)	(Huett	et	al,	2012)	and	Linear	Ubiquitin	Assembly	Complex	(LUBAC)	(Noad	et	al,	2017	in	press).	Additionally,	Parkin,	an	E3	ligase	involved	in	 mitophagy,	 has	 been	 identified	 as	 ubiquitinating	 Mycobacterium	 tuberculosis	(Manzanillo	 et	 al,	 2013).	 However,	 the	 precise	 substrate	 on	 the	 bacterial	 surface	 for	ubiquitination	by	these	E3	ligases	remains	unknown.	Glycans	are	also	a	type	of	‘eat-me’	signal	through	their	activity	as	a	danger	signal,	described	 in	 Chapter	 1.1.5.	 Upon	 rupture	 of	 the	 bacteria-containing	 vacuole	 (BCV),	previously	intra-luminal	glycans	become	exposed	to	the	cytosol,	marking	the	pathogen	and	BCV	for	autophagic	degradation.	
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Figure	1.5:	The	current	model	of	anti-bacterial	autophagy	pathways.	
(A)	Upon	entry	into	the	cell,	 the	bacterium	becomes	surrounded	by	a	host-derived	membrane,	forming	 a	 bacteria-containing	 vacuole	 (BCV).	 The	 BCV	 is	 targeted	 to	 the	 endosomal	 pathway	resulting	 in	 vacuole	 maturation	 and	 lysosomal	 degradation.	 (B)	 LC3-associated	 phagocytosis	(LAP):	 LC3	 is	 recruited	 to	 the	 single-membrane	 BCV,	 resulting	 in	 vacuole	 maturation	 and	lysosomal	fusion.	(C)	Galectin	8-dependent	pathway:	Glycans	hidden	on	the	intra-luminal	face	of	the	BCV	become	exposed	to	the	cytosol	upon	BCV	rupture.	Galectin	8	detects	glycans	and	binds	to	 the	 cargo	 receptor,	 NDP52,	 which	 in	 turn	 binds	 LC3C	 on	 the	 phagophore	 membrane.	 The	ruptured	 BCV	 and	 the	 bacterium	 become	 enclosed	 in	 an	 autophagosomal	membrane	 and	 are	subsequently	 degraded.	 (D)	 Ubiquitin-dependent	 pathway:	 Cytosolic	 bacteria	 become	ubiquitinated	 by	 E3	 ligases.	 The	 deposited	 ubiquitin	 (green	 triangles)	 is	 detected	 by	 cargo	receptors	NDP52,	p62	and	optineurin	resulting	in	degradation	of	the	BCV	and	bacterium.	
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As	described	 in	Chapter	 1.1.5,	 exposed	glycans	are	detected	by	Galectins,	which	are	 cytosolic	 lectins	 with	 specificity	 for	 glycans	 containing	 β(1-4)-linked	 galactosides	(Yang	et	al,	2008).	Only	Galectin	8	recruitment	 to	 the	ruptured	BCV	recruits	 the	cargo	receptor	 NDP52,	 via	 binding	 to	 the	 Galectin	 8	 C-terminal	 carbohydrate	 recognition	domain;	Galectin	1,	 3	 and	9	do	not	bind	NDP52	 (Li	et	al,	 2013).	Therefore,	Galectin	8	targets	the	damaged	vacuole	to	autophagosomal	degradation	via	an	NDP52-dependent	mechanism	 (Thurston	 et	al,	 2012).	 The	 physiological	 relevance	 of	 Galectin	 1,	 3	 and	 9	recruitment	is	currently	elusive.	
1.4 LC3-associated	phagocytosis	(LAP)	Whilst	 anti-bacterial	 autophagy	 is	 a	 powerful	 cytosolic	 defence	 mechanism	 against	invading	 bacteria,	 a	 form	 of	 non-canonical	 autophagy,	 termed	 LC3-associated	phagocytosis	 (LAP),	 can	 also	 target	 bacteria,	 such	 as	 Salmonella	 and	 Burkholderia	
pseudomallei	(Kageyama	et	al,	2011;	Gong	et	al,	2011).	LAP	activation	can	occur	through	TLR	signalling	(Sanjuan	et	al,	2007)	and	involves	LC3-PE	recruitment	to	the	single,	pre-existing	membrane	of	 a	vacuole	and	 subsequent	 lysosomal	 fusion	(Figure	 1.5)	 (Lai	&	Devenish,	2012).	The	double	membrane	structure	 indicative	of	 canonical	autophagy	 is	not	 formed	during	LAP	and	certain	autophagy	components	such	as	the	ULK1	complex,	are	not	required	(Martinez	et	al,	2011).	However,	several	components	of	the	canonical	autophagy	 pathway	 are	 required	 for	 LAP,	 such	 as	 the	 Atg16L	 complex,	 Beclin	 1	 and	Vps34.	Additionally,	LAP	requires	non-essential	autophagy	components	such	as	Rubicon	and	 NADPH	 oxidase.	 Rubicon	 associates	 with	 the	 Class	 III	 PI(3)Kinase	 complex,	discussed	in	Chapter	1.2.1,	ensuring	maintenance	of	PI(3)P	production	on	LAPosomes.	Additionally,	 Rubicon	 enables	 ROS	 production,	 required	 for	 functional	 LAP,	 through	stabilising	the	NADPH	oxidase	complex	(Martinez	et	al,	2015;	Yang	et	al,	2012;	Huang	et	
al,	2009).		
1.5 Evasion	of	autophagy	by	bacteria	As	cells	employ	autophagy	as	an	anti-bacterial	 innate	 immune	response,	bacteria	have	evolved	 mechanisms	 to	 sabotage,	 evade	 and	 utilise	 autophagy	 to	 enable	 bacterial	survival	(Huang	&	Brumell,	2014;	Kirkegaard	et	al,	2004).	Different	bacterial	species	use	different	 strategies	 to	 evade	 autophagy	 depending	 upon	 the	 intracellular	 location	inhabited	by	the	bacterium.		
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1.5.1 Autophagy	evasion	by	vacuole-dwelling	pathogens	Certain	 bacteria,	 such	 as	 Salmonella	 and	 Legionella,	 reside	 in	 bacteria-containing	vacuoles	 (BCVs).	 Whilst	 these	 bacteria	 are	 shielded	 from	 the	 cytosolic	 autophagy	machinery,	 they	 must	 delay	 or	 inhibit	 BCV	 maturation	 or	 prevent	 autophagosome-lysosome	fusion	in	order	to	establish	a	replicative	niche	within	the	BCV.		Several	 bacterial	 species	 inhibit	 BCV	 attack	 by	 the	 autophagy	 machinery.	
Legionella	 pneumophila,	 for	 example,	 inhibits	 cellular	 autophagy	 through	 the	 effector	protein	RavZ,	which	deconjugates	LC3	from	PE	on	phagophore	membranes	(Choy	et	al,	2012).	Legionella	can	thereby	replicate	in	the	BCV	without	being	targeted	by	autophagy.		Other	 bacterial	 species	 are	 able	 to	 inhibit	 vacuole	 acidification	 and	 replicate	within	LC3-positive-autophagosome-like	vacuoles,	 for	example,	Yersinia	pestis	(Pujol	et	
al,	 2009),	 Yersinia	 pseudotuberculosis	 (Moreau	 et	 al,	 2010)	 and	 Coxiella	 burnetti	(Romano	 et	 al,	 2007).	 Furthermore,	 certain	 species	 of	 bacteria	 utilise	 autophagy	 for	their	infection	cycle.	Francisella	tularensis,	for	example,	escapes	from	BCVs	and	re-enters	an	ER-derived	vacuole	in	an	autophagy-dependent	manner	(Checroun	et	al,	2006).	
1.5.2 Autophagy	evasion	by	professional	cytosol-dwelling	pathogens	Particular	bacteria,	such	as	Shigella	and	Listeria,	facilitate	rupture	from	the	BCV	to	enter	the	 cytosol	 where	 they	 gain	 actin-tails	 on	 one	 pole	 of	 the	 bacteria	 and	 spread	 to	neighbouring	 cells.	 These	 professional	 cytosol-dwelling	 bacteria	 therefore	 employ	mechanisms	for	effective	autophagy	evasion.	
Shigella	 evades	 the	 canonical	 autophagy	 pathway	 that	 detects	 bacterial	components	 required	 for	 actin	 tail	 formation.	 Actin	 tail	 polymerisation	 is	 initiated	through	expression	of	IcsA,	a	bacterial	outer	membrane	protein,	on	the	Shigella	surface.	IcsA	 in	 turn	 recruits	 the	 host	 proteins	 N-WASP	 (neuronal	 Wiskott-Aldrich	 syndrome	protein)	 and	 the	 Arp2/3	 (Actin	 related	 protein	 2/3)	 complex	 (Welch	 &	 Way,	 2013).	However,	IcsA	is	a	target	for	the	autophagy	machinery	via	interaction	with	Atg5,	which	subsequently	 interacts	 with	 TECPR1	 resulting	 in	 autophagy	 of	 Shigella	 (Ogawa	 et	 al,	2011).	Shigella	avoids	autophagic	attack	through	secretion	of	IcsB,	which	interacts	with	IcsA	and	outcompetes	Atg5	binding,	thus	‘hiding’	Shigella	from	autophagy	(Ogawa	et	al,	2005).	Shigella	also	evades	autophagy	through	the	effector	protein	VirA,	a	GAP	(GTP-ase	activating	 protein):	 VirA	 inactivates	 the	 GTPase	 Rab1,	 involved	 in	 ER-Golgi	 vesicle	trafficking	and	autophagosome	formation	(Ao	et	al,	2014;	Dong	et	al,	2012).		
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Shigella	flexneri	 also	avoids	early	attack	by	non-canonical	 autophagy	processes,	such	as	LC3-associated	phagocytosis,	through	secretion	of	the	effector	protein	IcsB	onto	the	 bacterial	 surface.	 IcsB	 recruits	 TOCA1	 (transducer	 of	 CDC24-dependent	 actin	assembly	1),	a	positive	regulator	of	N-WASP	(Leung	et	al,	2008),	to	the	bacterium.	LC3	and	NDP52	recruitment	close	to	the	bacterium	are	thereby	prevented	(Baxt	&	Goldberg,	2014).		 Listeria	monocytogenes	evades	autophagy	via	the	bacterial	surface	protein,	ActA.	ActA	is	required	for	actin	tail	polymerisation	on	this	bacterium	through	recruiting	and	activating	 host	 proteins	 including	 the	 Arp2/3	 complex	 and	 VASP	 (Vasodilator-stimulated	 phosphoprotein)	 (Goldberg,	 2001).	 Recruitment	 of	 these	 host	 proteins	shields	 Listeria	 from	 autophagic	 attack.	 However,	 this	 shielding	 is	 not	 dependent	 on	
Listeria	motility	ability	per	se,	 rather	 it	 is	dependent	upon	ActA	ability	 to	bind	 to	host	proteins;	 Listeria	 expressing	 ActA	 mutants	 that	 cannot	 recruit	 host	 proteins	 are	autophagised,	whilst	ActA-host	protein	fusion	aggregates	are	not	targeted	by	autophagy	(Yoshikawa	et	al,	2009).	
1.6 Plasma	membrane	composition	and	asymmetry	Following	 the	 discovery	 of	 the	 host	molecule	 glycans	 acting	 as	 a	 danger	 signal	 when	exposed	on	damaged	membranes	 (Thurston	et	al,	 2012),	 it	was	 of	 interest	 to	 identify	other	host	molecules	 that	 act	 as	a	danger	 signal	on	damaged	membranes.	Glycans	are	primarily	 located	 on	 the	 extracellular	 leaflet	 of	 the	 plasma	 membrane	 (PM),	 thereby	ensuring	they	are	located	in	a	distinct	compartment	from	their	receptor,	Galectin,	under	homeostatic	 conditions.	 Therefore,	 novel	 candidate	 danger	 signals	 could	 also	 be	asymmetrically	 distributed	 across	 the	 PM	 and	 be	 predominantly	 located	 on	 the	 outer	leaflet.	 Before	 discussing	 the	 danger	 signal	 candidate	 that	 has	 been	 the	 focus	 of	 this	research,	general	features	of	PM	composition	will	be	discussed.	The	mammalian	PM	is	composed	of	~50%	lipids.	The	most	common	lipid	families	are	phospholipids,	sphingolipids	and	sterols,	comprising	~50-60%,	~20%	and	~30-40%	of	 all	 PM	 lipids,	 respectively	 (Lange	 et	 al,	 1989)	 (Figure	 1.6A).	 Phospholipids	 are	composed	of	two	fatty	acyl	chains	attached	to	a	glycerol	backbone.	Addition	of	different	headgroups	to	carbon	1	of	the	backbone	increases	phospholipid	variation	(Figure	1.6B)	and	 alters	 the	 charge	 and	 shape	 of	 the	 resulting	 lipid,	 consequently	 affecting	 their	behaviour	 in	 membranes.	 The	 major	 phospholipids	 in	 the	 human	 PM	 are	
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phosphatidylcholine	(PC),	phosphatidylethanolamine	(PE),	phosphatidylserine	(PS)	and	phosphatidylinositol	(PI).		The	structure	of	sphingolipids	differs	from	phospholipids	(Figure	1.6A)	and	will	be	discussed	in	more	detail	in	Chapter	1.7.1.		The	major	sphingolipid	in	the	human	PM	is	 sphingomyelin	 (SM).	The	main	 sterol	 in	mammals	 is	 cholesterol	 and	 is	 required	 for	decreasing	membrane	permeability	 to	 ions,	 glucose	 and	water	 (Finkelstein,	 1976)	but	does	not	affect	diffusion	of	lipids	and	proteins	within	a	bilayer	leaflet.		
	
Figure	1.6:	The	structures	of	the	main	lipid	families	in	the	human	plasma	membrane.		
(Ai)	Phospholipids	are	composed	of	a	glycerol	backbone	(blue),	two	fatty	acid	chains	covalently	bound	 to	 C2	 and	 C3	 (R1	,	 R2),	 and	 a	 phosphate	 group	 attached	 at	 C1.	 (Aii)	 Sphingolipids	 are	composed	of	a	sphingosine	backbone	originating	 from	serine	(blue).	The	bold	structure	shows	sphingosine	 C18:1.	 A	 fatty	 acid	 chain	 is	 covalently	 bound	 via	 an	 amide	 bond	 at	 C2	 (R)	 and	 a	phosphate	group	 is	attached	at	C1.	(Aiii)	The	structure	of	 cholesterol	 is	based	on	 four	carbon	rings.	(B)	 Structures	of	headgroups	attached	 to	 the	C1	phosphate	group	 in	phospholipids	and	the	resulting	phospholipid	formed.	The	same	headgroups	are	also	utilised	in	sphingolipids.		
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It	 is	well	 established	 that	 the	 inner	and	outer	 leaflets	of	 the	plasma	membrane	differ	in	lipid	and	protein	composition	(Bretscher,	1973;	Ikeda	et	al,	2006;	Daleke,	2008;	van	 Meer	 et	 al,	 2008).	 	 Glycoproteins,	 glycolipids	 and	 GPI-anchored	 proteins	 are	predominantly	 located	 on	 the	 outer	 leaflet.	 In	 terms	 of	 lipid	 composition,	 SM,	 PC	 and	cholesterol,	which	are	neutral	 lipids,	are	enriched	in	the	outer	 leaflet	whilst	negatively	charged	lipids	PS	and	PI	are	located	primarily	in	the	inner,	cytoplasmic	leaflet	(Figure	
1.7).	PS	is	strictly	located	only	in	the	inner	leaflet;	appearance	in	the	outer	leaflet	alters	the	cell	membrane	properties	and	function	as	will	be	discussed	in	Chapter	1.6.2.				
		
Figure	1.7:	Overview	of	plasma	membrane	lipid	composition.		Diagram	indicating	the	asymmetric	lipid	composition	of	each	bilayer.	Under	resting	conditions,	SM,	PC	and	cholesterol	are	predominantly	located	on	the	outer	leaflet,	whilst	PE,	PS	and	PI	are	exclusively	located	on	the	inner	leaflet	thus	bestowing	a	net	positive	and	net	negative	charge	on	the	outer	and	inner	 leaflets,	respectively.	Glycolipids,	glycoproteins	and	GPI-anchored	proteins	(not	shown)	are	also	located	on	the	extracellular	leaflet	under	homeostatic	conditions.		 	
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1.6.1 Maintenance	of	plasma	membrane	asymmetry	PM	 asymmetry	 is	maintained	 in	 several	ways.	 Firstly,	 the	 rate	 of	 passive	 ‘flip-flop’	 of	phospholipids	between	the	leaflets	of	the	membrane	bilayer	is	very	slow.	For	example,	the	half-life	(t1/2)	of	PC	 is	approximately	6	hours	at	30°C.	This	slow	rate	of	 ‘flip-flop’	 is	due	to	the	energetically	unfavourable	transfer	of	the	lipid	polar	head	group	through	the	hydrophobic	bilayer.		Secondly,	 active	 transfer	 of	 lipids	 by	 translocase	 enzymes	 also	 maintains	 PM	asymmetry:	 flippase	enzymes	 translocate	 lipids,	 such	as	PS,	 into	 the	 inner	 leaflet	 from	the	outer	leaflet,	whilst	floppase	enzymes	transport	lipids	into	the	outer	leaflet	from	the	inner	leaflet	(Daleke,	2008;	Devaux	et	al,	2008).	Scramblase	enzymes	are	also	involved,	but	 these	 enzymes	 transport	 lipids	 down	 a	 concentration	 gradient	 in	 an	 energy-independent	manner.	
1.6.2 Consequences	of	altered	phospholipid	asymmetry	Appearance	of	PE	and	PS	in	the	PM	outer	leaflet	of	cells	has	been	implicated	in	a	wide	range	 of	 cellular	 processes.	 For	 example,	 in	 cases	 of	 cell	 stress	 and	 apoptosis,	 PS	becomes	enriched	on	the	outer	leaflet	of	the	PM	(Fadok	et	al,	1992;	Balasubramanian	&	Schroit,	 2003).	 This	 distinction	 from	 non-apoptotic	 cells	 is	 detected	 by	 macrophages	through	 receptors	 including	 the	 PS	 receptor	 (Fadok	 et	al,	 2000).	 The	 apoptotic	 cell	 is	subsequently	engulfed	and	destroyed.	An	 increased	 level	 of	 PE	 in	 the	 outer	 leaflet	 is	 important	 for	 functional	 cell	cytokinesis	 (Emoto	 &	 Umeda,	 2000).	 Furthermore,	 activated	 platelets	 possess	 an	increased	 level	 of	 PE	 and	PS	 in	 their	 outer	 leaflet	 enabling	wound	healing,	 due	 to	 the	increased	 negative	 cell	 surface	 charge	 promoting	 platelet	 adhesion	 and	 pro-thrombin	complex	 activation	 (Bevers	 et	al,	 1983;	 Rosing	 et	al,	 1988).	 Eventual	 clearance	 of	 the	complex	is	achieved	by	PS-mediated	phagocytosis	of	these	activated	platelets.	However,	an	increase	in	PS	and	PE	on	the	outer	leaflet	of	red	blood	cells	has	been	implicated	 in	 a	 number	 of	 diseases	 including	 sickle	 cell	 anaemia	 (Middelkoop	 et	 al,	1988;	 Tait	 &	 Gibson,	 1994)	 and	 thalassemia	 (Borenstain-Ben	 Yashar	 et	 al,	 1993;	Kuypers	et	al,	1996;	1998).	The	increase	in	PS	and	PE	in	the	outer	leaflet	contributes	to	these	diseases	 through	enabling	assembly	of	 complement	 cascade	proteins	on	 the	 cell	surface	 resulting	 in	 cell	 lysis,	 or	 through	 increasing	 clearance	 by	 phagocytosis.	Additionally,	 the	 negatively	 charged	 surface	 results	 in	 increased	 adhesion	 with	endothelium	causing	thromboembolisms.	
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Certain	 cell	 types,	 however,	 such	 as	 B	 cells,	 mast	 cells	 and	 particular	macrophages,	express	PS	on	 their	outer	surface	under	normal	homeostatic	conditions.	These	particular	cell	types	may	have	evolved	mechanisms	to	avoid	being	phagocytosed	(Dillon	et	al,	2001;	Balasubramanian	&	Schroit,	2003).	Alternatively,	PS	exposure	may	be	required	 for	 processes	 specific	 to	 these	 cell	 types,	 such	 as	 mast	 cell	 degranulation	(Martin	et	al,	2000).	In	 addition	 to	 alteration	 of	 PM	 asymmetry	 signalling	 apoptosis	 to	 other	 cells,	changes	to	subcellular	membrane	lipid	asymmetry	can	also	be	used	to	signal	damage	or	danger.	 For	 example,	 upon	 mitochondrial	 stress,	 cardiolipin	 is	 transported	 from	 its	homeostatic	 location	 in	 the	 inner	mitochondrial	membrane	to	 the	outer	mitochondrial	membrane,	 thereby	 becoming	 exposed	 to	 the	 cytosol.	 Cardiolipin	 is	 then	 detected	 by	LC3	via	cardiolipin-binding	sites	within	LC3	and	the	damaged	mitochondria	are	targeted	to	mitophagy	(Chu	et	al,	2013).	
1.7 Sphingomyelin	as	a	candidate	danger	signal	The	ability	of	PS	and	cardiolipin	to	act	as	a	signal	when	detected	in	an	abnormal	cellular	location	 led	 to	 the	 investigation	 of	 whether	 a	 PM	 outer	 leaflet	 lipid	 could	 trigger	 a	signalling	cascade	when	detected	inside	the	cell.		The	 two	 main	 PM	 lipid	 danger	 signal	 candidates	 were	 therefore	 PC	 and	sphingomyelin	(SM).	Of	these	two,	SM	was	of	the	most	interest	as	upon	its	degradation,	various	bioactive	lipids,	such	as	ceramide	and	sphingosine-1-phosphate,	are	formed,	the	significance	of	which	will	be	discussed	in	Chapter	1.9.	
1.7.1 Sphingomyelin	structure	Sphingomyelin	(SM)	is	a	member	of	the	sphingolipid	family.	Sphingolipids	are	present	in	all	eukaryotic	cell	membranes	and	are	enriched	in	the	PM	and	endosomal	membranes	of	animals	(Colbeau	et	al,	1971;	Renkonen	et	al,	1972)	and	yeast	(Hechtberger	et	al,	1994)	compared	 to	endoplasmic	 reticulum	membranes.	SM	 is	 the	major	 sphingolipid	species	present	 in	 mammals,	 and	 comprises	 ~20%	 of	 the	 total	 plasma	 membrane	 lipid	composition.	 This	 percentage	 varies	 between	 species;	 red	 blood	 cell	 membranes	 in	sheep,	for	example,	are	composed	of	~50%	SM	with	~0%	PC	(Dawson	et	al,	1960).	This	characteristic	 was	 utilised	 for	 establishing	 an	 assay	 to	 identify	 endogenous	sphingomyelin-binding	proteins,	and	is	presented	in	Chapter	4.	
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Sphingolipid	 family	 members	 are	 composed	 of	 a	 long	 chain	 base	 backbone,	commonly	sphingosine,	attached	via	an	amide	bond	at	carbon	position	2	to	a	fatty	acid,	and	attached	to	a	headgroup	at	carbon	position	1	(Figure	1.6).		Variation	 in	 sphingolipids	 is	 achieved	 through	 differences	 in	 three	 parts	 of	 the	molecule.	Firstly,	 the	long	chain	base	can	differ	 in	degrees	of	saturation,	hydroxylation	and	length,	ranging	from	14	to	22	carbon	atoms.	Additionally,	a	different	amino	acid	can	be	used	to	form	the	long	chain	base:	serine	is	commonly	used,	but	if	other	amino	acids	are	 used	 such	 as	 alanine	 or	 glycine,	 the	 long	 chain	 base	 backbone	 formed	 is	deoxysphingosine.	 Secondly,	 the	 fatty	 acid	 chain	 added	 can	 vary	 in	 length,	 saturation	and	hydroxylation	at	position	C2	of	 the	acyl	 chain.	This	 latter	hydroxylation,	 although	common	 in	 fatty	 acids,	 is	 seldom	 incorporated	 into	 SM	 although	 it	 is	 found	 in	 other	sphingolipids.	Palmitic	acid	(C16:0)	and	stearic	acid	(C18:0)	are	 the	most	common	SM	fatty	 acids	 present	 in	 mammalian	 peripheral	 or	 neural	 tissue,	 respectively	 (Slotte,	2013b).	Thirdly,	the	headgroup	added	at	C1	of	the	sphingosine	ranges	from	the	hydroxyl	group,	forming	ceramide,	to	carbohydrates,	forming	glycosphingolipids.	Sphingomyelin	is	formed	from	addition	of	a	phosphocholine	headgroup	(Figure	1.8).	Similarly	 to	phospholipids,	 these	variations	affect	 lipid	properties,	 such	as	 lipid	shape,	packing	ability	and	charge,	which	have	implications	for	the	lipid	function	(Slotte,	2013a).	 Mass	 spectrometry	 analysis	 of	 SM	 species	 present	 in	 human	 fibroblasts	indicated	 that	 d18:1/16:0	 SM	 is	most	 prevalent,	whilst	 in	 rat	 cerebellar	 granule	 cells,	d18:1/18:0	 SM	 is	 the	most	 common	 species,	 followed	 by	 d18:1/16:0	 (Valsecchi	 et	al,	2007).			 											
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Figure	1.8:	Comparison	of	phosphatidylcholine	and	sphingomyelin	structures.	Both	species	contain	a	phosphocholine	headgroup.	However,	PC	often	contains	unsaturated	acyl	chains	containing	at	least	one	cis	C=C	bond	(A),	whereas	the	acyl	chain	in	SM	is	often	saturated,	or	 containing	 a	 trans	 C=C.	 Therefore,	 SM	 is	 straighter	 than	 PC	 and	 can	 pack	 closer	 together	within	a	membrane.	(B)	The	hydrogen-bonding	capacity	of	each	molecule	also	differs:	SM	can	form	a	greater	number	of	hydrogen	bonds	with	 itself	and	cholesterol,	due	 to	 the	 -OH	and	 -NH	groups	(right	diagram,	in	blue)	present	in	the	sphingosine	backbone,	but	absent	in	PC.	The	red	dashed	line	in	SM	indicates	the	bond	cleaved	by	sphingomyelinase,	discussed	in	Chapter	1.8.					
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The	phospholipid	analogue	of	SM	is	phosphatidylcholine	(PC)	as	both	lipids	have	an	overall	 neutral	 charge	due	 to	 the	presence	of	 the	 same	phosphocholine	headgroup	
(Figure	1.8).	PC	is	thus	an	ideal	negative	control	for	various	SM	experiments,	which	will	be	 presented	 in	 Chapters	 3-4.	 However,	 despite	 similarities,	 SM	 has	 important	distinctions	from	PC.		Firstly,	 sphingolipids	 often	 contain	 saturated	 acyl	 chains	 or,	 if	 unsaturated,	contain	a	trans	C=C	opposed	to	cis	C=C	commonly	found	in	phospholipids.	Consequently,	SM	molecules	 are	 straighter	 than	 PC,	 enabling	 SM	 to	 contact	 neighbouring	molecules	along	a	larger,	flatter	surface.	As	a	result,	increased	van	der	Waals	forces	occur	between	sphingolipid	 molecules	 and	 cholesterol	 (McIntosh	 et	 al,	 1992;	 Holthuis	 et	 al,	 2001),	enabling	denser	packing	in	the	membrane.		Secondly,	 the	 region	 linking	 the	 non-polar	 hydrocarbon	 chains	 to	 the	 polar	headgroup	differs	between	sphingolipids	and	phospholipids	 resulting	 in	differences	 in	the	 inter-molecular	 interactions	 that	 each	 lipid	 can	 form.	 Sphingolipids	 contain	hydrogen	bond	donors	and	acceptors	through	the	presence	of	the	C2	amide	group	and	the	C3	–OH	group	(Figure	1.8)	(Pascher,	1976;	Holthuis	et	al,	2001).	In	phospholipids,	neither	of	these	groups	is	present,	thus	only	hydrogen	bond	acceptors	are	located	in	this	region.	 	Therefore,	SM	can	 form	inter-molecular	 interactions	with	other	SM	molecules,	and	cholesterol,	resulting	in	a	hydrogen-bonded	network	in	the	plane	of	the	membrane	(Boggs,	1987).	These	network	 interactions	enable	 the	 crucial	 role	of	SM	 in	membrane	domains.	 																			
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Figure	1.9:	Sphingolipid	metabolism	pathway.	Overview	 of	 the	 production	 and	 hydrolysis	 of	 ceramide	 and	 sphingomyelin.	 The	 enzymes	catalysing	each	reaction	are	indicated	in	blue.	GSLs,	glycosphingolipids.	
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Figure	1.10:	Generation	of	sphingomyelin	asymmetry	across	the	plasma	membrane.		
(1)	 Ceramide	 is	 synthesised	 on	 the	 cytosolic	 face	 of	 the	 endoplasmic	 reticulum	 (ER).	 (2)	Ceramide	destined	for	sphingomyelin	(SM)	production	is	transferred	to	the	cytosolic	face	of	the	Golgi	 apparatus	 via	 ceramide	 transfer	 protein	 (CERT).	 (3)	 Ceramide	 translocates	 across	 the	Golgi	membrane	 into	 the	Golgi	 lumen.	Here	 it	 is	converted	 to	SM	and	diacylglycerol	 (DAG)	via	the	activity	of	sphingomyelin	synthase.	(4)	Vesicles	budding	from	the	Golgi	therefore	contain	SM	on	their	 intra-luminal	 leaflet.	(5)	Upon	vesicle	fusion	with	the	plasma	membrane,	SM	becomes	located	on	the	outer	leaflet	of	the	plasma	membrane.				
1.7.2 Sphingomyelin	 synthesis	 and	 localisation	 to	 the	 plasma	
membrane		The	enzymatic	pathway	by	which	sphingomyelin	is	generated	is	depicted	in	Figure	1.9.	Unlike	phospholipids,	which	are	synthesised	solely	 in	 the	endoplasmic	reticulum	(ER),	steps	 for	SM	synthesis	occur	 in	different	parts	of	 the	cell	 and	on	different	 faces	of	 the	organelle	membrane	 to	 enable	 eventual	 asymmetry	 at	 the	 plasma	membrane	 (Figure	
1.10)	(Futerman	&	Riezman,	2005).	Firstly,	ceramide	is	formed	on	the	cytoplasmic	face	of	the	ER	(Mandon	et	al,	1992).	Ceramide	is	then	trafficked	to	the	Golgi	apparatus	either	
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through	a	vesicle-dependent	route	for	glycosphingolipid	production	(Funato	&	Riezman,	2001),	 or	 through	 a	 non-vesicular	 route	 via	 the	 protein,	 Ceramide	 Transfer	 Protein	(CERT)	(Hanada	et	al,	2003;	2009),	for	sphingomyelin	synthesis.	Ceramide	deposited	on	the	 Golgi	 membrane	 outer	 leaflet	 translocates	 across	 the	 membrane	 to	 the	 luminal	leaflet,	 through	 an	 unknown	mechanism.	 On	 the	 luminal	 leaflet	 of	 the	 cis	 and	medial	Golgi	 (Futerman	 et	 al,	 1990;	 Jeckel	 et	 al,	 1990),	 ceramide	 reacts	 with	phosphatidylcholine	 to	 form	 sphingomyelin	 and	 diacylglycerol	 through	 activity	 of	 SM	synthase	(SMS).	Two	SMS	types	are	known	to	exist:	SMS1	is	located	on	the	Golgi	luminal	leaflet	whilst	SMS2	 is	 located	on	the	outer	 leaflet	of	 the	PM	and	may	contribute	 to	SM	formation	from	ceramide	on	the	outer	leaflet	(Taniguchi	&	Okazaki,	2014).		Sphingomyelin	 asymmetry	 across	 the	 PM	 is	 generated	 through	 fusion	 of	 Golgi-derived	vesicles,	thus	containing	SM	on	their	luminal	surface,	with	the	PM	(Figure	1.10).	Sphingomyelin	asymmetry	is	maintained	through	its	slow	rate	of	‘flip-flop’	between	PM	bilayers;	SM	t1/2	is	days	(Holthuis	et	al,	2001).	However,	a	pool	of	SM	has	been	identified	on	 the	 inner	 leaflet	 of	 the	 PM	 through	 resistance	 to	 pretreatment	 with	 bacterial	sphingomyelinase	(Linardic	&	Hannun,	1994).	It	is	unclear	how	this	pool	would	become	located	on	the	inner	leaflet,	but	a	scramblase	enzyme	may	be	responsible	(Raggers	et	al,	2000;	Zhou	et	al,	1997).	
1.8 Sphingomyelinase	(SMase)	family	As	illustrated	in	the	sphingomyelin	production	pathway	(Figure	1.9),	sphingomyelinase	enzymes	 are	 responsible	 for	 specifically	 hydrolysing	 the	 SM	 phosphodiester	 bond	 to	produce	 phosphocholine	 and	 ceramide	 (Figure	 1.8).	 The	 sphingomyelinase	 (SMase)	family	is	composed	of	six	enzymes,	as	summarised	in	Table	1.2.				 	
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	 Cellular	
location	
pH	and	ion	dependence	 References		
Acid	sphingomyelinase	
(aSMase)	
Lysosomes	 Low	pH;	Zn2+	dependent.	 (Schuchman	et	al,	1991)	
Secreted	sphingomyelinase	
Extracellular	surface	 Neutral	pH;	Zn2+	dependent.	 (Tabas,	1999;	Schissel	et	al,	1996)	
Neutral	sphingomyelinase	1	
(nSMase1)	
Nucleus	 Neutral	pH;	Mg2+	dependent.	 (Mizutani	et	al,	2001)	
Neutral	sphingomyelinase	2	
(nSMase2)	
PM	inner	leaflet	 Neutral	pH;	Mg2+	dependent.	 (Hofmann	et	al,	2000)	
Neutral	sphingomyelinase	3	
(nSMase3)	
ER	&	Golgi	apparatus.	 Neutral	pH;	Mg2+	dependent.	 (Krut	et	al,	2006)		
Bacterial	sphingomyelinases	
(bSMase)		
Extracellular	 Neutral	pH;	Mg2+	dependent.	 (Flores-Díaz	et	al,	2016)	
Table 1.2: Sphingomyelinase	family	members.	
1.8.1 Acid	sphingomyelinases	Acid	 sphingomyelinase	 (aSMase)	 exists	 as	 two	 forms,	 a	 lysosomal	 and	 secreted	 form,	resulting	 from	 differential	 post-translational	 processing	 of	 the	 aSMase	 gene	 product	(Schissel	et	al,	1996).	aSMase	contains	six	predicted	N-glycosylation	sites,	five	of	which	are	utilised	for	correct	secretion	or	lysosomal	localisation	and	catalytic	activity	(Ferlinz	
et	 al,	 1997).	 Lysosomal	 targeting	 is	 achieved	 through	 the	 mannose-6-phosphate	receptor	 pathway	 (Hasilik	 &	 Neufeld,	 1980)	 and	 proteolytic	 cleavage	 results	 in	formation	of	the	mature	enzyme	(Jenkins	et	al,	2011).	Activation	of	aSMase	is	thought	to	be	 modulated	 by	 the	 lipid	 environment	 of	 each	 enzyme	 form.	 For	 example,	 lipids	enriched	 in	 lysosomes,	 such	 as	 lysobisphosphatidic	 acid	 (LBPA)	 and	 PI,	 have	 been	shown	to	increase	in	vitro	enzyme	activity	(Linke	et	al,	2001)	whilst	PI	derivatives	found	at	 the	 plasma	membrane,	 such	 as	 PI(3,4,5)P3,	 inhibited	 enzyme	 activity	 (Kölzer	 et	 al,	2003).	As	 discussed	 further	 in	 Chapter	 1.8.4,	 aSMase	 has	 important	 roles	 in	 cellular	signalling	 (Jenkins	et	al,	 2009),	 and	 the	absence	of	 aSMase	manifests	 in	Type	A	and	B	Niemann-Pick	 Disease,	 a	 lysosomal	 storage	 disease,	 resulting	 from	 increased	intracellular	sphingomyelin	and	cholesterol	levels.		
1.8.2 Neutral	sphingomyelinases	Neutral	sphingomyelinases	are	magnesium-dependent,	 integral-membrane	proteins,	of	which	three	forms	have	been	identified:	nSMase1,	2	and	3.	However,	nSMase1	does	not	
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function	 as	 a	 sphingomyelinase	 in	 vivo	 as	 overexpression	 of	 nSMase1	 in	 cells	 has	 no	effect	on	ceramide	or	sphingomyelin	levels	(Sawai	et	al,	1999).		nSMase2	was	subsequently	identified	and	specifically	cleaves	SM	(Hofmann	et	al,	2000;	Marchesini	 et	al,	 2003).	 nSMase2	 is	most	 significantly	 expressed	 in	 brain	 cells,	with	 lower	 level	of	 expression	 seen	 in	 the	 liver	 (Hofmann	et	al,	 2000).	The	enzyme	 is	located	 on	 the	 cytosolic	 face	 of	 the	 plasma	 membrane	 through	 two	 N-terminal	transmembrane	 regions	 that	 only	 traverse	 the	 inner	 leaflet	 of	 the	membrane.	 Both	N	and	C	termini	of	 the	enzyme,	and	the	catalytic	site,	are	cytosol-facing	(Tani	&	Hannun,	2007).	nSMase2	contains	two	distinct	binding	sites	for	the	anionic	phospholipids	PS	and	PA	(Wu	et	al,	2011),	and	these	lipids	are	required	for	enzyme	activity	(Marchesini	et	al,	2003;	 Liu	et	al,	 1998),	 although	 the	 degree	 of	 enzyme	 activation	 by	PS	 is	 contentious	(Hofmann	et	al,	2000).	nSMase3	 was	 identified	 in	 bovine	 brain	 and	 only	 contains	 a	 transmembrane	domain	 near	 the	 C	 terminus	 of	 the	 protein	 (Krut	 et	 al,	 2006).	 Integration	 into	 the	membrane	is	thus	suggested	to	occur	via	the	C	terminus	of	the	protein.	However,	its	role	
in	vivo	 is	 less	 clear	 as	 overexpression	does	not	 affect	 sphingolipid	 levels	 (Clarke	et	al,	2011).	
1.8.3 Bacterial	sphingomyelinases	Several	 bacterial	 species	 have	 been	 identified	 that	 secrete	 Mg2+-dependent	 SMases,	known	as	bacterial	sphingomyelinases	(bSMases),	which	target	host	cells.	bSMases	have	been	identified	in	Staphylococcus	aureus	(Doery	et	al,	1963),	Listeria	ivanovii	(González-Zorn	 et	 al,	 1999),	Helicobacter	 pylori	 (Lin	 et	 al,	 1998)	 and	 Bacillus	 cereus	 (Oda	 et	 al,	2010).	 The	 crystal	 structures	 of	 bSMases	 from	 B.cereus,	 L.ivanovii	 and	 S.aureus	 have	been	solved	(Ago	et	al,	2006;	Openshaw	et	al,	2005;	Huseby	et	al,	2007)	and	highlight	the	enzymatic	mechanism	conserved	between	bSMases.	bSMases	possess	the	same	fold	as	the	DNA	degrading	enzyme,	DNaseI,	and	two	histidine	residues	that	are	important	for	DNaseI	 activity	 are	 also	 conserved	 in	 bSMase	 (Clarke	 et	 al,	 2006).	 This	 common	enzymatic	mechanism	 is	 interesting	 given	 that	 both	 bSMase	 and	DNaseI	 enzymes	 are	cleaving	 a	 phosphodiester	 bond,	 although	 in	 sphingomyelin	 or	 a	 DNA	 substrate,	respectively.	Despite	the	low	level	of	sequence	identity	between	SMase	family	members,	these	conserved	histidine	residues	in	bSMase	are	also	conserved	in	nSMase2	(Clarke	et	
al,	2006).	
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1.8.4 Sphingomyelinases	in	cell	signalling	and	disease		Sphingomyelinases	have	been	implicated	in	many	cellular	processes	including	apoptosis,	ageing	and	cell	adhesion	and	migration	(Marchesini	&	Hannun,	2004;	Clarke	et	al,	2007;	Milhas	 et	 al,	 2010;	 Shamseddine	 et	 al,	 2015).	 These	 roles	 arise	 through	sphingomyelinase-dependent	 production	 of	 ceramide	 from	SM.	 The	 signalling	 roles	 of	ceramide	 and	 other	 downstream	 products	 of	 SM	 hydrolysis	 will	 be	 discussed	 in	
Chapter	1.9.	Several	 stimuli	 have	 been	 suggested	 to	 activate	 nSMase2	 including	 cytokines,	such	 as	 TNFα	 and	 IL-1β,	 stress	 stimuli	 and	 amyloid-beta	 peptides	 (Clarke	&	Hannun,	2006),	 the	 latter	 implicating	 nSMase2	 in	 Alzheimer’s	 disease	 progression	 (Zeng	 et	 al,	2005;	Grimm	et	al,	2005).	However,	it	is	surprising	that	activation	of	this	enzyme	results	in	 ceramide	signalling,	 given	 the	 location	of	nSMase2	on	 the	cytoplasmic	 leaflet	of	 the	plasma	membrane	whilst	its	substrate	is	located	on	the	outer	leaflet.	In	view	of	this,	the	proposed	inner	leaflet	pool	of	sphingomyelin	discussed	in	Chapter	1.7.2	could	act	as	a	substrate	for	activated	nSMase2.	aSMase	is	known	to	be	involved	in	the	stress	response	through	its	activation	by	PKCδ	and	reactive	oxygen	species,	which	are	themselves	activated	by	stress	stimuli	such	as	 ultraviolet	 and	 ionising	 radiation	 (Hannun	 &	 Obeid,	 2008).	 	 Furthermore,	 the	importance	of	aSMase	is	evident	in	patients	with	Type	A	and	B	Niemann-Pick	disease,	a	lysosomal	 storage	 disease	 resulting	 from	 deficient	 aSMase	 (Brady,	 1966;	 Schuchman,	2009).	 Defective	 aSMase	 activity	 results	 in	 intra-lysosomal	 or	 intra-endosomal	accumulation	 of	 SM	 and	 subsequent	 elevated	 intracellular	 cholesterol	 levels.	 Type	 A	Niemann-Pick	 disease	 infant	 patients	 suffer	 fatal	 neurodegeneration,	 whilst	 Type	 B	Niemann-Pick	disease	manifests	 in	other	organs	of	the	body	and	the	 life	expectancy	of	these	patients	is	longer.	
1.9 Sphingolipids	in	cell	signalling	and	disease	Sphingolipids,	such	as	SM,	are	essential	for	cell	survival	as	Chinese	Hamster	Ovary	cells	lacking	 serine-palmitoyl-transferase	 die	 unless	 SM	 is	 added	 externally	 (Hanada	 et	 al,	1992),	indicating	the	importance	of	sphingolipids	in	cellular	processes.		SM	modulates	 signalling	 through	 its	 formation	 of	microdomains	 in	 the	 plasma	membrane.	Receptors	and	effectors	can	be	positioned	within	these	microdomains,	also	known	as	 lipid	 rafts,	 that	 are	 enriched	 in	 SM	and	 cholesterol.	Many	 cellular	 signalling	processes	 have	 been	 attributed	 to	 lipid	 rafts	 such	 as	 T	 and	 B	 cell	 receptor	 activation	
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(Jury	 et	al,	 2007;	 Pierce,	 2002).	 However,	 techniques	 used	 to	 first	 identify	 lipid	 rafts,	namely	resistance	to	extraction	by	Triton-X100,	 the	effect	of	cholesterol	depletion	and	use	of	non-specific	toxins	to	probe	lipid	raft	location,	were	artifact	and	side-effect	prone	(Munro,	2003).	Thus,	the	existence	of	lipid	rafts	and	their	role	as	signalling	platforms	is	questionable.	 The	 development	 of	 super-resolution	 microscopy	 in	 recent	 years	 has	enabled	improved	visualisation	of	rafts	(Simons	&	Gerl,	2010).	However,	other	lipid	raft-independent	explanations	 for	signalling	mechanisms	still	 exist	 (Munro,	2003),	proving	lipid	rafts	remain	a	contentious	phenomenon.	SM	 also	 modulates	 signalling	 through	 hydrolysis	 producing	 several	 bioactive	sphingolipids	(Figure	1.9)	each	of	which	are	involved	in	a	broad	range	of	cell	signalling	and	survival	processes	in	a	wide	range	of	organisms	from	mammals	to	yeast	(Dickson,	1998).	Of	these	sphingolipids,	ceramide	and	sphingosine-1-phosphate	will	be	discussed	in	most	detail	here.		Ceramide	 is	 involved	 in	 regulating	 apoptosis,	 inflammation	 and	 autophagy	(Zheng	et	al,	 2006;	Hannun	&	Obeid,	 2008;	 Stancevic	&	Kolesnick,	 2010).	This	 lipid	 is	either	synthesised	de	novo	or	from	SM	through	the	activity	of	SMase	enzymes.	Ceramide	has	 been	 shown	 to	mediate	 apoptosis	 in	 response	 to	 stress	 (Hannun	&	Obeid,	 2008).	However,	a	pro-survival	role	of	ceramide	has	been	discovered	in	its	ability	to	promote	autophagy	 (Lavieu	 et	al,	 2007).	 This	 is	 possibly	 achieved	 through	 ceramide	 inhibiting	entry	of	 amino	acids	 at	 the	plasma	membrane,	 thereby	 starving	 the	 cell	 and	 initiating	autophagy	 (Hyde	 et	 al,	 2005;	 Guenther	 et	 al,	 2008).	 Additionally,	 ceramide	 has	 been	shown	 to	 inhibit	 the	 inhibitory	 class	 I	 PI(3)Kinase	 pathway	 and	 promote	 Beclin	 1	production	 (Scarlatti	 et	al,	 2004).	 Ceramide	 is	 also	 thought	 to	 target	mitochondria	 to	mitophagy	 through	 direct	 interaction	 with	 LC3B-PE	 on	 mitochondrial	 membranes	(Sentelle	 et	al,	 2012).	 The	 paradoxical	 apoptotic/survival	 signalling	 roles	 of	 ceramide	may	be	explained	by	the	duration	and	level	of	ceramide	increase.		Ceramide	 is	 also	 a	 precursor	 for	 several	 other	 bioactive	 lipids.	 For	 example,	ceramide	 is	phosphorylated	by	 ceramide	kinase	 to	 form	ceramide-1-phosphate,	which	has	 roles	 in	 inflammation	 and	 cell	 growth	 (Bornancin,	 2011).	 Alternatively,	 ceramide	can	be	converted	to	sphingosine,	which	becomes	phosphorylated	by	sphingosine	kinase	forming	sphingosine-1-phosphate.		 Sphingosine-1-phosphate	 (S1P)	 has	 also	 been	 implicated	 in	 a	 wide	 range	 of	cellular	processes	 including	 innate	and	adaptive	 immune	responses,	 inflammation,	cell	differentiation	and	cell	trafficking	(Obinata	&	Hla,	2012;	Maceyka	&	Spiegel,	2014;	Aoki	
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et	al,	2016).	These	roles	are	mediated	through	both	intracellular	activity	of	S1P	and	its	secretion	 from	 cells.	 Upon	 secretion,	 S1P	 acts	 in	 an	 autocrine	 or	 paracrine	 manner	through	 binding	 its	 receptor,	 S1PR,	 a	 G-protein	 coupled	 receptor,	 located	 on	 the	extracellular	leaflet	of	the	plasma	membrane	(Lee	et	al,	1998).	Five	types	of	S1PRs	have	been	 discovered,	 each	 possessing	 different	 biological	 functions.	 For	 example,	 S1PR1	activation	 results	 in	 increased	 cell	 migration	 of	 T	 and	 B	 lymphocytes	 from	 lymphoid	tissue	 (Cyster	 &	 Schwab,	 2012)	 whilst,	 conversely,	 activation	 of	 S1PR2	 inhibits	 cell	motility	and	results	in	B	cell	retention	in	germinal	centres	(Green	et	al,	2011).	S1P	also	regulates	starvation-induced	autophagy	(Lavieu	et	al,	2006).	Regulation	of	 cellular	 levels	of	 each	 lipid	 in	 the	 sphingolipid	pathway	 is	 crucial	for	 cell	 health	 and	 survival.	 Several	 diseases	have	been	 associated	with	 aberrant	 lipid	levels	and	signalling	such	as	Farber	disease	resulting	from	absence	of,	or	non-functional	point	mutations	in,	acid	ceramidase	(Zigdon	et	al,	2014).	Aside	 from	 a	 key	 role	 in	 potential	 lipid	 rafts	 and	 its	 conversion	 to	 bioactive	signalling	 lipids,	 little	 is	 known	 about	 sphingomyelin	 as	 a	 signalling	 molecule	 itself.	Therefore,	it	is	interesting	to	investigate	potential	sphingomyelin	exposure	on	bacteria-containing	 vacuoles	 and	 determine	 subsequent	 downstream	 signalling	 mechanisms	involving	 either	 conversion	 to	 bioactive	 lipids	 or	 detection	 by	 an	 endogenous	sphingomyelin-specific	receptor.		
1.10 Sphingomyelin-specific	toxins		Several	organisms	secrete	pore-forming	toxins,	which	interact	with	the	outer	 leaflet	of	the	 PM,	 self-assemble	 into	 transmembrane	 pores	 and	 kill	 the	 target	 cell	 via	 osmosis.	
Table	1.3	indicates	several	pore-forming	toxins	and	their	respective	ligand.		 For	 investigating	 SM	 intracellular	 location,	 an	 appropriate	 method	 of	 SM	visualisation	is	required.	Use	of	SM-specific	toxins	is	appealing	as	the	SMase	family	are	the	only	known	endogenous	SM	binding	proteins	and	the	precise	SM	binding	site	in	the	enzyme	is	unknown,	thus	it	is	not	possible	to	design	a	non-catalytic	SMase.	This	research	utilises	 Lysenin	 and	 Equinatoxin	 II,	 which	 will	 be	 introduced	 and	 discussed	 in	 the	following	sections.			 	
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Toxin	 Source	 Ligand	 References	
Aerolysin	 Bacteria	(Aeromonas	hydrophila)	 GPI-anchored	proteins	 (Diep	et	al,	1998);	(Abrami	et	al,	1998)	Cholera	toxin	 Bacteria	(Vibrio	cholerae)	 Glycolipid	GM1	 (Griffiths	et	al,	1986)	Equinatoxin	II	 Sea	anenome	(Actinia	equina)	 Sphingomyelin	 (Bakrac	et	al,	2008)	Sticholysin	II	 Sea	anemone	(Stichodactyla	
helianthus)	 Sphingomyelin	 (Mancheño	et	al,	2003)	Lysenin	 Earthworm	(Eisenia	foetida)	 Sphingomyelin	 (Yamaji	et	al,	1998)	Anthrax	toxin	 Bacteria	(Bacillus	anthracis)	 Anthrax	toxin	receptor	and	CMG2	protein.	 (Bradley	et	al,	2001)	Perfringolysin	 Bacteria	(Clostridium	perfringens)	 Cholesterol	 (Waheed	et	al,	2001)	
α-toxin	 Bacteria	(Clostridium	septicum)	 GPI-anchored	proteins	 (Gordon	et	al,	1999)		
Streptolysin	O	 Bacteria	(Streptococcus	pyogenes)	 Cholesterol	 (Prigent	&	Alouf,	1976;	Hotze	&	Tweten,	2012)	Listeriolysin		 Bacteria	(Listeria	monocytogenes)	 Cholesterol	 (Hotze	&	Tweten,	2012)	
Table	1.3:	A	selection	of	pore-forming	toxins	and	their	respective	ligand(s).	
1.10.1 Lysenin		Lysenin	is	a	34kDa	protein	isolated	from	coelomic	fluid	of	the	earthworm	Eisenia	foetida	(Sekizawa	 et	 al,	 1997).	 Lysenin	 was	 shown	 to	 bind	 the	 surface	 of	 cells	 and	 form	 a	nonameric	pore	complex	of	~2.5nm	diameter	(Yamaji-Hasegawa	et	al,	2003;	Podobnik	
et	al,	2016;	Bokori-Brown	et	al,	2016).	Specificity	for	SM	was	indicated	through	Lysenin-induced	haemolysis	 of	 sheep	 red	blood	 cells:	 only	 pre-incubation	 of	 Lysenin	with	 SM,	not	 PC,	 PE,	 PA,	 PS	 or	 PI,	 prevented	 haemolysis	 (Yamaji	 et	 al,	 1998).	 Furthermore,	Lysenin-mediated	 lysis	 of	 liposomes	 only	 occurred	 when	 liposomes	 contained	 SM	(Yamaji	et	al,	1998).	Lysenin	has	since	been	used	in	a	cellular	context	to	identify	SM-rich	cellular	 structures	 resulting	 in	 exogenously	 added	 Lysenin	 binding	 to	 the	 cell	 surface	(Abe	&	Kobayashi,	2014)	and	late	endosomes	(Yachi	et	al,	2012).	The	crystal	structure	of	Lysenin	co-crystallised	with	phosphocholine	and	SM	was	solved	indicating	a	potential	SM	binding	site	in	the	C	terminus	of	the	protein	(De	Colibus	
et	al,	2012).	A	sphingomyelin	acyl	chain	was	modelled	in	the	N-terminal,	pore-forming	module.	 Recently	 two	 independent	 studies	 elucidated	 the	 structure	 of	 the	 Lysenin	assembled	pore	showing	it	binding	as	a	monomer	via	its	C	terminus	to	an	SM	molecule	
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and	 subsequently	 oligomerising	 via	 its	 N	 terminus	 forming	 a	 nonameric	 complex.	 An	extensive	 conformational	 change	 then	 occurs	 resulting	 in	 complex	 insertion	 into	 the	membrane	(Bokori-Brown	et	al,	2016;	Podobnik	et	al,	2016).	The	predicted	binding	site	of	SM	in	the	N-terminal	domain	suggested	by	(De	Colibus	et	al,	2012)	was	therefore	not	compatible	with	the	binding	models	inferred	from	structures	of	the	assembled	complex.		
1.10.2 Equinatoxin	II	Equinatoxin	 II	 (Eqt-II)	 is	a	24kDa	protein	 from	the	actinoporin	 family	of	pore-forming	toxins.	 The	 protein	 was	 first	 isolated	 from	 the	 sea	 anemone	 Actinia	 equina	 and	subsequently	 has	 been	 shown	 to	 be	 a	 SM-specific	 toxin,	 through	 recognition	 of	 the	region	 below	 the	 phosphocholine	 head	 group	 (Bakrac	 et	 al,	 2008).	 Three	 or	 four	monomers	 oligomerise	 forming	 a	 pore	 (Belmonte	 et	 al,	 1993)	 and	 the	 solved	 crystal	structure	and	solution	structure	of	the	Eqt-II	monomer	indicate	the	protein	is	formed	of	two	β	sheets	each	associated	with	an	α	helix	and	that	the	N-terminal	α	helix	is	involved	in	 transmembrane	 pore	 formation	 (Athanasiadis	 et	 al,	 2001;	 Hinds	 et	 al,	 2002).	Additionally,	 the	structures	 indicate	a	cluster	of	 tryptophan	residues	are	exposed	on	a	surface	 loop.	 This	 cluster	 is	 involved	 in	 Eqt-II	 binding	 to	 SM	 and,	 in	 particular,	tryptophan	112	and	116	are	required	for	this	interaction	(Hong	et	al,	2002;	Bakrac	et	al,	2008).	 	 When	 Equinatoxin	 II	 is	 expressed	 in	 cells,	 it	 localises	 to	 the	 Golgi	 apparatus	(Bakrac	 et	 al,	 2010).	 However,	 when	 added	 to	 cells	 exogenously,	 it	 labels	 recycling	endosomes	and	late	endosomes	(Yachi	et	al,	2012).	
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Project	Aims		Cells	 detect	 cytosol-invading	 bacteria	 either	 directly	 through	 pattern-recognition	receptors	or	indirectly	through	danger	receptors	sensing	danger	signals	associated	with	rupture	of	 the	bacteria-containing	vacuole	 (BCV).	 In	particular,	 the	abnormal	cytosolic	appearance	of	host	molecules	otherwise	hidden	inside	the	BCV	is	detected.	For	example,	glycans,	located	on	the	extracellular	leaflet	of	the	plasma	membrane	under	homeostatic	conditions	and	inside	BCVs	upon	bacterial	uptake,	become	exposed	during	BCV	rupture	and	provide	a	danger	signal	that	is	detected	by	the	danger	receptor,	Galectin	8.			Similar	 to	 the	 distribution	 of	 glycans	 across	 the	 plasma	membrane	 bilayer,	 the	lipid	 composition	of	membranes	 is	 also	 asymmetric.	However,	 it	 is	 unknown	whether	outer	membrane	 lipids,	 such	as	 sphingomyelin,	 become	exposed	 to	 the	 cytosol	during	bacterial	entry	and	act	as	a	danger	signal.		My	specific	aims	are:	
• To	 determine	whether	 sphingomyelin	 is	 exposed	 on	 damaged	 BCVs	 and,	 if	 so,	when	 the	 exposure	 occurs	 in	 relation	 to	 other	 known	 markers	 of	 membrane	damage.	I	also	aim	to	investigate	the	possible	causes	of	BCV	damage.	(Chapter	3)	
• To	 identify	 endogenous	 sphingomyelin-binding	 proteins	 and	 whether	 they	 are	recruited	to	cytosol-invading	S.Typhimurium.	(Chapter	4)	
• To	 further	 explore	 candidates	 positively	 recruited	 to	 S.Typhimurium.	 In	particular,	 to	 investigate	 recruitment	 in	 relation	 to	 known	membrane	 damage	markers,	 such	 as	 Galectin	 8,	 and	 to	 determine	 whether	 recruitment	 is	sphingomyelin-dependent.	(Chapter	5)		These	aims	are	addressed	in	the	following	results	chapters.		
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Chapter	2:	Materials	and	Methods	
Materials	
2.1 Reagents	
	 Reagent		 Source	
Molecular	biology:	 Bovine	Serum	Albumin	(BSA)	 New	England	Biolabs	(NEB)	
	 In-Fusion	 ClonTech	
	 KOD	Hot	Start	DNA	Polymerse	 Novagen		
	 Phusion	 NEB	
	 Reaction	buffers	 NEB	
	 Restriction	enzymes	 NEB	
	 SYBR	safe	 Invitrogen	
	 T4	DNA	ligase	 NEB	
	 	 	Selection	agents:	 Ampicillin	 Melford	
	 Blastocidin		 Invitrogen	
	 Chloramphenicol	 Alfa	Aesar	
	 Gentamycin	 Gibco	
	 Histidinol	dihydrochloride	 SIGMA	
	 Kanamycin	 Merc	
	 Puromycin	 Invitrogen	
	 	 	Ghosts:	 Sheep	red	blood	cells	 Antibodies-online	
	 	 	Liposomes:	 Cholesterol	(sheep	wool)	 SIGMA	
	 Chloroform	 SIGMA	
	 Phosphatidylcholine	(porcine	brain)	 Avanti	Polar	Lipids	inc.	
	 Sphingomyelin	(chicken	egg)	 Avanti	Polar	Lipids	inc.	
	 OptiPrep	 SIGMA	
	 	 	Protease	inhibitors:	 Aprotinin	 SIGMA	
	 Benzamidine	 SIGMA	
	 Leupeptin	 SIGMA	
	 Phenylmethanesulphonyl	fluoride	(PMSF)	 SIGMA	
	 Protease	inhibitor	tablets	 Roche	
	 	 	Protein	purification:	 β-mercaptoethanol	 SIGMA	
	 Deoxyribonuclease	I	(DNaseI)	 SIGMA	
	 DTT		 SIGMA	
	 Imidazole	 SIGMA	
	 Isopropyl	β-D-1-thioglalctopyranoside	(IPTG)	 Melford	
	 Lysozyme	 SIGMA	
	 	 	Protein	identification:	 Coomassie	Instant	Blue	 Expedeon	
	 ECL	Prime	kit	 GE	Healthcare	
	 Precision	Plus	Protein	Dual	extra	standards	 BioRad	
	 Sample	buffer	 Invitrogen	
	 Silver	stain	kit	 BioRad	
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	 Reagent		 Source	
Microscopy:	 Antibodies	 Listed	below	
	 DAPI	mounting	medium	 Vector	
	 DRAQ5	 eBioscience	
	 ProLong	gold	anti-fade	mountant	 ThermoFischer	
	 Hoechst		 ThermoFischer	
	 Leibovitz’s	L-15	medium	 Gibco	
	 	 	General:		 Primers	 SIGMA	
	 MycoAlert™	Mycoplasma	Detection	Kit	 Lonza	
Table	2.1:	Reagents	used	in	this	study.		
2.2 Antibodies	
Antibody	 Catalogue	No.	 Source	 Application	
Primary	 	 	 	Goat	polyclonal	α-Galectin	8	 AF1305	 R&D	Systems	 IF	(1:50)	Mouse	polyclonal	α-NDP52	 H00010241-BO1P	 Abnova	 IF	(1:250)	Mouse	monoclonal	α-Ubiquitin	FK2	 BML-PW8810-0500	 Enzo	 IF	(1:20)	Mouse	monoclonal	α-LPS	(S.Typhimurium)	 B210-0407	 BioRad	 IF	(1:1x105)	Mouse	monoclonal	α-FliC	 629701	 Biolegend	 IF	(1:200)	Mouse	monoclonal	α-GFP	(JL8)	 632381	 ClonTech	 WB	(1:2000)	
Secondary	 	 	 	AlexaFluor-conjugated	α-goat	or	α-mouse		 Various	 Invitrogen	 IF	(1:500);	SIM(1:100)	HRP-conjugated	α-mouse		 P0447	 Dako	 WB	(1:5000)	
Table	 2.2:	 Antibodies	 used	 in	 this	 study.	 IF,	 immunofluorescence	 for	 conventional	microscopy;	WB,	western	blot;	SIM,	structured	illumination	microscopy.	
2.3 Bacterial	strains	
• Salmonella	 enterica	 serovar	 Typhimurium	 (S.Typhimurium),	 strain	 12023:	 gift	from	 David	 Holden,	 Imperial	 College,	 London.	 Used	 for	 infection	 of	 non-phagocytic	 cells.	 S.Typhimurium	 was	 used	 as	 an	 example	 of	 a	 Gram-negative	vacuole-dwelling	pathogen	that	is	targeted	by	xenophagy.	
• Salmonella	 enterica	 serovar	 Typhimurium	 (S.Typhimurium),	 strain	 12023	
ΔprgH/InvA:	gift	from	David	Holden,	Imperial	College	London.	Used	in	infection	model	of	vacuolar	bacteria.	
• Salmonella	 enterica	 serovar	 Typhimurium	 (S.Typhimurium),	 strain	 SL1344	
ΔsipA,	 sopB,	 sopE2	 (M701):	 gift	 from	 Wolf-Dietrich	 Hardt,	 ETH	 Zürich.	 This	strain	can	enter	cells.	Used	in	infection	model	of	‘minor’	damage.		
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• Salmonella	 enterica	 serovar	 Typhimurium	 (S.Typhimurium),	 strain	 SL1344	
ΔsipA,	sopB,	sopE2,	sopE	(M566):	gift	from	Wolf-Dietrich	Hardt,	ETH	Zürich.	This	strain	 can	 adhere	 to	 the	 cell	 surface	 but	 cannot	 enter	 cells.	 Used	 in	 infection	model	of	‘minor’	damage.		
• Salmonella	 enterica	 serovar	 Typhimurium	 (S.Typhimurium),	 strain	 SL1344	 -	M566/InvA:		made	by	Cara	Ellison.	This	strain	can	adhere	to	the	cell	surface	and	can	enter	cells	via	the	zipper	entry	mechanism	not	employed	by	Salmonella.	Used	in	infection	model	of	‘minor’	damage.	
• Shigella	flexneri	(S.flexneri),	 strain	M90T:	gift	 from	Chris	Tang,	 Imperial	College,	London.	 Used	 for	 infection	 of	 non-phagocytic	 cells.	 Shigella	 was	 used	 as	 an	example	of	a	Gram-negative	professional	cytosol-dwelling	pathogen	that	evades	xenophagy.	Shigella	rupture	their	vacuole	to	gain	entry	to	the	cytosol	where	they	polymerise	host	cell	actin	onto	one	pole	of	each	bacterium	forming	a	tail	enabling	motility	and	spread	to	neighbouring	cells.		
• Listeria	monocytogenes	(L.monocytogenes),	strain	EGD	(Bug	600):	gift	from	Pascal	Cossart,	 Institut	 Pasteur,	 Paris.	 Used	 for	 infection	 of	 non-phagocytic	 and	phagocytic	cells.	Listeria	was	used	as	an	example	of	a	Gram-positive,	professional	cytosol-dwelling	pathogen	that	evades	autophagy.	Listeria,	 like	Shigella,	 rupture	their	vacuole	 to	gain	entry	 to	 the	cytosol	where	 they	polymerise	host	 cell	actin	onto	one	pole	of	 each	bacterium	 forming	a	 tail	 enabling	motility	 and	 spread	 to	neighbouring	cells.		
• Listeria	 ivanovii	 (L.ivanovii),	 subspecies	 ivanovii.	 	 Used	 for	 infection	 of	 non-phagocytic	 and	 phagocytic	 cells.	 Listeria	 ivanovii	 expresses	 a	 bacterial	sphingomyelinase.	
• Streptococcus	 pyogenes	 (S.pyogenes),	 strain	 H293:	 gift	 from	 Imperial	 College,	London	Hammersmith.	Used	for	infection	of	non-phagocytic	cells.	S.pyogenes	was	used	as	an	additional	example	of	a	Gram-positive	pathogen	that	can	gain	access	to	the	cytosol.	
• Enteropathogenic	 Escherichia	 Coli	 (EPEC):	 gift	 from	 David	 Holden,	 Imperial	College,	London.	Used	for	infection	of	non-phagocytic	and	phagocytic	cells.	EPEC	was	 used	 as	 an	 example	 of	 a	 bacterium	 which	 adheres	 to	 the	 extracellular	surface,	secretes	effector	proteins	into	the	cell	but	does	not	enter	the	cell.	
• Escherichia	Coli	(E.coli),	strain	MC1061.	Used	for	plasmid	production.	
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• Escherichia	Coli	(E.coli),	strain	BL21.	Used	for	protein	expression.	
• Escherichia	 Coli	 (E.coli),	 strain	 Rosetta	 (DE3):	 gift	 from	 Paul	 Elliott,	 MRC-LMB.	Used	 for	 protein	 expression.	 This	 bacterial	 strain	 expresses	 tRNAs	 for	 codons	rarely	found	in	E.coli.	
2.4 Eukaryotic	cell	lines	All	cell	lines	were	tested	monthly	for	mycoplasma	using	MycoAlert™	Mycoplasma	Detection	Kit	(Lonza)	to	ensure	cells	were	mycoplasma	free.		
• HeLa,	 epithelial	 cell	 line	 derived	 from	 a	 human	 cervix	 eiptheliod	 carcinoma.	Obtained	from	European	Collection	of	Authenticated	Cell	Cultures	(ECACC).	Used	to	 investigate	 cell-autonomous	 immunity	 in	 a	 non-phagocytic	 cell	 line	 and	 to	identify	endogenous	sphingomyelin-binding	proteins.	
• HCT116,	 epithelial	 cell	 line	 derived	 from	 a	 human	 colon	 carcinoma.	 Obtained	from	European	Collection	of	Authenticated	Cell	Cultures	(ECACC).	Used	to	further	investigate	 cell-autonomous	 immunity	 in	 a	 non-phagocytic	 cell	 line	 and	 to	identify	endogenous	sphingomyelin-binding	proteins.	
• THP1,	 monocyte	 cell	 line	 derived	 from	 a	 patient	 with	 monocytic	 leukaemia.		Obtained	from	European	Collection	of	Authenticated	Cell	Cultures	(ECACC).	Used	to	investigate	cell-autonomous	immunity	in	a	phagocytic	cell	line	and	to	identify	endogenous	sphingomyelin-binding	proteins.	
• 293T,	epithelial	cell	 line	derived	from	human	embryonic	kidney	cells.	 	Obtained	from	 European	 Collection	 of	 Authenticated	 Cell	 Cultures	 (ECACC).	 Used	 for	retrovirus	production.	
• MEF,	murine	 embryonic	 fibroblasts,	 obtained	 as	 a	 gift	 from	 Chihiro	 Sasakawa,	University	 of	 Tokyo.	 Used	 to	 identify	 endogenous	 sphingomyelin-binding	proteins	in	mice.		 	
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2.5 Primers	
2.5.1 Primers	used	to	amplify	genes	The	following	primers	were	used	for	amplifying	genes	used	in	this	research.		
ID	 Gene	 D	 Sequence	 RE	CE_001	 LyseninCTD	 F	 GGCCGGACATGTCCATCATCCTGGGAAAGACCGAG	 PciI	CE_002	 Lysenin	 R	 CCGGCCGCGGCCGCTCAGCCCACGACTTCCAGGAT	 NotI	CE_003	 Lysenin	 F	 GGCCGGACATGTCCTCTGCCAAGGCCGCCGAGGGC	 PciI	CE_006	 nSMase2	 F	 GGCCGGACATGTCCGTTTTGTACACGACCCCCTTTCC	 PciI	CE_007	 nSMase2	 R	 CCGGCCGCGGCCGCCTATGCCTCCTCCTCCCCCGAAGA	 NotI	CE_185	 Atg5	 F	 GGCCGGACATGTCCACAGATGACAAAGATGTGCTTCG	 PciI	CE_186	 Atg5	 R	 CCGGCCGCGGCCGCTCAATCTGTTGGCTGTGGGATG	 NotI	CE_209	 Rab	5a	 F	 GGCCGGACATGTCCGCTAGTCGAGGCGCAACA	 PciI	CE_210	 Rab	5a	 R	 CCGGCCGCGGCCGCTTAGTTACTACAACACTGATTCCTGGTTGGTT	 NotI	CE_211	 Rab	5b	 F	 GGCCGGACATGTCCACTAGCAGAAGCACAGCTAGGC	 PciI	CE_212	 Rab	5b	 R	 CCGGCCGCGGCCGCTCAGTTGCTACAACACTGGCTCTTGTTC	 NotI	CE_213	 Rab	5c	 F	 GGCCGGACATGTCCGCGGGTCGGGGAGG	 PciI	CE_214	 Rab	5c	 R	 CCGGCCGCGGCCGCTCAGTTGCTGCAGCACTGGCTC	 NotI	CE_215	 Rab4a	 F	 GGCCGGACATGTCCTCGCAGACGGCCATGTC	 PciI	CE_216	 Rab4a	 R	 CCGGCCGCGGCCGCCTAACAACCACACTCCTGAGCGTT	 NotI	CE_219	 SH3BP5LN	 F	 GGCCGGACATGTCCGCTGAGCTCAGACAGGTTCCA	 PciI	CE_220	 SH3BP5LN	 R	 CCGGCCGCGGCCGCCTACAGGCTGACGCTGCGCT	 NotI	CE_221	 SH3BP5LC	 R	 GGCCGGCCATGGCCGCTGAGCTCAGACAGGTTCCA	 NcoI	CE_222	 SH3BP5LC	 R	 CCGGCCACGCGTCAGGCTGACGCTGCGCT	 MluI	CE_273	 GNG5		 F	 GGCCGGACATGTCCTCTGGCTCCTCCAGCGTCGC	 PciI	CE_274	 GNG5N	 R	 CCGGCCGCGGCCGCCTACAAAAAGGAACAGACTTTCTGGGGTCTG	 NotI	CE_275	 GNG5C	 R	 CCGGCCACGCGTCAAAAAGGAACAGACTTTCTGGGGTCTG	 MluI	
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ID	 Gene	 D	 Sequence	 RE	CE_360	 HPCAL1MSG	 F	 GGCCGGACATGTCCGGCAAACAGAACAGCAAGCT	 PciI	CE_361	 HPCAL1N	 R	 CCGGCCGCGGCCGCCTAGAACTGACTGGCACTGCT	 NotI	CE_362	 HPCAL1C	 R	 CCGGCCACGCGTGAACTGACTGGCACTGCT	 MluI	CE_378	 VPS29	 F	 GGCCGGACATGTCCTTGGTGTTGGTATTAGGAGAT	 PciI	CE_379	 VPS29N	 R	 CCGGCCGCGGCCGCCTAAGGTTTTTTGTATTCGATTCG	 NotI	CE_380	 VPS29C	 R	 CCGGCCACGCGTAGGTTTTTTGTATTCGATTCG	 MluI	CE_384	 Rab35	 F	 GGCCGGACATGTCCGCCCGGGACTACGACCACCTC	 PciI	CE_385	 Rab35	 R	 CCGGCCGCGGCCGCCTAGCAGCAGCGTTTCTTTCGTTTA	 NotI	CE_432	 HPCAL1w	t	 F	 GGCCGGCCATGGGCAAACAGAACAGCAAGCT	 NcoI		
Table	 2.3:	 Primers	 used	 to	 amplify	 indicated	 genes.	 	 All	 primers	 are	 shown	 in	 a	 5’	 to	 3’	direction	 and	 contain	 a	 CCGGCC	 at	 the	 5’	 end.	 Restriction	 enzyme	 sites	 are	 underlined.	 ID,	Primer	Identification	number;	D,	Direction;	F,	Forward;	R;	Reverse;	RE,	Restriction	enzyme;	w	t,	Wild	type.		
2.5.2 Primers	used	for	site-directed	mutagenesis	
ID	 Gene	 Mutation	 D	 Sequence	CE_015	
Lysenin	
W20A	 F	 GATGTGGTGGCCGTGGCGAAAGAGGGCTATGTG	CE_016	 W20A	 R	 CACATAGCCCTCTTTCGCCACGGCCACCACATC	CE_017	 Y24/26A	 F	 GTGGCGAAAGAGGGCGCTGTGGCCGAGAACCGGGGCAGC	CE_018	 Y24/26A	 R	 GCTGCCCCGGTTCTCGGCCACAGCGCCCTCTTTCGCCAC	CE_026	 Q229A	 F	 GCCTACAGCAGCGACGCGGGCGGCATCTACTTC	CE_027	 Q229A	 R	 GAAGTAGATGCCGCCCGCGTCGCTGCTGTAGGC	CE_028	 K21A	 F	 GTGGTGGCCGTGGCGGCAGAGGGCTATGTGTAC	CE_029	 K21A	 R	 GTACACATAGCCCTCTGCCGCCACGGCCACCAC	CE_033	 Y24D	 F	 GTGGCGAAAGAGGGCGATGTGTACGAGAACCGG	CE_034	 Y24D	 R	 CCGGTTCTCGTACACATCGCCCTCTTTCGCCAC	CE_035	 W187E	 F	 GTGTCCAGAAAGAGCGAGCCTGCCGCCACACTG	CE_036	 W187E	 R	 CAGTGTGGCGGCAGGCTCGCTCTTTCTGGACAC	
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ID	 Gene	 Mutation	 D	 Sequence	CE_046	 Lysenin	 K185A	 F	 ACCGTGGTGTCCAGAGCGAGCTGGCCTGCCGCC	CE_047	 K185A	 R	 GGCGGCAGGCCAGCTCGCTCTGGACACCACGGT	CE_398	 TECPR1	 W154A	 F	 ACGAAAGACAAGAAGGCGAATTCTT	CE_399	 W154A	 R	 CCGCACACAAGAATTCGCCTTCTTG	CE_433	 HPCAL1	 G2A	 F	 GGCCGGCCATGGCCAAACAGAACAGCAAGCT	
Table	2.4:	Primers	used	for	site-directed	mutagenesis	of	indicated	genes.		Mutated	 residues	 are	 shown	 in	 bold.	 All	 primers	 are	 shown	 in	 a	 5’	 to	 3’	 direction.	 ID,	 Primer	Identification	number;	F,	forward;	R;	Reverse.		
2.5.3 Primers	used	for	cloning	into	bacterial	expression	vectors	
ID	 Gene	 D	 Sequence	 B	CE_071	 Lysenin(CTD)	 F	 GGCCGGCCATGGCCATCATCCTGGGAAAGACC	 pK	CE_070	 Lysenin(CTD)	 R	 CCGGCCAAGCTTTCAATGATGATGATGATGATGGCCGGAGCCGCCCACGACTTCCAGGAT	 pK	CE_083	 GFP	 F	 GGCCGGACATGTCCGTGAGCAAGGGCGAGGAGCTG	 M11	CE_084	 GFP	 R	 CCGGCCGCGGCCGCTTACTTGTACAGCTCGTCCAT	 M11	CE_086	 Galectin	8	 F	 GGCCGGACGCGTATGATGTTGTCCTTA	 M11	CE_087	 Galectin	8	 R	 CCGGCCGCGGCCGCCTACCAGCTCCTTACTTC	 M11	CE_122	 bSMase	 F	 AAGTTCTGTTTCAGGGCCCGATGGAAAGCAAAAAAGATGACACCGAT	 pB	CE_113	 bSMase	 R	 ATGGTCTAGAAAGCTTTATTTGCTGTAGGCTTTAATC	 pB	CE_293	 SH3BP5L1	 F	 AAGTTCTGTTTCAGGGCCCGATGGCTGAGCTCAGACAGGTTC	 pB	CE_294	 SH3BP5L54	 F	 AAGTTCTGTTTCAGGGCCCGGAAGAACTGGATCCTAGAATACAG	 pB	CE_295	 SH3BP5L1	 F	 GCGAACAGATCGGTGGTATGGCTGAGCTCAGACAGGTTC	 pS	CE_296	 SH3BP5L54	 F	 GCGAACAGATCGGTGGTGAAGAACTGGATCCTAGAATACAG	 pS	CE_297	 SH3BP5L276	 R	 ATGGTCTAGAAAGCTTTATTAGCGGCGCCGTGCGTG	 pB/S	CE_298	 SH3BP5L356	 R	 ATGGTCTAGAAAGCTTTATTAGCCTCGCAAGTGCTCCAC	 pB/S	CE_299	 SH3BP5L393	 R	 ATGGTCTAGAAAGCTTTATTACAGGCTGACGCTGCGC	 pB/S	
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ID	 Gene	 D	 Sequence	 B	CE_417	 HPCAL1	 F	 GCGAACAGATCGGTGGTATGGGCAAACAGAACAGCAAGCT	 pS	CE_418	 HPCAL1	 R	 ATGGTCTAGAAAGCTTTATTAGAACTGACTGGCACTGCTGG	 pS	
Table	 2.5:	 Primers	 used	 for	 sub-cloning	 of	 indicated	 genes	 into	 bacterial	 expression	
vectors.	Restriction	enzyme	sites	are	underlined.	Ligation-independent	cloning	extensions	are	in	italics.	ID,	Primer	Identification	number;	D,	Direction;	F,	Forward;	R,	Reverse;	B,	Backbone	vector;	pK,	pOPIN-K;	pB,	pOPIN-B;	pS,	pOPIN-S;	M11,	pETM-11.			
2.5.4 Primers	used	for	sequencing	
Vector		 Name	 Direction	 Sequence	M6P		 GFP	(N-terminal)	 Forward	 TCAAGATCCGCCACAACATCG		M6P		 mCh	(N-terminal)	 Forward	 CCTACAAGGCCAAGAAG		M6P		 GFP	(C-terminal)	 Forward	 TAGACGGCATCGCAGCTTGGA		M6P		 M6P	 Reverse	 ACGCACACCGGCCTTATTCCA		pOPIN/pET-M	 T7	P	 Forward	 TAATACGACTCACTATAGGG	pOPIN/pET-M	 T7	Term	 Reverse	 CTAGTTATTGCTCAGCGG	
Table	2.6:	Primers	used	for	sequencing	of	indicated	plasmids.		
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2.6 Plasmids	M6P	 plasmids	 (Randow	 &	 Sale,	 2006)	 were	 used	 to	 produce	Murine	 Leukemia	 Virus	containing	 the	 plasmid	 of	 interest	 for	 expression	 of	 proteins	 in	mammalian	 cell	 lines.	pOPINB,	pOPINK,	pOPINS	vectors	(Berrow	et	al,	2007)	and	pETM-11	vector	were	used	for	protein	expression	 in	E.coli.	pOPIN	vectors	were	gifts	 from	Paul	Elliott	 (MRC-LMB)	and	pETM11	vector	was	a	gift	from	Arie	Geerlof	(EMBL,	Heidelberg).	All	plasmids	cloned	myself	are	preceded	with	CE.	Plasmids	preceded	by	KB	or	MW	were	gifts	from	Keith	Boyle	and	Michal	Wandel,	respectively.	
2.6.1 Plasmids	used	for	retroviral	transduction	of	eukaryotic	cells		
ID	 Plasmid	name	 Resistance	CE001	 GFP-Lysenin(full-length)	 Blastocidin	CE002	 Equinatoxin	II-GFP	 Blastocidin	CE003	 GFP-Lysenin(CTD)	 Blastocidin	CE006	 mCh-neutral	sphingomyelinase	2	(nSMase2)	 Puromycin	CE009	 GFP-Lysenin(W20A)	 Blastocidin	CE010	 GFP-Lysenin	Y24/26A	(W20A)	 Blastocidin	CE014	 mCh-Lysenin(W20A)	 Puromycin	CE015	 GFP-Lysenin	Q229A	(W20A)	 Blastocidin	CE016	 GFP-Lysenin	K21A	(W20A)	 Blastocidin	CE017	 GFP-Lysenin	Y24D	(W20A)	 Blastocidin	CE018	 GFP-Lysenin	E128R	(W20A)	 Blastocidin	CE019	 GFP-Lysenin	W187E	(W20A)	 Blastocidin	CE025	 GFP-Lysenin	K185A	(W20A)	 Blastocidin	CE055	 mCh-TECPR1(full-length)	 Puromycin	CE056	 GFP-TECPR1(full-length)	:	insert	from	KB	 Blastocidin	CE118	 GFP-Rab5a	:	insert	from	S.Munro	lab	 Blastocidin	CE119	 GFP-Rab5b	 Blastocidin	CE120	 GFP-Rab5c	 Blastocidin	
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ID	 Plasmid	name	 Resistance	CE122	 GFP-SH3BP5L	 Blastocidin	CE135	 GFP-Rab4a	:	insert	from	S.Munro	lab	 Blastocidin	CE151	 GFP-GNG5	 Blastocidin	CE185	 GFP-HPCAL1(MSG)	 Blastocidin	CE186	 HPCAL1(MSG)-GFP	 Blastocidin	CE196	 GFP-VPS29	 Blastocidin	CE197	 VPS29-GFP	 Blastocidin	CE200	 GFP-Rab35	 Blastocidin	CE212	 GFP-TECPR1	W154A(full-length)	 Blastocidin	CE214	 HPCAL1(wild	type)	-	GFP	 Blastocidin	CE216	 HPCAL1(G2A)	-GFP	 Blastocidin	KB201	 TECPR1(Dysf)	-GFP	 Blastocidin	MW284	 mCherry:Galectin	8	sim38	 Puromycin	
Table	 2.7:	 Plasmids	 used	 in	 the	 presented	 research	 for	 retroviral	 transduction	 of	
eukaryotic	cells.			 	
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2.6.2 Plasmids	used	for	expression	in	E.Coli	
ID	 Plasmid	name	 Backbone	 Resistance		CE057	 Lysenin(CTD)-GFP-HIS	 pOPIN	K	 Kanamycin	CE058	 Lysenin	K185A	(CTD)-GFP-HIS	 pOPIN	K	 Kanamycin	CE059	 HIS-GFP	 pETM-11	 Kanamycin	CE060	 HIS-GFP-Galectin	8	 pETM-11	 Kanamycin	CE082	 bSMase		(Staphylococcus	aureus)	 pOPIN	B	 Kanamycin	CE083	 bSMase		(Staphylococcus	aureus)	 pOPIN	K	 Kanamycin	CE160	 SH3BP5L	(1-393)	 pOPIN	B	 Kanamycin	CE162	 SH3BP5L	(1-393)	 pOPIN	S	 Kanamycin	CE163	 SH3BP5L	(1-356)	 pOPIN	B	 Kanamycin	CE165	 SH3BP5L	(1-356)	 pOPIN	S	 Kanamycin	CE166	 SH3BP5L	(1-276)	 pOPIN	B	 Kanamycin	CE168	 SH3BP5L	(1-276)	 pOPIN	S	 Kanamycin	CE169	 SH3BP5L	(54-356)	 pOPIN	B	 Kanamycin	CE171	 SH3BP5L	(54-356)	 pOPIN	S	 Kanamycin	CE172	 SH3BP5L	(54-276)	 pOPIN	B	 Kanamycin	CE174	 SH3BP5L	(54-276)	 pOPIN	S	 Kanamycin	CE211	 HPCAL1		 pOPIN	S	 Kanamycin	
Table	2.8:	Plasmids	used	for	expression	in	E.Coli.			 	
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Methods	
2.7 Molecular	cloning	techniques	
2.7.1 Polymerase	Chain	Reaction	(PCR)	PCR	 was	 use	 to	 amplify	 genes	 from	 existing	 plasmids,	 from	 cDNA	 libraries	 or	 to	introduce	point	mutations	 into	genes	of	 interest.	Amplification	primers	were	designed	to	include	an	N-terminal	clamp	region,	the	restriction	enzyme	site	and	several	bases	of	gene	specific	coding	region	to	give	an	annealing	temperature	of	55°C.	Primers,	supplied	by	SIGMA	in	a	 lyophilised,	desalted	form,	were	resuspended	in	10	mM	 Tris-HCl,	 pH	 8.5	 to	 a	 concentration	 of	 100	 µM.	 Primers	 were	 then	 diluted	 in	ultrapure	water	to	a	working	stock	of	10	µM	for	use	 in	PCR	reactions.	Either	KOD	Hot	Start	Polymerase	or	Phusion	High	Fidelity	polymerase	enzymes	were	used.	The	reaction	mixtures	 were	 set	 up	 in	 accordance	 with	 the	 manufacturer	 protocol.	 PCR	 reaction	mixtures	were	reacted	in	a	thermocycler	using	the	standard	cycling	protocol	applicable	for	 each	 polymerase	 enzyme.	 For	 KOD	 Hot	 Start	 polymerase	 reactions,	 the	 following	cycle	 was	 used:	 polymerase	 activation	 95	 °C,	 2	 minutes;	 denaturation	 95	 °C,	 20	 s;	annealing	 55	 °C,	 10	 s;	 extension	 70	 °C,	 15	 s/kb.	 For	 Phusion	 reactions,	 the	 following	cycle	was	used:	initial	denaturation	98°C,	30s;	denaturation	98	°C,	10	s;	annealing	55	°C,	10	 s;	 extension	 72	 °C,	 15	 s/kb;	 final	 extension	 72	 °C,	 10	 minutes.	 20-30	 cycles	 of	denaturation,	annealing	and	extension	were	used	for	both	polymerases.	Successful	 PCR	 reactions	were	 identified	 by	 addition	 of	 DNA	 loading	 dye	 (60	%	Glycerol,	10	mM	Tris-HCl,	0.15	%	(v/v)	Orange	G,	60	mM	EDTA)	and	separation	on	a	1	%	agarose	gel	 in	1x	TBE	buffer	(10x:	890	mM	Tris,	890	mM	Boric	acid,	20	mM	EDTA).	A	1kb	plus	DNA	ladder	(Invitrogen)	was	used	as	a	marker.	Bands	were	visualised	using	a	Gel	 Documentation	 System	 (BioRad)	 and	 bands	 of	 the	 correct	 size	 were	 cut	 out	 and	agarose	gel	was	removed	using	a	QIAquick®	gel	extraction	kit	(Qiagen).		
2.7.2 Mutational	PCR	Point	mutations	were	incorporated	into	genes	using	assembly	PCR.	Appropriate	forward	and	reverse	primers	were	designed,	each	consisting	of	15	bp	upstream	and	downstream	of	 the	 mutation	 site.	 Two	 separate	 PCR	 reactions	 were	 set	 up:	 one	 containing	 the	forward	 mutational	 primer	 with	 the	 reverse	 gene	 primer,	 the	 second	 containing	 the	forward	gene	primer	with	 the	reverse	mutational	primer.	Following	 identification	and	
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gel	extraction	of	correct	PCR	products,	a	third	PCR	reaction	was	set	up	to	assemble	the	products	of	reaction	1	and	2.	This	assembly	PCR	used	reaction	1	and	2	PCR	products	as	the	 template	 with	 the	 forward	 and	 reverse	 gene	 primers.	 Successful	 assembly	 PCR	reactions	were	determined	and	extracted	as	described	in	Chapter	2.7.1.	
2.7.3 DNA	digestion	using	restriction	enzymes	To	enable	 ligation	of	PCR	products	 into	backbone	vectors,	purified	PCR	products	were	digested	 with	 restriction	 enzymes	 in	 double	 digest	 reactions.	 For	 each	 reaction,	 the	appropriate	reaction	buffer	was	used	in	accordance	with	NEB	protocols,	and	0.2	mg/ml	BSA	was	included	if	required.	The	most	common	double	digests	used	were:	PciI	and	NotI	(N-terminal	 GFP	 backbone)	 and	 NcoI	 and	MluI	 (C-terminal	 GFP	 backbone).	 DNA	was	digested	for	60	minutes	at	37	°C.	Restriction	enzymes	were	removed	from	the	mixture	through	QIAquick®	 PCR	purification	kit	 (Qiagen)	or	 separation	on	a	1	%	NuSieve	gel.	Digested	bands	were	identified,	cut	out	from	the	gel	and	melted	at	75	°C.	
2.7.4 Ligation	Combining	the	gene	of	 interest	 into	a	backbone	plasmid	was	achieved	through	a	20	µl	ligation	 reaction	with	 the	 following	 components:	 4	 µl	 of	 backbone	 de-phosphorylated	with	2	µl	alkaline	phosphatase	(Roche)	for	30	minutes	at	37	°C,	2	µl	insert	and	1	µl	T4	DNA	ligase	(NEB).	A	negative	control	ligation	reaction	lacking	the	insert	was	carried	out	in	parallel.	The	ligation	reactions	were	incubated	for	at	least	15	minutes	at	r.t.	and	5	µl	of	each	mixture	was	transformed	into	50	µl	E.coli.		
2.7.5 Ligation-independent	cloning	The	 gene	 of	 interest	 was	 amplified	 by	 PCR	 with	 primers	 containing	 a	 15	 nucleotide	overlap	 between	 each	 termini	 of	 the	 gene	 and	 the	 vector.	 Following	 PCR	 product	purification,	0.5	µl	product,	0.5	µl	vector,	0.5	µl	5x	In-Fusion	and	1	µl	of	ultrapure	water	were	mixed	and	incubated	at	50	°C	for	15	minutes.	The	product	was	then	diluted	with	5	µl	elution	buffer,	3	µl	of	which	was	transformed	into	E.coli.	
2.7.6 	Transformation	of	E.coli	Chemically	 competent	 E.coli	 strain	 MC1061	 was	 removed	 from	 -80	 °C	 storage	 and	thawed	on	ice.	 	Cells	were	incubated	1:10	with	 ligation	product	for	30	minutes	at	4	°C	followed	by	a	heat	shock	of	5	minutes	at	37	°C	followed	by	a	1	minute	recovery	at	4	°C.	Bacteria	 were	 then	 incubated	 in	 SOB	 medium	 for	 1	 hour	 at	 220rpm,	 37	 °C	 before	
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pelleting	 (2,500rpm,	 5	 minutes)	 and	 plating	 on	 agar	 plates	 of	 appropriate	 resistance	(Ampicillin,	100	µg/ml;	Chloramphenicol,	30	µg/ml;	Kanamycin,	50	µg/ml).	Plates	were	incubated	overnight	at	37	°C.		
2.8 Eukaryotic	cell	culture	All	 cells	 were	 grown	 in	 the	 following	medium:	 Iscove’s	Modified	 Dulbecco’s	Medium,	IMDM,	(Gibco);	10	%	Fetal	Calf	Serum;	Gentamicin	(30	µg/ml).	This	medium	is	referred	to	 as	 complete	 IMDM	 medium	 in	 subsequent	 protocols.	 Adherent	 cell	 lines,	 HeLa,	HCT116	 and	MEF	 cells	were	 grown	 on	 plates	 in	 a	 static	 incubator	 at	 37	 °C,	 5	%	CO2.	Suspension	cells,	THP1	cells,	were	grown	in	flasks	in	a	shaking	incubator	at	125	rpm,	37	°C,	8	%	CO2.	
2.8.1 Retrovirus	production	and	transduction	Retrovirus	 production	 was	 achieved	 through	 transfection	 of	 293T	 cells	 seeded	 in	 24	well	 plates	 with	 the	 following	 plasmids:	 viral	 capsid	 protein	 (pMD-VSVG,	 150	 ng),	retroviral	 gag/pol	 (pMD-OGP,	 350	 ng)	 and	 pro-viral	 plasmid	 containing	 the	 gene	 of	interest,	500	ng.	Plasmids	were	mixed	with	150	mM	NaCl	and	polyethylenimine	(PEI).	The	mixture	was	incubated	for	10	minutes	prior	to	addition	to	293T	cells.	48	hours	later,	viral	 supernatants	 were	 harvested	 and	 contaminating	 cells	 were	 removed	 by	centrifugation	at	13,000rpm.	Viruses	were	stored	at	-20	°C.	Stable	cell	 lines	expressing	designed	constructs	were	created	through	retroviral	transduction	of	HeLa	cells	in	which	the	virus	was	diluted	in	polybrene	(SIGMA)	(8	μg/ml	in	complete	IMDM	medium),	added	to	 HeLa	 cells	 seeded	 in	 a	 24	 well	 plate	 and	 centrifuged	 at	 1,800	 rpm	 for	 2	 hours.	Expression	of	protein	of	interest	was	seen	48	hours	after	transduction.	Cells	were	then	placed	in	appropriate	selection	medium:	blastocidin	(5	µg/ml),	puromycin	(2	µg/ml)	or	histidinol	(10	mM).	
2.9 Bacterial	work	Several	 different	 bacterial	 species	 were	 used	 throughout	 my	 research.	 Each	 species	required	different	growth	conditions	and	infection	protocols.	
2.9.1 Infection	with	Salmonella	Typhimurium		Individual	S.enterica	serovar	Typhimurium	colonies	(strains	12023;	12023	ΔprgH/InvA;	M701;	M566	and	M566/InvA)	were	grown	overnight	in	LB	broth	in	a	shaker	at	37	°C.	3.5	hours	prior	to	infection	of	cells,	sub-inoculation	at	1/33	was	carried	out	into	fresh	warm	
Cara	J.	Ellison	 Chapter	2:	Materials	&	Methods	
	 57	
LB	medium.	Cells	grown	in	24	well	plates	were	placed	in	gentamycin	free	medium	and	infected	with	20	μl	of	sub-inoculation	per	well	for	15	minutes,	after	which,	medium	was	changed	to	100	μg/ml	gentamycin	medium	(Gen	high)	following	washes	with	warm	PBS.	Medium	 was	 changed	 to	 20	 μg/ml	 gentamycin	 medium	 (Gen	 low),	 2	 hours	 post	infection.		For	infection	with	S.Typhimurium	M566	strain,	sub-inoculation	and	infection	was	 carried	 out	 as	 for	 other	 S.Typhimurium	 strains	 but	 throughout	 the	 infection,	medium	was	not	changed	to	Gen	high	or	Gen	low,	thus	not	killing	extracellular,	surface-adhered	S.Typhimurium	M566.	
2.9.2 Infection	with	Shigella	flexneri		Individual	Shigella	flexneri	(strain	M90T)	colonies	were	grown	overnight	in	Tryptic	Soy	medium	 in	 a	 shaker	 at	 37	 °C.	 2.5	 hours	 prior	 to	 infection	 of	 cells,	 bacteria	were	 sub-cultured	at	1:100	into	fresh	warm	Tryptic	Soy	medium.	Following	sub-culture	duration,	
S.flexneri	culture	was	washed	in	PBS	and	resuspended	in	gentamycin	free	medium.	Cells	grown	in	24	well	plates	were	placed	in	gentamycin	free	medium,	infected	with	100	μl	of	sub-culture	and	centrifuged	for	10	minutes	at	2,000	rpm.	Following	centrifugation,	cells	were	 incubated	 at	 37	 °C	 to	 enable	 infection.	 Gen	 high	 medium	 was	 added	 after	 30	minutes	 of	 infection	 and	 two	warm	 PBS	washes.	 Medium	was	 changed	 to	 Gen	 low	 2	hours	post	infection.		
2.9.3 Infection	with	Listeria		Individual	Listeria	monocytogenes	(Bug600)	or	Listeria	ivanovii	colonies	were	grown	in	Brain	Heart	Medium	(SIGMA)	overnight	at	30	°C	and	were	not	sub-cultured.	Cells	grown	in	24	well	plates	were	placed	in	gentamycin	free	medium,	infected	with	1.5	µl	of	culture	and	 centrifuged	 for	 10	 minutes	 at	 2,000	 rpm.	 Following	 centrifugation,	 cells	 were	incubated	 at	 37	 °C	 to	 enable	 infection.	 Gen	 high	medium	was	 added	 60	minutes	 post	infection	 and	 two	warm	 PBS	washes.	 Medium	was	 changed	 to	 Gen	 low	 2	 hours	 post	infection.	
2.9.4 Infection	with	Streptococcus	pyogenes	Individual	S.pyogenes	colonies	were	grown	in	5	ml	Todd	Hewitt	Broth	(SIGMA)	+	0.5	%	yeast	 overnight	 at	 37	 °C	 in	 a	 waterbath	 as	 the	 bacteria	 do	 not	 grow	 whilst	 shaking.	Bacteria	 cultures	 were	 not	 sub-cultured.	 Prior	 to	 infection,	 S.pyogenes	 culture	 was	washed	 in	 PBS	 and	 resuspended	 in	 gentamycin	 free	medium.	 Cells	 grown	 in	 24	well	
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plates	 were	 placed	 in	 gentamycin	 free	 medium	 and	 infected	 with	 20	 µl	 of	 culture.	Medium	was	changed	to	Gen	high	1	hour	post	infection.	
2.9.5 Infection	with	Enteropathogenic	Escherichia	coli	(EPEC)	Individual	 EPEC	 colonies	were	 grown	 overnight	 in	 LB	 broth	 in	 a	 shaker	 at	 37	 °C.	 3.5	hours	prior	to	infection	of	cells,	sub-inoculation	at	1/33	was	carried	out	into	fresh	warm	LB	 medium.	 Cells	 grown	 in	 24	 well	 plates	 were	 placed	 in	 gentamycin	 free	 medium,	infected	 with	 40	 μl	 of	 sub-inoculation	 per	 well	 and	 centrifuged	 at	 2,000	 rpm	 for	 5	minutes,	20	°C.	Throughout	the	infection,	medium	was	not	changed	to	Gen	high	or	Gen	low,	thereby	avoiding	killing	of	extracellular,	surface-adhered	EPEC.	
2.9.6 Transformation	of	Salmonella	Typhimurium		
S.Typhimurium	grown	overnight	as	described	in	Chapter	2.9.1	were	subcultured	1:100	in	10	ml	LB	medium	and	grown	at	37	°C,	220rpm	until	an	OD	of	~0.6	was	reached.	The	subculture	 was	 then	 cooled	 to	 4	 °C	 for	 at	 least	 15	 minutes,	 washed	 three	 times	 and	resupsended	 in	 wash	 buffer	 (1	mM	MOPS,	 20	%	 (v/v)	 Glycerol)	 each	 time.	 After	 the	third	wash,	 the	bacterial	pellet	was	resuspended	 in	200	µl	MOPS	buffer,	and	100	µl	of	this	was	transferred	to	an	elecroporation	cuvette.	The	sample	was	electroporated	for	5	ms	at	2,000V	(Eppendorf	Multiporator)	with	10	µl	plasmid	(typical	concentration	of	200	ng/µl),	placed	on	 ice	 for	1	minute	and	then	recovered	 in	SOB	medium	at	37	°C	at	220	rpm	 for	 at	 least	 2	 hours.	 Following	 recovery,	 bacteria	 were	 pelleted	 (4,000	 rpm,	 5	minutes,	 4	 °C)	 and	 plated	 on	 TYE	 agar	 plates	 with	 appropriate	 antibiotic	 resistance.	Plates	were	placed	at	37	°C	overnight	to	allow	bacterial	colony	growth.	
2.10 Sterile	damage	assays	
2.10.1 Endosomal	lysis	Medium	on	cells	was	replaced	with	hypertonic	medium	(0.5	M	sucrose	in	PBS,	with	10	%	 (w/v)	 polyethyleneglycol	 (PEG))	 for	 10	minutes	 at	 37°C.	 Following	 this,	 cells	were	washed	and	 incubated	 in	60	%	PBS	 for	3	minutes	 followed	by	 incubation	 in	 complete	IMDM	medium	for	20	minutes	at	37	°C.	Cells	were	 then	 fixed	as	described	 in	Chapter	
2.11.		
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2.10.2 Lysosomal	lysis	Medium	 on	 cells	 was	 replaced	 with	 333	 µM	 Glycyl-L-phenylalanine	 2-naphthylamide	(GPN)	 for	10	minutes	at	37	 °C.	Following	 this,	 coverslips	were	washed	once	with	PBS	and	fixed	as	described	in	Chapter	2.11.		
2.11 Fixation	Following	 treatment,	 cells	 were	 washed	 twice	 with	 cold	 PBS	 and	 fixed	 in	 4	 %	paraformaldehyde	 at	 22	 °C.	 Following	15	minute	 incubation,	 cells	were	washed	 twice	more	and	placed	in	100	mM	glycine	in	PBS	until	analysis.	
2.12 Microscopy	Following	 fixation	 of	 cells	 seeded	 on	 glass	 coverslips	 (VWR	 International),	 cells	were	transferred	 to	 glass	 slides	 (Thermo	 Scientific)	 and	 fixed	 with	 4’,6-diamidino-2-phenylindole	(DAPI)	mounting	medium	(Vector	laboratories),	which	stains	cell	nuclei	by	binding	 AT	 regions	 of	 DNA.	 This	 DNA-binding	 property	 of	 the	 dye	 also	 results	 in	bacterial	 DNA	 being	 stained,	 thus	 enabling	 visualisation	 of	 non-fluorescent	 bacteria.	Coverslips	were	 then	 imaged	using	a	63x,	1.4	numerical	 aperture	objective	on	a	Zeiss	710	or	780	microscope.		
2.12.1 Antibody	staining	for	immunofluorescence	Where	 applicable,	 antibody	 staining	 was	 carried	 out	 before	 transferring	 fixed	 and	washed	 coverslips	 to	 DAPI	 mounting	 medium.	 Antibody	 staining	 of	 intracellular	proteins	was	 achieved	 by	 cell	 permeabilisation	 and	 blocking	 in	 PBS	 containing	 0.1	%	(w/v)	 Saponin	 and	 2	%	 (w/v)	 BSA	 for	 30	minutes	 at	 22	 °C.	 Appropriate	 dilutions	 of	primary	antibodies	were	applied	for	at	least	1.5	hours.	Coverslips	were	then	washed	10	times	in	PBS	after	which,	appropriate	dilutions	of	secondary	antibodies	were	applied	for	1	hour.	Coverslips	were	washed	10	times	 in	PBS,	once	 in	water	and	mounted	on	glass	slides.	 For	 identification	 of	 solely	 extracellular	 bacteria,	 cells	 were	 not	 permeabilised	before	addition	of	α-LPS	primary	antibody.	
2.12.2 Structured	Illumination	Microscopy	(SIM)	Super-resolution	microscopy	was	 used	 to	 gain	 further	 insight	 into	 the	 recruitment	 of	proteins	to	the	bacteria-containing	vacuole.	For	example,	it	was	interesting	to	visualise	the	location	of	 initial	vacuole	rupture	and	investigate	whether	proteins	were	recruited	
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to	the	entire	vacuole	or	to	microdomains.	Conventional	light	microscopy	did	not	permit	visualisation	of	the	vacuole	at	sufficient	resolution	to	answer	these	questions.		Several	 different	 super-resolution	 imaging	 techniques	 are	 available	 including	stimulated	emission	depletion	(STED),	photoactivated	 localisation	microscopy	(PALM),	stochastic	 optical	 reconstruction	 microscopy	 (STORM)	 and	 structured	 illumination	microscopy	 (SIM)	 (Schermelleh	 et	 al,	 2010).	 	 SIM	 was	 the	 most	 appropriate	 form	 of	super-resolution	 microscopy	 to	 use	 for	 this	 thesis	 research,	 as	 more	 than	 two	fluorescent	colours	can	be	imaged	simultaneously;	other	super	resolution	methods	can	currently	only	be	extended	to	dual	colour	imaging.	SIM	results	in	a	two-fold	improved	resolution	in	the	x,y	axis	compared	to	regular	confocal	 microscopy.	 The	 principle	 of	 SIM	 is	 achieved	 by	 unevenly	 illuminating	 the	entire	 field	 simultaneously	 with	 a	 light	 pattern	 formed	 from	 passing	 the	 light	 laser	through	 an	 optical	 grating.	 The	 emission	 signals	 from	 each	 object	 interfere	constructively	 and	 destructively	with	 the	 grating	 pattern,	 forming	moiré	 fringes.	 This	grating	projected	onto	the	object	is	rotated	15	times	at	each	focal	plane	producing	fringe	patterns	 from	 each	 orientation.	 A	 high-resolution	 image	 of	 the	 structure	 is	 then	determined	mathematically.		In	 practice,	 coverslips	were	 transferred	 to	 glass	 slides	 and	 fixed	with	 ProLong	Gold	Antifade	Mountant	(ThermoFisher	Scientific)	and	dried	at	r.t.	overnight.	Coverslips	were	imaged	using	Zeiss	Elyra	Structured	Illumination	microscope.	
2.12.3 Live	imaging	For	 live	 imaging	 of	 bacterial	 infections,	 cells	 were	 seeded	 in	 glass-bottomed	 imaging	dishes	(MatTek)	the	day	before	infection.	An	hour	prior	to	infection	with	each	species	of	bacteria,	 the	medium	 on	 the	 cells	 was	 changed	 to	 imaging	medium	 (Leibovitz’s	 L-15	medium	(Gibco)	with	10%	FCS).	10-15	minutes	post	 infection,	cells	were	washed	with	PBS	and	medium	was	replaced	with	fresh	imaging	medium.	Cells	were	imaged	typically	for	3	hours	in	one	minute	intervals.	Imaging	was	achieved	using	60x,	water	objective	of	Nikon	Eclipse	Ti	equipped	with	an	Andor	Revolution	XD	system	and	a	Yokogawa	CSU-X1	spinning	disk	unit.	 Imaging	sessions	were	analysed	using	 Imaris	software	versions	7.4	and	8.	
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2.12.3.1 Tracking	S.Typhimurium	infection		Following	 live	 imaging	 of	 S.Typhimurium	 infection,	 post-imaging	 analysis	 of	 infection	was	carried	out.	In	particular,	individual	bacteria	were	tracked	inside	cells	and	changes	in	 445	 nm,	 488	 nm	 and	 561	 nm	 fluorescence	 intensity	 around	 the	 bacteria	 were	measured	with	time.	An	increase	in	fluorescence	intensity	indicated	recruitment	of	the	protein	with	corresponding	fluorescence	to	the	bacterium.	Tracking	individual	bacteria	was	achieved	using	spot	detection	on	Imaris	software	version	8.	The	mean	fluorescence	intensity	 of	 each	 fluorescence	 channel	 at	 each	 time	 point	was	 normalised	 between	 1-100.	
2.12.4 High	content	imaging	and	analysis	Cells	were	seeded	in	triplicate	at	an	appropriate	density	in	24	well	IBIDI	glass-bottomed	plates	 and	 were	 infected	 and	 fixed	 as	 described	 in	 Chapter	 2.9.	 Depending	 on	 the	fluorophores	present	 in	 each	 sample,	 nuclei	were	 stained	either	using	Hoechst	dye	 (1	µg/ml	in	PBS)	or	Draq5	(final	concentration	of	5	µM	in	PBS).	Plates	were	then	analysed	on	Nikon	High	Content	microscope	using	either	a	20x,	0.75	numerical	aperture	or	40x,	0.95	numerical	aperture	air	objective.		
2.12.5 Quantification	of	bacteria	
2.12.5.1 Automated	quantification	of	high	content	images	Using	the	method	described	in	Chapter	2.12.4,	68	images	per	well	were	taken	using	the	20x	objective	at	set	positions	across	a	diameter	of	6	mm	with	1.2	mm	distance	between	frames	 excluding	 a	 centre	 circle	 of	 1mm	diameter,	 to	 avoid	 imaging	 of	 clumped	 cells.	Images	were	analysed	using	NIS-Elements	4.40	software	and	marker	positive	bacteria	were	counted	using	automated	algorithms	specifically	tailored	to	each	sample.	
2.12.5.2 Manual	quantification	of	high	content	images	Using	the	method	described	in	Chapter	2.12.4,	~30	images	per	well	were	taken	using	the	 40x	 objective	 at	 set	 positions	 across	 a	 diameter	 of	 3.8	mm	with	 1.1	mm	distance	between	 frames	 excluding	 a	 centre	 circle	 of	 0.6	mm.	 The	 number	 of	marker	 positive	bacteria	was	counted	manually	from	each	frame	image.	
2.12.5.3 Manual	quantification	of	coverslips	Bacteria	were	visualised	using	a	Zeiss	Axioskop	upright	fluorescence	microscope	100x,	1.3	numerical	aperture	objective.	At	least	100	bacteria	were	counted	per	coverslip.	
Cara	J.	Ellison	 Chapter	2:	Materials	&	Methods	
	 62	
2.13 Protein	expression	and	purification	
2.13.1 Methods	for	the	production	of	recombinant	GFP	and	GFP-
Galectin	8	
2.13.1.1 Cloning	and	over	expression	Constructs	of	GFP	and	GFP-Galectin	8	were	designed	and	cloned	 into	pETM-11	vector.	Positive	colonies	were	grown	overnight	in	2xTY	medium,	miniprepped	and	analysed	by	sequencing.	Correct	constructs	were	then	transformed	into	chemically	competent	BL21	
E.coli	as	described	in	Chapter	2.7.6.	From	 the	 transformation	 plate,	 a	 streak	 of	 colonies	 were	 grown	 up	 in	 200	ml	2xTY	 medium	 +	 kanamycin	 (30	 µg/ml	 final	 concentration)	 overnight	 at	 37	 °C.	 This	overnight	 culture	was	 used	 to	 innoculate	 2xTY	medium	 +	 kanamycin	 (30	 µg/ml	 final	concentration)	divided	 into	1	L	aliquots.	These	cultures	were	grown	at	30	°C,	210rpm	until	an	OD600	of	~0.7	was	reached.	The	cultures	were	then	cooled	to	18	°C	and	construct	expression	was	induced	by	addition	of	400	µM	isopropyl-	β-D-1-thiogalactopyranoside	(IPTG).	 Cultures	 were	 shaken	 overnight	 at	 18	 °C,	 210	 rpm	 and	 harvested	 by	centrifugation	at	4,000	rpm,	15	minutes,	4	°C	and	pellets	were	frozen	at	-80	°C.	
2.13.1.2 GFP	and	GFP-Galectin	8	purification	
E.coli	 pellets	were	 thawed	and	 resuspended	 in	buffer	A	 (20	mM	Tris	pH	7.4,	 300	mM	NaCl,	 50	 mM	 imidazole,	 2	 mM	 β-mercaptoethanol)	 with	 DNaseI	 (SIGMA),	 Lysozyme	(SIGMA)	and	protease	 inhibitor	 tablets	 for	30	minutes	 at	4	 °C	 and	 sonicated	on	50	%	power	 for	 4	 minutes.	 Cell	 membrane	 debris	 was	 removed	 by	 centrifugation	 at	20,000rpm,	30	minutes,	 4	 °C.	The	 supernatant	was	 filtered	using	 a	0.45	µm	 filter	 and	passed	 through	 a	 5	 ml	 His-trap	 Ni2+	 column.	 Non-specifically	 bound	 proteins	 were	removed	from	the	column	by	washing	in	5	ml	buffer	A	five	times.	Bound	proteins	were	then	eluted	in	10	ml	buffer	B	(20	mM	Tris	pH	7.4,	300	mM	NaCl,	500	mM	imidazole,	2	mM	 β-mercaptoethanol).	 The	 eluted	 sample	 was	 then	 run	 on	 an	 AKTA	 Purifier	 (GE	Healthcare)	Superdex	200	gel	 filtration	column	(GE	Healthcare)	 in	20	mM	Tris	pH	7.4,	150	mM	NaCl,	2	mM	DTT.	Pooled	fractions	were	concentrated	using	10,000	MW	cut	off	concentrators,	and	proteins	were	flash	frozen.	A	typical	yield	from	2	L	would	give	~10	mg	of	GFP	and		~1.5	mg	of	GFP-Galectin	8.	
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2.13.2 Methods	for	the	production	of	recombinant	Lysenin	
2.13.2.1 Cloning	and	over	expression	A	 construct	 of	 the	 Lysenin	 C-Terminal	 Domain	 (residues	 161-297)	 (Lysenin(CTD))	 was	designed	 and	 cloned	 from	 a	 plasmid	 containing	 full	 length	 Lysenin	 using	 the	 PCR	method	described	in	Chapter	2.7.1.	A	construct	was	then	designed	in	which	LyseninCTD	was	 C-terminally	 GFP-tagged	 with	 NcoI	 and	 HindIII	 restriction	 sites	 at	 the	 N	 and	 C-terminal	ends	respectively.	Lysenin(CTD)		was	then	ligated	into	the	NcoI,	HindIII	digested	pOPINK	vector	(Berrow	et	al,	2007).	The	ligation	product	was	transformed	into	E.coli	as	described	 in	Chapter	 2.7.6.	After	colony	PCR	screening,	and	sequencing	confirmation,	the	 construct	 was	 transformed	 into	 BL21	E.coli,	 grown	 up,	 induced	 and	 harvested	 as	described	for	GFP-Galectin	8	in	Chapter	2.13.1.1.	
2.13.2.2 Lysenin(CTD)-GFP	purification	
E.coli	 pellets	were	 thawed,	 lysed,	 sonicated,	 centrifuged	and	applied	 to	a	5ml	His-trap	Ni2+	 column	 as	 described	 in	Chapter	 2.13.1.2.	 The	 eluted	 sample	was	 then	 run	 on	 a	Superdex	 200	 gel	 filtration	 column	 in	 20	mM	Tris	 pH	 7.4,	 150	mM	NaCl,	 2	mM	DTT.	Unlike	purifications	of	GFP	and	GFP-Galectin	8,	Lysenin(CTD)-GFP	was	less	pure	following	the	 gel	 filtration	 step.	 Therefore,	 to	 further	 purify	 Lysenin(CTD)-GFP,	 the	 sample	 was	exchanged	into	20	mM	Tris	pH	8.5,	4	mM	DTT	using	a	desalting	column.	The	sample	was	then	 loaded	 onto	 a	 Resource	 Q	 column	 (GE	 healthcare).	 Lysenin(CTD)-GFP	 was	 eluted	against	a	linear	gradient	in	buffer	containing	20	mM	Tris	pH	8.5,	2	mM	DTT,	1	M	NaCl.	Peak	 fractions	 were	 pooled,	 concentrated	 and	 flash	 frozen.	 A	 typical	 yield	 from	 2	 L	would	give	~1.5	mg	of	Lysenin(CTD)-GFP.	
2.13.3 Methods	for	the	production	of	recombinant	bacterial	
sphingomyelinase		
2.13.3.1 Cloning	and	over	expression	A	Staphylococcus	aureus	bacterial	 sphingomyelinase	 (bSMase)	 construct	was	designed,	aa.	34-330,	 that	 lacked	a	 leader	peptide	and	was	cloned	 from	the	synthesised	S.aureus	bSMase	 gene	 (Life	 Technologies).	 Appropriate	 5’	 and	 3’	 extensions	 for	 ligation-independent	cloning	were	added	by	PCR.	The	bSMase	construct	was	 ligated	 into	NcoI,	HindIII	 digested	 pOPIN-B	 vector,	 as	 described	 in	Chapter	 2.7.5.	 The	 ligation	 product	was	transformed	into	E.coli	as	described	in	Chapter	2.7.6.	After	colony	PCR	screening,	
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and	sequencing	confirmation,	the	construct	was	transformed	into	BL21	E.coli,	grown	up,	induced	and	harvested	as	described	in	Chapter	2.13.1.1.		
2.13.3.2 Purification	of	bacterial	sphingomyelinase	
E.coli	 pellets	 expressing	 bSMase	 were	 thawed,	 lysed,	 sonicated	 and	 centrifuged	 as	described	 in	Chapter	 2.13.1.2.	 The	 filtered	 supernatant	 was	 purified	 using	 an	 AKTA	Purifier	(GE	Healthcare).	Firstly,	a	5	ml	His-Trap	Ni2+	sepharose	column	(GE	Healthcare)	was	 used	 and	 peak	 fractions	were	 pooled	 and	 applied	 to	 a	 Superdex	 75	 gel	 filtration	column	equilibrated	in	20	mM	MES,	4	mM	DTT,	200	mM	NaCl,	2	mM	MgCl2,	5	%	glycerol,	pH	 6.	 Peak	 fractions	 were	 pooled	 and	 concentrated.	 MgCl2	 was	 added	 to	 the	concentrated	protein	at	a	final	concentration	of	5	mM.	The	protein	was	then	flash	frozen.		A	typical	yield	from	2	L	would	give	~13	mg.	
2.13.4 Methods	for	the	production	of	recombinant	SH3BP5L	
2.13.4.1 Cloning	and	over	expression	Five	 constructs	of	 SH3BP5L	were	 cloned:	 aa.1-393	 (full-length);	1-356,	 lacking	part	of	the	C-terminal	flexible	domain;	1-276,	lacking	the	complete	C-terminal	flexible	domain;	54-356,	 lacking	 the	N-terminal	 flexible	 region	and	54-276,	 composed	of	 the	central	α-helical	region.	Each	construct	was	sub-cloned	into	pOPIN-B	and	pOPIN-S	vectors	using	ligation-independent	 cloning	 described	 in	 Chapter	 2.7.5.	 A	 small-scale	 (5	 ml)	expression	 test	was	 carried	 out	with	 each	 construct.	 Results	 from	 this	 test	 suggested	His6-SUMO-SH3BP5L(full-length)	 and	 His6-SH3BP5L(54-276)	 would	 be	 the	 most	 fruitful	 to	carry	forward	to	large-scale	expression.	Both	constructs	were	transformed	into	Rosetta	(DE3)	 E.coli	 as	 described	 in	 Chapter	 2.7.6	 and	 E.coli	 were	 grown	 up,	 induced	 and	harvested.	
2.13.4.2 Purification	of	SH3BP5L	
E.coli	 pellets	 expressing	 each	 SH3BP5L	 construct	 were	 thawed,	 lysed,	 sonicated	 and	centrifuged	as	in	Chapter	2.13.1.2.	Following	the	20,000rpm	centrifugation,	the	filtered	supernatant	was	applied	to	a	5	ml	His-Trap	Ni2+	sepharose	column	as	for	bSMase.	The	peak	fractions	were	pooled.	SH3BP5L(full-length)	 was	 dialysed	 overnight	 at	 4	 °C	 in	 20	mM	Tris	 pH	 8.5,	 4	mM	DTT,	0.5	mg	SUMO	protease.	The	 fractions	were	 then	applied	 to	a	Resource	Q	column	and	eluted	in	a	linear	gradient	with	buffer	20	mM	Tris	pH	8.5,	4	mM	DTT,	1	M	NaCl.	The	
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peaks	were	 pooled,	 concentrated	 and	 applied	 to	 a	 gel	 filtration,	 Superdex	 75	 column	equilibrated	 in	20mM	Tris	pH	8.5,	200	mM	NaCl,	4	mM	DTT.	The	peak	 fractions	were	pooled,	 concentrated	and	 flash	 frozen.	A	 typical	 yield	 from	6	L	would	give	~10	mg	of	SH3BP5L(full-length).	SH3BP5L(54-276)	protein	was	dialysed	overnight	at	4	°C	in	20	mM	MES	pH	6.0,	50	mM	 NaCl,	 4	 mM	 DTT,	 0.25	 mg	 3C	 protease.	 The	 sample	 was	 then	 concentrated	 and	applied	to	a	gel	filtration	Superdex	75	column	equilibrated	in	20	mM	MES	pH	6.0,	50	mM	NaCl,	 4	 mM	 DTT.	 The	 peak	 fractions	 were	 pooled,	 concentrated	 and	 flash	 frozen.	 A	typical	yield	from	6	L	gave	~5	mg	of	SH3BP5L(54-276).	
2.13.5 Methods	for	the	production	of	recombinant	HPCAL1	
2.13.5.1 Cloning	and	over	expression	Wild	 type	 HPCAL1	 was	 sub-cloned	 into	 pOPIN-S	 vector	 using	 ligation-independent	cloning	described	in	Chapter	2.7.5.	The	ligation	product	was	transformed	into	E.coli	as	described	 in	Chapter	 2.7.6.	After	colony	PCR	screening,	and	sequencing	confirmation,	the	 construct	 was	 transformed	 into	 BL21	E.coli,	 grown	 up,	 induced	 and	 harvested	 as	described	for	GFP-Galectin	8	in	Chapter	2.13.1.1.	
2.13.5.2 Purification	of	HPCAL1	
E.coli	 pellets	 expressing	 HPCAL1	 were	 thawed,	 lysed	 and	 sonicated	 as	 described	 in	
Chapter	2.13.1.2.	The	filtered	supernatant	following	the	20,000	rpm	centrifugation	was	applied	 to	 a	 5	 ml	 His-Trap	 Ni2+	 sepharose	 column.	 Peak	 fractions	 were	 pooled	 and	dialysed	overnight	at	4	°C	in	20	mM	Tris	pH	8.5,	4	mM	DTT,	1	mM	EDTA.	The	dialysed	sample	was	applied	to	a	Resource	Q	column	and	eluted	in	a	linear	gradient	with	buffer	20	mM	Tris	pH	8.5,	4	mM	DTT,	1	mM	EDTA,	1	M	NaCl.	Peak	fractions	were	concentrated	and	applied	to	a	gel	filtration	Superdex	75	column	in	20	mM	Tris	pH	8.5,	4	mM	DTT,	200	mM	 NaCl.	 Peak	 fractions	 were	 pooled,	 concentrated	 and	 flash	 frozen.	 A	 typical	 yield	from	2	L	would	give	~20	mg	of	HPCAL1.		 This	 protein	was	 non-myristoylated	 as	 post-translational	modifications	 are	 not	incorporated	in	proteins	expressed	in	E.coli.				
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2.14 Protein	detection	and	analysis	
2.14.1 Gel	electrophoresis	Proteins	were	separated	on	NuPAGE	4-12	%	Bis-Tris	Denaturing	Gels	(Invitrogen)	in	5	%	MES	running	buffer	(50	mM	MES,	50	mM	Tris	Base,	0.1	%	SDS,	1	mM	EDTA,	pH	7.3).		A	protein	marker	ladder	of	precision	plus	dual	extra	standards	(BioRad)	was	included.	Gels	were	run	at	160	V	for	50	minutes.		
2.14.2 Coomassie	blue	stain		Following	 gel	 electrophoresis,	 the	 gel	was	placed	 in	 Instant	 blue	 stain	 (Expedeon)	 for	~60	minutes	to	visualise	proteins.	Following	staining,	background	stain	was	removed	by	washing	the	gel	with	water.	The	gel	was	retained	in	water	to	prevent	the	gel	from	drying	out.	
2.14.3 Western	blot	Following	 gel	 electrophoresis,	 proteins	 were	 transferred	 to	 a	 methanol-activated	nitrocellulose	 PVDF	membrane	 (Millipore)	 at	 30	 V	 for	 1	 hour.	 Following	 transfer,	 the	membrane	was	blocked	in	5	%	non-fat	milk	powder	in	TBST	(100	mM	Tris-HCl	pH	7.4,	140	mM	NaCl	and	0.1	%	Tween)	 for	1	hour	at	r.t..	The	membrane	was	 then	 incubated	with	the	appropriate	primary	antibody	diluted	in	primary	antibody	solution	(2	%	BSA,	0.1	%	NaN3	in	TBST)	for	1	hour	at	r.t.	or	overnight	at	4	°C.	Unbound	primary	antibody	was	washed	 off	with	 5	 TBST	washes	 of	 5	minutes	 each.	 Appropriate	 HRP-conjugated	secondary	antibody	diluted	in	5	%	non-fat	milk	powder	in	TBST	was	then	applied	to	the	membrane	for	1	hour	at	r.t..	Unbound	secondary	antibody	was	washed	off	as	for	primary	antibody	and	the	proteins	were	visualised	using	ECLTM	Prime	western	blotting	detection	reagent	(Amersham,	GE	Healthcare)	in	accordance	with	manufacturer	protocols.	
2.14.4 Silver	stain	For	 detection	 of	 proteins	 at	 low	 concentrations,	 silver	 stain	 was	 used	 following	 gel	electrophoresis.	Proteins	were	visualised	using	silver	stain	kit	(BioRad)	according	to	the	manufacturer	protocol.	
2.15 Sphingomyelin-coated	bead-binding	assay	Per	sample,	100	µl	of	sphingomyelin-coated	agarose	beads	(Echelon),	containing		50	%	beads	 +	 50	%	 slurry,	were	washed	 three	 times	 by	 pelleting	 in	wash	 buffer	 of	 10	mM	
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HEPES	pH	7.4,	150	mM	NaCl,	and	0.25	%	Ipegal,	a	detergent.	Beads	were	then	incubated	with	5	µg	of	recombinant	protein	at	4	°C	with	constant	agitation	for	3	hours.	Following	binding,	 beads	were	pelleted	 and	 the	 supernatant	was	 retained.	 The	beads	were	 then	washed	 five	 times	 and	 resuspended	 in	 50	 µl	 of	 LDS	 sample	 buffer.	 Supernatant	 and	bound	samples	were	then	analysed	by	western	blot.	
2.16 Pretreatment	of	cells	with	bacterial	sphingomyelinase	
(bSMase)	Cells	were	pretreated	with	recombinant	S.aureus	bSMase	(7	µg/ml	final	concentration	in	PBS	or	 complete	medium)	 for	30	minutes	at	 r.t.	 or	37	 °C	prior	 to	binding	or	 infection	assays,	respectively.	bSMase	was	removed	by	washing	cells	twice	with	PBS.			
2.17 Surface	binding	assays	
2.17.1 Analysis	by	confocal	microscopy	Wild	type	HeLa	cells	were	seeded	in	24	well	plates	on	glass	coverslips	at	a	confluency	of	~0.5x105	cells/ml	and	appropriate	samples	were	pretreated	with	bSMase	as	described	in	Chapter	 2.16.	Following	pre-treatment,	cell	samples	were	 incubated	with	250	µl	of	either	recombinant	Lysenin(CTD)-GFP	or	recombinant	GFP-Galectin	8	at	10	µg/ml	for	30	minutes	at	4	°C.	Cells	were	washed	twice	with	cold	PBS	and	fixed.	
2.17.2 Analysis	by	flow	cytometry	Wild	type	HeLa	cells	were	seeded	in	24	well	plates	at	a	confluency	of	~0.5x105	cells/ml	(no	coverslips).	Cells	were	trypsinised	and	transferred	to	corresponding	1ml	FACS	tubes	and	 washed	 twice	 with	 PBS	 (1,500	 rpm,	 5	 minutes,	 4	 °C).	 The	 pellet	 was	 retained.	Appropriate	 samples	were	 pretreated	with	 bSMase	 as	 described	 in	Chapter	 2.16.	 All	samples	 were	 then	 incubated	 with	 50	 µl	 of	 etiher	 recombinant	 Lysenin(CTD)-GFP	 or	recombinant	GFP-Galectin	8	at	10	µg/ml	for	30	minutes	at	4	°C.	Cells	were	washed	twice	with	cold	PBS	and	fixed	with	4	%	PFA.	Cells	were	resupsended	in	PBS	to	a	volume	of	500	µl	 and	 analysed	 on	 BD	 LSRFortessaTM	 flow	 cytometer.	 Results	 were	 analysed	 using	FlowJo	version	7.				
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2.18 Lysate	preparation	
2.18.1 From	adherent	cells	Cells	were	grown	in	15	cm	dishes	to	full	confluency	(~20	x	106	cells	per	dish).	Either	10	or	25	dishes	of	each	cell	type	were	used	depending	on	the	assay.	Cells	were	trypsinised,	washed	and	pretreated	with	bSMase	as	described	in	Chapter	2.16.	Cells	were	washed	5	times	in	PBS	(1,500	rpm,	5	minutes,	4	°C)	to	remove	the	bSMase	enzyme.	The	cell	pellet	was	flash	frozen,	thawed	and	resuspended	in	a	small	volume	of	lysis	buffer	(Tris	pH	7.4	with	 1	 mM	 DTT	 and	 protease	 inhibitors:	 1	 µg/ml	 aproptinin,	 1	 mM	 benzamidine,	 5	µg/ml	 leupeptin,	 1	mM	 PMSF).	 The	 resuspended	 cells	were	 freeze-thawed	 5	 times	 in	liquid	nitrogen.	Following	the	final	freeze-thaw,	lysate	was	cleared	by	centrifugation	at	13,000	 rpm,	 15	 minutes,	 4	 °C.	 The	 supernatant	 was	 retained	 and	 ultra-centrifuged	(45,000	 rpm,	 45	minutes,	 4	 °C)	 to	 remove	 organelle	membranes	 and	 further	 cellular	debris.	 The	 supernatant	 was	 retained	 and	 diluted	 with	 lysis	 buffer	 to	 3.5	 ml	 total	volume.	
2.18.2 From	suspension	cells	THP1	cells	were	grown	as	described	in	Chapter	2.8	and	THP1	lysate	was	prepared	for	use	 in	 liposome	 binding	 assays.	 500	ml	 THP1	 cells	were	 harvested	 by	 centrifuging	 at	2,000	 rpm,	 10	 minutes,	 22	 °C.	 The	 supernatant	 was	 discarded.	 The	 THP1	 pellet	 was	pretreated	with	bSMase	and	 lysed	using	 the	 same	method	described	 for	 adherent	 cell	lysate	preparation	in	Chapter	2.18.1.	
2.19 	Methods	for	Sheep	Red	Blood	Cell	Ghosts	
2.19.1 Preparation	Firstly,	 1	ml	 of	 sheep	 red	 blood	 cells	was	washed	 to	 remove	 the	 potential	 buffy	 coat	composed	 of	 leukocytes	 and	 platelets.	 This	 was	 achieved	 by	 pelleting	 the	 cells	 three	times	 in	 cold	 PBS,	 2,300	 rpm,	 10	 minutes,	 4	 °C.	 Red	 blood	 cells	 were	 lysed	 by	resuspending	the	cells	in	5mM	Na2PO4,	pH	8.0.	To	pellet	red	blood	cell	membranes,	lysed	cells	were	centrifuged	at	22,000rpm,	10	minutes,	4	°C.	The	supernatant	was	discarded	and	the	pellet	was	further	resuspended	in	5	mM	Na2PO4	and	incubated	for	10	minutes	at	4	 °C.	 The	 cells	 were	 centrifuged	 again	 as	 described.	 A	 hard	 button	 pellet	 appeared	surrounded	by	a	 “halo”	of	 lysed	 red	blood	 cell	membranes	 (ghosts).	 	The	 supernatant	was	 aspirated	 to	 just	 above	 the	 halo	 and	 the	 remaining	 supernatant	 was	 swirled	 to	
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dislodge	the	ghosts	from	the	side	of	the	tube.	This	ghost-containing	supernatant	(~5	ml)	was	transferred	to	a	clean	falcon	tube.	
2.19.2 Binding	assays	500	 µl	 of	 the	 ghost-containing	 supernatant	 was	 used	 per	 sample	 and	 transferred	 to	eppendorf	 tubes.	 The	 ghosts	 were	 washed	 twice	 in	 cold	 PBS	 by	 centrifuging	 on	 a	benchtop	 centrifuge	 at	 13,000	 rpm,	 5	minutes,	 4	 °C.	After	 the	 second	wash,	 the	 ghost	pellet	 was	 incubated	 with	 recombinant	 protein	 or	 lysate	 for	 45	 minutes,	 4	 °C.	 After	binding,	 the	ghosts	were	pelleted	and	the	supernatant	was	retained.	Ghosts	were	then	washed	 three	 times	 as	 described	 above.	 After	 the	 final	 wash,	 ghost	 pellets	 were	resuspended	in	50	µl	of	LDS	sample	buffer.	Presence	of	protein	in	the	supernatant	and	bound	pellet	was	analysed	by	western	blot	or	silver	stain.		
2.20 Methods	for	Liposomes	
2.20.1 Preparation	Liposomes	were	prepared	containing	either	Porcine	brain	phosphatidylcholine	(PC)	and	cholesterol	or	Chicken	egg	sphingomyelin	(SM),	PC	and	Cholesterol.	Lipids	(Avanti	Polar	Lipids)	 were	 mixed	 in	 chloroform	 with	 ratios	 of	 PC	 :	 Cholesterol	 60:40;	 SM	 :	 PC	 :	Cholesterol	50:10:40	 (several	other	 ratios	were	 tested	but	 these	 ratios	were	 the	most	commonly	 used	 in	 my	 experiments).	 Lipids	 were	 dried	 under	 nitrogen	 flow	 and	followed	by	drying	in	a	dessicator	for	one	hour	at	r.t..	The	mixed	lipids	were	rehydrated	in	buffer	containing	a	density	gradient	medium	(50	mM	HEPES;	100	mM	KoAC;	1	mM	DTT;	10	%	OptiPrep	(SIGMA))	by	shaking	for	at	least	1	hour.	Liposomes	were	formed	by	passing	the	resuspended	lipid	mixtures	through	an	Avanti	extruder	with	a	400	nM	filter	(Whatman)	 in	 place	 followed	by	 a	 100	nM	 filter	 (Whatman).	 The	 lipid	mixtures	were	passed	through	each	filter	25	times.	Liposomes	containing	10	%	OptiPrep	of	a	~100	nm	diameter	were	thereby	formed.	
2.20.2 Validation	by	Dynamic	Light	Scattering	(DLS)	DLS	 was	 used	 to	 validate	 formation	 of	 liposomes	 of	 ~100	 nm	 diameter	 following	extrusion.	This	biophysical	 technique	 involves	passing	a	 laser	 light	source	through	the	liposome-containing	 sample.	 The	 laser	 light	 is	 diffracted	 by	 the	 liposomes	 and	 the	resulting	 diffraction	 pattern	 interferes,	 either	 constructively	 or	 destructively,	 with	patterns	 diffracted	 by	 other	 liposomes	 in	 the	 sample.	 This	 gives	 an	 overall	 scattered	
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light	 intensity	 that	 varies	 with	 time	 due	 to	 Brownian	 Motion	 of	 the	 particles.	 The	fluctuating	 light	 intensity	 is	 computed	 to	 give	 the	 diffusion	 coefficient	 which,	 when	applied	in	the	Stokes-Einstein	equation,	gives	the	hydronamic	radius	of	the	particles	in	the	sample.		To	analyse	the	extruded	liposomes,	100	µl	of	10	%	OptiPrep	liposomes	or	10	%	OptiPrep	 liposome	buffer	was	pipetted	 into	a	96	well	black	 flat-bottomed	polystyrene	plate	 (Corning)	 and	 analysed	 on	 a	 DynaPro	 Plate	 Reader	 II	 instrument	 (Wyatt	Technology)	at	25	°C.	Dynamics	v7	software	was	used	to	acquire	20	laser	acquisitions	of	10	s	duration	for	each	sample,	and	to	take	an	image	of	each	well,	thereby	visualising	the	presence	 of	 any	 bubbles	 which	 would	 give	 erroneous	 light	 scattering	 readings.	 The	liposome	 radius	 from	 each	 acquisition	 was	 calculated	 by	 the	 Dynamics	 software	 and	displayed	as	a	histogram.	
2.20.3 Liposome	flotation	assays	Freshly	made	10	%	OptiPrep-liposomes	were	transferred	to	Ultra-ClearTM	11	x	60	mm	centrifuge	tubes	(Beckman	Coulter),	added	to	lysate	or	recombinant	protein	at	20	µg/ml	and	 incubated	 for	 1	 hour,	 150	 rpm,	 r.t..	 After	 incubation	 of	 OptiPrep-containing	liposomes	with	lysate,	OptiPrep	was	carefully	layered	over	the	liposomes	to	form	a	30	%	density	layer,	followed	by	a	10	%	density	layer.	A	0	%	density	layer	was	the	final	layer	added	and	was	composed	of	 the	 rehydration	buffer	without	OptiPrep	 (50	mM	HEPES;	100	mM	KoAC;	1	mM	DTT).	Liposomes	were	floated	in	a	SW60Ti	swinging	bucket	rotor	at	 51,000	 rpm,	 30	 minutes,	 4	 °C.	 Floating	 liposomes	 were	 collected	 and	 washed	 by	adding	to	0%	OptiPrep	buffer,	followed	by	re-layering	OptiPrep	in	the	30	%,	10	%,	0	%	gradient.	 After	 the	 wash,	 floating	 liposomes	 were	 collected	 and	 transferred	 to	 an	eppendorf	 tube,	 and	 bound	 proteins	 were	 precipitated	 via	 methanol:chloroform	extraction.	
2.20.4 Methanol:chloroform	extraction	of	bound	proteins	Proteins	 bound	 to	 the	 liposomes	 were	 precipitated	 by	 adding	 methanol	 at	 the	 same	volume	as	initial	liposome	volume,	vortexing,	then	adding	half	the	volume	of	chloroform	compared	to	initial	liposome	volume.	The	mixture	was	vortexed	and	centrifuged	13,000	rpm,	5	minutes,	4	°C.	The	bound	proteins	form	a	layer	at	the	interface	of	the	methanol	and	chloroform.	The	top	layer	was	discarded	and	the	bottom	layer	was	resuspended	in	
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the	 same	 volume	 of	methanol	 as	 previously.	 The	mixture	 was	 centrifuged	 again.	 The	supernatant	was	discarded	and	the	pellet	was	dried	at	r.t..	
2.21 Mass	spectrometry	analysis	
2.21.1 TMT-labelling	Tandem	 Mass	 Tag	 (TMT)-labelling	 was	 used	 to	 quantify	 enrichment	 of	 proteins	 on	sphingomyelin-containing	 liposomes	 compared	 to	 phosphatidylcholine-containing	liposomes.		TMT	 labelling	 involves	 each	 sample	 in	 the	 experiment	 being	 labelled	 with	 a	different	 isobaric	 chemical	 tag	 (Thompson	 et	 al,	 2003).	 Ten	 different	 TMT	 tags	 exist,	although	my	 experiments	 only	 used	 two	 tags,	 one	 for	 each	 liposome	 type.	 The	 tag	 is	composed	of:	a	mass	reporter	region	containing	different	numbers	of	13C	and	15N,	giving	the	reporter	a	unique	mass;	a	variable	linker	region,	which	normalises	the	overall	mass	of	 the	 tag;	and	an	amine	reactive	group	which	 forms	an	 irreversible,	 covalent	bond	 to	primary	amines	in	the	protein.		Following	trypsin	digestion	and	labelling	of	each	sample	with	a	different	TMT	tag,	the	samples	are	mixed	and	analysed	by	MS/MS.	The	addition	of	an	isobaric	tag	to	each	protein	 results	 in	 identical	 peptides	 from	different	 samples	 co-eluting	during	 the	 first	MS	round.	The	tag	is	then	fragmented	between	the	mass	reporter	and	the	linker	region	by	collision-induced	dissociation,	releasing	the	reporter	ion	of	unique	mass.	The	relative	peptide	intensities	in	each	sample	are	then	quantified	through	quantification	of	intensity	of	the	corresponding	tag.		
Trypsin	digestion,	TMT-labelling,	data	acquisition	and	analysis	were	performed	by	Dr.	Sew	
Peak-Chew,	MRC-Laboratory	of	Molecular	Biology.	
2.21.1.1 Trypsin	digestion	Following	 liposome-lysate	 binding	 assays,	 protein	 pellets	 obtained	 from	methanol:chloroform	extraction	were	re-suspended	 in	8	M	urea	 in	50	mM	ammonium	bicarbonate	 +	 10	 mM	 DTT	 and	 incubated	 at	 56	 °C	 for	 30	 minutes.	 DTT	 reduces	disulphide	bonds	and	disulphide	bond	formation	was	prevented	by	addition	of	200	mM	iodoacetamide	(IAA)	for	30	minutes	at	r.t.	in	the	dark.	The	reaction	was	quenched	by	the	addition	 of	 100	mM	DTT	 at	 r.t.	 for	 10	minutes.	 The	 samples	were	 then	 digested	with	0.25	mg/ml	trypsin	(Promega)	in	ammonium	bicarbonate	over	night	at	37	°C.		Digestion	
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was	 stopped	 by	 the	 addition	 of	 trifluoroacetic	 acid	 (TFA).	 The	 peptide	mixtures	were	then	desalted	using	poros	R3	resin	(Applied	Biosystem)	and	bound	peptides	were	eluted	with	60	%	acetonitrile	(MeCN)	in	0.1	%	TFA	and	lyophilised.	Desalting	removes	excess	salt,	 which	 can	 contribute	 to	 background	 noise	 detected	 by	 the	 instrument	 and	 can	affect	peptide	ionisation.	
2.21.1.2 Tandem	mass	tag	(TMT)	labelling	Peptide	mixtures	from	each	condition	were	re-suspended	in	5	%	MeCN	and	the	peptide	concentrations	 were	 determined	 by	 Pierce	 Quantitative	 Colorimetric	 Peptide	 assay	(Thermo	 Scientific)	 according	 to	 manufacturer	 instructions.	 TMT	 duplex	 reagents	(Thermo	 Fisher	 Scientific)	were	 re-constituted	 to	 19.5	mg/ml	 in	MeCN.	 20	 µl	 of	 TMT	duplex	 reagent	 was	 added	 to	 each	 peptide	 mixture	 in	 170	 mM	 triethlyammonium	bicarbonate	(TEAB)	and	incubated	for	1.5	hours	at	r.t.	TEAB	is	a	volatile	buffer	used	in	ion-exchange	 chromatography.	 The	 labelling	 reactions	were	 terminated	 by	 incubation	with	5	%	hydroxylamine	 for	15	minutes;	 the	amine	group	reacts	with	 the	excess	TMT	reagent.	The	labelled	samples	were	pooled	followed	by	MeCN	removal	by	speed	vacuum	and	were	desalted.	Eluted	peptides	were	partially	dried	down	 in	a	 speed	vacuum	and	prepared	for	LC-MSMS.	
2.21.1.3 LC-MSMS	The	 labelled	peptides	were	analysed	on	a	Q	Exactive	Plus	hybrid	quadrupole-Orbitrap	mass	 spectrometer	 (Thermo	Fisher	Scientific).	Liquid	 chromatography	was	performed	on	a	fully	automated	Ultimate	3,000	RSLC	nano	System	(Thermo	Scientific)	fitted	with	a	100	µm	x	2	cm	PepMap100	C18	nano	trap	column	and	a	75	μm	×	25	cm	reverse	phase	C18	nano	column	(Aclaim	PepMap,	Thermo	Scientific).	Samples	were	separated	using	a	binary	gradient	consisting	of	buffer	A	(2	%	MeCN,	0.1	%	formic	acid)	and	buffer	B	(80	%	MeCN,	0.1	%	formic	acid).	Peptides	were	eluted	with	a	 linear	gradient	 from	4	to	50	%	buffer	 B	 over	 90-108	minutes	with	 a	 flow	 rate	 of	 300	 nl/min.	 The	HPLC	 system	was	coupled	 to	 a	 Q	 Exactive	 Plus	mass	 spectrometer	 (Thermo	 Scientific)	 equipped	with	 a	nanospray	ion	source.	The	mass	spectrometer	was	operated	in	standard	data-dependent	mode	 and	 performed	 a	 survey	 full-scan	 (MS,	 m/z	 =	 350-1600)	 with	 a	 resolution	 of	140,000,	followed	by	MS2	acquisitions	of	the	15	most	intense	ions	with	a	resolution	of	35,000	and	NCE	of	32%.	MS	target	values	of	3x106	and	MS2	target	values	of	1x105	were	used.		Dynamic	exclusion	was	enabled	for	40	s.	
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2.21.1.4 Data	analysis	The	acquired	MSMS	raw	files	were	processed	using	Proteome	Discoverer	(version	2.1,	Thermo	Scientific).	MSMS	spectra	were	searched	against	uniprot	human	or	mouse	2016	database	using	Mascot	(version	2.4,	Matrix	Science).	Carbamidomethylation	of	cysteines	was	 set	 as	 fixed	modification	while	methionine	 oxidation,	 N-terminal	 acetylation	 and	TMT2plex	 (peptide	 N	 terminus	 and	 Lysine)	 were	 set	 as	 variable	 modifications.	 The	abundance	 values	 of	 the	 TMT	 reporter	 ion	 was	 scaled	 to	 the	 control	 channel	 and	normalised	 to	 total	peptide	amount.	Only	high	confident	peptides	with	 false	discovery	rate	 (FDR)	 of	 1	 %	 were	 included	 in	 the	 results.	 The	 proteins	 table	 output	 file	 from	Proteome	Discoverer	was	 filtered	 for	proteins	with	FDR	of	1	%	and	exported	as	excel	files.	
2.22 Statistical	analysis	Where	appropriate,	statistical	significance	between	data	sets	was	analysed	by	paired	t-tests	using	GraphPad	Prism.		Ns,	non-significant;	∗∗P<0.001;	∗∗∗∗P<0.0001.						 	
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Chapter	 3:	 Investigating	 sphingomyelin	 exposure	 on	
bacteria-containing	vacuoles	
3.1 Summary	This	 Chapter	 details	 the	 utilisation	 of	 Lysenin,	 a	 sphingomyelin-specific	 toxin	 from	earthworms,	as	a	cytosolic	sphingomyelin	reporter	and	consequently	as	a	new	marker	for	membrane	damage.	My	 research	 reveals	 that	 sphingomyelin	becomes	 cytosolically	exposed	 on	 damaged	 bacteria-containing	 vacuoles	 (BCVs),	 indicated	 through	 Lysenin	recruitment	 to	 BCVs	 in	 a	 sphingomyelin-dependent	 manner.	 Furthermore,	 Lysenin	recruitment	 to	 BCVs	 occurs	 before	 other	 known	membrane	 damage	markers,	 such	 as	Galectin	 8,	 indicating	 that	 sphingomyelin	 is	 exposed	 before	 complete	 BCV	 rupture	through	which	glycans	become	exposed.	Two	phases	of	BCV	damage,	‘minor’	and	‘major’,	may	therefore	occur.	
3.2 Introduction	Upon	entry	of	 a	bacterium	 into	a	 cell,	 the	bacterium	resides	 in	 a	host	 cell	membrane-derived	vacuole	known	as	the	bacteria-containing	vacuole	(BCV).	Through	BCV	rupture,	the	intra-luminal	leaflet	of	the	vacuole	becomes	exposed	to	the	cytosol,	simultaneously	exposing	 host	 molecules,	 a	 subset	 of	 which	 signal	 danger	 to	 the	 cell,	 as	 discussed	 in	
Chapter	 1.1.5.	 Molecules	 employed	 as	 danger	 signals	 are	 located	 in	 different	compartments	 from	 their	 receptor	 under	 homeostatic	 conditions.	 One	 mechanism	through	which	this	is	achieved	utilises	the	asymmetrical	distribution	of	host	molecules	across	the	plasma	membrane	(PM)	bilayer.	Glycans,	for	example,	are	exclusively	located	on	the	PM	outer	leaflet	whilst	the	glycan-specific	danger	receptor,	Galectin	8,	is	cytosolic.	Glycans	are	hidden	on	 the	 intra-luminal	 leaflet	of	 the	BCV	and	become	exposed	 to	 the	cytosol	 during	 BCV	 rupture,	 where	 they	 are	 detected	 and	 trigger	 anti-bacterial	autophagy	(Figure	1.5).	With	 the	 knowledge	 of	 host	 glycans	 acting	 as	 a	 danger	 signal,	 it	 was	 of	 great	interest	to	investigate	whether	host	lipids	that	are	asymmetrically	distributed	across	the	PM,	such	as	sphingomyelin,	become	exposed	to	the	cytosol	upon	BCV	rupture	and	thus	whether	they	could	function	as	a	danger	signal.		This	Chapter	describes	my	explorations	into	sphingomyelin	exposure	on	BCVs	and	how	this	exposure	could	relate	to	known	markers	of	membrane	damage	and	autophagy	induction,	primarily	Galectin	8.	
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3.3 Exposure	 of	 intra-luminal	 sphingomyelin	 on	 Salmonella-
containing	vacuoles		In	 order	 to	 visualise	 cytosolically	 exposed	 sphingomyelin	 (SM),	 it	 was	 important	 to	develop	 a	 cytosolic	 SM	 reporter.	 No	 known	 endogenous	 SM-binding	 proteins	 exist,	which	forms	the	basis	of	Chapters	4	and	5.	Therefore,	two	non-mammalian	SM-specific	toxins	were	investigated:	Lysenin,	from	the	earthworm	Eisenea	foetida,	and	Equinatoxin	II	 (Eqt-II),	 from	 the	 sea	 anemone	 Actinia	 equina,	 as	 discussed	 in	 Chapter	 1.10.	Retroviral	plasmids	encoding	GFP-Lysenin	or	Eqt	II-GFP	were	generated	as	described	in	
Chapter	2.7.		Following	transduction	of	HeLa	cells,	as	described	 in	Chapter	 2.8,	GFP-Lysenin	was	 diffusely	 distributed	 throughout	 the	 cytosol	 (Figure	 3.1A.i)	 whilst	 EqtII-GFP	appeared	distinctly	 localised	 at	 the	Golgi	 apparatus	 region	 (Figure	 3.1B.i).	 For	 initial	infection	 assays,	 Salmonella	 Typhimurium	 was	 used.	 S.Typhimurium	 is	 a	 bacterial	species	that	resides	in	a	Salmonella-containing	vacuole	(SCV)	and	in	a	small	percentage	of	 cases	 ruptures	 its	vacuole	 thereby	becoming	exposed	 to	 the	cytosol.	Upon	 infection	with	S.Typhimurium,	strong	recruitment	of	Lysenin	 to	bacteria	was	evident,	as	donut-shaped	rings	were	clearly	visible	around	 the	bacteria	(Figure	 3.1A.ii).	This	suggested	SM	 is	 indeed	exposed	on	Salmonella-containing	vacuoles	 (SCVs).	 Infection	assays	with	Eqt	 II-GFP	expressing	 cells	did	not	 result	 in	 localisation	of	Eqt	 II	 to	S.Typhimurium	at	early	time	points	post	infection	(p.i.)	(data	not	shown)	or	at	later	points	(Figure	3.1B.ii).	Therefore,	 Lysenin	 toxin	was	more	 appropriate	 for	my	 investigations	 and	 thus	 use	 of	Lysenin	was	pursued.		
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Figure	3.1:	Lysenin	is	recruited	to	S.Typhimurium	but	Equinatoxin	II	is	not.	Confocal	micrographs	of	HeLa	 cells	 expressing	 (A)	GFP-Lysenin(full-length)	 or	 (B)	 Equinatoxin	 II-GFP.	Cells	were	either	(i)	uninfected	or	(Aii)	infected	with	mCh-expressing	S.Typhimurium	and	analysed	at	30	minutes	or	(Bii)	4	hours	post	infection.	Scale	bar,	10µm.		To	 investigate	 SM	 exposure	 on	 SCVs	 further,	 creation	 of	 a	 stable	 cell	 line	expressing	 GFP-Lysenin	 was	 required.	 However,	 cells	 expressing	 GFP-Lysenin	ultimately	died,	making	the	design	of	a	non-toxic	Lysenin	derivative	a	necessity.	To	this	effect,	 a	 form	of	Lysenin	 (amino	acids	161-297)	was	created	 that	 lacks	 the	N-terminal	oligomerisation	 domain,	 thus	 is	 non-toxic,	 but	 retains	 sphingomyelin	 specificity	(Kiyokawa,	2005).	This	 construct,	GFP-Lysenin(C-Terminal	Domain,	CTD),	was	 still	 recruited	 to	
S.Typhimurium	 (Figure	 3.2A)	 with	 5%	 and	 10%	 of	 bacteria	 being	 positive	 at	 30	minutes	and	60	minutes	p.i.,	respectively.		Additionally,	an	alternative	non-toxic	full	length	Lysenin	construct	was	designed	with	 a	 point	 mutation	 (W20A)	 which	 prevents	 oligomerisation,	 and	 thus	 toxicity,	 of	Lysenin	(Kwiatkowska	et	al,	2007;	Kulma	et	al,	2010).	This	construct,	hereafter	referred	to	 as	 Lysenin(W20A),	 was	 also	 recruited	 to	 S.Typhimurium	 (Figure	 3.2B)	 and	 labelled	approximately	10%	and	20%	of	bacteria	at	30	and	60	minutes	p.i.,	respectively.		
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Figure	3.2:	Non-toxic	Lysenin	constructs	are	recruited	to	S.Typhimurium.	Confocal	micrographs	 of	HeLa	 cells	 expressing	 (A)	 GFP-Lysenin(CTD)	 (aa.161-297)	 or	 (B)	 GFP-Lysenin(W20A).	Cells	were	(i)	uninfected	or	(ii)	infected	with	mCh-expressing	S.Typhimurium	and	analysed	 at	 30	 minutes	 p.i..	 (C)	 Confocal	 micrograph	 of	 the	 same	 field	 of	 view	 as	 in	 Bii	 but	imaged	using	the	same	488nm	laser	intensity	as	for	Bi.	(D)	Quantification	of	non-toxic	Lysenin	construct	 recruitment	 to	 mCh-S.Typhimurium.	 Lysenin-positive	 bacteria	 were	 counted	 by	automated	 counting.	 Graph	 shows	mean	 +/-	 S.E.M	 of	 triplicate	wells	 from	 three	 independent	experiments.	n>6000	bacteria	counted	per	well.	Scale	bar,	10µm.	CTD,	C-terminal	domain.	
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Due	to	its	greater	construct	similarity	with	the	wild	type,	Lysenin(W20A)	construct	was	 the	 preferred	 Lysenin	 form	 to	 use	 for	 stable	 cell	 line	 generation	 to	 further	investigate	sphingomyelin	exposure	on	bacteria-containing	vacuoles.	It	 is	 important	 to	 note	 that	 a	 lower	 488nm	 laser	 intensity	 was	 used	 to	 image	infected	 cells	 compared	 to	 uninfected	 cells,	 in	 order	 to	 prevent	 overexposure	 of	 the	strong	 GFP-Lysenin(W20A)	 rings	 around	 the	 S.Typhimurium;	 GFP-Lysenin(W20A)	was	 still	present	in	the	cytosol	(Figure	3.2.C).	
3.4 Exposure	 of	 sphingomyelin	 on	 vacuoles	 containing	 other	
bacterial	species	Having	discovered	that	SM	is	exposed	on	vacuoles	containing	S.Typhimurium,	it	was	of	interest	 to	determine	whether	 this	was	a	Salmonella-specific	phenomenon	or	whether	this	exposure	occurred	on	vacuoles	containing	other	bacteria.		Firstly,	 other	 invasive,	 Gram-negative	 bacteria	 were	 tested,	 such	 as	 Shigella	
flexneri.	 Shigella	 flexneri	 is	a	 professional	 cytosol-dwelling	 pathogen	 that	 ruptures	 its	BCV	 to	 gain	 access	 to	 the	 cytosol.	 Infection	 with	 Shigella	 flexneri	 resulted	 in	 Lysenin	localisation	to	the	bacteria,	with	25%	of	Shigella	being	Lysenin-positive	at	30	minutes	p.i.	
(Figure	3.3A).	The	Lysenin	‘coat’	at	later	time	points	p.i.	appeared	to	be	being	shed	by	the	 S.flexneri	bacterium,	 reminiscent	 of	 Galectin	 8	 coat	 shedding	 and	 consistent	 with	Lysenin	 detecting	 SM	 on	 vacuolar	membrane	 remnants	 and	 not	 directly	 the	 bacterial	surface	(data	not	shown).		Following	this	result,	invasive,	Gram-positive	bacteria	were	tested.	To	this	effect,	GFP-Lysenin(W20A)	 or	 mCh-Lysenin(W20A)	 expressing	 cells	 were	 infected	 with	 Listeria	
monocytogenes	 or	 Streptococcus	 pyogenes,	 respectively.	 Listeria	 monocytogenes	 is	 a	professional	cytosol-dwelling	pathogen,	like	Shigella,	whilst	Streptococcus	pyogenes	can	exist	 extracellularly	 but	 can	 also	 invade	 several	 cell	 types	 including	 epithelial	 cells	(Dombek	 et	 al,	 1999).	 Lysenin(W20A)	 also	 formed	 distinct	 donut-shaped	 rings	 around	these	 bacterial	 species	 (Figure	 3.3B,C),	 suggesting	 SM	 exposure	 occurs	 on	 bacteria-containing	vacuoles	irrespective	of	the	bacterial	species.	
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Figure	3.3:	Lysenin	is	recruited	to	other	bacterial	species.	
(A)i.	 Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 GFP-Lysenin(CTD)	 infected	 with	mCh-expressing	 Shigella	 flexneri	 and	 analysed	 at	 30	 minutes	 p.i..	 ii.	 The	 percentage	 of	GFP-Lysenin(W20A)-positive	 Shigella	 at	 30	 minutes	 p.i.	 was	 manually	 counted	 from	 automated	images	 taken	 with	 a	 40x	 objective.	 Graph	 shows	mean	 +/-	 S.E.M	 of	 one	 experiment.	 n>1100	bacteria	counted	per	well.	(B	&	C)	Confocal	micrographs	of	HeLa	cells	expressing	Lysenin(W20A)	infected	with	(B)	Listeria	monocytogenes	or	(C)	Streptococcus	pyogenes.	Cells	were	analysed	at	30	minutes	p.i..	Scale	bar,	10µm.	
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3.5 Exposure	 of	 sphingomyelin	 upon	 sterile	 damage	 of	 host	
membranes		The	 results	 of	 bacterial	 infection	 assays	 indicated	 Lysenin	 was	 recruited	 to	 a	membranous	vacuole	in	which	a	bacteria	was	present,	implying	that	sphingomyelin	was	exposed.	However,	it	was	unknown	whether	the	sphingomyelin	was	only	exposed	in	the	presence	of	bacteria,	and	whether	this	exposure	was	the	result	of	membrane	damage.		To	 answer	 these	 questions,	 sterile	 lysis	 assays	 that	 damage	 the	membranes	 of	intracellular	 vesicles,	 in	 particular	 endosomes	 and	 lysosomes,	 were	 carried	 out.	 An	increased	 number	 of	 GFP-Lysenin(W20A)	 punctae	 occurred	 in	 cells	 in	 which	 lysosomes	and	endosomes	had	been	lysed,	compared	to	the	diffuse	distribution	of	Lysenin	seen	in	control	cells	(Figure	3.4).		
	
Figure	3.4:	Lysenin	is	recruited	to	sterile	host	membrane	damage.	Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 GFP-Lysenin(W20A).	 Cells	 were	 either	
(A)	untreated,	(B)	treated	with	PBS	containing	0.5M	sucrose	and	10%	PEG	(endosomal	lysis)	or	
(C)	treated	with	333µM	GPN	(lysosomal	lysis).	Scale	bar,	10µm.		
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As	discussed	previously,	a	 lower	488nm	laser	 intensity	was	used	when	imaging	the	lysed	cells	compared	to	the	control	cells	to	avoid	overexposure	of	the	Lysenin	dots	
(Figure	 3.4).	 Imaging	 with	 the	 same	 laser	 intensity	 revealed	 that	 Lysenin	 was	 not	depleted	from	the	cytosol	upon	membrane	damage	(data	not	shown).	As	these	assays	were	carried	out	in	sterile	conditions,	no	bacteria	were	present.	The	 result	 therefore	 confirms	 that	 Lysenin	 binds	 a	 host-derived	 ligand	 (SM)	 and	suggests	 that	 the	 SM	detected	 by	 Lysenin	 is	 exposed	 as	 a	 result	 of	 vesicle	membrane	damage.	 Furthermore,	 this	 indicates	 that	 GFP-Lysenin(W20A)	 is	 recruited	 to	 bacteria-containing	vacuoles	that	are	damaged.		
3.6 Validating	Lysenin	specificity	for	sphingomyelin		
3.6.1 Liposome	binding	assays	Although	 evidence	 from	 the	 literature	 suggested	 Lysenin	 specifically	 detects	sphingomyelin,	it	was	necessary	to	confirm	that	Lysenin	was	being	recruited	to	BCVs	in	a	 sphingomyelin-dependent	 manner.	 I	 confirmed	 Lysenin	 sphingomyelin	 specificity	through	in	vitro	liposome	binding	assays	discussed	in	Chapter	4.3.4.3.	In	these	assays,	recombinant	Lysenin(CTD)-GFP,	purified	as	described	 in	Chapter	 2.13.2,	 only	bound	 to	liposomes	containing	sphingomyelin	not	phosphatidylcholine	(Figure	4.5).		
3.6.2 Cell	surface	binding	of	Lysenin		Under	 resting	 conditions,	 the	 Lysenin	 ligand	 was	 not	 located	 intracellularly,	 as	 GFP-Lysenin	 displayed	 a	 diffuse	 cytosolic	 distribution	 in	 uninfected	 cells	 (Figure	 3.1A).	Therefore,	it	was	important	to	test	whether	the	ligand	was	present	on	the	outer	leaflet	of	the	PM	before	 internalisation	 in	an	SCV.	Lysenin	binding	 to	 the	surface	of	mammalian	cells	was	thus	explored.	Comparing	HeLa	cell	surface	binding	of	recombinant	Lysenin(CTD)-GFP	to	binding	of	 recombinant	 	 GFP-Galectin	 8	 or	 GFP,	 purified	 as	 discussed	 in	 Chapter	 2.13.1,	revealed	that	Lysenin(CTD)-GFP	bound	the	cell	surface,	as	did	GFP-Galectin	8,	the	positive	control.	 The	 negative	 control,	 GFP	 did	 not	 bind.	 Furthermore,	 no	 cell	 surface	 binding	was	 detected	 for	 Lysenin	 K185A(CTD)-GFP,	 a	 Lysenin	 mutant	 not	 recruited	 to	 SCVs	discussed	 in	Chapter	 3.6.4.	Flow	cytometry	was	used	to	quantify	 these	visual	binding	results	(Figure	3.5).	These	results	confirmed	that	the	ligand	of	Lysenin	was	located	on	the	 outer	 leaflet	 of	 the	 plasma	 membrane	 under	 resting	 conditions.	 Furthermore,	Lysenin	bound	this	ligand	in	the	absence	of	other	cellular	proteins,	suggesting	Lysenin	is	
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directly	recruited	to	this	ligand	on	SCVs	rather	than	via	an	indirect	mechanism	involving	Lysenin	interacting	with	an	SCV-recruited	host	protein.	
	
Figure	3.5:	Recombinant	Lysenin(CTD)	binds	the	surface	of	HeLa	cells.	HeLa	cells	were	incubated	at	4°C	with	indicated	recombinant	proteins.	Binding	was	analysed	by	confocal	 microscopy	 (right)	 and	 flow	 cytometry	 (left).	 Fluorescence	 of	 unstained	 cells	 is	indicated	by	a	black	histogram	line.	Scale	bar,	10µm.	
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3.6.3 Lysenin	recruitment	in	the	absence	of	sphingomyelin		To	 confirm,	 in	 vivo,	 that	 Lysenin	 recruitment	 to	 SCVs	 occurred	 in	 a	 sphingomyelin-dependent	 manner,	 it	 was	 interesting	 to	 investigate	 whether	 removing	 exposed	sphingomyelin	had	an	effect	on	Lysenin	recruitment	to	S.Typhimurium.	To	achieve	this,	neutral	sphingomyelinase	2	(nSMase2)	was	cloned	from	human	brain	cDNA.	nSMase2	is	a	 member	 of	 the	 sphingomyelinase	 family	 which	 cleaves	 sphingomyelin	 to	 form	ceramide	 and	phosphocholine,	 as	 discussed	 in	Chapter	 1.8.	 Thus,	 upon	 expression	 of	nSMase2	in	cells,	any	sphingomyelin	exposed	on	SCVs	would	be	converted	to	ceramide.		mCh-nSMase2	 was	 expressed	 in	 HeLa	 cells	 followed	 by	 co-expression	 of	 GFP-Lysenin(W20A).	mCh-nSMase2	appeared	bound	to	membranous	structures	throughout	the	cell,	 including	 the	 PM,	 as	 expected	 given	 its	 transmembrane	 spanning	 region.	 Upon	infection	of	 these	 cells	with	S.Typhimurium,	Lysenin(W20A)	 recruitment	 to	bacteria	was	significantly	 reduced	 with	 only	 a	 bright	 ‘dot’	 often	 being	 visible	 on	 the	 SCV	 (Figure	
3.6A)	 opposed	 to	a	complete	donut-shaped	ring	seen	 in	 the	absence	of	nSMase2.	This	decrease	in	Lysenin	binding	was	quantified	showing	a	decrease	from	~10%	to	2.5%	at	30	minutes	p.i.	(Figure	3.6B),	 thereby	 implying	Lysenin(W20A)	 is	recruited	to	SCVs	 in	a	sphingomyelin-dependent	manner.	Importantly,	this	result	was	not	due	to	expression	of	nSMase2	 impairing	 SCV	 membrane	 damage,	 as	 Galectin	 8	 recruitment	 to	 SCVs	 was	unaffected	 by	 nSMase2	 (Figure	 3.6B).	 Lysenin(W20A)	 recruitment	 was	 not	 entirely	abolished	 which	 could	 be	 explained	 by	 Lysenin	 binding	 with	 such	 a	 high	 affinity	 for	sphingomyelin,	 given	 its	 toxin	 characteristic,	 that	 in	 some	 cases	 Lysenin	 may	 be	recruited	 to	 the	 SCV	 before	 nSMase2	 cleaves	 the	 sphingomyelin.	 Alternatively,	 the	bacteria	 may	 have	 entered	 the	 cell	 at	 a	 part	 of	 the	 plasma	 membrane	 at	 which	 the	membrane-associated	nSMase2	was	 less	prevalent	and	 thus	 sphingomyelin	 levels	may	not	have	been	reduced	as	rapidly	or	significantly,	 thus	Lysenin	recruitment	would	still	occur	(Figure	3.6A	–	white	arrow).	Interestingly,	 certain	 bacterial	 species	 secrete	 sphingomyelinases	 as	 virulence	factors,	 discussed	 in	 Chapter	 1.8.3.	 Listeria	 ivanovii,	 for	 example,	 secretes	 a	sphingomyelinase;	 Listeria	 monocytogenes	 does	 not.	 To	 further	 confirm	 Lysenin	recruitment	 to	 BCVs	was	 sphingomyelin-dependent,	 Lysenin	 recruitment	 to	 L.ivanovii	was	 tested.	 Strikingly,	 Lysenin	 recruitment	 to	 L.ivanovii	 was	 abolished	 compared	 to	
L.monocytogenes	 (Figure	 3.6C),	 confirming	 sphingomyelin-dependent	 recruitment	 of	Lysenin	to	BCVs.			
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Figure	3.6	legend	is	on	the	following	page.	
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Figure	 3.6:	 Lysenin	 recruitment	 to	 bacteria-containing	 vacuoles	 is	 sphingomyelin-
dependent.	
(A)	Confocal	micrographs	of	HeLa	cells	expressing	mCh-nSMase2	and	GFP-Lysenin(W20A)	infected	with	S.Typhimurium	and	analysed	at	30	minutes	p.i..	White	arrow	indicates	a	Lysenin-positive	vacuole.	Scale	bar,	10µm.	
(B)	 HeLa	 cells	 expressing	 GFP-Lysenin(W20A)	 or	 YFP-Galectin	 8	 either	 with	 or	 without	 mCh-nSMase2	 were	 infected	 with	 BFP-expressing	 S.Typhimurium.	 Marker	 positive	 bacteria	 were	manually	counted	from	automated	images	taken	with	a	40x	objective.	Graph	indicates	mean	+/-	S.E.M	of	triplicate	wells	of	one	experiment.	n>700	bacteria	counted	per	well.	
(C)	 THP1	 cells	 expressing	 GFP-Lysenin(W20A)	 were	 infected	 with	 Listeria	 monocytogenes	 or	
Listeria	ivanovii.	Lysenin-positive	Listeria	were	counted	manually	at	60	minutes	p.i.	using	a	100x	objective.	Graph	shows	mean	+/-	S.E.M	of	triplicate	coverslips	of	one	experiment.	n>150	bacteria	counted	per	coverslip.						 To	further	confirm	that	the	SM	recruiting	Lysenin	to	the	SCV	originated	from	the	outer	 leaflet	 of	 the	 plasma	membrane,	 it	was	 interesting	 to	 test	 the	 effect	 on	 Lysenin	recruitment	to	SCVs	when	plasma	membrane	SM	was	removed	before	infection.	In	order	to	 achieve	 this,	 recombinant	 Staphylococcus	 aureus	 bacterial	 sphingomyelinase	(bSMase)	 was	 expressed	 in	 E.coli	 and	 purified	 as	 detailed	 in	 Chapter	 2.13.3.	Pretreatment	of	cells	expressing	GFP-Lysenin(W20A)	or	YFP-Galectin	8	prior	to	 infection	with	S.Typhimurium	abolished	Lysenin	recruitment	(Figure	3.7).	Galectin	8	recruitment	levels	were	partially	 reduced	(Figure	 3.7).	This	Galectin	8	 recruitment	 reduction	was	not	 due	 to	 bSMase	 acting	 non-specifically	 and	 cleaving	 glycans	 from	 the	 plasma	membrane,	as	surface	binding	assays	comparing	untreated	or	pretreated	cells	revealed	pretreatment	 did	 not	 affect	 Galectin	 8	 binding,	 whilst	 Lysenin(CTD)-GFP	 binding	 was	abolished	(Figure	3.8).	These	results	suggested	the	presence	of	sphingomyelin	could	be	required	for	SCV	rupture.		
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Figure	 3.7:	 Removal	 of	 cell	 surface	 sphingomyelin	 prior	 to	 infection	 prevents	 Lysenin	
recruitment	to	S.Typhimurium.	HeLa	 cells	 expressing	 either	 GFP-Lysenin(W20A)	 or	 YFP-Galectin	 8	 were	 either	 untreated	 or	pretreated	with		bacterial	sphingomyelinase	(10.5µg/ml)	before	infection	with	mCh-expressing	
S.Typhimurium.	 Cells	 were	 fixed	 at	 30	 and	 60	 minutes	 p.i..	 Percentage	 of	 marker	 positive	
S.Typhimurium	at	each	time	point	was	counted	by	automated	counting.	Graph	shows	mean	+/-	S.E.M	of	triplicate	wells	from	three	independent	experiments.	**P=0.0043,	****P<0.0001,	Paired	t-test.	n>2000	bacteria	counted	per	well.		
	
Figure	3.8:	Pretreatment	of	cells	with	bSMase	abolishes	recombinant	Lysenin	cell	surface	
binding	but	does	not	affect	Galectin	8	binding.	Flow	 cytometry	 analysis	 of	 recombinant	 Lysenin(CTD)-GFP	 and	 GFP-Galectin	 8	 binding	 to	untreated	HeLa	cells	 (green	and	dark	blue)	or	HeLa	cells	pretreated	with	bSMase	(10.5µg/ml)	(red	and	cyan).		
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3.6.4 Mutational	analysis	of	Lysenin	Following	 confirmation	 that	 Lysenin	 recruitment	 to	 SCVs	 was	 SM-dependent,	 it	 was	important	 to	 design	 mutants	 of	 Lysenin(W20A)	 that	 abolished	 recruitment	 to	 SCVs.	 To	achieve	 this,	 a	 series	 of	 point	 mutations	 were	 introduced	 in	 different	 regions	 of	 the	Lysenin(W20A)	 construct.	 The	 mutations	 introduced	 were	 derived	 from	 the	 crystal	structure	 of	 wild	 type,	 full-length	 Lysenin	 and	 are	 summarised	 in	 Table	 3.1.	 The	mutations	are	mapped	onto	the	structure	shown	in	Figure	3.9.			
Mutation	 Location	of	mutation	 Localisation	to	S.Typhimurium?	K21A	 In	N-terminal	Pore	Forming	Module.	 Yes	Y24D		 Yes	Y24A,	Y26A	 Yes	
Y24A,	Y26A,	Q229A		 In	N-terminal	Pore	Forming	Module	and		C-terminal	domain.	 Yes	E128R	 In	N-terminal	Pore	Forming	Module.	 Yes	K185A	 In	C-terminal	domain.	 No	W187E	 In	C-terminal	domain.	 No	
Table	3.1:	Mutations	introduced	into	full-length	Lysenin(W20A)	and	tested	for	recruitment	
to	S.Typhimurium.	
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Figure	3.9:	Location	of	mutants	introduced	into	Lysenin(W20A)	molecule.	
(A)	 Cartoon	 representation	 of	 full-length,	 wild	 type	 Lysenin	 (pdb:	 3ZXG).	 N-	 and	 C-terminal	domains	are	shown	in	green	and	cyan,	respectively.	
(B)	Cartoon	representation	of	Lysenin	N-terminal	domain	with	a	putative	sphingomyelin	(SM)	binding	site	shown.	Trp20	is	shown	in	magenta.	
(C)	Cartoon	representation	of	Lysenin	C-Terminal	Domain(CTD)	unbound	(blue	Cα)	with		overlay	of	Lysenin	bound	to	phosphocholine	(POC)	(purple	Cα)	(pdb:	3ZX7)	.	Residues	of	interest	are	shown	as	sticks.		 		
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The	literature	suggested	mutating	both	Y24A	and	Y26A,	located	in	the	N-terminal	region	 proposed	 to	 interact	with	 a	 SM	 acyl	 chain,	would	 abolish	 Lysenin-SM	 binding,	when	 tested	via	 lipid	dot	blot	assays	 (De	Colibus	et	al,	2012).	However,	 this	 construct	was	still	recruited	to	SCVs	and	labelled	approximately	17	and	25%	of	S.Typhimurium	at	30	 and	 60	 minutes	 p.i.,	 respectively	 (Figure	 3.10).	 The	 increase	 in	 recruitment	 to	
S.Typhimurium	when	mutating	Y24A,	Y26A,	compared	to	the	15%	and	20%	labelled	by	wild	type	Lysenin(W20A)	at	30	and	60	minutes,	respectively,	was	not	investigated	further	as	 the	 aim	 of	 these	 mutational	 analyses	 was	 to	 identify	 a	 mutation	 that	 abolished	recruitment	to	SCVs.		Given	 that	 the	 N	 terminus	was	 not	 essential	 for	 ligand	 binding	 in	 cells,	 as	 the	C-terminal	 domain	 construct	 of	 Lysenin	still	 localised	 to	 bacteria,	 it	 was	 unsurprising	that	Y24A,	Y26A	mutations	did	not	prevent	Lysenin	recruitment.	This	pointed	towards	the	C	terminus	being	involved	in	SM	binding.	In	support	of	this,	the	crystal	structure	of	Lysenin	bound	to	phosphocholine	(POC),	which	is	the	headgroup	of	sphingomyelin	and	phosphatidylcholine,	showed	two	potential	POC	binding	sites	in	the	C-terminal	domain.	In	addition,	a	sulphate	was	observed	in	the	SM-bound	structure	adjacent	to	one	POC	site.	The	sulphate	may	be	analogous	to	an	additional	POC	or	SM	site.	Mutation	of	Glutamine	229	 to	 an	 alanine	 did	 not	 abrogate	 Lysenin	 recruitment	 to	 S.Typhimurium.	 However,	mutation	 of	 either	 of	 two	 residues	 that	 co-ordinate	 one	POC	 (K185A)	 or	 the	 sulphate	(W187E)	was	sufficient	to	abrogate	Lysenin	recruitment	to	SCVs	(Figure	3.10).		The	choice	of	residues	for	mutation	was	designed	such	that	only	surface	residues	were	targeted	and	any	misfolding	of	Lysenin	was	minimised.	Both	Lys185	and	Trp187	are	surface	exposed	and	protein	expression	of	either	mutant	in	cells	seemed	unaffected.	The	K185A	mutant	was	subsequently	used	as	a	negative	control	in	cell	surface	binding	assays	(Chapter	3.6.2)	and	liposome	binding	assays	(Chapter	4.3.4).			Taken	 together,	 the	 results	 and	 observations	 from	 these	 sections	 (Chapter	 3.6)	indicated	 that	 the	 Lysenin	 constructs	 used	 in	 my	 assays	 possess	 SM	 specificity.	Therefore,	 a	 high	 level	 of	 confidence	 can	 be	 placed	 in	 Lysenin(W20A)	 detecting	 SM	specifically.			 	
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Figure	3.10:	Mutations	in	the	C-terminal	domain	of	Lysenin	abolish	recruitment.	
(A)	Confocal	micrographs	of	HeLa	cells	expressing	indicated	point	mutants	in	the	Lysenin(W20A)	construct.	 Cells	were	 infected	with	S.Typhimurium	 and	 analysed	 at	 60	minutes	 p.i..	 Scale	 bar,	10µm.	
(B)	Percentage	of	mCh-expressing	S.Typhimurium	positive	for	GFP-Lysenin(W20A)	point	mutants	was	 counted	 by	 automated	 counting.	 Graph	 shows	mean	 +/-	 S.E.M	 of	 triplicate	wells	 of	 three	independent	 experiments.	 ***P=0.0001,	 ****P<0.0001,	 Paired	 t-test.	 n>6100	 bacteria	 counted	per	well.	 	
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3.7 Lysenin	recruitment	to	SCVs	in	relation	to	other	membrane	
damage	markers	Having	discovered	that	sphingomyelin	exposure	occurs	on	damaged	bacteria-containing	vacuoles,	implied	by	Lysenin	recruitment,	it	was	interesting	to	determine	whether	these	SCVs	 were	 also	 positive	 for	 Galectin	 8,	 a	 marker	 of	 membrane	 damage	 and	 bacterial	cytosolic	 entry.	 To	 explore	 the	 localisation	 of	 multiple	 markers	 to	 SCVs,	 a	 super-resolution	microscopy	technique,	Structured	Illumination	Microscopy	(SIM),	was	used;	SIM,	described	 in	Chapter	 2.12.2,	 results	 in	 a	 two-fold	 improved	 resolution	 in	 the	 xy	axis	compared	to	images	taken	with	a	confocal	microscope.		SIM	analysis	revealed	Lysenin(W20A)	localised	with	endogenous	or	over-expressed	Galectin	8	 on	 the	 same	S.Typhimurium	 (Figure	 3.11A,B).	 Additionally,	 it	was	 evident	that	the	SCV	was	ruptured,	as	the	membrane	did	not	appear	to	encircle	the	Salmonella	completely	 (Figure	 3.11Bii,iii).	 Quantification	 of	 Lysenin(W20A)	 and	 Galectin	 8	recruitment	to	S.Typhimurium	showed	that	approximately	9%	of	S.Typhimurium	were	double	positive	for	both	proteins	at	60	minutes	p.i.	(Figure	3.11C).	Sphingomyelin	was	thus	 suggested	 to	 be	 exposed	 during	 SCV	 membrane	 damage	 and	 bacterial	 cytosolic	entry.	Interestingly,	Galectin	8	and	Lysenin	did	not	appear	to	completely	co-localise	on	the	SCV;	each	protein	localised	to	possible	membrane	micro-domains	that	only	partially	co-localised	(Figure	3.11A,B	–	white	arrows).	Exposed	sphingomyelin	and	glycans	may	therefore	be	located	on	different	parts	of	the	SCV	membrane.				
Figure	3.11:	Lysenin	localises	with	Galectin	8	on	a	proportion	of	bacteria.	
(A	 &	 B)	 Structured	 illumination	 micrographs	 of	 HeLa	 cells	 expressing	 (A)	 GFP-Lysenin(W20A)	
(B)	mCh-Lysenin(W20A)	 and	 YFP-Galectin	 8	 infected	 with	 BFP-expressing	 S.Typhimurium	 and	analysed	 at	 60	minutes	 p.i..	 (A)	 Galectin	 8	 was	 visualised	 using	 a	 Galectin	 8	 antibody.	White	arrows	 indicate	 areas	 of	 low	 Lysenin-Galectin	 8	 co-localisation.	 (C)	 Percentage	 of	
S.Typhimurium	 positive	 for	 Lysenin(W20A)	 or	 Galectin	 8	 at	 30	 and	 60	 minutes	 p.i.	 as	 counted	manually	 from	automated	 images	 taken	with	a	40x	objective.	Graph	shows	mean	+/-	S.E.M.	of	triplicate	wells	from	two	independent	experiments.	n>	390	bacteria	counted	per	well.	Scale	bar,	1µm.	
	
Figure	3.11	is	on	the	following	page.		
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Figure	3.11	legend	is	on	the	previous	page.	
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In	 addition	 to	 localisation	 of	 Lysenin	 and	 Galectin	 8	 to	 the	 same	 SCVs,	 sterile	damage	 assays	 indicated	 that	 Lysenin	 and	 Galectin	 8	 largely	 localised	 to	 the	 same	damaged	 endosomes	 and	 lysosomes,	 although	 a	 few	 structures	were	 Lysenin-positive	only	(Figure	3.12).		
	
	
Figure	3.12:	Lysenin	co-localises	with	Galectin	8	on	damaged	host	membranes.	Confocal	micrographs	of	HeLa	cells	expressing	GFP-Lysenin(W20A)	and	mCh-Galectin	8.	Cells	were	either	(A)	untreated,	(B)	 treated	with	PBS	containing	0.5M	sucrose	and	10%	PEG	(endosomal	lysis)	 or	 (C)	 treated	 with	 333µM	 GPN	 (lysosomal	 lysis).	 White	 arrows	 indicate	 examples	 of	Lysenin	 and	 Galectin	 8	 co-localisation;	 yellow	 arrows	 indicate	 examples	 of	 Lysenin-positive,	Galectin	8-negative	structures.	Scale	bar,	10µm.		 		
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As	Galectin	8	is	a	known	inducer	of	anti-bacterial	autophagy	(Chapter	1.3.2.1),	investigating	 whether	 Lysenin-positive	 SCVs	 were	 positive	 for	 other	 known	 anti-bacterial	 autophagy	 inducer	molecules,	 such	 as	NDP52	 and	 ubiquitin,	was	 of	 interest.	Indeed,	antibody-staining	for	endogenous	NDP52	or	polyubiquitin	revealed	that	Lysenin	localised	 on	 the	 same	 SCVs	 as	 NDP52	 and	 ubiquitin	 (Figure	 3.13).	 	 Interestingly,	Lysenin	 did	 not	 completely	 co-localise	 with	 ubiquitin	 on	 the	 SCV	 (Figure	 3.13B	 –	arrow)	suggesting	the	presence	of	SCV	membrane	micro-domains,	as	was	identified	with	Galectin	 8	 and	 Lysenin.	 SIM	 imaging	 of	 Lysenin	 and	 ubiquitin	 location	 on	 the	 SCV	membrane	would	therefore	be	informative.		
	
Figure	3.13:	Lysenin	positive	SCVs	are	also	positive	for	NDP52	and	Ubiquitin.	
(A)	 Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 GFP-Lysenin(CTD)	 infected	 with	
S.Typhimurium	and	stained	for	NDP52	at	60	minutes	p.i..		
(B)	 Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 GFP-Lysenin(CTD)	 infected	 with	
S.Typhimurium	 and	 stained	 for	 ubiquitin	 at	 60	 minutes	 p.i..	 White	 arrow	 indicates	 Lysenin-positive,	ubiquitin-negative	region	of	the	SCV.	Scale	bar,	10µm.		 The	 localisation	 of	 NDP52	 and	 ubiquitin	 with	 Lysenin	 on	 the	 same	 SCVs	suggested	 that	 investigations	 into	 SM	as	 a	 recruitment	mechanism	of	 early	 autophagy	inducers	 could	 be	 worthwhile.	 However,	 due	 to	 other	 aspects	 of	 sphingomyelin	exposure	being	the	focus	of	my	research,	this	line	of	investigation	has	yet	to	be	pursued.	
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3.8 Minor	and	major	damage	of	the	SCV	compartment	Having	determined	that	Lysenin	localised	to	the	same	SCVs	as	Galectin	8	in	a	proportion	of	cases,	it	was	of	great	interest	to	determine	the	timing	of	Lysenin	recruitment	to	these	bacteria	 relative	 to	 Galectin	 8,	 as	 this	 would	 indicate	when	 SM	 exposure	 occurred	 in	relation	to	glycan	exposure	and	cytosolic	entry	of	bacteria.		Fixed	 imaging	 of	 infection	 provided	 snap-shots	 of	 recruitment	 at	 specific	 time	points,	 which	 gave	 an	 indication	 of	 the	 recruitment	 order.	 However,	 a	 method	 of	continuously	 visualising	 protein	 recruitment	 to	 an	 individual	 SCV	 in	 real-time	 was	required	 to	 enable	 analysis	 of	 SCV	 damage	 progression.	 To	 achieve	 this,	 live	 imaging	using	a	spinning	disk	confocal	microscope	was	employed.	Additionally,	post-live	imaging	tracking	was	 used.	 Through	 this	 technique,	 described	 in	Chapter	 2.12.3.1,	 individual	BFP-expressing	S.Typhimurium	were	tracked	inside	cells	and	changes	 in	488nm	(GFP)	or	561nm	(mCh)	fluorescence	intensity	(F.I.)	around	the	bacterium	were	measured	with	time.	An	increase	in	F.I.	was	indicative	of	recruitment	of	the	corresponding	fluorescent	protein	to	the	bacterium	and	the	SCV.	Live	imaging	of	S.Typhimurium	infection	in	cells	co-expressing	Lysenin(W20A)	and	Galectin	8,	followed	by	tracking	individual	infection	events,	elucidated	that	Lysenin	was	recruited	 to	 S.Typhimurium	 before	 Galectin	 8	 (Figure	 3.14).	 Quantification	 of	 this	recruitment	showed	Lysenin	was	recruited	very	early,	within	30	minutes	p.i.,	and	before	Galectin	 8	 (Figure	 3.11C).	 For	 example,	 at	 30	 minutes	 p.i.,	 approximately	 8%	
S.Typhimurium	 were	 Lysenin-single	 positive	 compared	 to	 approximately	 0%	Galectin	8-single	 positive.	 At	 60	 minutes	 p.i.,	 approximately	 3%	 S.Typhimurium	were	Galectin	 8-positive,	 but	 these	 were	 also	 positive	 for	 Lysenin,	 indicating	 Lysenin	 had	already	been	recruited	(Figure	3.11C).	This	indicated	sphingomyelin	is	exposed	before	glycans	and	therefore	before	bacterial	cytosolic	entry.	On	 further	 investigation	 by	 live	 imaging,	 it	 was	 apparent	 that	 not	 only	 was	Lysenin	 recruited	 to	 the	 bacteria	 before	 Galectin	 8,	 but	 that	 the	 appearance	 of	 each	protein	 around	 the	 bacteria	 differed;	 Lysenin	 appeared	 more	 gradually	 compared	 to	Galectin	 8	 which	 appeared	 in	 a	 sharp	 burst	 (Figure	 3.14).	 This	 suggested	 that	sphingomyelin	is	exposed	more	gradually	than	glycans.	
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Figure	3.14:	Lysenin	is	recruited	to	S.Typhimurium	before	Galectin	8.	Tracking	of	 an	 individual	S.Typhimurium	 in	HeLa	 cells	 expressing	GFP-Lysenin(W20A)	and	mCh-Galectin	8.	Cells	were	infected	with	BFP-expressing	S.Typhimurium	and	imaged	from	10	minutes	p.i.	 in	one	minute	 intervals.	Graph	 indicates	 changes	 in	mean	488nm	and	561nm	 fluorescence	intensity	 around	 the	 bacterium.	 Time	 indicated	 is	 from	 the	 start	 of	 the	 track	 rather	 than	bacterial	entry	into	the	cell.	Graph	shown	is	a	representative	example.			 	The	 exposure	 of	 sphingomyelin	 before	 glycans	 suggested	 that	 sphingomyelin	becomes	exposed	on	the	cytosolic	leaflet	of	the	SCV	before	rupture	of	the	SCV	exposing	glycans	on	the	 intra-luminal	 leaflet.	Therefore,	SCV	rupture	may	progress	through	two	different	stages.	Firstly,	a	‘minor’	form	of	damage	may	occur	sufficient	for	sphingomyelin	translocation	onto	the	cytosolic	leaflet,	thus	recruiting	Lysenin,	but	not	severe	enough	to	enable	glycans	to	be	exposed;	their	larger	headgroups	could	be	sterically	hindered	from	being	exposed	at	a	small	damage	site.	A	more	‘major’	form	of	damage	may	then	occur	of	sufficient	magnitude	for	SCV	rupture	and	glycan	exposure,	thereby	recruiting	Galectin	8.	Live	 imaging	 of	 S.Typhimurium	 infection	 revealed	 that	 appearance	 of	 a	 possible	breakage	 point	 in	 the	 Lysenin-positive	 SCV	 membrane,	 indicating	 major	 rupture,	coincided	 with	 Galectin	 8	 recruitment	 (Figure	 3.15).	 	 This	 possible	 breakage	 point	could	 be	 imaged	 in	 greater	 resolution	 in	 future	 experiments	 using	 Live	 Structured	Illumination	Microscopy.		 	
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Figure	 3.15:	 Galectin	 8	 recruitment	 to	 S.Typhimurium	 coincides	 with	 rupture	 of	 the	
Lysenin-positive	vacuole.	Selected	 frames	 from	 live	 imaging	 of	 HeLa	 cells	 expressing	 GFP-Lysenin(W20A)	 and	mCh-Galectin	8	infected	with	BFP-expressing	S.Typhimurium.	White	arrow	indicates	appearance	of	a	small	break	in	the	SCV	membrane.		Scale	bar,	2µm.			 In	view	of	this	two-stage	damage	progression,	determining	an	indicative	marker	for	minor	versus	major	damage	was	of	interest.	The	location	of	the	flagella	during	SCV	rupture	was	 initially	 tested	 for	 suitability	 as	 such	 a	marker;	 for	 example,	 whether	 in	minor	 damage,	 Salmonella	 flagella	 were	 still	 enclosed	 within	 the	 SCV,	 whilst	 flagella	extended	 beyond	 the	 SCV	 in	 major	 damage.	 SIM	 analysis	 revealed	 that	 Salmonella	flagella	 could	 indeed	 be	 located	 within,	 or	 extend	 from,	 the	 SCV;	 in	 some	 cases	 the	flagella	 were	 tightly	 wrapped	 around	 the	 bacterium	 and	 confined	 within	 a	Lysenin-positive	SCV	membrane,	whilst	 in	other	cases	 the	 flagella	were	elongated	and	had	escaped	the	confines	of	the	Lysenin-positive	vacuole	(Figure	3.16).			 	
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Figure	3.16:	S.Typhimurium	flagella	are	located	inside,	or	extend	from,	the	vacuole.	Structured	 illumination	micrographs	 of	 HeLa	 cells	 expressing	mCh-Lysenin(W20A)	infected	with	BFP-expressing	S.Typhimurium	and	fixed	at	(A)	15	minutes	(B)	30	minutes	(C)	60	minutes	p.i..	Flagella	were	visualised	using	an	antibody	against	FliC.	Scale	bar,	1µm.				 	
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The	relationship	between	Galectin	8	 recruitment	and	 flagella	 location	was	 then	investigated.	 It	 was	 predicted	 that	 Lysenin-positive	 SCVs	 containing	 confined	 flagella	would	 be	 Galectin	 8-negative,	 indicative	 of	minor	 damage,	 and	 Lysenin-positive	 SCVs	containing	elongated	flagella	would	be	Galectin	8-positive,	 indicative	of	major	damage.	SIM	analysis	of	S.Typhimurium	infection	in	HeLa	cells	co-expressing	mCh-Lysenin(W20A)	and	YFP-Galectin	8	 revealed	 some	double	positive	 SCVs	did	 contain	 flagella	 extending	beyond	 the	 vacuole	 (Figure	 3.17A).	 However,	 other	 double	 positive	 SCVs	 contained	flagella	 seemingly	 enclosed	within	 the	 vacuole	 (Figure	 3.17B).	 Therefore,	 it	 was	 not	possible	to	use	the	flagella	location	as	a	marker	of	SCV	damage	stage.	
	
Figure	3.17:	Flagella	location	is	not	indicative	of	minor	versus	major	stages	of	SCV	rupture.	Structured	 illumination	 micrographs	 of	 HeLa	 cells	 expressing	 mCh-Lysenin(W20A)	 and	 YFP-Galectin	 8	 infected	 with	 BFP-expressing	 S.Typhimurium.	 Flagella	 were	 visualised	 using	 an	antibody	against	FliC	at	60	minutes	p.i..	Scale	bar,	1µm.			
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3.9 Identifying	the	cause	of	minor	damage	and	early	exposure	
of	sphingomyelin	The	 cause	 of	minor	 or	major	 BCV	 rupture	 is	 unknown.	One	 attractive	 cause	 of	minor	damage	was	the	protrusion	of	the	Salmonella	 type	III	secretion	system	(TTSS)	into	the	host	 plasma	membrane	 to	 enable	 cell	 entry.	 TTSS	 are	 needle-shaped	 protrusions	 that	extend	 from	 the	 bacterium	 across	 the	 host	 cell	membrane.	 Bacterial	 effector	 proteins	are	translocated	across	the	TTSS	into	the	host	cell	cytosol	to	subvert	cellular	functions	for	bacterial	benefit	(Hueck,	1998;	Schlumberger	&	Hardt,	2006).	Salmonella	encode	two	TTSS	 on	Salmonella	 Pathogenicity	 Island	 1	 (SPI-1)	 and	 2	 (SPI-2),	 each	 translocating	 a	different	 set	 of	 effector	 proteins.	 SPI-1	 TTSS	 expression	 is	 induced	 by	 environmental	factors	 triggering	 activation	 of	 the	 transcription	 factor,	 HilA	 (Bajaj	 et	al,	 1996)	 and	 is	essential	for	bacterial	entry	into	non-phagocytic	cells	(Jones	et	al,	1994;	Penheiter	et	al,	1997).	 Entry	 is	 achieved	 by	 translocation	 of	 several	 bacterial	 effector	 proteins	responsible	 for	 modifying	 the	 host	 cell	 cytoskeleton,	 inducing	 ruffle	 formation	 and	bacterial	uptake.	SPI-2	expression	occurs	after	 internalisation	of	the	bacterium	into	an	SCV	 and	 is	 regulated	 by	 intravacuolar	 environmental	 signals	 such	 as	 vacuole	acidification	(Deiwick	et	al,	1999;	Yu	et	al,	2010).	It	 seemed	 plausible	 that	 a	 TTSS	 protruding	 through	 the	 SCV	 membrane	 may	cause	minor,	localised	damage	to	the	membrane	and	provide	a	continuous	membranous	pathway	along	which	sphingomyelin	could	diffuse	 from	the	 intra-luminal	 leaflet	 to	 the	cytosolic	leaflet.	The	observed	gradual	recruitment	of	Lysenin	(Figure	3.14)	supported	this	hypothesis	as	a	cause	of	the	gradual	appearance	of	sphingomyelin.	To	investigate	whether	SPI-1	was	involved	in	membrane	damage	and	subsequent	sphingomyelin	exposure,	a	mutant	Salmonella	Typhimurium	strain	that	lacked	the	SPI-1	TTSS	was	used.	However,	these	bacteria	were	unable	to	enter	cells	and	thus	the	addition	of	a	cell	entry	mechanism	was	required.	To	this	effect,	these	Salmonella	were	engineered	to	express	Invasin	from	Yersinia	enterocolitica.	This	protein	enables	Yersinia	species	to	adhere	to	the	cell	surface	and	enter	cells	via	a	SPI-1	independent	mechanism.	Thus,	the	
Salmonella	expressing	Invasin	would	be	able	to	infect	cells	and	are	hereafter	referred	to	as	∆SPI-1/InvA.		The	 Randow	Group	 had	 previously	 shown	 that	 ∆SPI-1/InvA	 Salmonella	 do	 not	recruit	 Galectin	 8	 (data	 not	 shown).	 Similar	 to	 this,	 infection	 of	 mCh-Lysenin(W20A)	expressing	 cells	 with	 ∆SPI-1/InvA	 Salmonella	 resulted	 in	 no	 Lysenin	 recruitment	
Cara	J.	Ellison	 	 Chapter	3:	Results	
	 104	
(Figure	 3.18).	 This	 suggested	 the	 cell	 entry	 mechanism	 of	 Salmonella	 must	 be	responsible	for	causing	the	SCV	damage,	both	minor	and	major	forms.			
	
	
Figure	3.18:	Lysenin	recruitment	to	S.Typhimurium	is	SPI-1	TTSS	dependent.	Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 mCh-Lysenin(W20A)	 infected	 with	
(A)	S.Typhimurium	wild	 type	 (wt)	 or	 (B)	 S.Typhimurium	∆SPI-1/InvA.	 Cells	were	 fixed	 at	 60	minutes	p.i.	and	stained	with	Hoechst	dye	to	visualise	nuclei	and	bacteria.	Scale	bar,	50µm.		 	Following	 the	 finding	 that	 neither	 minor	 nor	 major	 membrane	 damage	 was	caused	 in	 the	 absence	 of	 SPI-1,	 it	was	 important	 to	 assess	whether	 SPI-1	 alone	 could	cause	membrane	damage	or	whether	SPI-1-dependent	cell	entry	was	also	required.	To	determine	this,	HeLa	cells	were	infected	with	Enteropathogenic	Eschericia	Coli	(EPEC),	a	bacterial	species	that	adheres	to	the	cell	surface,	projects	its	TTSS	through	the	host	cell	plasma	membrane	but	does	not	enter	the	host	cell.	If	the	Salmonella	SPI-1	TTSS	poking	through	the	SCV	membrane	were	providing	a	pathway	for	sphingomyelin	to	translocate	to	 the	cytosolic	 leaflet,	 it	would	be	expected	 that	 the	EPEC	needle	protruding	 through	the	plasma	membrane	would	mimic	this	and,	thus,	Lysenin	would	be	recruited	to	sites	of	EPEC	 adhesion.	However,	 this	was	 not	 the	 case;	 Lysenin	was	 not	 recruited	 to	 sites	 of	EPEC	attachment	(Figure	3.19A).		
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This	negative	result	may	have	been	due	to	the	host	cell	plasma	membrane	having	insufficient	curvature	compared	to	that	of	an	SCV,	thus	a	TTSS	pushing	through	a	curved	membrane	 may	 enable	 sphingomyelin	 diffusion.	 To	 test	 this,	 THP1	 cells,	 a	 human	phagocytic	 cell	 line,	 were	 infected	 with	 EPEC.	 EPEC	 would	 be	 phagocytosed	 and	protrude	its	TTSS	through	the	phagosome	membrane	without	entering	the	cytosol.	Thus,	this	 would	 be	 equivalent	 to	 the	 Salmonella	 SPI-1	 TTSS	 protruding	 into	 an	 SCV	membrane.	 Nevertheless,	 in	 THP1	 cells	 expressing	 GFP-Lysenin(W20A),	 no	 Lysenin-positive	EPEC	were	detected	(Figure	 3.19B),	 suggesting	 the	EPEC	TTSS	 is	not	able	 to	induce	membrane	damage.	However,	confirmation	of	EPEC	phagocytosis,	as	opposed	to	surface	 adherence,	would	be	 required,	 by	 staining	non-permeabilsed	 cells	 for	LPS,	 for	example.		To	 investigate	whether	cell	entry	effector	proteins	 translocated	 into	the	cytosol	via	 the	 TTSS	 were	 the	 cause	 of	 membrane	 damage,	 two	 Salmonella	 strains	 lacking	various	combinations	of	essential	invasion	proteins	were	tested.	The	first,	M701,	lacked	SipA,	SopB	and	SopE2	but	still	possessed	SopE	(Müller	et	al,	2009)	and	the	second,	M566,	lacked	SipA,	SopB,	SopE2	and	SopE	(Misselwitz	et	al,	2011).	SipA,	SopB,	SopE2	and	SopE	are	 functionally	 redundant	 in	 the	 bacterial	 invasion	 process.	 M701	 Salmonella	 are	predicted	 to	enter	cells,	whilst	M566	are	similar	 to	EPEC	as	 they	are	unable	 to	 invade	cells,	but	still	adhere	to	the	cell	surface	and	protrude	the	SPI-1	TTSS	through	the	plasma	membrane.	 Infection	 with	 M701	 Salmonella	 resulted	 in	 Lysenin	 recruitment	 (Figure	
3.19C),	suggesting	that	the	presence	of	only	one	invasion	effector	protein	is	sufficient	to	cause	 ‘minor’	damage.	Upon	infection	with	M566,	no	mCh-Lysenin(W20A)	recruitment	to	these	Salmonella	was	detected	(Figure	 3.19D,E)	 either	during	 initial	 attachment,	 at	6	minutes	p.i.,	or	during	later	time	points	of	attachment,	at	60	minutes	p.i..		Following	 this,	 investigating	 whether	 the	 Salmonella	 SPI-1	 TTSS	 of	 the	 M566	strain	poking	 through	a	membrane	with	higher	curvature	could	 induce	minor	damage	was	important.	For	these	experiments,	the	M566	were	required	to	enter	cells.	Through	genetic	manipulation,	M566	Salmonella	were	engineered	to	express	the	InvA	protein,	as	described	in	Chapter	2.9.6.	Confirmation	of	M566/InvA	cell	entry	ability	was	achieved	through	 LPS	 staining	 of	 non-permeabilised	 cells	 (Figure	 3.20A);	 at	 60	 minutes	 p.i.,	approximately	50%	of	M566	Salmonella	were	LPS-negative,	thus	intracellular.	HeLa	cells	expressing	mCh-Lysenin(W20A)	 and	 YFP-Galectin	 8	 were	 infected	with	 this	M566/InvA	strain;	 however,	 quantification	 showed	 negligible	 Lysenin	 and	 Galectin	 8	 recruitment	
(Figure	3.20B).		
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Taken	 together,	 these	 results	 suggest	 that,	 in	 addition	 to	 SPI-1	 TTSS-mediated	damage	 of	 the	 SCV	membrane,	 invasion	 effector	 proteins	 are	 also	 involved	 in	 causing	SCV	 membrane	 damage.	 However,	 confirmation	 that	 SPI-1	 TTSS	 assembly	 and	 host	membrane	protrusion	occurred	in	bacterial	strains	that	do	not	enter	the	cytosol	would	be	 required	 before	 forming	 a	 definitive	 conclusion	 to	 the	 question	 of	 whether	membrane	 damage	 is	 caused	 solely	 by	 SPI-1	 TTSS	 protrusion	 through	 the	 SCV	membrane.	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	 3.19:	 Type	 III	 secretion	 needles	 of	 bacteria	 protruding	 through	 the	 plasma	
membrane	do	not	cause	membrane	damage.	Confocal	 micrographs	 of	 (A)	 HeLa	 cells	 expressing	 mCh-Lysenin(W20A)	 or	 (B)	 THP1	 cells	expressing	 GFP-Lysenin(W20A)	 infected	 with	 Enteropathogenic	 Eschericia	 Coli	 (EPEC)	 and	analysed	at	30	minutes	p.i..	(C-E)	HeLa	cells	expressing	mCh-Lysenin(W20A)	infected	with	mutant	strains	 of	 S.Typhimurium	M701	 (ΔSipA,	 SopB,	 SopE2)	 and	M566	 (ΔSipA,	 SopB,	 SopE2,	 SopE).	Cells	were	analysed	at	(C)	30	minutes,	(D)	6	minutes	,	(E)	60	minutes	p.i..	Scale	bar	(B)	5µm.	All	other	scale	bars,	10µm.	
	
Figure	3.19	is	on	the	following	page.	
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Figure	3.19	legend	is	on	the	previous	page.	 	
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Figure	 3.20:	 Lysenin	 and	 Galectin	 8	 are	 not	 recruited	 to	 intracellular	 M566	
S.Typhimurium.	
(A)	HeLa	cells	infected	with	M566	or	M566/InvA	S.Typhimurium,	were	probed	with	an	antibody	against	 LPS	 (cells	 were	 non-permeabilised)	 at	 60	 minutes	 p.i..	 Intracellular	 (LPS-negative)	
S.Typhimurium	were	counted	manually	from	confocal	images	taken	with	a	63x	objective.	Graph	shows	mean	 +/-	 S.E.M	 of	 three	 coverslips	 from	 one	 experiment.	 n>320	 bacteria	 counted	 per	coverslip.	 (B)	 HeLa	 cells	 expressing	mCh-Lysenin(W20A)	and	 YFP-Galectin	 8	were	 infected	with	M566/InvA	 S.Typhimurium	 and	 fixed	 at	 indicated	 time	 points.	 Bacteria	 were	 visualised	 by	staining	 for	 LPS	 following	 cell	 permeabilisation.	 Marker	 positive	 M566/InvA	 S.Typhimurium	were	 counted	 by	 automated	 counting.	 Graph	 shows	 mean	 +/-	 S.E.M	 of	 three	 wells	 from	 one	experiment.	n>20,000	bacteria	were	counted	per	well.			
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3.10 Identifying	the	cause	of	major	damage		One	 possible	 cause	 of	 SCV	 major	 damage	 may	 be	 bacterial	 division	 within	 an	 SCV	causing	mechanical	 stress	 on	 the	membrane.	 It	 would	 be	 hypothesised	 that	 Lysenin-single	positive	SCVs	would	contain	only	one	bacterium,	whilst	Lysenin-Galectin	8-double	positive	 SCVs	 would	 contain	 more	 than	 one	 bacterium.	 To	 investigate	 this,	 mCh-Lysenin(W20A)-expressing	 HeLa	 cells	 were	 infected	 with	 wild	 type	 S.Typhimurium	 and	antibody-stained	 for	 endogenous	 Galectin	 8.	 The	 number	 of	 SCVs	 containing	 one	bacterium	or	more	than	one	was	subsequently	quantified.	At	both	very	early	time	points,	15	minutes	 p.i.,	 and	 later	 in	 infection,	 60	minutes	 p.i.,	 SCVs	 that	 were	 Lysenin-single	positive	but	contained	more	than	one	bacterium	were	observed,	and	at	60	minutes	p.i.,	SCVs	 that	 were	 double	 positive	 but	 only	 containing	 one	 bacterium	 were	 identified	
(Figure	3.21).	Bacterial	division	was	therefore	not	a	cause	of	major	damage.	However,	these	quantification	results	were	obtained	by	counting	 fixed	bacteria	 in	a	single	plane.	Thus,	the	bacterium	may	have	appeared	as	one	but	been	in	the	process	of	dividing	or	the	bacterium	may	 have	 divided	 yet	 been	 on	 top	 of	 the	 other	 bacterium,	 appearing	 as	 a	single	bacterium.	Quantification	by	live	imaging	would	ultimately	resolve	this.			
	
Figure	3.21:	Major	damage	is	not	caused	by	bacterial	replication.	HeLa	 cells	 expressing	 mCh-Lysenin(W20A)	 were	 infected	 with	 S.Typhimurium	 and	 stained	 for	Galectin	8	at	indicated	time	points.	The	number	of	Lysenin-single	positive	SCVs	containing	only	one	 or	 >1	 bacterium	 and	 Lysenin-Galectin	 8-double	 positive	 SCVs	 containing	 only	 one	 or	 >1	bacterium	 was	 quantified.	 Graph	 shows	 mean	 +/-	 S.E.M	 for	 triplicate	 coverslips	 of	 one	experiment	counted	by	microscopy	using	a	100x	objective.	n>	50	SCVs	counted	per	coverslip	at	15	and	60	minutes	p.i.,	respectively.	SCV,	Salmonella-containing	vacuole.	
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	 Another	 possible	 theory	 is	 that	 the	 minor	 damage	 resulting	 in	 sphingomyelin	exposure	 is	 a	 precursor	 for	major	 damage:	 sphingomyelin	 exposure	with	 subsequent	hydrolysis	 to	 ceramide	 and	 other	 downstream	 lipids,	 such	 as	 sphingosine,	 may	 de-stabilise	the	SCV	membrane,	causing	major	membrane	rupture.	Lysenin	binding	would	thus	 be	 predicted	 to	 reduce	 or	 delay	 SCV	 rupture	 through	 preventing	 catabolism	 of	sphingomyelin.	 However,	 Lysenin	 co-expression	with	 Galectin	 8	 in	 HeLa	 cells	 did	 not	affect	 the	 number	 of	 Galectin	 8-positive	 SCVs	 compared	 to	 in	 the	 absence	 of	 Lysenin	
(Figure	 3.22).	 Lysenin	 binding	 did	 not,	 therefore,	 appear	 to	 reduce	 SCV	 rupture.	However,	Lysenin	binding	may	delay	SCV	rupture.	Therefore,	it	would	be	interesting	to	assess	the	effect	of	Lysenin	on	the	timing	of	Galectin	8	recruitment	to	SCVs	by	tracking	live	imaging	infection	events	and	comparing	the	time	post	infection	at	which	Galectin	8	recruitment	occurs	in	the	absence	or	presence	of	Lysenin.			
		
Figure	3.22:	Lysenin	does	not	reduce	Galectin	8	recruitment	to	S.Typhimurium.	Percentage	 of	 S.Typhimurium	positive	 for	mCh-Galectin	 8	 in	 the	 absence	 or	 presence	 of	 GFP-Lysenin(W20A)	was	manually	counted	from	automated	 images	taken	with	a	40x	objective.	Graph	shows	mean	 +/-	 S.E.M	 of	 triplicate	wells	 from	 two	 independent	 experiments.	 n>400	 bacteria	counted	per	well.	ns,	non-significant.					
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3.11 Conclusion	The	 results	 described	 in	 this	 Chapter	 elucidate	 that	 sphingomyelin	 is	 exposed	 on	damaged	 Salmonella-containing	 vacuoles	 (SCVs)	 indicated	 by	 recruitment	 of	 the	sphingomyelin-specific	 toxin,	 Lysenin,	 to	 SCVs.	 Lysenin	 was	 also	 recruited	 to	professional	 cytosol-dwelling	 bacteria	 such	 as	 Shigella	 flexneri	 and	 Listeria	
monocytogenes,	 suggesting	 that	 sphingomyelin	 exposure	 is	 not	 bacterial	 species-dependent.		Sphingomyelin	 exposure	 was	 also	 revealed	 to	 occur	 before	 Galectin	 8	recruitment,	 indicating	 that	 sphingomyelin	 is	exposed	on	 the	cytosolic	 face	of	 the	SCV	before	the	SCV	had	ruptured.	Occurrence	of	two	phases	of	SCV	damage	were	therefore	suggested:	 ‘minor’	 damage	 in	 which	 sphingomyelin	 diffuses	 around	 a	 small	 point	 of	damage	 from	the	 intra-luminal	side	 to	 the	cytosolic	side,	and	 ‘major’	damage	 in	which	the	vacuole	bursts	open	and	glycans	are	exposed.	However,	the	recruitment	of	Lysenin	to	SCVs	before	Galectin	8	could	also	be	explained	by	differences	 in	abundance	of	each	respective	 ligand	or	due	to	differences	 in	 ligand-binding	mechanisms	of	 the	respective	protein.			The	 cause	 of	 minor	 and	 major	 SCV	 rupture	 was	 also	 investigated	 and	 results	suggested	that	the	SPI-1	TTSS	protruding	through	the	SCV	membrane	might	be	involved	in	causing	membrane	damage.	Entry	effector	proteins,	such	as	SopE,	were	also	indicated	to	 be	 involved,	 implying	 that	 physical	 protrusion	 of	 the	 SPI-1	 TTSS	 through	 the	 SCV	membrane	may	not	be	solely	responsible	for	membrane	damage.	This	 Chapter	 also	 validates	 Lysenin	 specificity	 for	 sphingomyelin	 through	 cell	surface	binding	assays	and	the	significant	reduction	of	Lysenin	recruitment	 in	cases	of	reduced	 sphingomyelin	 exposure.	 Furthermore,	 mutants	 have	 been	 designed	 that	successfully	abolish	Lysenin	recruitment	to	SCVs.	Taken	 together,	 these	 results	 suggest	 that	 the	 host	 lipid	 sphingomyelin	 is	exposed	on	damaged	BCVs	and	may	function	as	an	early	danger	signal	occurring	before	the	Galectin	8	response.						
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Chapter	 4:	 Identifying	 endogenous	 sphingomyelin-
binding	proteins	
4.1 Summary	This	 Chapter	 describes	 the	 successful	 establishment,	 execution	 and	 analysis	 of	 an	enrichment	 assay	 to	 identify	 endogenous	 sphingomyelin-binding	 proteins.	 I	 tested	multiple	 different	 methods	 of	 assay	 design,	 ultimately	 using	 liposomes	 containing	 or	lacking	sphingomyelin.	49	candidate	proteins	were	identified	and	tested	for	recruitment	to	 S.Typhimurium.	 Twelve	 candidates	 were	 recruited,	 of	 which	 TECPR1,	 SH3BP5L,	HPCAL1	and	VPS29	became	the	subject	of	further	investigation.	
4.2 Introduction	Following	 my	 observations	 that	 sphingomyelin	 was	 exposed	 on	 damaged	 bacteria-containing	 vacuoles,	 elucidating	 the	 biological	 importance	 of	 this	 exposure	 was	paramount.	 One	 method	 for	 ascertaining	 the	 biological	 relevance	 was	 to	 identify	endogenous	receptors	for	sphingomyelin.	If	such	a	sphingomyelin-binding	protein	could	be	 identified,	 investigating	 its	 properties,	 function	 and	 binding	 partners	 would	illuminate	the	relevance,	or	biological	purpose,	of	sphingomyelin	exposure	and	confirm	whether	sphingomyelin	acts	as	a	danger	signal.		In	 this	 Chapter,	 I	 describe	 the	 design	 and	 execution	 of	 an	 enrichment	 assay	 to	identify	 endogenous	 sphingomyelin-binding	 proteins.	 The	 approach	 taken	 was	 to	compare	 enrichment	 of	 cell	 lysate	 proteins	 bound	 to	 a	 sphingomyelin-rich	 surface	relative	 to	 a	 sphingomyelin-negative	 surface,	 as	 a	 negative	 control.	 Identification	 and	enrichment	quantification	of	bound	proteins	was	achieved	by	Tandem	Mass	Tag	(TMT)	labelling	 followed	 by	 tandem	 mass	 spectrometry	 analysis.	 Here,	 I	 also	 present	 the	results	of	 the	enrichment	assay	and	 summarise	 the	 sphingomyelin-binding	 candidates	identified.	
4.3 Designing	the	enrichment	assay	The	 most	 fundamental	 step	 in	 designing	 the	 assay	 was	 to	 ensure	 an	 optimal	sphingomyelin-rich	surface	was	used.	Various	sphingomyelin-rich	surfaces	were	tested	before	selecting	the	optimal	method	to	pursue.		
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4.3.1 Sphingomyelin	–	coated	beads	Firstly,	sphingomyelin-coated	beads	were	assessed	for	enrichment	assay	suitability.	To	test	 this,	 sphingomyelin-coated	 agarose	 beads	 (Echelon)	 were	 incubated	 with	recombinant	Lysenin(CTD)-GFP,	 recombinant	Lysenin	K185A(CTD)-GFP	or	GFP-Galectin	8	as	described	in	Chapter	2.15.	However,	whilst	Lysenin(CTD)-GFP	did	bind	the	beads,	the	negative	 controls	 of	 Lysenin	 K185A(CTD)-GFP	 (discovered	 in	Chapter	 3.6.4)	 and	 GFP-Galectin	8,	also	bound	the	beads,	suggesting	non-specific	interactions	between	the	beads	and	these	proteins	(Figure	4.1).	Varying	the	level	of	detergent	in	the	assay	is	one	way	to	prevent	 such	 interactions	 but	 a	 preliminary	 test	 with	 increased	 detergent	 did	 not	prevent	non-specific	binding	(data	not	shown).	Sphingomyelin-coated	beads	were	thus	sub-optimal	for	the	enrichment	assay.		
	
Figure	4.1:	Sphingomyelin-coated	beads	bind	Lysenin	non-specifically.	Western	 blot	 probing	with	 an	α-GFP	 antibody.	 Assay	 incubating	 sphingomyelin-coated	 beads	with	Lysenin(CTD)-GFP,	Lysenin	K185A(CTD)-GFP	or	GFP-Galectin	8.	10%	Input	is	shown.	I,	input;	B,	bound;	S,	supernatant	after	binding;	W,	supernatant	after	first	post-binding	wash.			 	
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4.3.2 Sheep	Red	Blood	Cells	Following	 the	 results	using	 sphingomyelin-coated	beads,	 it	was	 then	 tested	whether	a	cell	 plasma	 membrane	 could	 be	 used	 for	 the	 sphingomyelin-rich	 surface.	 	 To	 avoid	potential	endocytosis	of	cell	lysate	proteins	applied	to	the	cell	surface,	a	readily	available,	non-endocytic	 cell	 type	 was	 investigated:	 sheep	 red	 blood	 cells	 (RBCs).	 Sheep	 RBC	membranes	 are	 composed	 of	 68%	 SM	 and	 phospholipids,	 which	 is	 higher	 than	 in	humans	and	other	animals	such	as	pigs,	rats	and	rabbits	(de	Gier	&	van	Deenen,	1961).	Intact	sheep	RBCs	were	sub-optimal	for	use	in	the	enrichment	assay,	as	will	be	discussed	in	Chapter	4.3.3.	
4.3.3 Lysed	Sheep	Red	Blood	Cells	(ghosts)	Lysed	and	washed	sheep	red	blood	cells,	hereafter	known	as	ghosts,	were	investigated	for	 enrichment	 assay	 suitability,	 as	 their	 sphingomyelin-rich	 surface	 would	 still	 be	present	 and	 exposed.	 Ghosts,	 prepared	 as	 described	 in	 Chapter	 2.19,	 did	 not	 bind	recombinant	GFP	(Figure	4.2A).	Thus,	non-specific	protein-ghost	interactions	were	not	occurring,	 contrary	 to	 the	 results	with	 sphingomyelin-coated	 beads.	 Upon	 addition	 of	Lysenin(CTD)-GFP	to	ghosts,	 the	free	GFP	did	not	bind,	but	Lysenin(CTD)-GFP	did	(Figure	
4.2B).	The	absence	of	Lysenin(CTD)-GFP	in	the	supernatant	is	a	clear	read-out	for	binding	to	ghosts.		Pretreatment	 of	 the	 ghosts	 with	 recombinant	 bacterial	 sphingomyelinase	(bSMase),	 used	 in	 assays	 described	 in	 Chapter	 3.6.3,	 prevented	 Lysenin(CTD)-GFP	binding	 (Figure	 4.2C),	 confirming	 Lysenin	 binding	 to	 ghosts	 was	 sphingomyelin-dependent.		
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Figure	4.2:	Sheep	red	blood	cell	ghosts	bind	recombinant	Lysenin(CTD)	in	a	sphingomyelin-
dependent	manner.		Silver	stains	of	sheep	red	blood	cell	ghost	binding	assays.	
(A)	Untreated	ghosts	were	incubated	with	recombinant	GFP.		
(B)	Untreated	ghosts	were	incubated	with	recombinant	Lysenin(CTD)-GFP.		
(C)	Ghosts	pretreated	with	varying	concentrations	of	bSMase	were	incubated	with	recombinant	Lysenin(CTD)-GFP.		The	absence	of	recombinant	Lysenin(CTD)-GFP	in	the	supernatant,	highlighted	by	the	green	box,	is	indicative	of	binding	to	ghosts.	The	presence	of	recombinant	Lysenin(CTD)-GFP	in	the	supernatant,	highlighted	by	the	blue	box,	is	indicative	of	no	binding	to	ghosts.	10%	Input	is	shown.	G,	ghosts	alone;	I,	input;	S,	supernatant	after	pretreatment	of	ghosts	with	bSMase;	S,	supernatant	after	binding;	B,	bound	proteins;	E,	bSMase	input	at	67µg/ml.	
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Pretreatment	 of	 ghosts	 with	 bSMase	 would	 provide	 a	 sphingomyelin-negative	surface	for	the	enrichment	assay.	Therefore,	ghosts,	opposed	to	intact	sheep	RBCs,	were	a	more	suitable	sphingomyelin-rich	surface,	as	pretreatment	of	intact	sheep	RBCs	with	bSMase	 resulted	 in	 their	 lysis,	 with	 consequential	 haemoglobin	 release	 into	 the	supernatant.	 This	 haemoglobin	would	 swamp	 the	 total	 sample	 signal	 detected	 by	 the	mass	spectrometry	instrument,	rendering	intact	sheep	RBCs	unusable	for	the	assay.		To	confirm	Lysenin	bound	 the	ghosts	when	present	 in	a	whole	 cell	 lysate,	 thus	more	 representative	 of	 the	 eventual	 enrichment	 assay,	 ghosts	 were	 incubated	 with	lysates	of	cells	expressing	GFP-Lysenin(CTD).	Cell	lysates	were	prepared	using	mechanical	lysis	as	described	 in	Chapter	 2.18.1.	Western	blot	analysis	 indicated	GFP-Lysenin(CTD)	bound	to	untreated,	but	not	pretreated,	ghosts	(Figure	4.3)	thereby	implying	the	ghosts	would	 be	 functional	 to	 bind	 endogenous	 sphingomyelin-binding	 proteins	 in	 the	 cell	lysates.			
		
Figure	 4.3:	 Ghosts	 bind	 GFP-Lysenin(CTD)	 in	 HeLa	 cell	 lysates	 in	 a	 sphingomyelin-
dependent	manner.	Western	blot	probing	with	an	α-GFP	antibody.	Lanes	2	and	3:	Lysates	of	HeLa	cells	expressing	GFP-Lysenin(CTD)	were	incubated	with	untreated	ghosts.	Lanes	4	and	5:	Lysates	of	HeLa	cells	expressing	GFP-Lysenin(CTD)	were	incubated	with	pretreated	ghosts.	The	supernatant	was	retained.	Lanes	 6	 and	 7:	 Supernatant	 from	 lane	 4	 was	 incubated	 again	 with	 pretreated	 ghosts.	 The	supernatant	was	retained.	Lanes	 8	 and	 9:	 Supernatant	 from	 lane	 6	 was	 incubated	 again	 with	 pretreated	 ghosts.	 The	supernatant	was	retained.	Lanes	10	and	11:	Supernatant	from	lane	8	was	incubated	with	untreated	ghosts.	10%	Input	is	shown.	I,	input	GFP-Lysenin(CTD)	lysate;	S,	supernatant;	B,	bound	proteins.	
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A	method	to	deplete	the	cell	lysate	of	proteins	that	non-specifically	interact	with	the	 ghosts	 was	 to	 incubate	 the	 lysate	 with	 bSMase-pretreated	 ghosts	 and	 retain	 the	supernatant.	 GFP-Lysenin(CTD)	 was	 still	 able	 to	 bind	 untreated	 ghosts	 after	 several	rounds	 of	 this	 depletion	 step	 (Figure	 4.3).	 It	 is	 important	 to	 note	 that	 potential	candidates	that	bind	a	ligand	in	addition	to	SM	would	also	be	removed	from	the	lysate	upon	 first	 incubation	 with	 bSMase-pretreated	 ghosts.	 To	 account	 for	 this,	 analysis	 of	proteins	bound	 to	untreated	or	pretreated	ghosts	without	 the	depletion	step	was	also	included	in	the	enrichment	assay	(Figure	4.4).		
	
Figure	 4.4:	 Diagram	 of	 experiment	 design	 for	 identifying	 endogenous	 sphingomyelin-
binding	proteins	using	ghosts.		
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In	 view	 of	 the	 successful	 control	 experiments	 investigating	 Lysenin	 binding	 to	ghosts,	 a	 preliminary	 test	 enrichment	 assay	 was	 subsequently	 executed	 incubating	untreated	 or	 pretreated	 ghosts	 with	 lysate	 from	 HeLa	 cells	 in	 accordance	 with	 the	experimental	 diagram	detailed	 in	Figure	 4.4.	 Bound	proteins	 from	each	 sample	were	run	on	an	SDS-polyacrylamide	gel	 and	visualised	with	Coomassie	 stain.	Protein	bands	were	cut	out	and	submitted	for	unlabelled	mass	spectrometry	analysis.	The	results	were	inconclusive:	 the	 sheep	 proteins	 residing	 in	 the	 red	 blood	 cell	 membranes	 were	sufficiently	 abundant	 to	 swamp	 the	 signal	 detected	 by	 the	 mass	 spectrometry	instrument,	thus	shielding	cell	lysate	proteins	from	detection.	No	promising	candidates	were	 identified.	 In	 light	 of	 this,	 this	 method	 was	 not	 pursued	 further	 and	 a	 new	enrichment	assay	method	was	required.	
4.3.4 Liposomes	To	 eliminate	 background	 protein	 levels,	 it	 was	 essential	 to	 use	 a	 protein-free	sphingomyelin	 surface.	Thus,	 all	 proteins	 identified	 in	 the	 enrichment	 assay	would	be	attributable	to	the	input	lysate.	For	this	reason,	liposomes	were	tested	for	suitability	as	the	enrichment	assay	surface.		
4.3.4.1 Liposome	composition	and	production	A	 crucial	 step	 in	 designing	 the	 liposome	 enrichment	 assay	was	 to	 decide	which	 lipid	species	 to	 use	 in	 the	 sphingomyelin-positive	 and	 negative	 liposomes.	 The	 positive	liposomes	 would	 contain	 sphingomyelin	 (SM),	 but	 a	 suitable	 negative	 control	 lipid	possessing	a	similar	overall	charge	and	head	group	size	to	SM	was	required	to	minimise	different	 subsets	 of	 host	 proteins	 binding	 solely	 due	 to	 differences	 in	 lipid	characteristics.	 The	 most	 suitable	 lipid	 for	 the	 negative	 control	 liposomes	 was	phosphatidylcholine	(PC)	due	to	its	overall	negative	charge	and	same	headgroup	as	SM,	as	 described	 in	 Chapter	 1.7.1.	 Cholesterol	 was	 included	 in	 both	 liposome	 types	 to	stabilise	the	liposomes	and	increase	liposome	impermeability.		Following	lipid	species	selection,	the	lipid	composition	of	each	liposome	required	optimisation.	 For	 the	 SM	 liposomes,	 a	 composition	 of	 100%	 SM	 was	 desirable.	Liposomes	were	tested	containing	 lipid	mixtures	of	100%,	70%,	60%,	50%	of	Chicken	Egg	 SM	 with	 0%,	 30%,	 40%,	 50%	 cholesterol,	 respectively.	 However,	 lipid	 mixtures	containing	greater	than	60%	SM	did	not	resuspend	in	the	liposome	buffer	and	thus	did	not	form	liposomes.	Therefore,	60%	SM	was	the	maximum	percentage	of	SM	that	could	
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be	included.	Additionally,	inclusion	of	10%	Porcine	Brain	PC	in	the	SM	lipid	mixture	was	observed	 to	 aid	 flotation	 of	 the	 liposomes,	 as	 will	 be	 discussed	 in	 the	 next	 section,	suggesting	 that	 such	 liposomes	 were	 more	 stable.	 Therefore,	 the	 SM	 liposome	composition	pursued	was	SM	:	PC	:	cholesterol	at	a	ratio	of	50	:	10	:	40.		For	the	negative	control	 liposomes,	PC	was	used	 in	place	of	SM	and	the	same	percentage	of	cholesterol	was	used,	thus	the	composition	was	PC	:	cholesterol	at	a	ratio	of	60	:	40.		Following	 mixing	 and	 drying	 of	 the	 lipids	 at	 the	 appropriate	 ratios,	 the	 lipid	mixtures	were	 extruded	 through	 two	different	 filters	 as	described	 in	Chapter	 2.20.1;	firstly	through	a	400nm	filter	to	remove	large	aggregates	and	secondly	through	a	100nm	filter	to	form	liposomes	of	~100nm	in	diameter.	The	resulting	liposomes	were	therefore	a	mixture	 of	 Small	 Unilamellar	 Vesicles	 (SUVs)	 (up	 to	 100nm)	 and	 Large	 Unilamellar	Vesicles	 (LUVs)	 (100-400nm).	 The	 diameter	 of	 these	 liposomes	 was	 measured	 using	Dynamic	 Light	 Scattering	 (DLS),	 as	 described	 in	 Chapter	 2.20.2.	 A	 distribution	 of	liposome	diameters	around	100nm	was	expected,	and	observed	(Figure	4.5).			
		
Figure	4.5:	Measuring	the	diameter	of	extruded	liposomes.	Histograms	displaying	 the	diameter	of	 liposomes	composed	of	 	(A)	PC	 :	cholesterol	 (60:40)	or	
(B)	SM	:	PC	:	cholesterol	(50:10:40),	as	measured	by	dynamic	light	scattering.		
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4.3.4.2 Liposome	flotation	Following	 liposome	production,	 it	was	 important	 to	optimise	 removal	of	unbound	cell	lysate	 proteins	 from	 the	 liposomes.	 Two	main	methods	 are	 commonly	 used:	 pelleting	and	 flotation.	 In	 the	 former	method,	 following	 incubation	with	 lysates,	 liposomes	 are	ultra-centrifuged	and	pelleted.	The	supernatant	is	discarded	and	pelleting	in	fresh	buffer	washes	 the	 liposomes.	 However,	 unbound	 lysate	 proteins	 could	 also	 pellet	 with	 the	liposomes	 during	 each	 wash.	 In	 the	 latter	 method,	 liposomes	 of	 specific	 density	 are	formed	containing	10%	OptiPrep	(SIGMA),	a	density-gradient	medium.	After	incubation	of	OptiPrep-containing	liposomes	with	lysate,	OptiPrep	is	layered	over	the	liposomes	to	form	a	30%	density	layer,	followed	by	a	10%	OptiPrep	layer	and	a	0%	OptiPrep	layer,	as	described	in	Chapter	2.20.3.	When	centrifuged,	the	liposomes,	and	thus	bound	proteins,	float	 to	 the	 interface	 between	 the	 0%	 and	 10%	 density	 layers,	 whilst	 the	 unbound	proteins	 remain	 in	 the	 30%	 density	 layer.	 This	 physical	 separation	 between	 the	liposomes	 and	 the	 unbound	 supernatant	 enables	 clean	 collection	 of	 the	 floating	liposomes	 and	 contaminating	 un-bound	 proteins	 are	 unlikely	 to	 be	 present.	 The	liposomes	 can	 then	 be	 refloated	 (rewashed)	 to	 remove	 any	 non-specific	 liposome-protein	 interactions.	 This	 method	 of	 washing	 would	 give	 greater	 purity	 in	 bound	proteins	 identified	 by	mass	 spectrometry,	 thus	 this	method	 of	 liposome	washing	was	used	in	my	enrichment	assay.		
4.3.4.3 Testing	Lysenin	binding	to	liposomes	Having	 determined	 the	 assay	 method,	 liposome	 binding	 to	 recombinant	 Lysenin(CTD)-GFP	 was	 tested;	 Lysenin(CTD)-GFP	 only	 bound	 sphingomyelin-containing	 liposomes	
(Figure	4.6A).	This	also	confirmed	that	Lysenin	is	a	sphingomyelin-specific	protein,	as	discussed	in	Chapter	3.6.1.		These	 control	 assays	 were	 further	 extended	 to	 test	 liposome	 binding	 to	 GFP-Lysenin(CTD)	 in	 cell	 lysates.	 For	 these	 assays,	 HeLa	 cell	 lines	 expressing	 GFP	 or	 GFP-Lysenin(CTD)	 or	 GFP-Lysenin	 K185A(CTD)	 were	 used.	 Lysates	 of	 these	 cell	 lines	 were	produced	 using	 the	 same	mechanical,	 non-detergent	 lysis	 method	 used	 for	 the	 ghost	assays.	 Proteins	 bound	 to	 liposomes	 after	 two	 flotation	 washes	 were	 analysed	 by	western	blot.	Only	sphingomyelin	liposomes	bound	GFP-Lysenin(CTD)	and	neither	type	of	liposome	bound	GFP	or	GFP-Lysenin	K185A(CTD)	(Figure	4.6B).	These	results	validated	the	assay	and	enabled	progression	to	the	stage	of	executing	the	enrichment	assay.			
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Figure	4.6:	 Sphingomyelin-containing	 liposomes	bind	 recombinant	 Lysenin(CTD)-GFP	and	
lysate	GFP-Lysenin(CTD).	
(A)	 Silver	 stain	 of	 recombinant	 Lysenin(CTD)-GFP	 binding	 to	 PC	 liposomes	 (containing	phosphatidylcholine	 and	 cholesterol)	 or	 SM	 liposomes	 (containing	 sphingomyelin,	phosphatidylcholine	and	cholesterol).	25%	Input	is	shown.	
(B)	Western	blot	of	liposome	binding	assay	testing	lysates	from	HeLa	cells	expressing	GFP,	GFP-Lysenin(CTD)	or	GFP-Lysenin	K185A(CTD)	 for	binding	to	PC	and	SM	liposomes.	Probed	with	an	α-GFP	antibody.	5%	input	is	shown.	I,	 input;	 S	 or	 S1,	 supernatant	 after	 first	 wash;	 S2,	 supernatant	 after	 second	 wash;	 B,	 bound	proteins.		
Cara	J.	Ellison	 	 Chapter	4:	Results	
	 125	
4.4 Execution	of	the	liposome	enrichment	assay	For	 the	 enrichment	 assay,	 four	 different	 cell	 types	 were	 used	 as	 the	 source	 of	 cell	lysates:	HeLa,	HCT116,	MEF	and	THP1.	Extending	 the	 cell	 types	used	 to	beyond	HeLa	cells	ensured	identification	of	sphingomyelin-binding	proteins	that	may	not	be	present	in	HeLa	cells.	Additionally,	THP1	cells	were	included	as	these	are	a	monocytic	cell	line;	thus,	any	sphingomyelin-binding	proteins	identified	from	these	cells	may	illuminate	the	role	 of	 sphingomyelin	 exposure	 in	 cells	 of	 the	 immune	 system.	 The	 liposomes	 were	incubated	with	 lysates,	prepared	using	the	same	mechanical	method	described	earlier,	and	 washed	 twice	 using	 the	 flotation	method.	 Floating	 liposomes	 were	 collected	 and	bound	proteins	were	extracted	by	methanol:chloroform,	as	detailed	in	Chapter	2.20.4.	The	 dried	 pellets	 were	 submitted	 for	 TMT	 labelling	 followed	 by	 mass	 spectrometry	identification	and	quantification.		
4.5 Results	from	the	liposome	enrichment	assay	
Table	 4.1	 compares	 the	 total	 number	 of	 proteins	 and	 the	 total	 number	 of	 enriched	proteins	identified	from	the	enrichment	assay	using	lysates	from	different	cell	types.		
Table	 4.1:	 Proteins	 identified	 by	 TMT-labelled	 mass	 spectrometry	 analysis	 of	 the	
liposome	binding	enrichment	assay.	A	 repeat	 of	 the	 enrichment	 assay	 using	 HCT116	 and	 THP1	 lysates	 analysed	 by	unlabelled	 mass	 spectrometry	 identified	 similar	 proteins,	 instilling	 confidence	 in	 the	TMT-labelled	 data.	 The	 main	 criterion	 used	 for	 determining	 sphingomyelin-binding	candidates	 was	 the	 enrichment	 ratio;	 proteins	 with	 a	 ratio	 higher	 than	 1.4	 were	considered	 to	 be	 enriched	 and	 thus	were	 included	 as	 candidates.	 The	Appendix	 lists	proteins	with	an	abundance	ratio	greater	 than	1.4	 in	each	cell	 type.	To	extend	 the	 list	further,	proteins	with	an	enrichment	ratio	of	1-1.4	were	subsequently	included.		From	the	list	of	proteins	in	this	enrichment	range,	the	literature	was	consulted	for	information	 on	 sub-cellular	 location,	 function	 and	 domains	 present.	 In	 particular,	
	 Cell	type	HeLa	 HCT116	(1st)	 HCT116	(2nd)	 THP1	(1st)	 THP1	(2nd)	 MEF	
Number	of	proteins	identified	 924	 1786	 755	 1608	 1142	 542	
Number	of	enriched	proteins	
(ratio	>1.4)		 61	 69	 49	 53	 53	 32	
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proteins	 located	 in	 the	 cytosol,	 involved	 in	 cell	 signalling	 pathways,	 membrane	trafficking,	 lipid	metabolism	or	containing	 lipid-binding	domains	were	of	 interest.	The	final	 candidate	 list	 is	 detailed	 in	Table	 4.2,	 and	Figure	 4.7	 indicates	 the	 cell	 types	 in	which	each	candidate	was	identified.			 Candidate	 UniProt	ID	 UniProt	Function	1	 2'-5'OAS	 P29728	 Innate	antiviral	response:	activated	by	dsRNA.	2	 ACSL5	 Q9ULC5	 Long	chain	fatty	acid	metabolism	pathway.	3	 AKAP11	 Q9UKA4	 Protein	kinase	A	signalling	pathway.	4	 AKAP12	 Q02952	 Protein	kinase	A	and	C	signalling	pathway.	5	 Alox5	 P09917	 Inflammatory	signalling	pathway.	6	 ATG5	 Q9H1Y0	 Autophagy.	7	 ATG12	 O94817	 Autophagy.	8	 Coronin1A	 P31146	 Phagocytosis.	9	 DKFZp779L0468	 Q68DQ4	 cAMP-dependent	protein	kinase	regulation.	10	 DOCK2	 Q92608	 Lymphocyte	migration.	11	 DUSP22	 Q9NRW4	 JNK	signalling	pathway	regulation.	12	 ELMO1	 Q92556	 Regulates	Rac	and	Rho	GTPases.	13	 ELMO2	 Q96JJ3	 Regulates	Rac	and	Rho	GTPases.	14	 ERICH5	 Q6P6B1	 Unknown.	15	 FABP5	 Q01469	 Lipid-binding.	16	 FAM129B	 Q96TA1	 Negative	regulation	of	apoptosis.	17	 Gephyrin	 Q9NQX3	 Membrane-protein	cytoskeletal	interactions.	18	 GNG5	 P63218	 Transmembrane	signalling	pathways.	19	 HPCAL1	 P37235	 Calcium-dependent	rhodopsin	phosphorylation.	20	 IST1	 P53990	 ESCRT	pathway.	21	 LAMTOR5	 O43504	 mTORC1	activation	in	autophagy.	22	 LRRC57	 Q8N9N7	 Unknown.	23	 MARCKS	 P29966	 Protein	kinase	C	substrate		24	 MARCKSL1	 P49006	 Actin	cytoskeleton	regulation	for	cell	movement.	25	 PAFAH2	 Q99487	 Lipid	production	regulation.	26	 PLA2G4A	 P47712	 Inflammatory	response	initiation.	27	 PLEKHO2	 Q8TD55	 Neutrophil	degranulation.	28	 PNPLA4	 P41247	 Lipid	metabolism	pathway.	29	 Rab11a	 P62491	 Intracellular	membrane	trafficking.	30	 Rab13	 P51153	 Intracellular	membrane	trafficking.	
Table	4.2	continues	on	the	following	page.	
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31	 Rab35	 Q15286	 Intracellular	membrane	trafficking.	32	 Rab4a	 P20338	 Intracellular	membrane	trafficking.	33	 Rab5a	 P20339	 Intracellular	membrane	trafficking.	34	 Rab5b	 P61020	 Intracellular	membrane	trafficking.	35	 Rab5c	 P51148	 Intracellular	membrane	trafficking.	36	 RhoC	 P08134	 Small	GTPase-mediated	signal	transduction.	37	 RhoG	 P84095	 Macropinocytosis.	38	 SH3BP1	 Q9H299	 Unknown.		39	 SH3BP5	 O60239	 Intracellular	B	cell	signalling	pathways.	40	 SH3BP5L	 Q7L8J4	 Intracellular	signalling	pathways.	41	 SPAG1	 Q07617	 Role	in	fertilisation.	42	 TECPR1	 Q7Z6L1	 Autophagy.	43	 TMED2	 Q15363	 Early	secretory	pathway	vesicular	protein	trafficking.	44	 TUSC2	 O75896	 Intercellular	signalling.	45	 VAPA	 Q9P0L0	 Vesicle	trafficking	and	signalling	pathways	e.g.	NFκB.	46	 VPS29	 Q9UBQ0	 Intracellular	protein	transport.	47	 WDR48	 Q8TAF3	 Activates	deubiquitinases	USP1	and	USP46.	48	 YES1	(Lyn)	 P07947	 Regulation	of	cell	growth	and	survival.	49	 ZNRF2	 Q8NHG8	 Ubiquitination	pathway.	
Table	4.2:	List	of	candidates	from	liposome	enrichment	assay	using	HeLa,	HCT116,	THP1	
and	MEF	cell	lysates.		
	
Figure	4.7:	Diagram	of	the	cell	types	from	which	each	candidate	was	identified.	Numbers	correlate	to	candidate	proteins	listed	in	Table	4.2.	
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The	 results	 from	 the	 liposome	 enrichment	 assay	 were	 promising	 as	 proteins	involved	in	 lipid	signalling,	 in	addition	to	other	 intracellular	signalling	pathways,	were	identified.	
4.6 Testing	the	candidates	The	initial	assay	used	to	assess	sphingomyelin-binding	ability	of	the	candidates	was	to	infect	 cells	 stably	 expressing	 each	 candidate	 with	 S.Typhimurium	 and	 observe,	 by	confocal	microscopy,	recruitment	of	candidates	to	the	bacteria.	For	 each	 candidate,	 primers	were	 designed	 for	 PCR	 amplification	 from	 human	cDNA	 libraries.	Following	successful	PCR	reactions,	each	candidate	was	cloned	 into	N-	and	C-terminal	GFP	vectors	(Randow	&	Sale,	2006)	unless	specified	in	the	literature	that	protein	functionality	is	hindered	by	the	particular	location	of	the	tag,	as	is	the	case	with	Rab	proteins	for	example.	Stable	HeLa	cell	 lines	expressing	each	GFP-tagged	candidate	were	generated.	Each	candidate	was	cloned	into	both	vectors	and	cell	lines	of	both	were	made	 to	enable	 immediate	assessment	of	whether	 the	 tag	 location	on	 the	protein	was	affecting	candidate	behaviour.	Table	4.3	 indicates	the	results	of	testing	the	candidates	for	 recruitment	 to	 S.Typhimurium,	 whilst	 Figure	 4.8	 shows	 positive	 candidate	recruitment	to	S.Typhimurium.		
	
Candidate		 Tag	
Recruited	to	
S.Typhimurium?	1	 2'-5'OAS	 GFP	N	term	 No		 2'-5'OAS	 GFP	C	term	 No	2	 ACSL5	 GFP	N	term	 No		 ACSL5	 GFP	C	term	 No	3	 AKAP11	 Unable	to	clone	 	4	 AKAP12	 Unable	to	clone	 	5	 Alox5	 GFP	N	term	 No		 Alox5	 GFP	C	term	 No	6	 ATG5	 GFP	N	term	 Yes	7	 ATG12	 GFP	N	term	 No	8	 Coronin1A	 GFP	N	term	 No		 Coronin1A	 GFP	C	term	 No	9	 DKFZp779L0468	 Unable	to	clone	 	10	 DOCK2	 Unable	to	clone	 	
Table	4.3	continues	on	the	following	page.	
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Candidate	 Tag	 Recruited	to	
S.Typhimurium?	11	 DUSP22	 GFP	N	term	 No	12	 ELMO1	 GFP	N	term	 No		 ELMO1	 GFP	C	term	 No	13	 ELMO2	 GFP	N	term	 No		 ELMO2	 GFP	C	term	 No	14	 ERICH5	 GFP	N	term	 No	15	 FABP5	 GFP	N	term	 No	16	 FAM129B	 GFP	N	term	 No		 FAM129B	 GFP	C	term	 No	17	 Gephyrin	 GFP	N	term	 No		 Gephyrin	 GFP	C	term	 No	18	 GNG5	 GFP	N	term	 Yes		 GNG5	 GFP	C	term	 No	19	 HPCAL1	 GFP	N	term	 Yes		 HPCAL1	 GFP	C	term	 Yes	20	 IST1	 GFP	N	term	 No		 IST1	 GFP	C	term	 No	21	 LAMTOR5	 GFP	N	term	 No		 LAMTOR5	 GFP	C	term	 No	22	 LRRC57	 GFP	N	term	 No		 LRRC57	 GFP	C	term	 No	23	 MARCKSL1	 GFP	N	term	 No		 MARCKSL1	 GFP	C	term	 No		25	 PAFAH2	 GFP	N	term	 No		 PAFAH2	 GFP	C	term	 No	26	 PLA2G4A	 GFP	N	term	 No	27	 PLEKHO2	 GFP	N	term	 No		 PLEKHO2	 GFP	C	term	 No	28	 PNPLA4	 GFP	N	term	 No		 PNPLA4	 GFP	C	term	 No	29	 Rab11a	 GFP	N	term	 No	30	 Rab13	 GFP	N	term	 Yes	
Table	4.3	continues	on	the	following	page.	
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Candidate	 Tag	
Recruited	to	
S.Typhimurium?	31	 Rab35	 GFP	N	term	 Yes	32	 Rab4a	 GFP	N	term	 Yes	33	 Rab5a	 GFP	N	term	 Yes	34	 Rab5b	 GFP	N	term	 Yes	35	 Rab5c	 GFP	N	term	 Yes	36	 RhoC	 GFP	N	term	 No		 RhoC	 GFP	C	term	 No	37	 RhoG	 GFP	N	term	 Faintly		 RhoG	 GFP	C	term	 No	38	 SH3BP1	 GFP	N	term	 No		 SH3BP1	 GFP	C	term	 No	39	 SH3BP5	 GFP	N	term	 No	40	 SH3BP5L	 GFP	N	term	 Yes		 SH3BP5L	 GFP	C	term	 No	41	 SPAG1	 GFP	N	term	 No	42	 TECPR1	 GFP	N	term	 Yes	43	 TMED2	 GFP	N	term	 No	44	 TUSC2	 GFP	N	term	 No		 TUSC2	 GFP	C	term	 No	45	 VAPA	 GFP	N	term	 No		 VAPA	 GFP	C	term	 No	46	 VPS29	 GFP	N	term	 Yes		 VPS29	 GFP	C	term	 Yes	47	 WDR48	 GFP	N	term	 No	48	 YES1	(Lyn)	 GFP	N	term	 No		 YES1	(Lyn)	 GFP	C	term	 No	49	 ZNRF2	 GFP	N	term	 No		 ZNRF2	 GFP	C	term	 No	
	
Table	 4.3:	 Successfully	 cloned	 candidates	 and	 their	 corresponding	 behaviour	 upon	
S.Typhimurium	infection.	N	term,	N-terminally	tagged;	C	term,	C-terminally	tagged.	
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Figure	4.8:	Recruitment	of	candidates	to	S.Typhimurium.	(Figure	on	previous	two	pages)	Confocal	micrographs	of	HeLa	cells	expressing	candidates	tagged	with	GFP	at	their	N	terminus	unless	stated	otherwise.	Cells	were	either	(i)	uninfected	or	(ii)	infected	with	S.Typhimurium	and	fixed	at	60	minutes	p.i..	Atg5	and	GNG5	cells	were	 fixed	at	2.5hrs	and	2hrs,	 respectively.	Scale	bar,	10µm.			 Of	the	49	candidate	proteins,	twelve	were	recruited	to	S.Typhimurium,	consistent	with	recruitment	to	exposed	sphingomyelin	on	the	SCV.	Several	of	these	twelve	proteins	are	known	to	be	recruited	to	BCVs,	such	as	Rab	4,	5a/b/c,	13	and	35	(Stein	et	al,	2012;	Sherwood	&	Roy,	2013),	or	known	to	be	crucial	autophagy	components,	such	as	Atg5,	as	discussed	 in	Chapter	 1.2.2	 (Mizushima	et	al,	2011).	These	proteins	were	not	pursued	further	 initially.	 In	 contrast,	 three	 of	 these	 twelve	 candidates,	 SH3BP5L,	HPCAL1,	 and	GNG5,	were	previously	unknown	to	be	recruited	to	S.Typhimurium	and	were	therefore	a	focus	of	further	investigation.	Additionally,	VPS29	is	thought	to	be	targeted	by	bacterial	effector	 proteins	 (Kihara	 et	 al,	 2001;	 McDonough	 et	 al,	 2013)	 and	 thus	 warranted	investigation.	 Finally,	 TECPR1	 was	 also	 of	 great	 interest	 as	 its	 involvement	 in	 anti-bacterial	 autophagy	 has	 been	 detailed	 (Ogawa	 et	 al,	 2011),	 with	 a	 particular	 role	 in	autophagosome	maturation	(Chen	et	al,	2012),	as	described	in	Chapter	1.2.3.	However,	these	 described	 TECPR1	 functions	 occur	 via	 an	 Atg5-dependent,	 non-sphingomyelin	mechanism.	
4.7 Conclusion	This	 Chapter	 detailed	 the	 establishment	 and	 execution	 of	 an	 enrichment	 assay	 to	identify	 endogenous	 sphingomyelin-binding	 proteins.	 Multiple	 different	 methods	 of	enrichment	 assay	 design	were	 tested;	 liposomes	 containing	 or	 lacking	 sphingomyelin	were	ultimately	used.	Following	execution	of	the	assay,	a	candidate	list	composed	of	49	proteins	was	formulated	and	each	candidate	was	subsequently	tested	for	recruitment	to	
S.Typhimurium.	Twelve	candidates	were	recruited.	Of	these,	TECPR1,	SH3BP5L,	HPCAL1	and	VPS29	became	the	subject	of	further	investigation	due	to	their	previously	unknown	recruitment	to	S.Typhimurium,	or	in	the	case	of	TECPR1,	its	known	involvement	in	anti-bacterial	autophagy	occurring	in	a	non-sphingomyelin-dependent	manner.	
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Chapter	5:	 Investigating	endogenous	sphingomyelin-
binding	candidates		
5.1 Summary	This	 Chapter	 describes	 the	 analysis	 of	 promising	 candidates	 obtained	 from	 my	enrichment	 assay	 for	 endogenous	 sphingomyelin-binding	 proteins.	 My	 investigations	primarily	 focussed	 on	TECPR1,	 SH3BP5L	 and	HPCAL1	 recruitment	 to	S.Typhimurium.	Excitingly,	my	research	has	revealed	that	TECPR1	is	a	possible	endogenous	receptor	for	sphingomyelin	exposed	on	damaged	membranes.	My	 investigations	 into	SH3BP5L	and	HPCAL1	have	elucidated	 that	neither	protein	 is	 recruited	 to	 SCVs	 in	 a	 sphingomyelin-dependent	manner.	Preliminary	analysis	of	VPS29	recruitment	 indicated	that	VPS29	is	recruited	 to	 undamaged,	 Galectin	 8-negative,	 SCVs.	 Further	 investigations	 into	 the	recruitment	 characteristics	 of	 VPS29	 and	 its	 potential	 role	 in	 anti-bacterial	 cytosolic	defence,	or	pro-bacterial	intracellular	survival,	are	therefore	warranted.		
5.2 Introduction	To	 further	 investigate	 enrichment	 assay	 candidates	 that	 were	 recruited	 to	
S.Typhimurium,	the	following	panel	of	experiments	was	used.		Firstly,	I	investigated	candidate	recruitment	to	SCVs	in	relation	to	other	membrane	damage	markers,	 such	 as	Galectin	 8	 and	Lysenin.	 Secondly,	 I	 determined	 the	 effect	 of	nSMase2	 expression	 on	 candidate	 recruitment	 to	 SCVs	 to	 assess	whether	 recruitment	occurs	 in	 a	 sphingomyelin-dependent	 manner.	 Thirdly,	 depending	 upon	 the	 result	 of	nSMase2	 expression,	 I	 subsequently	 tested	 recombinant	 candidate	 binding	 to	sphingomyelin	 liposomes	 to	 provide	 conclusive	 in	 vitro	 evidence	 for	 specific	sphingomyelin-binding.	The	fourth	experiment,	which	I	have	yet	to	test,	is	to	investigate	the	effect	of	 the	candidate	on	S.Typhimurium	proliferation	 in	cells,	 indicating	whether	the	 candidate	 functions	 to	 restrict	 intracellular	 bacterial	 replication.	 This	 would	 be	assessed	 by	 bacterial	 colony	 forming	 unit	 assays	 using	 cells	 in	 which	 the	 candidate	expression	level	is	depleted	by	silencer	RNAs.		This	Chapter	describes	the	results	from	these	experiments	and	mainly	focuses	on	the	 following	 identified	 candidates:	 Tectonin	 β-propeller	 repeat-containing	 protein	 1	(TECPR1),	 SH3	 domain-binding	 protein	 5-like	 (SH3BP5L)	 and	 Hippocalcin-like	 1	(HPCAL1).	The	end	of	this	Chapter	presents	preliminary	investigations	into	Rab	proteins	
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and	 Vacuolar	 protein	 sorting-associated	 29	 (VPS29).	 Guanine	 nucleotide-binding	protein	G	subunit	gamma-5	(GNG5)	has	yet	to	be	investigated.	
5.3 Tectonin	  β-propeller	 repeat-containing	 protein	 1	
(TECPR1)	TECPR1	 was	 identified	 in	 HeLa,	 both	 HCT116	 repeat	 samples	 and	 MEFs	 with	 an	enrichment	 ratio	 of	 2,	 1.8,	 1.44	 and	 1.42,	 respectively	 and	 was	 recruited	 to	
S.Typhimurium	 (Figure	 4.8).	 TECPR1	 was	 also	 identified	 in	 non-TMT	 mass	spectrometry	 analysis	 of	 the	 enrichment	 assay	 in	 which	 total	 peptide	 number	 was	recorded;	here,	TECPR1	was	only	bound	to	sphingomyelin-containing	liposomes.	Thus,	TECPR1	was	a	very	promising	endogenous	sphingomyelin-binding	candidate.	TECPR1	 is	 a	 130kDa	 protein	 containing	 two	 dysferlin	 (dysf)	 domains,	 a	pleckstrin	homology	(PH)	domain,	an	Atg5	 interacting	region	(AIR)	and	two	predicted	WD40-like	β	 propellers	arranged	as	depicted	 in	Figure	 5.1.	TECPR1	 is	expressed	 in	a	broad	range	of	tissues	including	intestinal	and	brain,	and	is	suggested	to	be	located	on	lysosomes	(Chen	et	al,	2012).		
		
Figure	5.1:	Domain	architecture	of	TECPR1	Schematic	 diagram	 of	 TECPR1	 domain	 organisation.	 TECPR1	 is	 composed	 of	 two	 Dysferlin	domains,	an	AIR,	a	PH	domain	and	nine	TECPR	repeats.		Abbreviations:	Dysf,	Dysferlin;	AIR,	Atg5	interacting	region;	PH,	Pleckstrin	homology.		 TECPR1	 is	 known	 to	 be	 involved	 in	 xenophagy	 of	 ΔIcsB	 Shigella,	 which	 are	targeted	for	autophagy	due	to	the	lack	of	IcsB-mediated	inhibition	of	autophagic	attack	and	 LC3-associated	 phagocytosis,	 described	 in	Chapter	 1.5.2.	 TECPR1	 is	 recruited	 to	LC3	and	Atg5	positive	ΔIcsB	Shigella	and	a	reduction	in	TECPR1	cellular	levels	reduces	the	number	of	LC3	positive	ΔIcsB	Shigella	but	increases	the	total	number	of	intracellular	bacteria,	 indicating	 that	 TECPR1	 is	 required	 for	 bacterial	 clearance	 via	 autophagy	(Ogawa	 et	 al,	 2011).	 A	 role	 for	 TECPR1	 in	 mitophagy	 has	 also	 been	 indicated	 with	TECPR1	 -/-	mouse	 embryonic	 fibroblasts	 displaying	 reduced	 clearance	 of	 depolarised	
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mitochondria;	 however	 TECPR1	 is	 not	 thought	 to	 be	 involved	 in	 non-selective	autophagy	(Ogawa	et	al,	2011).		TECPR1	 involvement	 in	 selective	 autophagy	 occurs	 through	 Atg5	 binding	 to	TECPR1	 AIR,	 and	 thus	 interacting	 with	 the	 Atg12-Atg5-Atg16L	 complex	 essential	 for	autophagosome	elongation	discussed	in	Chapter	1.2.2	(Behrends	et	al,	2010;	Ogawa	&	Sasakawa,	2011;	Ogawa	et	al,	2011).	Interestingly,	Atg5	and	Atg12	were	both	enriched	in	my	liposome	assay	and	Atg5	was	one	of	the	12	candidates	recruited	to	SCVs.	TECPR1	recruitment	to	phagosomes	is	suggested	to	occur	through	binding	WIPI-2,	a	PI(3)P.	The	interaction	was	confirmed	in	immunoprecipitation	assays	and	additionally,	a	reduction	in	cellular	levels	of	WIPI-2	decreases	the	number	of	TECPR1-positive	bacteria	(Ogawa	et	
al,	 2011).	 Additional	 studies	 suggest	 TECPR1	 is	 involved	 in	 autophagosome-lysosome	fusion	 through	 its	 lysosomal	 location	 and	 Atg5	 binding	 relieving	 potential	 auto-inhibition	of	the	PH	domain,	enabling	PH	domain	binding	to	PI(3)P	on	autophagosomes.	Thus,	 TECPR1	 brings	 the	 lysosome	 into	 close	 proximity	 with	 the	 autophagosome	enabling	fusion	(Chen	et	al,	2012).	Interestingly,	 another	 protein	 of	 the	 tectonin	 β-propeller	 containing	 family,	TECPR2,	 is	 thought	 to	 promote	 autophagy	 (Oz-Levi	 et	al,	 2012;	 Behrends	 et	al,	 2010;	Stadel	et	al,	2015).	TECPR2	contains	an	LC3-interacting	region	and	TECPR	repeats	but	does	not	contain	signature	residues	of	a	Dysferlin	domain,	an	AIR	or	a	PH	domain.		TECPR1	 was	 already	 being	 investigated	 in	 the	 Randow	 laboratory	 by	 a	postdoctoral	researcher,	Dr.	Keith	Boyle.	However,	despite	experimental	efforts,	the	SCV	ligand	 of	 this	 protein	 remained	 unknown.	 I	 was	 interested	 to	 investigate	 TECPR1	behaviour	in	relation	to	Lysenin,	as	this	would	provide	information	regarding	the	type	of	ligand	recognised	by	TECPR1	and	time	of	TECPR1	ligand	exposure	during	SCV	damage.		 	
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5.3.1 Full-length	 TECPR1	 recruitment	 to	 S.Typhimurium	 in	 relation	
to	Lysenin	and	Galectin	8	Quantification	 of	 fixed	 confocal	 images	 by	 Dr.	 Boyle	 had	 previously	 shown	 the	recruitment	of	TECPR1	(full-length)	to	SCVs	occurred	before	Galectin	8	recruitment.	It	was	therefore	important	to	investigate	the	timing	of	TECPR1(full-length)	recruitment	to	SCVs	in	relation	to	Lysenin,	as	this	would	give	insights	into	whether	the	TECPR1	ligand	becomes	exposed	during	minor	rupture.		Firstly,	 Lysenin	 and	 TECPR1	 co-localisation	 on	 SCVs	 was	 investigated.	 To	 this	effect,	 HeLa	 cells	 co-expressing	 GFP-Lysenin(W20A)	 and	 mCh-TECPR1(full-length)	 were	infected	with	 S.Typhimurium;	 a	 proportion	 of	 bacteria	 were	 double	 positive	 for	 both	Lysenin	 and	 TECPR1	 at	 early	 and	 later	 time	 points	 (~10%	 and	 ~15%	 at	 30	 and	 60	minutes	p.i.,	respectively)	(Figure	5.2).	Therefore,	the	TECPR1	ligand	is	exposed	to	the	cytosol	at	a	similar	stage	during	SCV	damage	as	sphingomyelin.																													
Figure	5.2	is	on	the	following	page.	
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Figure	5.2:	TECPR1	and	Lysenin	
co-localise	 on	 a	 proportion	 of	
S.Typhimurium.		
(A)	 HeLa	 cells	 expressing	 GFP-Lysenin(W20A)	 and	 mCh-TECPR1	were	infected	with	BFP-expressing	
S.Typhimurium	and	fixed	at	30	and	60	minutes	 p.i..	 The	percentage	 of	marker	 positive	 S.Typhimurium	was	 manually	 counted	 from	automated	 images	 taken	 with	 a	40x	 objective.	 Graph	 shows	 mean	+/-	 S.E.M	 of	 triplicate	 wells	 from	one	 experiment.	 n>950	 bacteria	counted	per	well.		
(B)	 Structured	 illumination	micrographs	 of	 HeLa	 cells	expressing	 mCh-Lysenin(W20A)	 and	GFP-TECPR1	 infected	 with	 BFP-expressing	 S.Typhimurium	 and	analysed	 at	 15	 minutes	 p.i..	 Scale	bar,	2µm.		
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Following	 this,	 it	 was	 important	 to	 assess	 the	 recruitment	 order	 of	 TECPR1	versus	Lysenin	to	determine	whether	the	TECPR1	ligand	is	exposed	simultaneously	with	sphingomyelin.	 To	 determine	 this,	 tracking	 live	 imaging	 of	 S.Typhimurium	 infection	events	in	cells	was	conducted	as	detailed	in	Chapter	2.12.3.1	and	Chapter	3.8.	Briefly,	individual	S.Typhimurium	were	tracked	inside	cells	and	changes	in	mean	445nm	(CFP),	488nm	(GFP)	and	561nm	(mCh)	fluorescence	intensity	(F.I.)	around	the	bacterium	were	measured	 with	 time.	 An	 increase	 in	 F.I.	 indicated	 recruitment	 of	 the	 corresponding	fluorescent	 protein	 to	 the	 SCV.	 Tracking	 of	 infection	 in	HeLa	 cells	 co-expressing	 GFP-TECPR1(full-length)	and	mCh-Lysenin(W20A)	indicated	that	TECPR1(full-length)	was	recruited	to	SCVs	 before	 Lysenin(W20A)	 (Figure	 5.3)	 suggesting	 that	 the	 TECPR1	 ligand	 becomes	exposed	before	sphingomyelin.			
	
Figure	5.3:	TECPR1	is	recruited	to	S.Typhimurium	before	Lysenin.	Tracking	of	three	S.Typhimurium	infection	events	in	HeLa	cells	expressing	GFP-TECPR1(full-length)	and	 mCh-Lysenin(W20A).	 Cells	 were	 infected	 with	 BFP-expressing	 S.Typhimurium	 and	 imaged	from	10	minutes	p.i.	in	one	minute	intervals.	Graphs	indicate	changes	in	mean	488nm	(GFP)	and	561nm	(mCh)	fluorescence	intensity	(F.I.)	around	the	bacterium.	Graphs	indicate	time	from	the	start	of	 the	 track	rather	 than	bacterial	entry	 into	 the	cell.	Arrowhead	 indicates	second	peak	of	TECPR1	recruitment.	Representative	graphs	are	shown.		
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In	 several	 tracking	 events,	 two	 peaks	 of	 TECPR1	 recruitment	 were	 apparent	
(Figure	 5.3	 -	arrow).	As	TECPR1	was	known	to	be	recruited	before	Galectin	8,	 it	was	interesting	to	determine	how	this	second	TECPR1	peak	related	to	the	timing	of	Galectin	8	 recruitment.	 To	 this	 effect,	 HeLa	 cells	 expressing	 GFP-TECPR1(full-length),	 mCh-Lysenin(W20A)	 and	 CFP-Galectin	 8	 were	 infected	 with	 S.Typhimurium	 and	 infection	events	 were	 tracked.	 Strikingly,	 the	 second	 TECPR1	 recruitment	 peak	 occurred	simultaneously	 with	 Galectin	 8	 recruitment	 to	 the	 SCV	 (Figure	 5.4),	 implying	 that	exposure	of	the	TECPR1	ligand	occurs	more	than	once	during	SCV	damage.	Alternatively,	TECPR1	 may	 bind	 two	 different	 ligands,	 one	 exposed	 on	 the	 cytosolic	 leaflet	 during	minor	 damage,	 and	 the	 other	 exposed	 on	 the	 intra-luminal	 leaflet	 of	 the	 SCV	 during	major	damage.			
		
Figure	 5.4:	 TECPR1	 is	 recruited	 to	 S.Typhimurium	 in	 two	 phases.	 The	 second	 phase	 is	
coincident	with	Galectin	8	recruitment.		Tracking	of	three	S.Typhimurium	infection	events	in	HeLa	cells	expressing	GFP-TECPR1(full-length),	mCh-Lysenin(W20A)	and	CFP-Galectin	8.	Cells	were	infected	and	imaged	as	described	in	Figure	5.3.	Graphs	 indicate	 changes	 in	mean	445nm	 (CFP),	 488nm	 (GFP)	 and	561nm	 (mCh)	 fluorescence	intensity	(F.I.)	around	the	bacterium.	Graphs	indicate	time	from	the	start	of	the	track	rather	than	bacterial	entry	into	the	cell.	Representative	graphs	are	shown.		 	
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To	test	whether	the	presence	of	Lysenin	on	SCVs	was	contributing	to	this	double	peak	 appearance	 of	 TECPR1,	 the	TECPR1	 recruitment	 pattern	was	 investigated	 in	 the	absence	of	Lysenin.	To	this	effect,	HeLa	cells	expressing	GFP-TECPR1(full-length)	and	mCh-Galectin	 8	 or	 mCh-TECPR1(full-length)	 and	 YFP-Galectin	 8	 were	 used;	 the	 reversed	combination	 of	 fluorophores	was	 used	 in	 this	 latter	 case	 to	 ensure	 protein	 behaviour	was	not	fluorophore-dependent.		Upon	infection	with	S.Typhimurium	and	tracking	of	infection	events,	the	second	TECPR1	 peak	 still	 occurred	 (Figure	 5.5Ai,	 Bi	 -	 arrows),	 although	 not	 in	 every	 event	
(Figure	5.5Aii).	Surprisingly,	in	some	instances,	the	time	difference	between	the	start	of	TECPR1	recruitment	and	start	of	Galectin	8	recruitment	was	smaller	compared	to	when	in	 the	 presence	 of	 Lysenin	 (Figure	 5.5Aiii,	 Bii).	 This	 could	 support	 the	 hypothesis	discussed	in	Chapter	3.10	in	which	Lysenin	binding	stabilises	the	SCV	and	delays	major	rupture.	 However,	 it	 cannot	 be	 excluded	 that	 expressing	 TECPR1	 has	 an	 effect	 on	Galectin	8	recruitment	or	vice	versa.	Given	the	variation	between	tracked	events	(Figure	
5.5),	 it	 will	 be	 essential	 to	 experimentally	 obtain	 the	 time	 difference	 between	recruitment	 of	 TECPR1,	 Lysenin	 and	 Galectin	 8	 in	 cells	 expressing	 different	combinations	of	these	proteins.		The	statistical	significance	of	any	time	differences	could	then	be	determined.											
Figure	5.5:	Double	phase	TECPR1	recruitment	can	still	occur	in	the	absence	of	Lysenin.		Tracking	 of	 individual	 S.Typhimurium	 in	 HeLa	 cells	 expressing	 (A)	GFP-TECPR1(full-length),	mCh-Galectin	8;	(B)	mCh-TECPR1(full-length),	YFP-Galectin	8.		Cells	were	infected	and	imaged	as	for	Figure	5.3.		
(A)i	and	(B)i:	TECPR1	is	recruited	before	Galectin	8	and	second	TECPR1	peak	occurs.	Peaks	are	indicated	by	arrowheads.	
(A)ii:	TECPR1	second	peak	does	not	always	occur.	
(A)iii	and	(B)ii:	TECPR1	and	Galectin	8	recruitment	can	occur	simultaneously.				
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Figure	5.5	is	on	the	following	page.		
	
Figure	5.5	legend	is	on	the	previous	page.	
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5.3.2 TECPR1	 Dysferlin	 domain	 recruitment	 to	 S.Typhimurium	 in	
relation	to	Lysenin	and	Galectin	8	Given	my	 finding	 that	 TECPR1	 has	multiple	 phases	 of	 recruitment	 to	 the	 SCV,	 it	 was	essential	to	determine	whether	this	recruitment	behaviour	only	occurred	with	the	full-length	molecule.	Dr.	Boyle	had	previously	shown	that	the	minimal	region	of	TECPR1	that	is	recruited	to	S.Typhimurium	is	 the	N-terminal	Dysferlin	(Dysf)	domain	(Figure	 5.1).	Therefore,	 it	 was	 important	 to	 determine	 the	 recruitment	 pattern	 of	 TECPR1(Dysf)	 in	relation	to	Lysenin	and	Galectin	8.	Infection	events	in	HeLa	cell	lines	co-expressing	GFP-TECPR1(Dysf)	and	either	mCh-Lysenin(W20A)	or	CFP-Galectin	8	were	tracked	revealing	that	TECPR1(Dysf)	was	still	recruited	to	SCVs	before	Lysenin	and	Galectin	8	(Figure	5.6A,B).	Subsequently,	 infection	 events	 in	 cell	 lines	 co-expressing	 all	 three	 proteins,	 GFP-TECPR1(Dysf),	 mCh-Lysenin(W20A)	 and	 CFP-Galectin	 8	 were	 tracked.	 A	 less	 pronounced	second	 TECPR1(Dysf)	 peak	 of	 recruitment	 was	 apparent,	 which	 was	 coincident	 with	Galectin	8	recruitment	(Figure	5.6C	-	arrow).		
	
Figure	5.6:	TECPR1	Dysferlin	domain	 is	recruited	 to	S.Typhimurium	before	Lysenin	and	
Galectin	8.	Tracking	of	 individual	S.Typhimurium	 in	HeLa	cells	expressing	(A)	GFP-TECPR1(Dysf)	 and	mCh-Lysenin(W20A);	(B)	GFP-TECPR1(Dysf)	and	CFP-Galectin	8	(C)	GFP-TECPR1(Dysf),	 	mCh-Lysenin(W20A)	and	 CFP-Galectin	 8.	 Cells	 were	 infected	 and	 imaged	 as	 for	 Figure	 5.3.	 Representative	 graphs	shown.	Arrowhead	indicates	second	peak	of	TECPR1(Dysf)	recruitment.	
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Taken	together,	these	results	indicate	that	recruitment	of	TECPR1(Dysf)	domain	to	SCVs	 is	 responsible	 for	 the	 first	 peak	 of	 TECPR1(full-length)	 recruitment	 and,	 to	 a	 lesser	extent,	the	second	peak.	
5.3.3 Full-length	 TECPR1	 recruitment	 to	 sterile	 damage	 of	 host	
membranes	To	 test	whether	 TECPR1	 recruitment	 to	 SCVs	was	membrane	 damage	 dependent,	 the	behaviour	 of	 TECPR1	 in	 relation	 to	 Lysenin	 upon	host	 sterile	membrane	damage	was	investigated.	 Either	 endosomal	 or	 lysosomal	 lysis	 in	 cells	 co-expressing	 GFP-Lysenin(W20A)	 and	 mCh-TECPR1(full-length)	 resulted	 in	 a	 punctate	 appearance	 of	 both	TECPR1	and	Lysenin,	suggesting	TECPR1,	like	Lysenin,	is	recruited	to	SCVs	in	a	damage-dependent	 manner.	 Some	 co-localisation	 on	 structures	 was	 evident	 (Figure	 5.7A	 –	white	 arrows)	 but	 other	 structures	 were	 single	 positive	 for	 TECPR1(full-length)	 (Figure	
5.7A	 –	blue	arrow)	or	Lysenin	(Figure	 5.7A	 –	orange	arrow).	Furthermore,	a	greater	level	 of	 TECPR1(full-length)	 punctae	 was	 observed	 compared	 to	 Lysenin.	 Fixation	 as	 a	possible	 cause	of	 this	TECPR1	appearance	was	 ruled	out	by	 live	 imaging	of	 lysosomal	lysis	 assays	 in	 mCh-Lysenin(W20A),	 GFP-TECPR1	 co-expressing	 cells;	 TECPR1	 was	recruited	to	a	greater	number	of	damaged	lysosomes	relative	to	Lysenin	(Figure	5.7B).	Damaged	 structures	 detected	 by	 TECPR1	 were	 therefore	 suggested	 to	 be	different	 from	 those	 detected	 by	 Lysenin.	 Alternatively,	 TECPR1	may	 bind	more	 than	one	 ligand	 found	on	different	endosomal	and	 lysosomal	membranes,	enabling	TECPR1	to	bind	a	greater	number	of	damaged	membranes	compared	to	Lysenin.		 		 	
Figure	5.7:	Full-length	TECPR1	 is	 recruited	 to	a	greater	number	of	damaged	membrane	
structures	compared	to	Lysenin.		
(A)	Confocal	micrographs	of	endosomal	and	lysosomal	lysis	assays	in	HeLa	cells	expressing	GFP-Lysenin(W20A)	 and	mCh-TECPR1(full-length).	White	 arrows	 indicate	 regions	 of	 co-localisation;	 blue	arrow	 indicates	TECPR1-positive,	Lysenin-negative	 structure;	orange	arrow	 indicates	Lysenin-positive,	TECPR1-negative	structures.	
(B)	 Selected	 frames	 from	 live	 imaging	 of	 lysosomal	 lysis	 of	 HeLa	 cells	 expressing	 mCh-Lysenin(W20A)	and	GFP-TECPR1.	Scale	bar,	10µm.	
Figure	5.7	is	on	the	following	page.	
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Figure	5.7	legend	is	on	the	previous	page.	
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5.3.4 Full-length	TECPR1	recruitment	in	the	absence	of	SM	The	finding	that	TECPR1	was	recruited	very	early	to	SCVs,	similar	to	Lysenin,	suggested	that	the	TECPR1	ligand	is	exposed	on	the	cytosolic	leaflet	as	a	result	of	minor	damage.	Additionally,	 the	 detection	 of	 a	 second	 peak	 of	 TECPR1	 recruitment	 to	 the	 SCV,	coincident	 with	 Galectin	 8,	 suggested	 that	 TECPR1	 may	 therefore	 either	 bind	 two	different	 ligands	 or	 the	 same	 ligand	 exposed	 twice	 through	 minor	 and	 major	 SCV	rupture.	Identifying	the	TECPR1	ligand(s)	on	SCVs	was	therefore	of	great	interest.	In	 view	 of	 the	 results	 indicating	 TECPR1	 and	 Lysenin	 co-localisation	 on	 SCVs	during	 minor	 damage,	 it	 was	 interesting	 to	 investigate	 the	 recruitment	 pattern	 of	TECPR1	 in	 the	 absence	 of	 sphingomyelin.	 This	 was	 achieved	 by	 co-expressing	mCh-nSMase2	 in	 GFP-TECPR1(full-length)	 expressing	 cells.	 Excitingly,	 upon	 infection	 of	these	 cells	 GFP-TECPR1(full-length)	 recruitment	 was	 abolished:	 ~12%	 and	 ~20%	 of	
S.Typhimurium	were	TECPR1-positive	in	the	absence	of	nSMase2	at	30	and	60	minutes	p.i.,	respectively,	whilst	~0%	were	TECPR1-positive	at	each	time	point	in	the	presence	of	 nSMase2	 (Figure	 5.8A).	 Both	 peaks	 of	 TECPR1	 recruitment	 to	 SCVs	 were	 thus	suggested	 to	 be	 sphingomyelin-dependent.	 Of	 course,	 the	 second	 recruitment	 peak	could	 be	 caused	 by	 a	 different	 ligand	whilst	 sphingomyelin	 is	 required	 for	 the	 initial	recruitment	of	TECPR1	to	the	SCV.	Live	imaging	of	GFP-TECPR1(full-length)	in	the	presence	of	 mCh-nSMase2	 showed	 that	 whilst	 the	 characteristic	 recruitment	 appearance	 of	TECPR1	no	longer	occurred,	TECPR1	occasionally	appeared	around	the	bacterium	for	a	very	 short	 duration	 (data	 not	 shown).	 This	 may	 suggest	 that	 a	 second,	 non-sphingomyelin	 ligand	 was	 present.	 Alternatively,	 TECPR1	 may	 have	 bound	 the	 SCV	before	nSMase2	 cleavage	of	 sphingomyelin.	Upon	nSMase2	 removal	 of	 sphingomyelin,	TECPR1	would	then	rapidly	dissociate,	explaining	the	brief	appearance.		Interestingly,	 upon	 treatment	 of	 GFP-TECPR1(full-length)	 expressing	 cells	 with	recombinant	 bSMase	 prior	 to	 infection,	 GFP-TECPR1(full-length)	 recruitment	 to	
S.Typhimurium	 was	 abolished,	 similarly	 to	 pretreatment	 of	 GFP-Lysenin(W20A)	expressing	cells	(Figure	5.8B).		From	 these	 SMase	 experiments,	 it	 was	 possible	 to	 conclude	 that	 TECPR1	recruitment	to	SCVs	occurs	in	a	sphingomyelin-dependent	manner.		
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Figure	5.8:	TECPR1	recruitment	to	S.Typhimurium	is	sphingomyelin-dependent.	
(A)	HeLa	cells	expressing	GFP-Lysenin(W20A),	GFP-TECPR1(full-length)	or	YFP-Galectin	8	either	with	or	without	mCh-nSMase2	were	infected	with	BFP-expressing	S.Typhimurium	and	fixed	at	30	and	60	 minutes	 p.i..	 The	 percentage	 of	 marker	 positive	 S.Typhimurium	 at	 each	 time	 point	 was	counted	manually	 from	automated	 images	 taken	with	 a	 40x	objective.	Graph	 shows	mean	+/-	S.E.M	of	triplicate	wells	from	three	independent	experiments.	n>850	bacteria	counted	per	well.		
(B)	HeLa	cells	expressing	either	GFP-Lysenin(W20A),	GFP-TECPR1(full-length)	or	YFP-Galectin	8	were	either	 untreated	 or	 pretreated	 with	 bacterial	 sphingomyelinase	 (10.5µg/ml)	 for	 30	 minutes	before	infection	with	mCh-expressing	S.Typhimurium.	Cells	were	fixed	at	30	and	60	minutes	p.i..	Percentage	 of	marker	 positive	S.Typhimurium	was	 counted	by	 automated	microscopy	 at	 each	time	point.	Graphs	show	mean	+/-	S.E.M	of	triplicate	wells	from	three	independent	experiments.	**P=0.0043,	****P<0.0001,	Paired	t-test.	n>2000	bacteria	counted	per	well.	
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5.3.5 Recombinant	TECPR1(Dysf)	binding	to	sphingomyelin	liposomes	Following	 identification	 of	 TECPR1	 in	 the	 liposome	 enrichment	 assay	 and	 subsequent	findings	 that	 recruitment	 of	 full-length	 TECPR1	 to	 SCVs	was	 abolished	 by	 expressing	nSMase2	 or	 pretreating	 cells	 with	 bSMase,	 it	 was	 interesting	 to	 determine	 whether	recombinant	TECPR1	could	bind	sphingomyelin	liposomes.		To	 answer	 this	 question,	 recombinant	 TECPR1(Dysf)	 purified	 from	 E.coli	 by	 Dr.	Boyle,	was	tested;	full-length	TECPR1	was	insoluble	in	E.coli.	Additionally,	recombinant	TECPR1	W154A(Dysf)	purified	from	E.coli	by	Dr.	Boyle,	was	included	in	the	assay.	Residue	W154	was	identified	as	part	of	a	putative	membrane-interacting	region	of	the	domain,	following	 structural	 analyses	of	 the	Dysf	domain	 in	 collaboration	with	Dr.	Paul	Elliott.	Recruitment	of	GFP-TECPR1	W154A(Dysf)	to	S.Typhimurium	was	tested	by	Dr.	Boyle	and	found	to	be	abolished	(data	not	shown).	Thus,	it	was	of	great	interest	to	investigate	the	effect	of	this	point	mutant	on	Dysf	domain	binding	to	sphingomyelin	liposomes.		Using	the	same	method	as	for	the	enrichment	assay	described	in	Chapter	4.3.4,	sphingomyelin	 liposomes	 and	 negative	 control	 liposomes	 were	 incubated	 with	 the	appropriate	 recombinant	 proteins,	 washed	 twice	 via	 the	 flotation	method	 and	 bound	proteins	were	 extracted.	 Strikingly,	 TECPR1(Dysf)	 only	 bound	 sphingomyelin	 liposomes	and	 the	 point	 mutation	 of	 TECPR1	 W154A(Dysf)	 abolished	 this	 binding	 (Figure	 5.9).	Excitingly,	this	was	the	first	biochemical	evidence	that	TECPR1(Dysf)	binds	sphingomyelin.	
	
Figure	5.9:	Recombinant	TECPR1(Dysf)	binds	sphingomyelin-containing	liposomes.	Silver	 stain	 of	 liposome	 binding	 assay	 testing	 Lysenin(CTD)-GFP,	 TECPR1(Dysf)	 and	 TECPR1	W154A(Dysf)	 for	 binding	 to	 PC	 liposomes	 and	 SM	 liposomes.	 Figure	 is	 representative	 of	 two	repeat	binding	assays.	25%	Input	is	shown.	I,	input;	S,	supernatant	after	binding;	B,	bound.	
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5.3.6 The	 effect	 of	 W154A	 point	 mutation	 on	 full-length	 TECPR1	
recruitment		Since	 the	 point	mutation	 of	W154A	 prevented	 TECPR1(Dysf)	 binding	 to	 sphingomyelin	liposomes	and	abolished	recruitment	of	TECPR1(Dysf)	to	S.Typhimurium,	it	was	essential	to	 investigate	 whether	 this	 single	 point	 mutation	 prevents	 full-length	 TECPR1	recruitment.	To	determine	this,	W154A	was	mutated	in	GFP-TECPR1(full-length)	and	HeLa	cell	 lines	 stably	 co-expressing	 this	 construct,	 in	 addition	 to	 mCh-Galectin	 8,	 were	generated.		Upon	infection,	GFP-TECPR1	W154A(full-length)	recruitment	to	S.Typhimurium	was	significantly	 reduced	 compared	 to	 GFP-TECPR1(full-length);	 only	 ~3%	 and	 ~5%		
S.Typhimurium	were	GFP-TECPR1	W154A(full-length)	-positive	 at	 30	 and	 60	minutes	 p.i.,	respectively	 (Figure	 5.10A).	 However,	 GFP-TECPR1	W154A(full-length)	 recruitment	 was	not	 fully	abolished	and	still	 localised	with	mCh-Galectin	8	on	a	proportion	of	bacteria:	~1%	 and	 ~7%	 of	 S.Typhimurium	 were	 double	 positive	 at	 30	 and	 60	 minutes	 p.i.,	respectively,	 although	 this	 was	 considerably	 lower	 than	 the	 ~14%	 and	 ~20%	
S.Typhimurium	 that	 were	 wild	 type	 TECPR1	 and	 Galectin	 8	 double	 positive	 (Figure	
5.10B,C).		
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Figure	 5.10:	Mutating	 Trp154	 in	 TECPR1	 reduces	 recruitment	 of	 full-length	 TECPR1	 to	
S.Typhimurium.		HeLa	 cells	 expressing	 (A)	 GFP-TECPR1(full-length)	 or	 GFP-TECPR1	 W154A(full-length),	 (B)	GFP-TECPR1(full-length)	 and	 mCh-Galectin	 8	 or	 (C)	 GFP-TECPR1	W154A(full-length)	 and	 mCh-Galectin	 8,	were	infected	with	BFP-expressing	S.Typhimurium	and	fixed	at	indicated	time	points.		The	 percentage	 of	 marker	 positive	 S.Typhimurium	 at	 each	 time	 point	 was	 counted	manually	from	automated	 images	 taken	with	 a	 40x	 objective.	 Graph	 shows	mean	+/-	 S.E.M	of	 triplicate	wells	from	two	repeat	experiments.	n>250	bacteria	counted	per	well.			
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Live	imaging	of	S.Typhimurium	infection	indicated	that	of	the	small	proportion	of	GFP-TECPR1	 W154A(full-length)-positive	 bacteria,	 GFP-TECPR1	 W154A(full-length)	 was	recruited	before	mCh-Galectin	8	and	that	an	increase	in	recruitment	occurred	coincident	with	Galectin	8,	similar	to	the	two	waves	of	recruitment	observed	with	full-length,	wild	type	TECPR1	(Figure	11).	 		
	
	
Figure	5.11:	TECPR1	W154A(full-length)	is	recruited	before	Galectin	8.	Selected	frames	from	live	imaging	of	infection	of	HeLa	cells	expressing	GFP-TECPR1	W154A(full-length)	and	mCh-Galectin	8.	 	Cells	were	infected	with	BFP-expressing	S.Typhimurium	and	imaged	from	 15	 minutes	 p.i.	 in	 one	 minute	 intervals.	 Frames	 indicate	 TECPR1	 W154A(full-length)	 is	recruited	to	S.Typhimurium	before	Galectin	8	and	is	recruited	again	coincident	with	Galectin	8.	Scale	bar,	5µm.							
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The	similarly	early	recruitment	of	TECPR1	W154A(full-length)	and	TECPR1(full-length)	suggested	 that	 the	mutant	protein	was	still	being	recruited	 to	SCVs	by	sphingomyelin.	Indeed,	 co-expressing	 nSMase2	 abolished	 GFP-TECPR1	 W154A(full-length)	 recruitment,	inferring	 TECPR1	 W154A(full-length)	 recruitment	 is	 sphingomyelin	 dependent	 (Figure	
5.12).	 	
	
Figure	5.12:	TECPR1	W154A(full-length)	recruitment	is	sphingomyelin-dependent.	HeLa	cells	expressing	GFP-TECPR1	W154A(full-length)	and	mCh-nSMase2	were	 infected	with	BFP-expressing	S.Typhimurium	and	fixed	at	60	minutes	p.i..	The	 percentage	 of	 marker	 positive	 S.Typhimurium	 at	 each	 time	 point	 was	 counted	 manually	from	automated	 images	 taken	with	 a	 40x	 objective.	 Graph	 shows	mean	+/-	 S.E.M	of	 triplicate	wells	from	two	repeat	experiments.	n>500	bacteria	counted	per	well.	*P<0.01,	paired	t-test.			A	 further	 investigation	 into	 TECPR1	 W154A(full-length)	 	 focused	 on	 its	 role	 in	causing	membrane	damage.	Dr.	Boyle	had	previously	shown	wild	type	TECPR1(full-length)	expression	 increased	 Galectin	 8	 recruitment	 to	 SCVs.	 Thus,	 it	 was	 interesting	 to	determine	whether	 this	 increase	 in	membrane	 damage	was	 dependent	 upon	 TECPR1	recruitment	 to	 the	 SCV.	 To	 this	 effect,	 infection	 of	 HeLa	 cells	 either	 expressing	mCh-Galectin	 8	 only	 or	 co-expressing	 GFP-TECPR1	 W154A(full-length)	 	 revealed	 that	expression	 of	 GFP-TECPR1	W154A(full-length)	 	did	 not	 increase	Galectin	 8	 recruitment	 to	SCVs	(Figure	5.13).	Recruitment	of	TECPR1	to	SCVs	was	thus	suggested	to	be	involved	in	causing	SCV	membrane	damage.		 	
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Figure	5.13:	Full-length	TECPR1	recruitment	to	S.Typhimurium	increases	vacuole	damage.	HeLa	 cells	 expressing	 mCh-Galectin	 8	 only	 or	 with	 GFP-TECPR1(full-length)	 	 or	 GFP-TECPR1	W154A(full-length)	 were	 infected	 with	 BFP-expressing	 S.Typhimurium	 and	 fixed	 at	 30	 and	 60	minutes	p.i..	The	percentage	of	marker	positive	S.Typhimurium	at	each	time	point	was	counted	manually	 from	automated	 images	 taken	with	 a	 40x	objective.	Graph	 shows	mean	+/-	 S.E.M	of	triplicate	wells	from	two	repeat	experiments.	n>400	bacteria	counted	per	well.			 	
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5.3.7 Conclusions	of	TECPR1	investigation	
Construct	 Recruited	to	SCVs?	
Order	of	
recruitment	
Recruited	in	
presence	of	
nSMase2?	
Binds	
sphingomyelin	
liposomes?	Full-length	 Yes	 Before	Lysenin	and	Galectin	8	 No	 Not	yet	tested	Full-length	(W154A)	 Significantly	reduced	but	not	abolished	 Before	Galectin	8	(not	yet	tested	with	Lysenin)	 No	 Not	yet	tested	N-terminal	Dysf	domain	 Yes	 Before	Lysenin	and	Galectin	8	 No	 Yes	N-terminal	Dysf	domain	(W154A)	 No	(data	from	Dr.	Boyle)	 -	 -	 No	
Table	5.1:	Summary	of	TECPR1	recruitment	to	S.Typhimurium	containing	vacuoles	(SCVs)			The	 results	 of	 the	 TECPR1	 investigations	 are	 summarised	 in	 Table	 5.1	 and	 suggest	recruitment	of	TECPR1	to	SCVs	occurs	in	a	sphingomyelin-dependent	manner.		However,	 if	 both	 TECPR1	 and	 Lysenin	 are	 being	 recruited	 to	 SCVs	 by	 exposed	sphingomyelin,	recruitment	of	both	proteins	would	be	expected	to	occur	simultaneously.	As	 TECPR1	 was	 constantly	 recruited	 before	 Lysenin,	 it	 could	 be	 argued	 that	 the	recruitment	 ligands	are	different.	Alternatively,	such	a	difference	could	be	rationalised	by	differing	sphingomyelin-binding	mechanisms	of	each	protein.	This	will	be	discussed	further	in	Chapter	6.	The	results	 in	Table	 5.1	also	suggest	 that	 the	N-terminal	Dysf	domain	 is	not	 the	only	sphingomyelin-detecting	domain	in	the	protein.	One	experiment	to	investigate	this	further	 would	 be	 to	 test	 the	 C-terminal	 Dysf	 domain	 (Figure	 5.1)	 for	 binding	 to	sphingomyelin	liposomes.	Although	Dr.	Boyle	has	previously	shown	that	the	C-terminal	Dysf	domain	alone	is	not	recruited	to	SCVs,	in	the	context	of	the	full-length	molecule,	the	C-terminal	Dysf	domain	may	be	able	to	bind	to	its	ligand	(possibly	sphingomyelin)	thus	enabling	 TECPR1	 W154A(full-length)	 to	 still	 be	 recruited,	 albeit	 to	 a	 lesser	 extent.	Alternatively,	other	domains	in	TECPR1,	such	as	the	PH	domain	or	AIR	domain	(Figure	
5.1),	 could	 be	 involved	 in	 full-length	 TECPR1	 recruitment	 through	 binding	 PI(3)P	 or	Atg5,	respectively.		 	
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5.4 SH3	domain-binding	protein	5-like	(SH3BP5L)	SH3BP5L,	 a	 43kDa	 protein,	was	 identified	 in	 one	 THP1	 repeat	 sample	with	 a	 ratio	 of	1.69.	 The	 domain	 architecture	 of	 SH3BP5L	 is	 indicated	 in	 (Figure	 5.14).	 No	 detailed	function	has	been	determined	for	this	protein,	although	SH3BP5,	a	related	protein,	may	act	as	a	guanine	nucleotide	exchange	factor	(GEF)	for	Rab11	(Sato	et	al,	2016).	However,	I	tested	SH3BP5	for	recruitment	to	S.Typhimurium	and	it	was	not	recruited.	
	
Figure	5.14:	Domain	architecture	of	SH3BP5L.	
5.4.1 SH3BP5L	recruitment	to	S.Typhimurium	GFP-SH3BP5L	 recruitment	 to	 S.Typhimurium	 was	 visualised	 and	 its	 background	punctate	 appearance	 suggested	SH3BP5L	was	 located	on	endosomes	 (Figure	 4.8).	 To	investigate	whether	SH3BP5L	was	recruited	to	damaged	SCVs,	HeLa	cells	co-expressing	GFP-SH3BP5L	and	mCh-Lysenin(W20A)	were	infected	with	S.Typhimurium;	GFP-SH3BP5L	did	not	co-localise	with	Lysenin-positive	SCVs	(Figure	5.15).		
	
Figure	5.15	legend	is	on	the	following	page.	
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Figure	5.15:	SH3BP5L	does	not	co-localise	with	Lysenin	on	S.Typhimurium.	Confocal	micrographs	of	HeLa	cells	expressing	GFP-SH3BP5L	and	mCh-Lysenin(W20A).	Cells	were	
(A)	uninfected	or	(B)	 infected	with	S.Typhimurium	and	analysed	at	30	minutes	p.i..	 Scale	bar,	10µm.		 To	investigate	SH3BP5L	recruitment	behaviour	in	real-time,	live	imaging	of	cells	co-expressing	 GFP-SH3BP5L	 with	 mCh-Lysenin(W20A)	 was	 employed	 and	 showed	SH3BP5L	was	 recruited	 transiently	 to	 bacteria	 before	 Lysenin	with	 no	 significant	 co-localisation	 (Figure	 5.16).	 SH3BP5L	 may	 therefore	 not	 be	 recruited	 to	 damaged	membranes.			
	
	
Figure	5.16:	SH3BP5L	is	recruited	to	S.Typhimurium	before	Lysenin.	Selected	 frames	 from	 live	 imaging	 of	 infection	 of	 HeLa	 cells	 expressing	 GFP-SH3BP5L	 and	mCh-Galectin	8.	 	Cells	were	 infected	with	BFP-expressing	S.Typhimurium	and	 imaged	 from	15	minutes	p.i.	in	one	minute	intervals.	Scale	bar,	5µm.			
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	 Interestingly,	 sterile	damage	assays	 in	cells	expressing	GFP-SH3BP5L	and	mCh-Galectin	 8	 did	 not	 result	 in	 recruitment	 of	 SH3BP5L	 to	 damaged	 lysosomes	 when	visualised	by	 live	 imaging	 (data	not	 shown).	Therefore,	 SH3BP5L	 recruitment	 to	 SCVs	occurs	 before	 damage	 and	 possibly	 via	 a	 bacteria-dependent	 mechanism,	 such	 as	activity	of	a	bacterial	effector	protein.	
5.4.2 Recombinant	SH3BP5L	binding	to	liposomes	Irrespective	 of	 SH3BP5L	 recruitment	 to	 SCVs	 occurring	 before	 SCV	 damage,	 it	 was	interesting	 to	 investigate	 the	 potential	 ligand	 of	 SH3BP5L.	 The	 low	 pI,	 thus	 positive	charge	at	pH	7.2	of	the	cytosol,	suggested	that	it	might	bind	to	negatively	charged	lipids.	Therefore,	two	constructs	of	this	protein	were	designed	for	bacterial	expression	to	test	in	 liposome	 binding	 assays:	 the	 full-length	 protein	 and	 residues	 54-276	 which	 only	included	the	domain	of	unknown	function	(Figure	5.14).	Each	of	these	constructs	was	cloned	 into	 a	 pOPIN-B	 vector	 (N-terminal	 His6	 tag)	 and	 pOPIN-S	 vector	 (N-terminal	His6-SUMO	tag)	and	a	small-scale	expression	test	was	carried	out	to	investigate	whether	these	 constructs	 could	 be	 expressed	 in	 E.coli;	 His6-SUMO-SH3BP5L(full-length)	 and	 His6-SH3BP5L(54-276)	 expressed	 better	 than	 the	 alternatively	 tagged	 constructs.	 These	 two	constructs	were	purified	(Figure	5.17)	using	the	method	in	Chapter	2.13.4.			
	
Figure	5.17:	Purification	of	SH3BP5L	constructs.	Chromatograms	 indicating	 gel	 filtration	 purification	 of	 SH3BP5L(full-length)	 and	 SH3BP5L(54-276)	using	 a	 Superdex	 200	 (16/600)	 column	 and	 Superdex	 75	 (16/600)	 column,	 respectively.	Representative	fractions	across	the	peak	were	analysed	by	SDS	PAGE	analysis.	
Cara	J.	Ellison	 	 Chapter	5:	Results	
	 161	
Purified	 SH3BP5L(full-length)	 and	 SH3BP5L(54-276)	 were	 then	 tested	 for	 binding	 to	sphingomyelin	 or	 negative	 control	 liposomes;	 neither	 construct	 bound	 either	 type	 of	liposome	(Figure	5.18).		
		
Figure	5.18:	SH3BP5L	does	not	bind	to	liposomes	containing	phosphatidylcholine	(PC)	or	
sphingomyelin	(SM).	Silver	 stain	 of	 recombinant	 SH3BP5L(full-length)	 or	 SH3BP5L(54-276)	 binding	 assay	 to	 PC	 or	 SM	liposomes.	 25%	 Input	 is	 shown.	 I,	 input;	 S,	 supernatant	 after	 binding;	 B,	 extracted	 bound	proteins.			
	
Figure	5.19:	SH3BP5L	recruitment	to	S.Typhimurium	is	not	sphingomyelin-dependent.		Confocal	micrographs	of	HeLa	cells	expressing	GFP-SH3BP5L	and	mCh-nSMase2.	Cells	were	(A)	uninfected	or	(B)	infected	with	S.Typhimurium	and	analysed	at	60	minutes	p.i..	Scale	bar,	10µm.	
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To	 test	 whether	 SH3BP5L	 was	 recruited	 to	 SCVs	 by	 sphingomyelin	 in	 vivo,	GFP-SH3BP5L	 and	mCh-nSMase2	 expressing	 cells	 were	 infected	with	 S.Typhimurium.	Recruitment	 to	SCVs	was	not	abolished	 in	cells	 co-expressing	nSMase2	(Figure	 5.19),	indicating	 SH3BP5L	 recruitment	 was	 not	 sphingomyelin-dependent.	 However,	quantification	 of	 recruitment	 in	 the	 presence	 of	 nSMase2	would	 be	 required	 before	 a	definitive	 conclusion	 can	 be	 drawn	 as	 to	 the	 role	 of	 sphingomyelin	 in	 SH3BP5L	recruitment.		
5.4.3 Possible	alternative	recruitment	ligands	of	SH3BP5L	Given	 the	 very	 early	 recruitment	 of	 SH3BP5L	 to	 undamaged	 SCVs,	 a	 possible	recruitment	 ligand	may	be	phosphatidylethanolamine	 (PE)	or	phosphatidylserine	 (PS)	as	these	lipids	are	also	located	on	the	cytosolic	leaflet	of	the	plasma	membrane	(Chapter	
1.6)	and	so	would	be	present	on	the	cytosolic	 leaflet	of	 the	SCV	from	the	beginning	of	SCV	formation.	Additionally,	the	positive	charge	of	the	protein	would	enable	binding	to	negatively	 charged	 lipids,	 such	 as	 PS.	 To	 test	 this	 hypothesis,	 recombinant	 SH3BP5L	binding	to	liposomes	containing	PS,	or	other	lipids,	could	be	assessed.		It	could	be	counter-argued	that	SH3BP5L	would	thus	be	expected	to	be	recruited	to	the	cytosolic	leaflet	of	the	plasma	membrane	under	resting	conditions.	As	this	was	not	observed,	SH3BP5L	may	be	a	curvature-sensing	protein	and	thus	can	only	bind	PE	or	PS	on	curved	membranes	such	as	of	an	SCV.	Certain	proteins	are	able	to	sense	membrane	curvature	 through	 a	 type	 of	 domain	 known	 as	 a	BAR	domain.	 Therefore,	 determining	whether	 SH3BP5L	 possesses	 a	 BAR	 domain	 in	 the	 predicted	 central	 helical	 region,	would	be	of	interest.			 Despite	 the	 hypothesised	 alternative	 SH3BP5L	 ligand,	 I	 have	 not	 pursued	SH3BP5L	further	to	date,	owing	to	lack	of	co-localisation	with	Lysenin-positive	SCVs,	no	recruitment	 to	 damaged	 endosomes	 or	 lysosomes,	 no	 binding	 to	 sphingomyelin	liposomes	 and	 continued	 recruitment	 in	 the	 presence	 of	 nSMase2.	 These	 data	 thus	suggested	SH3BP5L	is	recruited	to	SCVs	in	a	sphingomyelin-independent	manner.			 	
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5.5 Hippocalcin-like	1	(HPCAL1)	HPCAL1	 was	 identified	 in	 HeLa,	 HCT116	 (both	 repeats)	 and	 THP1	 (both	 repeats)	samples	with	a	ratio	of	1.59,	1.68,	1.64,	1.95	and	1.54,	respectively.	HPCAL1,	also	known	as	 Vilip-3,	 is	 a	 22kDa	 protein	 of	 the	 neuronal	 calcium-binding	 protein	 family.	 It	 is	primarily	expressed	in	brain	cells	although	it	has	also	been	identified	in	epithelial	cells	(Kapushesky	et	al,	2012).	HPCAL1,	like	the	other	family	members	contains	four	EF-hand	domains	(Figure	5.20),	which	bind	calcium.		
	
Figure	5.20:	Domain	architecture	of	HPCAL1.	Schematic	diagram	of	HPCAL1	domain	organisation.	HPCAL1	contains	four	calcium-binding	EF-hand	domains.		Each	 family	member	 is	N-terminally	myristoylated	most	 likely	at	glycine	2,	and	the	myristoyl	group	is	sequestered	in	a	hydrophobic	pocket	of	the	protein	under	resting	conditions.	Upon	calcium-binding,	 the	protein	undergoes	a	conformational	change	and	the	myristoyl	 group	 becomes	 exposed	 and	 can	 insert	 into	membranes.	 Although	 each	family	member	is	highly	conserved	at	the	amino	acid	level,	variation	in	residues	exposed	upon	myristoyl	group	release	from	the	pocket	is	thought	to	confer	membrane	specificity	on	the	protein	(Ames	&	Lim,	2012).	The	solution	structure	of	myristoylated	HPCAL1	in	a	non-calcium	bound	state	has	been	solved	and	highlights	pocket	residues	which	interact	with	the	myristoyl	group	(Li	et	al,	2016).		HPCAL1	 has	 been	 suggested	 to	 localise	 with	 Enterohemorrhagic	 E.coli	 (EHEC)	effector	proteins	such	as	 the	 translocated	 intimin	receptor	(Blasche	et	al,	2014)	and	 it	has	been	identified	in	a	screen	as	a	ceramide-binding	protein	(Bidlingmaier	et	al,	2016).		
5.5.1 Investigating	HPCAL1	recruitment	to	S.Typhimurium	GFP-HPCAL1	and	HPCAL1-GFP	recruitment	to	S.Typhimurium	was	determined	by	fixed	confocal	 imaging	 (Figure	 4.8).	 Initial	 further	 investigations	 of	 HPCAL1	 used	 the	 N-terminally	tagged	construct	and,	for	reasons	discussed	in	Chapter	5.5.2,	this	construct	is	hereafter	referred	to	as	HPCAL1(MSG).	Infection	 of	 cells	 co-expressing	 GFP-HPCAL1(MSG)	 and	mCh-Galectin	 8	 indicated	that	HPCAL1(MSG)	was	recruited	to	Galectin	8-positive	SCVs	(Figure	5.21).			
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Figure	5.21:	HPCAL1(MSG)	is	recruited	to	Galectin	8-positive	S.Typhimurium.	Confocal	micrographs	of	HeLa	cells	expressing	GFP-HPCAL1(MSG)	with	mCh-Galectin	8.	Cells	were	either	(A)	uninfected	or	(B)	infected	with	S.Typhimurium	and	analysed	at	60	minutes	p.i..	Scale	bar,	10µm.	 	Analysis	by	 live	 imaging	showed	HPCAL1	was	recruited	 to	 the	SCV	at	 the	same	time	 as	 Galectin	 8	 (data	 not	 shown),	 thus	 suggesting	 the	 HPCAL1	 ligand	 was	 only	exposed	 upon	 major	 rupture.	 With	 the	 N-terminal	 myristoyl	 switch	 being	calcium-dependent,	 it	 seemed	plausible	 that	 calcium	would	 only	 be	 released	 from	 the	SCV	upon	major	membrane	damage	and	thus	only	then	could	the	myristoyl	group	insert	into	 the	 SCV	membrane.	 Intriguingly,	 live	 imaging	 of	 infection	with	S.Typhimurium	 in	HeLa	 cells	 expressing	 GFP-HPCAL1(MSG)	 and	 mCh-Lysenin	 resulted	 in	 no	 HPCAL1	recruitment	to	Lysenin-positive	SCVs	(data	not	shown),	suggesting	that	Lysenin	binding	may	be	shielding	sphingomyelin	from	HPCAL1	or	sterically	hindering	HPCAL1	binding.	
5.5.2 HPCAL1	recruitment	only	occurs	in	the	absence	of	N-terminal	
myristoylation	When	cloning	candidates	from	my	enrichment	assay,	N-terminal	PciI	or	NcoI	restriction	sites	 were	 used	 for	 ligation	 into	 the	 N-terminal	 or	 C-terminal	 GFP	 tag	 vectors,	respectively.	 	 In	 order	 to	 keep	 the	 gene	 in	 frame,	 two	 bases	 were	 added	 after	 the	restriction	 enzyme	 site,	 thus	 resulting	 in	 the	 addition	 of	 an	 extra	 amino	 acid.	 The	resulting	construct	was	HPCAL1(MSG)	containing	a	serine	residue	between	Met1	and	Gly2.	For	 the	 majority	 of	 proteins,	 addition	 of	 an	 extra	 residue	 after	 the	 start	 codon	 is	
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non-consequential.	However,	as	HPCAL1	is	N-terminally	myristoylated	at	glycine	2,	the	presence	 of	 an	 extra	 amino	 acid	 most	 likely	 inhibits	 myristoylation.	 Therefore,	constructs	 were	 designed	 without	 the	 extra	 amino	 acid,	 HPCAL1(wild	 type),	 and	 a	myristoylation	 mutant	 with	 Gly2Ala,	 HPCAL1(G2A),	 was	 also	 designed.	 Surprisingly,	HPCAL1(wild	type)	was	not	recruited	to	S.Typhimurium	(Figure	5.22).		
	
Figure	 5.22:	 Recruitment	 of	 HPCAL1(wild	 type)	 to	 S.Typhimurium	 is	 inhibited	 by	 the	
presence	of	the	N-myristoyl	group.	Confocal	micrographs	of	HeLa	cells	expressing	(A)	HPCAL1(wild	type)-GFP	(i.e.	myristoylated)	only	or	(B)	with	mCh-Galectin	8.	Cells	were	infected	with	S.Typhimurium	and	analysed	at	60	minutes	p.i..	Scale	bar,	10µm.		 Intriguingly,	 the	 myristoylation	 mutant,	 HPCAL1(G2A),	 was	 recruited	 to	 SCVs,	co-localised	with	Galectin	8	and	partially	co-localised	with	Lysenin	(Figure	5.23).	This	suggested,	 HPCAL1(G2A)	 recruitment	 behaviour	 was	 similar	 to	 the	 initial	 construct	 of	HPCAL1(MSG).	 Expressing	 nSMase2	 in	 cells	 expressing	 HPCAL1(G2A)-GFP	 resulted	 in	 a	reduction	in	recruitment	to	SCVs	(~10%	reduced	to	~3%)	(Figure	5.24).	Thus,	the	non-myristoylated	 forms	 of	HPCAL1	bind	 SCVs	 in	 a	mechanism	 involving,	 but	 not	 entirely	dependent	 upon,	 sphingomyelin.	 Additionally,	 HPCAL1(wild	 type)	 –GFP	 was	 still	 not	recruited	 to	SCVs	 in	 the	presence	of	nSMase2	(Figure	 5.24),	 suggesting	HPCAL1	does	not	bind	ceramide,	contrary	to	suggestions	in	the	literature	(Bidlingmaier	et	al,	2016).	
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Figure	5.23	legend	is	on	the	following	page.	
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Figure	5.23:	Non-myristoylated	HPCAL1	is	recruited	to	S.Typhimurium.	
(A-B)	 Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 either	 HPCAL1(G2A)-GFP	 (i.e.	 non-myristoylated)	 only	 or	 with	 mCh-Galectin	 8.	 Cells	 were	 (A)	 uninfected	 or	 (B)	 infected	 and	analysed	at	60	minutes	p.i..		
(C)	 Percentage	 of	 S.Typhimurium	 positive	 for	 mCh-Galectin	 8	 and	 HPCAL1(G2A)-GFP	 at	 60	minutes	 p.i.	 as	 counted	 manually	 from	 automated	 images	 taken	 with	 a	 40x	 objective.	 Graph	shows	mean	+/-	S.E.M	of	triplicate	wells	from	one	experiment.	n>600	bacteria	counted	per	well.	
(D)	 Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 HPCAL1(G2A)-GFP	 with	 mCh-Lysenin(W20A).	Cells	were	infected	and	analysed	at	30	minutes	p.i..	Scale	bar,	10µm.								
		
Figure	 5.24:	 Recruitment	 of	 non-myristoylated	 HPCAL1	 to	 S.Typhimurium	 is	 partially	
sphingomyelin-dependent.		Percentage	 of	 S.Typhimurium	 positive	 for	 HPCAL1(wild	 type)	 or	 HPCAL1(G2A)	 in	 the	 absence	 or	presence	of	nSMase2	as	counted	manually	 from	automated	 images	 taken	with	a	40x	objective.	Graph	 shows	mean	+/-	 S.E.M	of	 triplicate	wells	 from	one	experiment.	n>600	bacteria	 counted	per	well.		
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5.5.3 Recombinant	HPCAL1	binding	to	liposomes		The	 decrease	 in	 recruitment	 of	 HPCAL1(G2A)-GFP	 to	 SCVs	 in	 the	 presence	 of	 nSMase2	warranted	 further	 investigation.	 Therefore,	 HPCAL1	 was	 tested	 in	 liposome	 binding	assays.	 In	order	 to	achieve	 this,	 full-length	wild	 type	HPCAL1	was	purified	 from	E.coli	
(Figure	5.25)	as	described	in	Chapter	2.13.5.			
	
Figure	5.25:	Purification	of	non-myristoylated	wild	type	HPCAL1.	Chromatogram	 indicating	 gel	 filtration	 purification	 of	 non-myristoylated	 full-length	 HPCAL1	using	a	Superdex	75	(16/600)	column.	Representative	fractions	across	the	peak	were	analysed	by	SDS	PAGE	analysis.		Upon	 testing	 non-myristoylated	wild	 type	HPCAL1	 in	 liposome	 binding	 assays,	HPCAL1	 curiously	 bound	 both	 phosphatidylcholine	 liposomes	 and	 sphingomyelin	liposomes	in	the	presence	or	absence	of	calcium	(Figure	5.26).	However,	as	this	protein	was	purified	from	E.coli,	the	recombinant	protein	was	non-myristoylated	and	thus	was	not	 a	 biochemical	 representation	 of	 HPCAL1(wild	 type),	 rather	 it	 was	 equivalent	 to	HPCAL1(G2A)	and	HPCAL1(MSG).		
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Figure	5.26	legend	is	on	the	following	page.	
Figure	5.26:	Non-myristoylated	wild	type	HPCAL1	weakly	binds	to	 liposomes	containing	
phosphatidylcholine	(PC)	or	sphingomyelin	(SM).	Silver	stain	of	recombinant	non-myristoylated	wild	type	HPCAL1	binding	to	PC	or	SM	liposomes.	S,	supernatant;	B,	extracted	bound	proteins.			
5.5.4 Explanations	for	the	HPCAL1	conundrum	Taken	together,	the	data	suggest	that	non-myristoylated	HPCAL1	can	interact	with	SCVs	whilst	 the	myristoyl	group	prevents	 this	 interaction.	One	explanation	 for	 this	could	be	that	 the	 presence	 of	 a	 myristoyl	 group	 non-specifically	 targets	 the	 protein	 to	intracellular	 membranes	 and	 thus	 insufficient	 unbound	 protein	 is	 available	 to	 be	recruited	to	SCVs.	However,	HPCAL1(wild	type)	–GFP	is	diffusely	distributed	throughout	the	cell	when	uninfected	(Figure	5.22A),	negating	this	explanation.	An	 alternative	 explanation	 could	 arise	 from	 the	 mechanism	 of	 the	 calcium-dependent	 myristoyl	 switch	 in	 HPCAL1,	 described	 in	 Chapter	 5.5:	 the	 lack	 of	recruitment	of	HPCAL1(wild	type)	to	SCVs	could	be	due	to	insufficient	calcium	release	from	the	damaged	SCV	to	initiate	the	protein	conformational	change	for	the	myristoyl	switch	to	 be	 released.	 Therefore,	 the	 myristoyl	 group	 would	 remain	 inside	 the	 hydrophobic	pocket	 and	 shield	 the	membrane-interacting	 residues.	 In	 the	 case	 of	 HPCAL1(G2A)	 and	HPCAL1(MSG),	 the	 membrane-interacting	 residues	 are	 constitutively	 exposed,	 as	 no	myristoyl	group	is	present,	enabling	protein	interaction	with	the	SCV	membrane.		To	 investigate	 this	 calcium	 dependence,	 mCh-Galectin	 8	 cells	 expressing	 either	HPCAL1(wild	 type)	 –GFP	 or	 HPCAL1(G2A)-GFP	 were	 infected	 with	 S.Typhimurium	 in	 the	presence	 of	 1mM	 CaCl2.	 No	 HPCAL1(wild	 type)	–GFP	 recruitment	 to	 S.Typhimurium	 was	observed	(data	not	shown),	suggesting	that	either	very	little	calcium	is	taken	up	into	the	SCV	during	infection,	even	if	present	in	the	extracellular	medium,	or	that	this	is	not	the	reason	 for	 the	 lack	 of	 HPCAL1(wild	 type)	 –GFP	 to	 SCVs.	 Alternatively,	 in	 this	 calcium	experiment,	 binding	 could	 be	 occurring	 but	 very	 transiently;	 live	 imaging	 in	 the	presence	of	extracellular	calcium	would	be	required	to	assess	this.		 	
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5.6 Investigating	other	candidates	recruited	to	Salmonella	
5.6.1 Rab	proteins	Several	 Rab	GTPases	were	 enriched	 from	multiple	 cell	 types	 in	my	 enrichment	 assay.	The	Rab	proteins	found	to	be	most	enriched	were	Rab	4a,	Rab	5a/b/c,	Rab	11a,	Rab	13	and	 Rab	 35.	 Each	 of	 these,	 except	 Rab	 11a	 and	 Rab	 13,	 displayed	 recruitment	 to	
S.Typhimurium.	A	vast	deal	of	information	is	detailed	in	the	literature	about	Rab	protein	function,	 and	 their	 involvement	 in	 SCV	 maturation	 has	 also	 been	 significantly	investigated	(Stein	et	al,	2012).		Whilst	 I	 have	 not,	 as	 yet,	 investigated	 these	 proteins	 as	 significantly	 as	 other	candidates,	 I	 investigated	 whether	 their	 recruitment	 to	 SCVs	 is	 sphingomyelin-dependent.	To	this	effect,	cells	expressing	GFP-Rab5a	with	mCh-nSMase2	were	infected	with	 S.Typhimurium.	 Analysis	 by	 fixed	 confocal	 imaging	 indicated	 that	 Rab5a	 protein	recruitment	 still	 occurred	 in	 the	 presence	 of	 nSMase2	 (Figure	 5.27),	 although	quantification	 is	 required	 to	 assess	whether	 recruitment	 is	 reduced.	Therefore,	Rab5a	protein	recruitment	to	SCVs	is	thought	to	be	sphingomyelin-independent.		
	
	
Figure	5.27:	Rab5a	recruitment	to	S.Typhimurium	is	sphingomyelin-independent	Confocal	 micrographs	 of	 HeLa	 cells	 expressing	 GFP-Rab5a	 and	 mCh-nSMase2.	 Cells	 were	
(A)	uninfected	 or	 (B)	 infected	 with	 S.Typhimurium	 and	 analysed	 60	 minutes	 p.i..	 Scale	 bar,	10µm.	 	
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5.6.2 	Vacuolar	protein	sorting-associated	protein	29	(VPS29)		VPS29,	 a	 21kDa	 protein,	 was	 identified	 in	 one	 THP1	 sample	 with	 a	 ratio	 of	 1.	 The	domain	architecture	of	VPS29	is	indicated	in	Figure	5.28.			
	
Figure	5.28:	Domain	architecture	of	VPS29.	VPS29	is	comprised	of	one	domain,	a	calcineurin-like	phosphoesterase.		 VPS29	 associates	 with	 VPS26	 and	 VPS35	 to	 form	 the	 cargo	 recognition	 sub-complex.	This	complex	interacts	with	a	sub-complex	composed	of	sorting	nexins,	to	form	a	large	protein	complex,	known	as	the	retromer.	The	retromer	is	essential	for	retrograde	trafficking	 (Seaman,	 2012).	 Intriguingly,	 VPS29	has	 been	 identified	 as	 a	 target	 for	 the	
Legionella	effector	protein	RidL;	RidL-mediated	inhibition	of	VPS29	promotes	bacterial	proliferation	(Finsel	et	al,	2013).	Conversely,	VPS29	is	required	for	Coxiella	 replication	as	 reducing	 cellular	 levels	 of	 VPS29	 reduced	 bacterial	 replication	 (McDonough	 et	 al,	2013).		
5.6.2.1 Investigating	VPS29	recruitment	to	S.Typhimurium	Both	N-	and	C-terminally	tagged	VPS29	was	recruited	to	S.Typhimurium	at	60	minutes	p.i.	and	at	2	hours	p.i.	as	visualised	by	confocal	microscopy	(Figure	4.8).	To	determine	whether	 VPS29	 was	 recruited	 to	 damaged	 SCVs,	 VPS29	 recruitment	 was	 assessed	 in	relation	to	Galectin	8	recruitment.	Intriguingly,	VPS29	and	Galectin	8	did	not	localise	to	the	same	bacteria	(Figure	5.29).	Quantification	of	this	apparent	exclusive	recruitment	is	required	 and	 has	 not	 yet	 been	 achieved	 owing	 to	 time	 constraints.	 It	 will	 also	 be	interesting	 to	 determine	 whether	 sphingomyelinase	 expression	 affects	 VPS29	recruitment	to	S.Typhimurium.		
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Figure	5.29:	VPS29	does	not	co-localise	with	Galectin	8	on	Salmonella-containing	vacuoles.	Confocal	 micrographs	 of	 HeLa	 cells	 co-expressing	 GFP-VPS29	 and	 mCh-Galectin	 8	 either	
(A)	uninfected	or	(B)	 infected	with	S.Typhimurium	and	 fixed	at	60	minutes	p.i..	White	arrows	indicate	VPS29-positive,	Galectin	8-negative	SCVs.	Scale	bar,	10µm.	
5.7 Conclusion	This	Chapter	describes	 the	 analysis	 of	 several	 candidates	 identified	 in	my	enrichment	assay.	 TECPR1	 recruitment	 to	 SCVs	 was	 most	 substantially	 investigated	 and	 my	investigations	 have	 revealed	 that	 TECPR1	 is	 a	 possible	 endogenous	 receptor	 for	sphingomyelin	 exposed	 on	 damaged	 SCVs.	 Further	 investigations	 into	 the	 biological	significance	of	TECPR1	recruitment	to	SCVs	are	therefore	warranted.	Investigations	into	other	candidates,	such	as	SH3BP5L,	HPCAL1	and	VPS29,	have	elucidated	 that	 SH3BP5L	 and	 HPCAL1	 are	 recruited	 to	 SCVs	 in	 a	 sphingomyelin-independent	manner,	whilst	VPS29	is	recruited	to	undamaged,	Galectin	8-negative,	SCVs.	It	 would	 be	 interesting	 to	 further	 investigate	 the	 biological	 relevance	 of	 VPS29	recruitment	to	undamaged	SCVs.			
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Chapter	6:	Discussion	
One	mechanism	by	which	cells	detect	cytosol-invading	bacteria	is	through	recognition	of	host	 molecules,	 such	 as	 glycans,	 which	 are	 previously	 hidden	 within	 the	 bacteria-containing	 vacuole	 (BCV)	 and	 become	 exposed	 to	 the	 cytosol	 upon	 BCV	 damage.	 The	presence	of	glycans	in	the	cytosol	acts	as	a	danger	signal	and	is	detected	by	the	danger	receptor,	Galectin	8	(Thurston	et	al,	2012).		Glycans	 are	 known	 to	 be	 located	 exclusively	 on	 the	 extracellular	 leaflet	 of	 the	plasma	membrane	under	homeostatic	conditions.	Lipid	species	of	the	plasma	membrane	are	also	known	to	be	asymmetrically	distributed	across	the	bilayer,	with	neutral	lipids,	sphingomyelin,	 phosphatidylcholine	 and	 cholesterol,	 enriched	 in	 the	 outer	 leaflet	 and	the	negatively	charged	lipids	PS,	PI	and	PA,	located	on	the	inner	leaflet	(Bretscher,	1973).	The	 focus	 of	 my	 investigations	 has	 been	 to	 determine	 whether	 sphingomyelin	becomes	exposed	to	the	cytosol	during	bacterial	entry	and	activates	hitherto	unknown	sphingomyelin-specific	binding	proteins.			
Sphingomyelin	exposure	My	research	has	revealed	that	sphingomyelin	becomes	exposed	to	the	cytosol	on	BCVs.	I	determined	this	through	developing	Lysenin,	a	sphingomyelin-specific	earthworm	toxin,	into	 a	 cytosolic	 sphingomyelin	 reporter.	 Lysenin	 was	 recruited	 to	 BCVs	 in	 a	 host-derived-sphingomyelin-dependent	manner	upon	cytosolic	entry	of	both	Gram-negative	and	Gram-positive	bacteria	(Chapter	3.3-3.6).	Moreover,	Lysenin	was	recruited	to	BCVs	before	Galectin	8,	indicating	sphingomyelin	exposure	occurred	prior	to	glycan	exposure	
(Chapter	 3.7).	 Such	 differences	 in	 recruitment	 could	 be	 rationalised	 through	sphingomyelin	 diffusing	 to	 the	 cytosolic	 leaflet	 of	 the	 BCV,	 as	 a	 result	 of	 a	 minor	membrane	damage	event,	before	major	membrane	damage	occurs	exposing	glycans	on	the	luminal	leaflet	(Figure	6.1A).	
Salmonella	 are	 known	 to	 primarily	 reside	within	 SCVs	 upon	 infection	 but	 in	 a	proportion	of	 cases,	 can	 rupture	 the	 SCV	 and	 enter	 the	 cytosol.	 The	 cause	of	 this	 SCV	rupture	 is	 unknown.	My	 research	has	 elucidated	 that	 a	 host	molecule,	 sphingomyelin,	previously	hidden	in	the	vacuole	becomes	exposed	to	the	cytosol	before	cytosolic	entry	of	the	bacterium.	It	was	therefore	interesting	to	investigate	possible	causes	of	this	minor	damage	enabling	sphingomyelin	translocation	to	the	SCV	cytosolic	leaflet.		
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One	 hypothesis	 involves	 the	 needle-like	 Salmonella	 type	 III	 secretion	 system	(TTSS)	 (Chapter	 3.8-3.10).	Salmonella	 encode	 two	TTSS	 on	Salmonella	 Pathogenicity	Island	1	(SPI-1)	and	2	(SPI-2);	SPI-1	TTSS	is	required	for	entry	into	non-phagocytic	cells	(Penheiter	et	al,	1997;	Schlumberger	&	Hardt,	2006).	SPI-1	TTSS	protrudes	into	the	host	cell	membrane	 and	 bacterial	 effector	 proteins	 are	 subsequently	 secreted	 through	 the	SPI-1	 TTSS	 structure	 into	 the	 cell	 cytosol	 where	 they	 induce	 cytoskeletal	rearrangements	 to	 enable	 bacterial	 uptake.	 Protrusion	 of	 the	 SPI-1	 TTSS	 through	 the	highly	 curved	 SCV	 membrane	 may	 therefore	 provide	 a	 continuous,	 membranous	pathway	 along	which	molecules	with	 small	 headgroups,	 such	 as	 sphingomyelin,	 could	diffuse	 from	 the	 inner	 leaflet	 of	 the	 SCV	 to	 the	 cytosolic	 leaflet.	 The	 larger	headgroup	present	on	glycans	would	prevent	glycan	diffusion	along	such	a	pathway.		In	support	of	this	TTSS	hypothesis,	membrane	damage	was	dependent	upon	the	presence	of	the	SPI-1	TTSS	needle:	ΔSPI-1/InvA	did	not	recruit	Lysenin	or	Galectin	8	at	equivalent	 time	 points	 to	 wild	 type	 Salmonella.	 SPI-1	 TTSS	 protrusion	 into	 the	 SCV	membrane	was	therefore	required	for	membrane	damage.		However,	 further	 investigations	 indicated	 a	 role	 for	 bacterial	 entry	 effector	proteins	 in	 membrane	 damage,	 as	 a	 mutant	 Salmonella	 strain	 (M566)	 possessing	 a	functional	TTSS	but	 lacking	the	 invasion	effector	proteins	SipA,	SopB,	SopE2	and	SopE	did	not	cause	membrane	damage.	A	Salmonella	strain	(M701)	that	only	lacks	SipA,	SopB	and	 SopE2	 did	 cause	 SCV	 damage,	 implicating	 SopE	 in	 causing	 membrane	 damage.	Nevertheless,	as	these	four	entry	effector	proteins	are	redundant	for	bacterial	entry,	 it	would	be	interesting	to	determine	whether	SipA,	SopB	or	SopE2	would	also	be	sufficient	individually	 to	 cause	membrane	 damage	 and,	 if	 so,	 to	 investigate	 the	mechanisms	 by	which	 each	 of	 the	 four	 entry	 effector	 proteins	 contribute	 to	 membrane	 damage.	Potential	mechanisms	by	which	SopE	could	cause	membrane	damage	will	be	 focussed	on	in	this	discussion,	although	these	mechanisms	may	be	applicable	to	the	other	entry	effector	proteins.	The	 known	 roles	 of	 SopE	 include	 an	 involvement	 in	 actin	 rearrangements	required	 for	 cell	 uptake	 of	 the	 bacterium	 (Hardt	 et	 al,	 1998;	 Rudolph	 et	 al,	 1999).	However,	SopE	may	cause	this	membrane	damage	by	activating	a	usually	inactive	host	flippase	 or	 scramblase	 located	 in	 the	 plasma	 membrane	 portion	 forming	 the	 SCV.	Alternatively,	SopE	may	activate	a	bacterial	flippase	or	scramblase	effector	protein.	One	bacterial	flippase	has	been	discovered,	MurJ	in	E.coli,	but	this	is	located	in	the	bacterial	
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membrane	rather	than	being	a	secreted	effector	protein	(Sham	et	al,	2014).	To	date,	no	known	bacterial	effector	proteins	have	been	annotated	as	flippases	or	scramblases.	To	confirm	this	potential	involvement	of	SopE	in	membrane	damage,	SopE	could	be	expressed	in	HeLa	cells.	Firstly,	upon	infection	of	these	cells	with	M566	Salmonella,	SCV	damage	would	be	expected	to	occur,	visualised	by	Lysenin	recruitment.	Secondly,	if	SopE	were	activating	a	host	 sphingomyelin	 flippase	 in	 the	plasma	membrane,	Lysenin	recruitment	to	the	cytosolic	leaflet	of	the	plasma	membrane	would	be	expected.		An	 argument	 against	 this	 TTSS	 hypothesis	 could	 reason	 that	 if	 the	 SPI-1	 TTSS	were	causing	SCV	damage,	a	higher	percentage	of	Lysenin-positive	Salmonella	would	be	expected	 than	 the	~10-15%	 I	 observed,	 given	 the	 requirement	 of	 SPI-1	 TTSS	 for	 cell	entry.	 However,	 it	 is	 possible	 that	 a	 host	 pathway	 could	 repair	 the	majority	 of	 SPI-1	TTSS-induced	minor	damage	events	(Kreibich	et	al,	2015).	This	repair	pathway	could	be	activated	 through	 sphingomyelin	 exposure	 either	 directly	 or	 through	 conversion	 of	sphingomyelin	to	downstream	signalling	lipids.	
	
Sphingomyelin	as	a	precursor	for	bioactive	signalling	lipids	Lipids,	such	as	sphingomyelin,	are	crucial	 for	maintenance	of	membrane	structure	and	integrity.	In	support	of	this,	I	observed	that	removal	of	sphingomyelin	from	membranes	has	 drastic	 consequences	 on	 cell	 integrity,	 as	 during	 development	 of	 my	 enrichment	assay,	pretreatment	of	 sheep	 red	blood	cells	with	S.aureus	 bacterial	 sphingomyelinase	(bSMase)	caused	cell	lysis.	Furthermore,	Listeria	ivanovii	secretes	a	bSMase	into	the	BCV	lumen	to	remove	sphingomyelin	from	the	luminal	 leaflet.	Lysenin	was	not	recruited	to	
L.ivanovii	 due	 to	 the	 absence	 of	 sphingomyelin	 on	 the	 inner	 leaflet	 thus	 no	sphingomyelin	 translocation	 to	 the	 cytosolic	 leaflet	 could	 occur	 (Chapter	 3.6.3).	 The	removal	of	luminal	leaflet	sphingomyelin	by	L.ivanovii	 is	thought	to	facilitate	increased	bacterial	entry	 into	 the	cytosol	compared	to	Listeria	 species	 lacking	a	bSMase,	such	as	
L.monocytogenes	 (González-Zorn	et	al,	 1999).	 It	 is	 therefore	 possible	 that	 the	 primary	role	of	sphingomyelin	in	the	membrane	is	for	membrane	integrity.	However,	certain	lipids	are	important	secondary	messenger	signalling	molecules,	known	as	bioactive	lipids.	Sphingomyelin	is	a	precursor	for	the	bioactive	lipid,	ceramide,	which	is	subsequently	converted	into	the	bioactive	lipids	sphingosine	and	sphingosine-1-phosphate	(Figure	1.9),	which	have	crucial	roles	in	cell	signalling	such	as	apoptosis,	cell	 migration	 and	 inflammation	 (Hannun	 &	 Obeid,	 2008;	 Maceyka	 &	 Spiegel,	 2014).	Exposed	 sphingomyelin	 on	 BCVs	 could	 therefore	 be	 a	 substrate	 for	 conversion	 into	
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these	bioactive	signalling	lipids,	triggering	a	signalling	response	to	cytosolic	invasion	by	the	pathogen	(Figure	6.1B).	Preliminary	 investigations	 into	visualising	 the	appearance	of	ceramide	on	BCVs	were	 not	 forthcoming:	 no	 ceramide	 appeared	 on	 S.Typhimurium	 in	 HeLa	 cells	 when	stained	with	 an	α-ceramide	 antibody	 and	no	 recruitment	 of	 a	 cytosolically	 expressed,	catalytically	 inactive	 neutral	 ceramidase	 from	 Pseudomonas	 aeruginosa	 bacteria	 was	visualised.	Whilst	these	detection	reagents	may	be	ineffective,	and	thus	other	ceramide	detection	reagents	should	be	explored,	two	different	hypotheses	could	explain	this	lack	of	ceramide	appearance.	Firstly,	 the	 level	 of	 nSMase2	 expression	 in	 HeLa	 cells	 may	 be	 insufficient	 for	ceramide	production	on	BCVs;	nSMase2	is	thought	to	be	located	mainly	in	brain	tissue	and	 at	 low	 levels	 in	 the	 liver	 and	 thymus	 (Hofmann	 et	 al,	 2000).	 Low-level	 nSMase2	expression	 is	 supported	 by	 my	 data	 indicating	 that	 Lysenin	 is	 recruited	 to	
S.Typhimurium	 and	 that	 recruitment	 is	 significantly	 reduced	 upon	 over-expression	 of	nSMase2.	 In	 order	 to	 confirm	 this	 explanation,	 one	 could	 confirm	 transcription	 of	 the	nSMase2	gene	in	HeLa	cells	by	quantitative	PCR	or	detect	endogenous	nSMase2	in	HeLa	cell	lysates	by	western	blotting.	Secondly,	 turnover	of	 ceramide	produced	on	BCVs	 from	sphingomyelin	may	be	occurring	 too	 rapidly	 to	 be	 detected.	 As	 proof	 of	 principle,	 one	 could	 deplete	 cells	 of	ceramidase,	 thus	 inhibiting	 conversion	 of	 ceramide	 to	 sphingosine,	 and	 test	 whether	ceramide	is	present	on	BCVs.	There	are	five	types	of	ceramidase	enzymes	in	mammalian	cells:	 one	 neutral,	 one	 acid	 and	 three	 alkaline	 forms.	 It	 could	 be	 important	 to	 reduce	cellular	expression	levels	of	neutral	and	acid	ceramidase	enzymes	given	their	presence	on	 the	 outer	 leaflet	 of	 the	 plasma	 membrane	 (Hwang	 et	 al,	 2005)	 and	 in	 lysosomes	(Bernardo	et	al,	1995;	Ferlinz	et	al,	2001),	respectively;	alkaline	ceramidases	are	located	in	the	ER	(Mao	et	al,	2001)	and	Golgi	(Sun	et	al,	2010;	Xu	et	al,	2006)	and	thus	would	be	unlikely	 to	 contribute	 to	 ceramide	 turnover	 on	 the	 BCV.	 Alternatively,	 inhibitors	 of	cellular	ceramidases	could	be	used	such	as	Ceranib1	and	2	(Draper	et	al,	2011;	Saied	&	Arenz,	2014).	An	 important	 focus	 of	 future	 research	 would	 be	 investigating	 the	 role	 of	sphingomyelin	and	 the	sphingomyelin	hydrolysis	pathway	 in	anti-bacterial	autophagy.	For	 example,	 one	 could	 compare	 recruitment	 of	 autophagy	 markers,	 such	 as	 LC3,	 to	BCVs	 upon	 increasing	 sphingomyelin	 turnover	 or	 inhibiting	 progression	 of	 the	
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sphingomyelin	 hydrolysis	 pathway	 by	 depleting	 cellular	 ceramidase	 and	 other	downstream	enzymes	of	the	pathway,	such	as	sphingosine	kinase	(SK).	Furthermore,	investigating	the	effect	of	modulating	sphingomyelin	hydrolysis	on	bacterial	replication	would	be	informative.	A	preliminary	experiment	assessing	bacterial	replication	 with	 increased	 turnover	 of	 exposed	 sphingomyelin,	 through	 nSMase2	expression,	indicated	that	S.Typhimurium	replication	was	unaffected.	However,	it	would	be	 insightful	 to	 assess	 the	 effect	 on	 bacterial	 replication	 of	 inhibiting	 sphingomyelin	hydrolysis	pathway	progression.		Additionally,	 exploring	 whether	 signalling	 initiated	 from	 sphingomyelin	hydrolysis	initiates	innate	immune	signalling	pathways	culminating	in	NFκB	activation,	for	example,	would	be	of	great	interest.		Discovery	of	such	cellular	consequences	resulting	from	sphingomyelin	exposure	would	confirm	sphingomyelin	exposure	on	SCVs	is	a	danger	signal.												
Figure	 6.1:	 Model	 of	 sphingomyelin	 exposure	 and	 detection	 on	 bacteria-containing	
vacuoles.	
(A)	 Sphingomyelin	 is	 exposed	 to	 the	 cytosol	during	minor	damage.	Lysenin	 is	 a	 tool	 to	detect	minor	membrane	 damage.	Major	 damage	 follows	 in	which	 glycans	 are	 exposed	 to	 the	 cytosol	and	detected	by	Galectin	8.		
(B)	 Exposed	 sphingomyelin	 is	 a	 precursor	 for	 the	 bioactive	 lipids	 ceramide,	 sphingosine	 and	sphingosine-1-phosphate.	 These	 lipids	 could	 act	 as	 second	 messengers	 and	 initiate	 an	 anti-bacterial	cellular	response.	
	(C)	 Sphingomyelin	 exposure	 is	 detected	 by	 TECPR1	 via	 its	 N-terminal	 Dysferlin	 domain	 and	possibly	additional	domains.	TECPR1	is	recruited	to	the	vacuole	in	a	second	wave	during	major	rupture.	This	recruitment	mechanism	may	be	mediated	by	sphingomyelin	or	via	a	second	ligand	such	as	Atg5	(purple	triangle).		
	
Figure	6.1	is	on	the	following	page.	
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Sphingomyelin	detection	by	endogenous	sphingomyelin-specific	proteins	In	addition	to	sphingomyelin	conversion	to	bioactive	sphingolipids,	sphingomyelin	itself	could	be	acting	as	a	danger	signal	 through	detection	by	an	endogenous	sphingomyelin	receptor.	 No	 endogenous	 sphingomyelin-binding	 proteins	 were	 known;	 therefore,	identification	of	such	proteins	was	of	interest.	My	 investigations	 into	 cellular	 proteins	 enriched	 on	 sphingomyelin-containing	liposomes	identified	TECPR1	as	a	promising	sphingomyelin-binding	protein.	TECPR1	is	known	 to	be	 involved	 in	 anti-bacterial	 autophagy	 (Ogawa	et	al,	 2011)	but	 through	 an	Atg5-dependent	mechanism	(Chen	et	al,	2012).		My	research	has	revealed	that	TECPR1	is	recruited	to	SCVs	in	a	sphingomyelin-dependent	manner	(Chapter	5.3.4).	Furthermore,	the	N-terminal	TECPR1	Dysf	domain	displayed	 sphingomyelin-binding	properties	 in	vitro	and	 introduction	of	 a	 single	point	mutation	(W154A)	abolished	this	in	vitro	Dysf	–	sphingomyelin	binding	(Chapter	5.3.5).	However,	in	vivo,	TECPR1(full-length)	recruitment	to	SCVs	is	not	solely	achieved	through	the	N-terminal	 Dysf	 domain	 binding	 sphingomyelin,	 as	 introduction	 of	 the	 W154A	 point	mutation	into	the	full-length	TECPR1	molecule,	did	not	completely	abolish	recruitment	to	SCVs,	although	recruitment	was	considerably	reduced.	Live	imaging	analysis	revealed	TECPR1	 W154A(full-length)	 was	 recruited	 before	 Galectin	 8,	 and	 in	 a	 sphingomyelin-dependent	manner,	to	a	small	proportion	of	SCVs	(Chapter	5.3.6).	This	suggested	that	multiple	domains	of	full-length	TECPR1	are	able	to	detect	sphingomyelin	and	recruit	the	full-length	molecule	to	the	SCV,	although	recruitment	via	the	N-terminal	Dysf	domain	is	the	predominant	recruitment	mechanism	(Figure	6.1C).	Given	 the	 sphingomyelin-dependent	 nature	 of	 TECPR1	 recruitment	 to	 SCVs,	appearance	of	TECPR1	and	Lysenin	on	SCVs	would	be	expected	to	occur	simultaneously.	However,	in	post-live	imaging	tracking	of	individual	S.Typhimurium	inside	cells,	TECPR1	was	always	recruited	to	SCVs	before	Lysenin	(Chapter	 5.3.1).	Whilst	 this	discrepancy	could	 imply	 TECPR1	 does	 not	 bind	 sphingomyelin,	 this	 conflicting	 result	 could	 be	rationalised	 by	 Lysenin	 taking	 longer	 than	 TECPR1	 to	 bind	 sphingomyelin,	 due	 to	Lysenin’s	unusual	sphingomyelin-binding	mechanism:	Literature	evidence	suggests	that	Lysenin	binds	clustered	sphingomyelin,	as	Lysenin	binding	to	sphingomyelin-containing	liposomes	 is	 reduced	 upon	 addition	 of	 glycolipids,	 which	 prevent	 clustering,	 into	 the	liposomes	 (Ishitsuka	 et	 al,	 2004).	 However,	 it	 is	 difficult	 to	 distinguish	 from	 these	experiments	 whether	 Lysenin	 binds	 already	 clustered	 sphingomyelin,	 or	 whether	Lysenin	binding	induces	sphingomyelin	clustering.	The	EM	and	crystal	structures	of	the	
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Lysenin	oligomeric	pore	suggests	that	Lysenin	binds	sphingomyelin	in	a	1:1	ratio	via	its	C	 terminus	 and	 oligomerisation	 between	 the	N	 termini	 results	 in	 pore	 formation	 and	insertion	 into	 the	membrane	 (Bokori-Brown	 et	al,	 2016;	 Podobnik	 et	al,	 2016).	 Thus,	sphingomyelin	clustering	could	be	induced	through	Lysenin	N	termini	oligomerisation.		Whilst	oligomerisation	would	not	be	expected	 to	occur	 in	my	system	as	a	non-oligomeric	 form	 of	 Lysenin	 (Lysenin(W20A))	 was	 used,	 I	 observed	 during	 liposome	flotation	 assays	 that	 adding	 increasing	 concentrations	 of	 a	 different	 non-oligomeric	Lysenin	form	(Lysenin(CTD))	to	sphingomyelin-liposomes	prevented	flotation,	most	likely	through	 increased	 sphingomyelin	 clustering,	 resulting	 in	 increased	 liposome	permeability	 and	OptiPrep	diffusion	out	of	 the	 liposomes.	Therefore,	 it	 is	 evident	 that	even	 non-oligomeric	 forms	 of	 Lysenin	 bind	 and	 cluster	 sphingomyelin,	 which	 could	explain	how	Lysenin	takes	longer	to	bind	and	appears	shortly	after	TECPR1.		Additionally	 in	 support	 of	 TECPR1	 binding	 sphingomyelin,	 analysis	 of	 tracked	infection	events	revealed	a	decrease	in	TECPR1	binding	to	the	SCV	occurred	as	Lysenin	was	 recruited	 (Figure	 5.3).	 However,	 in	 the	 absence	 of	 Lysenin,	 TECPR1	 remained	bound	 to	 the	 SCV	 (Figure	 5.5).	 Lysenin,	 therefore,	 may	 compete	 TECPR1	 off	 the	membrane	 and	 cluster	 the	 sphingomyelin,	 further	 decreasing	 the	 levels	 of	 free	sphingomyelin	on	the	SCV	available	to	TECPR1.		Further	tracking	of	Salmonella	infection	events	indicated	full-length	TECPR1	was	recruited	to	the	SCV	in	two	waves	with	the	second	wave	being	coincident	with	Galectin	8	
(Figure	5.4).	Thus,	TECPR1	could	either	be	recruited	to	the	SCV	by	sphingomyelin	twice,	when	 exposed	 in	 minor	 and	 major	 damage,	 or	 by	 two	 different	 ligands.	 A	 possible	second	 recruitment	 mechanism	 could	 be	 via	 PI(3)P	 or	 Atg5	 binding	 as	 studies	 have	suggested	 that	TECPR1	 contributes	 to	 autophagosome-lysosome	 fusion	by	 locating	 on	lysosomes	and	binding	PI(3)P	on	autophagosomes	permitted	by	Atg5-AIR	binding	(Chen	
et	al,	2012;	Kim	et	al,	2014).	Therefore,	it	would	be	extremely	interesting	to	investigate,	by	live	imaging,	the	timing	of	PI(3)P	production	on	SCVs	and	Atg5	recruitment	to	SCVs	in	relation	to	TECPR1,	Lysenin	and	Galectin	8.		Having	 discovered	 a	 key	 mechanism	 by	 which	 TECPR1	 is	 recruited	 to	 SCVs,	investigation	 into	 downstream	 signalling	 cascades	 initiated	 by	TECPR1	 recruitment	 is	required.		 In	 addition	 to	 further	 TECPR1	 investigations,	 it	 will	 be	 interesting	 to	 explore	other	candidates	 identified	 in	my	enrichment	assay.	For	example,	assessing	the	role	of	sphingomyelin	 in	 recruitment	 of	 GNG5	 to	 SCVs,	 and	 determining	 the	 role	 of	 VPS29	
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recruitment	 to	 undamaged	 SCVs	 in	 either	 cellular	 cytosolic	 defence	 or	 pro-bacterial	survival.		
Sphingomyelin	as	a	danger	signal	for	the	detection	of	membrane	damage	My	research	has	focused	on	bacteria	as	the	agents	of	membrane	damage	through	which	sphingomyelin	is	exposed.	However,	other	pathogens,	such	as	viruses,	have	been	shown	to	damage	membranes.	For	example,	Adenovirus	invasion	damages	the	host	endosomal	membrane	surrounding	the	virus,	resulting	in	recruitment	of	Galectin	8	and	initiation	of	an	anti-viral	autophagy	response	(Montespan	et	al,	2017).	Thus,	it	would	be	interesting	to	 determine	 whether	 sphingomyelin	 is	 exposed	 during	 viral	 invasion	 and	 whether	exposure	initiates	an	anti-viral	signalling	cascade	required	for	viral	restriction.	Additionally,	 my	 studies	 elucidated	 that	 sphingomyelin	 becomes	 exposed	 on	membranes	damaged	through	sterile,	chemical	lysis.	It	would	therefore	be	interesting	to	extend	this	finding	to	a	biological	cause	of	sterile	membrane	damage.	In	particular,	it	is	known	 that	 Tau	 (tubulin-associated	 unit)	 protein	 aggregates,	 a	 cause	 of	neurodegenerative	 diseases	 such	 as	 Alzheimer’s	 Disease,	 become	 internalised	 in	neurons	during	Tau	spreading.	It	has	recently	been	reported	that	Galectin	3	recruitment	to	 Tau-containing	 endosomes	 (TCEs)	 can	 occur,	 indicative	 of	 endosomal	 damage	(Calafate	 et	al,	 2016).	 It	would	 be	 interesting	 to	 determine	whether	 sphingomyelin	 is	exposed	on	TCEs	and	whether	the	bioactive	sphingolipid	signalling	cascade	is	initiated,	given	 the	 high	 level	 of	 nSMase2	 in	 brain	 cells,	 and	 the	 role	 this	 pathway	 plays	 in	neurodegenerative	diseases.		Investigating	sphingomyelin	exposure	on	membranes	damaged	by	other	agents	may	 thus	 provide	 compelling	 evidence	 in	 support	 of	 sphingomyelin	 exposure	 in	 the	cytosol	acting	as	a	danger	signal	in	the	host	response	to	cytosolic	invasion.					
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	HeLa	sample.
Accession Description Coverage
#	
Peptides #	PSMs
#	Unique	
Peptides MW	[kDa]
Abundance	
Ratio:	(127)	
/	(126)
P55010 Eukaryotic	translation	initiation	factor	5	OS=Homo	sapiens	GN=EIF5	PE=1	SV=2 22.5058 9 26 9 49.192 3.53
P29966 Myristoylated	alanine-rich	C-kinase	substrate	OS=Homo	sapiens	GN=MARCKS	PE=1	SV=4 37.04819 10 52 10 31.536 3.445
P10644 cAMP-dependent	protein	kinase	type	I-alpha	regulatory	subunit	OS=Homo	sapiens	GN=PRKAR1A	PE=1	SV=1 54.06824 22 80 16 42.955 3.136
F8WAR4 MICOS	complex	subunit	MIC19	OS=Homo	sapiens	GN=CHCHD3	PE=1	SV=1 21.57676 5 9 5 27.718 2.73
Q15907 Ras-related	protein	Rab-11B	OS=Homo	sapiens	GN=RAB11B	PE=1	SV=4 72.47706 20 249 20 24.473 2.566
Q5CZB5 Putative	uncharacterized	protein	DKFZp686M0430	OS=Homo	sapiens	GN=DKFZp686M0430	PE=2	SV=1 17.11322 15 28 1 125.01 2.433
P17612 cAMP-dependent	protein	kinase	catalytic	subunit	alpha	OS=Homo	sapiens	GN=PRKACA	PE=1	SV=2 41.31054 14 38 5 40.564 2.392
O95372 Acyl-protein	thioesterase	2	OS=Homo	sapiens	GN=LYPLA2	PE=1	SV=1 32.46753 7 18 7 24.721 2.284
Q9BRQ8 Apoptosis-inducing	factor	2	OS=Homo	sapiens	GN=AIFM2	PE=1	SV=1 41.55496 13 47 13 40.501 2.188
B2RB89 Protein	kinase,	cAMP-dependent,	catalytic,	beta,	isoform	CRA_a	OS=Homo	sapiens	GN=PRKACB	PE=2	SV=1 34.75783 12 32 3 40.597 2.145
A0A024R6C9 Dihydrolipoamide	S-succinyltransferase	(E2	component	of	2-oxo-glutarate	complex),	isoform	CRA_a	OS=Homo	sapiens	GN=DLST	PE=3	SV=138.18985 18 58 18 48.724 2.081
Q7Z6L1 Tectonin	beta-propeller	repeat-containing	protein	1	OS=Homo	sapiens	GN=TECPR1	PE=1	SV=1 1.716738 2 4 2 129.614 2.01
P51148 Ras-related	protein	Rab-5C	OS=Homo	sapiens	GN=RAB5C	PE=1	SV=2 74.07407 17 263 13 23.468 1.947
P80723 Brain	acid	soluble	protein	1	OS=Homo	sapiens	GN=BASP1	PE=1	SV=2 84.14097 17 68 17 22.68 1.917
Q504R6 RAB13	protein	(Fragment)	OS=Homo	sapiens	GN=RAB13	PE=2	SV=1 32.78689 8 59 5 27.182 1.909
A0A024RB09 RAB5B,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB5B	PE=3	SV=1 59.53488 10 125 6 23.692 1.903
P20339 Ras-related	protein	Rab-5A	OS=Homo	sapiens	GN=RAB5A	PE=1	SV=2 73.02326 14 163 10 23.644 1.873
E7EW49 CLIP-associating	protein	2	OS=Homo	sapiens	GN=CLASP2	PE=1	SV=1 1.519155 2 3 2 165.596 1.869
B2R9K4 cDNA,	FLJ94434,	highly	similar	to	Homo	sapiens	platelet-activating	factor	acetylhydrolase	2,	40kDa	(PAFAH2),	mRNA	OS=Homo	sapiens	PE=2	SV=125.5102 8 15 8 44.037 1.844
Q4LE58 EIF4G1	variant	protein	(Fragment)	OS=Homo	sapiens	GN=EIF4G1	variant	protein	PE=2	SV=1 7.019704 9 12 9 178.045 1.839
P41247 Patatin-like	phospholipase	domain-containing	protein	4	OS=Homo	sapiens	GN=PNPLA4	PE=2	SV=3 2.766798 1 2 1 27.963 1.818
B4DJV9 cDNA	FLJ60607,	highly	similar	to	Acyl-protein	thioesterase	1	(EC	3.1.2.-)	OS=Homo	sapiens	PE=2	SV=1 13.30798 3 7 3 28.26 1.804
Q9BZG1 Ras-related	protein	Rab-34	OS=Homo	sapiens	GN=RAB34	PE=1	SV=1 62.54826 16 68 16 29.026 1.763
Q709C8 Vacuolar	protein	sorting-associated	protein	13C	OS=Homo	sapiens	GN=VPS13C	PE=1	SV=1 5.462297 17 27 17 422.124 1.734
Q92917 G	patch	domain	and	KOW	motifs-containing	protein	OS=Homo	sapiens	GN=GPKOW	PE=1	SV=2 6.932773 2 2 2 52.197 1.715
Q01546 Keratin,	type	II	cytoskeletal	2	oral	OS=Homo	sapiens	GN=KRT76	PE=1	SV=2 6.269592 5 11 1 65.8 1.71
O00764 Pyridoxal	kinase	OS=Homo	sapiens	GN=PDXK	PE=1	SV=1 6.730769 1 2 1 35.08 1.703
I6L9I9 FMNL1	protein	OS=Homo	sapiens	GN=FMNL1	PE=2	SV=1 10.22364 6 12 1 69.416 1.702
Q9NQX3 Gephyrin	OS=Homo	sapiens	GN=GPHN	PE=1	SV=1 11.68478 7 13 7 79.698 1.701
Q9UKA4 A-kinase	anchor	protein	11	OS=Homo	sapiens	GN=AKAP11	PE=1	SV=1 1.20989 2 5 2 210.38 1.667
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P82909 28S	ribosomal	protein	S36,	mitochondrial	OS=Homo	sapiens	GN=MRPS36	PE=1	SV=2 36.8932 4 12 4 11.459 1.659
B2R6Q2 Alkaline	phosphatase	OS=Homo	sapiens	PE=2	SV=1 27.8626 15 52 15 57.244 1.655
Q9P032 NADH	dehydrogenase	[ubiquinone]	1	alpha	subcomplex	assembly	factor	4	OS=Homo	sapiens	GN=NDUFAF4	PE=1	SV=1 17.14286 3 7 3 20.254 1.654
P20338 Ras-related	protein	Rab-4A	OS=Homo	sapiens	GN=RAB4A	PE=1	SV=3 72.47706 13 73 10 24.374 1.63
J3QRU1 Non-specific	protein-tyrosine	kinase	OS=Homo	sapiens	GN=YES1	PE=1	SV=1 1.824818 1 2 1 61.348 1.626
Q9Y5A9 YTH	domain-containing	family	protein	2	OS=Homo	sapiens	GN=YTHDF2	PE=1	SV=2 11.05354 6 9 6 62.296 1.617
P49006 MARCKS-related	protein	OS=Homo	sapiens	GN=MARCKSL1	PE=1	SV=2 29.23077 4 7 4 19.517 1.604
P37235 Hippocalcin-like	protein	1	OS=Homo	sapiens	GN=HPCAL1	PE=1	SV=3 32.12435 6 9 3 22.299 1.597
P61026 Ras-related	protein	Rab-10	OS=Homo	sapiens	GN=RAB10	PE=1	SV=1 86 17 143 12 22.527 1.596
Q13409 Cytoplasmic	dynein	1	intermediate	chain	2	OS=Homo	sapiens	GN=DYNC1I2	PE=1	SV=3 7.210031 4 7 4 71.412 1.585
Q96PY5 Formin-like	protein	2	OS=Homo	sapiens	GN=FMNL2	PE=1	SV=3 7.274401 9 17 4 123.243 1.57
E9PCR7 2-oxoglutarate	dehydrogenase,	mitochondrial	OS=Homo	sapiens	GN=OGDH	PE=1	SV=1 25.81888 21 46 21 117.59 1.552
Q9H0U4 Ras-related	protein	Rab-1B	OS=Homo	sapiens	GN=RAB1B	PE=1	SV=1 91.54229 26 437 11 22.157 1.55
A0A024R6D1 NIMA	(Never	in	mitosis	gene	a)-related	kinase	9,	isoform	CRA_a	OS=Homo	sapiens	GN=NEK9	PE=4	SV=1 8.171604 6 10 6 107.081 1.539
A0A024RA58 Deafness,	autosomal	dominant	5,	isoform	CRA_a	OS=Homo	sapiens	GN=DFNA5	PE=4	SV=1 2.217742 1 1 1 54.52 1.525
Q5U0I6 H.sapiens	ras-related	Hrab1A	protein	OS=Homo	sapiens	GN=RAB1A	PE=2	SV=1 93.17073 28 455 13 22.663 1.524
O95466 Formin-like	protein	1	OS=Homo	sapiens	GN=FMNL1	PE=1	SV=3 8.363636 9 15 2 121.777 1.513
A0A024QYY9 Spectrin	domain	with	coiled-coils	1,	isoform	CRA_a	OS=Homo	sapiens	GN=SPECC1	PE=4	SV=1 20.78652 20 42 20 118.512 1.487
A0A024R324 Ras	homolog	gene	family,	member	A,	isoform	CRA_a	OS=Homo	sapiens	GN=RHOA	PE=3	SV=1 65.80311 16 92 7 21.754 1.476
Q9Y3B3 Transmembrane	emp24	domain-containing	protein	7	OS=Homo	sapiens	GN=TMED7	PE=1	SV=2 4.464286 1 2 1 25.156 1.468
Q8NFA0 Ubiquitin	carboxyl-terminal	hydrolase	32	OS=Homo	sapiens	GN=USP32	PE=1	SV=1 1.870324 2 3 2 181.54 1.467
Q8IVF7 Formin-like	protein	3	OS=Homo	sapiens	GN=FMNL3	PE=1	SV=3 7.587549 7 12 4 117.139 1.464
A0A024R3Z5 LanC	lantibiotic	synthetase	component	C-like	1	(Bacterial),	isoform	CRA_b	OS=Homo	sapiens	GN=LANCL1	PE=4	SV=1 16.78832 6 10 6 46.455 1.462
H7BY55 Complement	decay-accelerating	factor	OS=Homo	sapiens	GN=CD55	PE=1	SV=2 30.18182 18 61 18 58.873 1.46
O60936 Nucleolar	protein	3	OS=Homo	sapiens	GN=NOL3	PE=1	SV=2 33.65385 5 11 5 22.616 1.455
Q02952 A-kinase	anchor	protein	12	OS=Homo	sapiens	GN=AKAP12	PE=1	SV=4 18.51852 24 43 10 191.367 1.444
Q5M9N0 Coiled-coil	domain-containing	protein	158	OS=Homo	sapiens	GN=CCDC158	PE=1	SV=2 2.156334 1 1 1 127.062 1.441
Q13637 Ras-related	protein	Rab-32	OS=Homo	sapiens	GN=RAB32	PE=1	SV=3 78.66667 17 59 16 24.982 1.44
P08754 Guanine	nucleotide-binding	protein	G(k)	subunit	alpha	OS=Homo	sapiens	GN=GNAI3	PE=1	SV=3 52.82486 17 58 9 40.506 1.415
Q14204 Cytoplasmic	dynein	1	heavy	chain	1	OS=Homo	sapiens	GN=DYNC1H1	PE=1	SV=5 17.58502 67 121 67 532.072 1.407
A0A024RBY9 Holocytochrome	c	synthase	(Cytochrome	c	heme-lyase),	isoform	CRA_a	OS=Homo	sapiens	GN=HCCS	PE=4	SV=1 3.731343 1 1 1 30.582 1.404
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	HCT116	sample.
Accession Description Coverage #	Peptides #	PSMs
#	Unique	
Peptides MW	[kDa]
Abundance	
Ratio:	(127)	/	
(126)
A0A024R6C9 Dihydrolipoamide	S-succinyltransferase	(E2	component	of	2-oxo-glutarate	complex),	isoform	CRA_a	OS=Homo	sapiens	GN=DLST	PE=3	SV=137.96909492 16 45 16 48.724 2.635
Q9BRQ8 Apoptosis-inducing	factor	2	OS=Homo	sapiens	GN=AIFM2	PE=1	SV=1 64.07506702 17 41 17 40.501 2.348
E7ESP4 Integrin	alpha-2	OS=Homo	sapiens	GN=ITGA2	PE=1	SV=1 31.21019108 22 50 1 102.762 2.332
P49006 MARCKS-related	protein	OS=Homo	sapiens	GN=MARCKSL1	PE=1	SV=2 44.61538462 6 25 6 19.517 2.273
Q9Y5A9 YTH	domain-containing	family	protein	2	OS=Homo	sapiens	GN=YTHDF2	PE=1	SV=2 5.008635579 3 4 3 62.296 2.196
E9PCR7 2-oxoglutarate	dehydrogenase,	mitochondrial	OS=Homo	sapiens	GN=OGDH	PE=1	SV=1 48.55491329 43 86 43 117.59 2.178
A0A024R5Z8 RAB11A,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB11A	PE=3	SV=165.74074074 15 92 1 24.378 2.03
P29966 Myristoylated	alanine-rich	C-kinase	substrate	OS=Homo	sapiens	GN=MARCKS	PE=1	SV=4 50.30120482 10 28 10 31.536 1.982
C9JEJ2 Choline-phosphate	cytidylyltransferase	A	OS=Homo	sapiens	GN=PCYT1A	PE=1	SV=1 25.78947368 10 17 10 43.237 1.912
P82909 28S	ribosomal	protein	S36,	mitochondrial	OS=Homo	sapiens	GN=MRPS36	PE=1	SV=2 69.90291262 5 9 5 11.459 1.896
P09622 Dihydrolipoyl	dehydrogenase,	mitochondrial	OS=Homo	sapiens	GN=DLD	PE=1	SV=2 25.93320236 11 23 11 54.143 1.858
Q5CZB5 Putative	uncharacterized	protein	DKFZp686M0430	OS=Homo	sapiens	GN=DKFZp686M0430	PE=2	SV=146.67242869 41 90 3 125.01 1.854
Q7Z6L1 Tectonin	beta-propeller	repeat-containing	protein	1	OS=Homo	sapiens	GN=TECPR1	PE=1	SV=112.87553648 9 16 9 129.614 1.836
Q99536 Synaptic	vesicle	membrane	protein	VAT-1	homolog	OS=Homo	sapiens	GN=VAT1	PE=1	SV=2 60.55979644 18 68 18 41.893 1.833
P10644 cAMP-dependent	protein	kinase	type	I-alpha	regulatory	subunit	OS=Homo	sapiens	GN=PRKAR1A	PE=1	SV=152.23097113 17 27 17 42.955 1.809
A0A024R8B2 Frequenin	homolog	(Drosophila),	isoform	CRA_a	OS=Homo	sapiens	GN=FREQ	PE=4	SV=1 48.94736842 7 14 7 21.865 1.79
Q96PY5 Formin-like	protein	2	OS=Homo	sapiens	GN=FMNL2	PE=1	SV=3 2.486187845 2 3 2 123.243 1.749
P11047 Laminin	subunit	gamma-1	OS=Homo	sapiens	GN=LAMC1	PE=1	SV=3 1.056556868 1 1 1 177.489 1.738
P08134 Rho-related	GTP-binding	protein	RhoC	OS=Homo	sapiens	GN=RHOC	PE=1	SV=1 56.47668394 10 47 2 21.992 1.726
Q15907 Ras-related	protein	Rab-11B	OS=Homo	sapiens	GN=RAB11B	PE=1	SV=4 67.43119266 16 91 2 24.473 1.698
P37235 Hippocalcin-like	protein	1	OS=Homo	sapiens	GN=HPCAL1	PE=1	SV=3 56.47668394 11 24 11 22.299 1.685
D3DRP5 Chromosome	9	open	reading	frame	19,	isoform	CRA_a	(Fragment)	OS=Homo	sapiens	GN=C9orf19	PE=4	SV=124.501 245 7 13 7 37.761 1.681
B4E2L0 cDNA	FLJ54730,	highly	similar	to	cAMP-dependent	protein	kinase,	beta-2-catalytic	subunit	(EC	2.7.11.11)	OS=Homo	sapiens	PE=2	SV=129.14572864 10 18 3 46.193 1.659
Q9H4A6 Golgi	phosphoprotein	3	OS=Homo	sapiens	GN=GOLPH3	PE=1	SV=1 5.369127517 1 1 1 33.79 1.656
A0A024R9D8 Sperm	associated	antigen	1,	isoform	CRA_b	OS=Homo	sapiens	GN=SPAG1	PE=4	SV=1 6.803455724 4 7 4 103.544 1.649
A8K9A4 cDNA	FLJ75154,	highly	similar	to	Homo	sapiens	heterogeneous	nuclear	ribonucleoprotein	C	(C1/C2),	mRNA	OS=Homo	sapiens	PE=2	SV=14.575163399 1 2 1 33.592 1.646
P26599 Polypyrimidine	tract-binding	protein	1	OS=Homo	sapiens	GN=PTBP1	PE=1	SV=1 26.93032015 10 26 10 57.186 1.614
O00425 Insulin-like	growth	factor	2	mRNA-binding	protein	3	OS=Homo	sapiens	GN=IGF2BP3	PE=1	SV=25.872193437 2 4 1 63.666 1.603
Q504R6 RAB13	protein	(Fragment)	OS=Homo	sapiens	GN=RAB13	PE=2	SV=1 49.18032787 11 46 8 27.182 1.585
P20339 Ras-related	protein	Rab-5A	OS=Homo	sapiens	GN=RAB5A	PE=1	SV=2 65.11627907 10 46 7 23.644 1.581
Q6IQ22 Ras-related	protein	Rab-12	OS=Homo	sapiens	GN=RAB12	PE=1	SV=3 28.27868852 6 20 5 27.231 1.579
A0A024QYY9 Spectrin	domain	with	coiled-coils	1,	isoform	CRA_a	OS=Homo	sapiens	GN=SPECC1	PE=4	SV=1 0.936329588 1 1 1 118.512 1.548
A0A024R2L1 WD	repeat	domain	48,	isoform	CRA_c	OS=Homo	sapiens	GN=WDR48	PE=4	SV=1 3.249630724 2 3 2 76.162 1.543
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P63218 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-5	OS=Homo	sapiens	GN=GNG5	PE=1	SV=377.94117647 4 9 4 7.314 1.541
A0A024R324 Ras	homolog	gene	family,	member	A,	isoform	CRA_a	OS=Homo	sapiens	GN=RHOA	PE=3	SV=1 72.02072539 12 68 4 21.754 1.54
Q9UBI6 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-12	OS=Homo	sapiens	GN=GNG12	PE=1	SV=369.44444444 5 18 5 8.001 1.531
Q96HR9 Receptor	expression-enhancing	protein	6	OS=Homo	sapiens	GN=REEP6	PE=1	SV=1 11.41304348 2 3 2 20.72 1.515
P12931 Proto-oncogene	tyrosine-protein	kinase	Src	OS=Homo	sapiens	GN=SRC	PE=1	SV=3 33.58208955 13 25 8 59.797 1.504
A0A024RB09 RAB5B,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB5B	PE=3	SV=165.11627907 10 44 7 23.692 1.496
E0WN38 MHC	class	I	antigen	(Fragment)	OS=Homo	sapiens	GN=HLA-C	PE=3	SV=1 37.56906077 5 9 1 21.083 1.491
H0UI80 Negative	elongation	factor	C/D	OS=Homo	sapiens	GN=TH1L	PE=1	SV=1 2.170283806 1 2 1 67.304 1.486
Q9ULE6 Paladin	OS=Homo	sapiens	GN=PALD1	PE=1	SV=3 45.91121495 33 70 33 96.693 1.484
Q9UBQ5 Eukaryotic	translation	initiation	factor	3	subunit	K	OS=Homo	sapiens	GN=EIF3K	PE=1	SV=1 6.422018349 1 1 1 25.043 1.48
F8W930 Insulin-like	growth	factor	2	mRNA-binding	protein	2	OS=Homo	sapiens	GN=IGF2BP2	PE=1	SV=15.950413223 3 5 2 66.745 1.474
Q96CT7 Coiled-coil	domain-containing	protein	124	OS=Homo	sapiens	GN=CCDC124	PE=1	SV=1 8.071748879 1 1 1 25.82 1.468
Q02952 A-kinase	anchor	protein	12	OS=Homo	sapiens	GN=AKAP12	PE=1	SV=4 51.34680135 70 161 32 191.367 1.464
P17612 cAMP-dependent	protein	kinase	catalytic	subunit	alpha	OS=Homo	sapiens	GN=PRKACA	PE=1	SV=230.1994302 9 16 2 40.564 1.45
Q96FX8 p53	apoptosis	effector	related	to	PMP-22	OS=Homo	sapiens	GN=PERP	PE=2	SV=1 3.626943005 1 2 1 21.372 1.449
Q53F62 ADP-ribosylation	factor	GTPase	activating	protein	1	isoform	a	variant	(Fragment)	OS=Homo	sapiens	PE=2	SV=16.157635468 2 3 2 44.641 1.448
B3KX18 Claudin	OS=Homo	sapiens	PE=2	SV=1 5.263157895 1 2 1 22.046 1.445
P08754 Guanine	nucleotide-binding	protein	G(k)	subunit	alpha	OS=Homo	sapiens	GN=GNAI3	PE=1	SV=355.64971751 18 85 10 40.506 1.443
P62760 Visinin-like	protein	1	OS=Homo	sapiens	GN=VSNL1	PE=1	SV=2 34.55497382 6 10 6 22.128 1.437
Q9Y3B8 Oligoribonuclease,	mitochondrial	OS=Homo	sapiens	GN=REXO2	PE=1	SV=3 7.594936709 1 2 1 26.816 1.435
Q9UJZ2 Cytovillin	2	(Fragment)	OS=Homo	sapiens	GN=VIL2	PE=2	SV=1 54.60526316 9 27 1 18.405 1.426
Q13137 Calcium-binding	and	coiled-coil	domain-containing	protein	2	OS=Homo	sapiens	GN=CALCOCO2	PE=1	SV=1.4663677 3 1 1 1 52.221 1.421
Q9BW60 Elongation	of	very	long	chain	fatty	acids	protein	1	OS=Homo	sapiens	GN=ELOVL1	PE=1	SV=1 4.659498208 1 1 1 32.641 1.42
Q9NZM1 Myoferlin	OS=Homo	sapiens	GN=MYOF	PE=1	SV=1 49.19941776 89 182 89 234.561 1.418
A5Y5A3 PC1/MRPS28	fusion	protein	OS=Homo	sapiens	PE=2	SV=1 29.49640288 6 15 6 31.161 1.417
Q9H008 Phospholysine	phosphohistidine	inorganic	pyrophosphate	phosphatase	OS=Homo	sapiens	GN=LHPP	PE=1	SV=27.777777778 1 2 1 29.147 1.415
J3KQ41 COP9	signalosome	complex	subunit	7b	OS=Homo	sapiens	GN=COPS7B	PE=1	SV=1 6.834532374 1 1 1 31.502 1.414
A8K9V9 cDNA	FLJ76064	OS=Homo	sapiens	PE=2	SV=1 13.22580645 3 5 3 34.511 1.414
Q6P4Q7 Metal	transporter	CNNM4	OS=Homo	sapiens	GN=CNNM4	PE=1	SV=3 2.322580645 1 1 1 86.552 1.413
Q9P0H9 Protein	RER1	OS=Homo	sapiens	GN=RER1	PE=1	SV=1 12.61682243 2 3 2 24.801 1.406
B2R694 Terpene	cyclase/mutase	family	member	OS=Homo	sapiens	PE=2	SV=1 1.229508197 1 2 1 83.37 1.404
Q6FGS1 TPD52L2	protein	OS=Homo	sapiens	GN=TPD52L2	PE=1	SV=1 84.46601942 14 33 14 22.224 1.403
Q6P6B1 Glutamate-rich	protein	5	OS=Homo	sapiens	GN=ERICH5	PE=2	SV=1 12.56684492 3 5 3 39.911 1.402
A8K9X0 Protein	YIPF	OS=Homo	sapiens	PE=2	SV=1 3.389830508 1 1 1 26.209 1.402
J9JID7 Lamin	B2,	isoform	CRA_a	OS=Homo	sapiens	GN=LMNB2	PE=1	SV=1 10.16129032 5 7 5 69.906 1.401
O75533 Splicing	factor	3B	subunit	1	OS=Homo	sapiens	GN=SF3B1	PE=1	SV=3 2.147239264 2 2 2 145.738 1.401
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	HCT116	sample	(repeat)
Accession Description Coverage
#	
Peptides #	PSMs
#	Unique	
Peptides
MW	
[kDa]
Abundance	
Ratio:	(127)	
/	(126)
Q5CZB5 Putative	uncharacterized	protein	DKFZp686M0430	OS=Homo	sapiens	GN=DKFZp686M0430	PE=2	SV=134.485739 42 154 3 125 2.91
A0A024R9D8 Sperm	associated	antigen	1,	isoform	CRA_b	OS=Homo	sapiens	GN=SPAG1	PE=4	SV=13.23974082 3 5 3 103.5 2.684
Q9Y5A9 YTH	domain-containing	family	protein	2	OS=Homo	sapiens	GN=YTHDF2	PE=1	SV=2 8.98100173 5 13 5 62.3 2.33
P29966 Myristoylated	alanine-rich	C-kinase	substrate	OS=Homo	sapiens	GN=MARCKS	PE=1	SV=428.9156627 6 13 6 31.54 2.266
Q504R6 RAB13	protein	(Fragment)	OS=Homo	sapiens	GN=RAB13	PE=2	SV=1 43.852459 12 55 9 27.18 2.187
Q15907 Ras-related	protein	Rab-11B	OS=Homo	sapiens	GN=RAB11B	PE=1	SV=4 66.9724771 16 167 2 24.47 2.117
Q02952 A-kinase	anchor	protein	12	OS=Homo	sapiens	GN=AKAP12	PE=1	SV=4 44.332211 72 263 33 191.4 2.041
A0A024R6C9 Dihydrolipoamide	S-succinyltransferase	(E2	component	of	2-oxo-glutarate	complex),	isoform	CRA_a	OS=Homo	sapiens	GN=DLST	PE=3	SV=127.8145695 13 35 13 48.72 2.021
E9PCR7 2-oxoglutarate	dehydrogenase,	mitochondrial	OS=Homo	sapiens	GN=OGDH	PE=1	SV=18.86319846 7 10 7 117.6 2.012
P55010 Eukaryotic	translation	initiation	factor	5	OS=Homo	sapiens	GN=EIF5	PE=1	SV=2 17.6334107 7 17 7 49.19 2.006
P13645 Keratin,	type	I	cytoskeletal	10	OS=Homo	sapiens	GN=KRT10	PE=1	SV=6 50.8561644 27 93 24 58.79 2.003
C1IDX9 Ubiquitin-like	protein	ATG12	OS=Homo	sapiens	GN=ATG12	PE=2	SV=1 4.81283422 1 1 1 20.62 1.999
P35908 Keratin,	type	II	cytoskeletal	2	epidermal	OS=Homo	sapiens	GN=KRT2	PE=1	SV=2 43.9749609 26 97 19 65.39 1.971
Q9BRQ8 Apoptosis-inducing	factor	2	OS=Homo	sapiens	GN=AIFM2	PE=1	SV=1 63.002681 20 59 20 40.5 1.964
Q7Z460 CLIP-associating	protein	1	OS=Homo	sapiens	GN=CLASP1	PE=1	SV=1 2.53576073 4 6 4 169.3 1.948
B4E2L0 cDNA	FLJ54730,	highly	similar	to	cAMP-dependent	protein	kinase,	beta-2-catalytic	subunit	(EC	2.7.11.11)	OS=Homo	sapiens	PE=2	SV=18.29145729 3 7 1 46.19 1.913
P10644 cAMP-dependent	protein	kinase	type	I-alpha	regulatory	subunit	OS=Homo	sapiens	GN=PRKAR1A	PE=1	SV=147.7690289 16 34 16 42.96 1.897
B2R9K4 cDNA,	FLJ94434,	highly	similar	to	Homo	sapiens	platelet-activating	factor	acetylhydrolase	2,	40kDa	(PAFAH2),	mRNA	OS=Homo	sapiens	PE=2	SV=113.2653061 5 7 5 44.04 1.8 5
O75896 Tumor	suppressor	candidate	2	OS=Homo	sapiens	GN=TUSC2	PE=1	SV=3 19.0909091 2 4 2 12.07 1.796
P63218 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-5	OS=Homo	sapiens	GN=GNG5	PE=1	SV=339.7058824 4 15 4 7.314 1.75
P49006 MARCKS-related	protein	OS=Homo	sapiens	GN=MARCKSL1	PE=1	SV=2 72.3076923 6 18 6 19.52 1.735
Q5T749 Keratinocyte	proline-rich	protein	OS=Homo	sapiens	GN=KPRP	PE=1	SV=1 3.45423143 2 4 2 64.09 1.666
C9JEJ2 Choline-phosphate	cytidylyltransferase	A	OS=Homo	sapiens	GN=PCYT1A	PE=1	SV=1 23.9473684 9 16 9 43.24 1.66
Q4LE58 EIF4G1	variant	protein	(Fragment)	OS=Homo	sapiens	GN=EIF4G1	variant	protein	PE=2	SV=15.41871921 8 14 8 178 1.657
A0A024R324 Ras	homolog	gene	family,	member	A,	isoform	CRA_a	OS=Homo	sapiens	GN=RHOA	PE=3	SV=149.2227979 14 95 6 21.75 1.655
P37235 Hippocalcin-like	protein	1	OS=Homo	sapiens	GN=HPCAL1	PE=1	SV=3 57.5129534 10 18 6 22.3 1.635
H6VRG1 Keratin	1	OS=Homo	sapiens	GN=KRT1	PE=3	SV=1 40.620155 28 81 26 66.09 1.632
P20339 Ras-related	protein	Rab-5A	OS=Homo	sapiens	GN=RAB5A	PE=1	SV=2 66.9767442 11 77 8 23.64 1.602
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Q8WVD5 RING	finger	protein	141	OS=Homo	sapiens	GN=RNF141	PE=1	SV=1 8.26086957 2 3 2 25.52 1.576
P17612 cAMP-dependent	protein	kinase	catalytic	subunit	alpha	OS=Homo	sapiens	GN=PRKACA	PE=1	SV=27.97720798 3 7 1 40.56 1.575
P20338 Ras-related	protein	Rab-4A	OS=Homo	sapiens	GN=RAB4A	PE=1	SV=3 60.0917431 13 62 1 24.37 1.567
P51148 Ras-related	protein	Rab-5C	OS=Homo	sapiens	GN=RAB5C	PE=1	SV=2 70.3703704 14 121 11 23.47 1.559
A0A024RB09 RAB5B,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB5B	PE=3	SV=159.0697674 9 53 6 23.69 1.531
A0A024R0J7 HCG1995540,	isoform	CRA_a	OS=Homo	sapiens	GN=hCG_1995540	PE=3	SV=1 33.4677419 9 40 5 27.49 1.53
P08134 Rho-related	GTP-binding	protein	RhoC	OS=Homo	sapiens	GN=RHOC	PE=1	SV=1 40.4145078 10 59 2 21.99 1.525
A0A024R5Z8 RAB11A,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB11A	PE=3	SV=165.2777778 15 166 1 24.38 1.519
Q6P6B1 Glutamate-rich	protein	5	OS=Homo	sapiens	GN=ERICH5	PE=2	SV=1 17.9144385 5 11 5 39.91 1.492
Q709C8 Vacuolar	protein	sorting-associated	protein	13C	OS=Homo	sapiens	GN=VPS13C	PE=1	SV=111.5 07914 37 62 37 422.1 1.472
A0A024R6D1 NIMA	(Never	in	mitosis	gene	a)-related	kinase	9,	isoform	CRA_a	OS=Homo	sapiens	GN=NEK9	PE=4	SV=11.02145046 1 1 1 107.1 1.459
P12931 Proto-oncogene	tyrosine-protein	kinase	Src	OS=Homo	sapiens	GN=SRC	PE=1	SV=3 24.4402985 11 20 7 59.8 1.457
Q7Z6L1 Tectonin	beta-propeller	repeat-containing	protein	1	OS=Homo	sapiens	GN=TECPR1	PE=1	SV=120 15 27 15 129.6 1.447
Q53HB3 Proteasome	26S	ATPase	subunit	1	variant	(Fragment)	OS=Homo	sapiens	PE=1	SV=1 17.9545455 7 15 6 49.18 1.446
Q9UBI6 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-12	OS=Homo	sapiens	GN=GNG12	PE=1	SV=356.9444444 4 7 4 8.001 1.433
A0A024RB87 RAP1B,	member	of	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAP1B	PE=4	SV=184.2391304 17 72 7 20.81 1.424
A0A024R056 Guanine	nucleotide	binding	protein	(G	protein),	beta	polypeptide	1,	isoform	CRA_a	OS=Homo	sapiens	GN=GNB1	PE=4	SV=142.6470588 12 50 7 37.35 1.414
H0Y8C2 60S	ribosomal	protein	L22-like	1	(Fragment)	OS=Homo	sapiens	GN=RPL22L1	PE=1	SV=116.9014085 2 2 2 16.89 1.413
P62879 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(T)	subunit	beta-2	OS=Homo	sapiens	GN=GNB2	PE=1	SV=345.88235 9 13 57 8 37.31 1.412
Q9UL15 BAG	family	molecular	chaperone	regulator	5	OS=Homo	sapiens	GN=BAG5	PE=1	SV=19.84340045 3 3 3 51.17 1.409
A0A024R2L1 WD	repeat	domain	48,	isoform	CRA_c	OS=Homo	sapiens	GN=WDR48	PE=4	SV=1 3.24963072 2 2 2 76.16 1.403
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	THP1	sample.
Accession Description Coverage
#	
Peptid
es #	PSMs
#	Unique	
Peptides
MW	
[kDa]
Abundance	
Ratio:	
(127)	/	
(126)
B2R6X5 cDNA,	FLJ93166,	highly	similar	to	Homo	sapiens	heat	shock	70kDa	protein	6	(HSP70B')	(HSPA6),	mRNA	OS=Homo	sapiens	PE=2	SV=112.2862 6 20 1 70.914 3.469
Q92608 Dedicator	of	cytokinesis	protein	2	OS=Homo	sapiens	GN=DOCK2	PE=1	SV=2 60 120 647 118 211.812 2.842
P29966 Myristoylated	alanine-rich	C-kinase	substrate	OS=Homo	sapiens	GN=MARCKS	PE=1	SV=4 41.8675 10 64 10 31.536 2.726
Q96JJ3 Engulfment	and	cell	motility	protein	2	OS=Homo	sapiens	GN=ELMO2	PE=1	SV=2 63.75 46 200 38 82.562 2.682
P02686 Myelin	basic	protein	OS=Homo	sapiens	GN=MBP	PE=1	SV=3 4.60526 1 1 1 33.097 2.622
Q92556 Engulfment	and	cell	motility	protein	1	OS=Homo	sapiens	GN=ELMO1	PE=1	SV=2 63.6864 43 174 35 83.776 2.592
A0A090N8Y8 Zinc	and	ring	finger	2,	isoform	CRA_b	OS=Homo	sapiens	GN=ZNRF2	PE=4	SV=1 5.78512 1 2 1 24.1 2.567
A0A024R324 Ras	homolog	gene	family,	member	A,	isoform	CRA_a	OS=Homo	sapiens	GN=RHOA	PE=3	SV=1 81.3472 19 328 8 21.754 2.506
I6L9I9 FMNL1	protein	OS=Homo	sapiens	GN=FMNL1	PE=2	SV=1 16.9329 12 21 1 69.416 2.504
Q8TD55 Pleckstrin	homology	domain-containing	family	O	member	2	OS=Homo	sapiens	GN=PLEKHO2	PE=1	SV=1 16.3265 9 23 9 53.317 2.344
A0A024R9D8 Sperm	associated	antigen	1,	isoform	CRA_b	OS=Homo	sapiens	GN=SPAG1	PE=4	SV=1 7.12743 5 7 5 103.544 2.186
P08134 Rho-related	GTP-binding	protein	RhoC	OS=Homo	sapiens	GN=RHOC	PE=1	SV=1 73.057 14 216 2 21.992 2.149
Q504R6 RAB13	protein	(Fragment)	OS=Homo	sapiens	GN=RAB13	PE=2	SV=1 56.1475 15 83 12 27.182 2.137
P80723 Brain	acid	soluble	protein	1	OS=Homo	sapiens	GN=BASP1	PE=1	SV=2 80.1762 14 53 14 22.68 2.112
Q15907 Ras-related	protein	Rab-11B	OS=Homo	sapiens	GN=RAB11B	PE=1	SV=4 70.1835 19 218 3 24.473 2.11
B1AH77 Ras-related	C3	botulinum	toxin	substrate	2	OS=Homo	sapiens	GN=RAC2	PE=1	SV=1 91.2162 14 123 9 16.765 2.085
P37235 Hippocalcin-like	protein	1	OS=Homo	sapiens	GN=HPCAL1	PE=1	SV=3 60.6218 11 32 11 22.299 1.958
B4DVC8 cDNA	FLJ56250	OS=Homo	sapiens	PE=2	SV=1 12.1771 5 6 1 58.785 1.844
Q3KQU3 MAP7	domain-containing	protein	1	OS=Homo	sapiens	GN=MAP7D1	PE=1	SV=1 0.83234 1 2 1 92.764 1.841
P60763 Ras-related	C3	botulinum	toxin	substrate	3	OS=Homo	sapiens	GN=RAC3	PE=1	SV=1 51.0417 10 67 3 21.365 1.825
A0A024R5Z8 RAB11A,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB11A	PE=3	SV=1 81.9444 18 215 2 24.378 1.807
Q96TA1 Niban-like	protein	1	OS=Homo	sapiens	GN=FAM129B	PE=1	SV=3 9.65147 8 11 8 84.085 1.803
B2R9K4 cDNA,	FLJ94434,	highly	similar	to	Homo	sapiens	platelet-activating	factor	acetylhydrolase	2,	40kDa	(PAFAH2),	mRNA	OS=Homo	sapiens	PE=2	SV=115.3061 4 6 4 44.037 1.748
P63218 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-5	OS=Homo	sapiens	GN=GNG5	PE=1	SV=3 48.5294 5 9 5 7.314 1.725
A0A024RB09 RAB5B,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB5B	PE=3	SV=1 65.1163 12 93 7 23.692 1.723
Q7L8J4 SH3	domain-binding	protein	5-like	OS=Homo	sapiens	GN=SH3BP5L	PE=1	SV=1 37.9135 15 25 15 43.473 1.691
Q6ICQ8 ARHG	protein	(Fragment)	OS=Homo	sapiens	GN=ARHG	PE=2	SV=1 84.8168 16 123 15 21.295 1.642
A0A024QZT7 ER	lumen	protein-retaining	receptor	OS=Homo	sapiens	GN=KDELR2	PE=3	SV=1 19.8113 3 6 2 24.406 1.611
A0A024R978 Chromosome	1	open	reading	frame	24,	isoform	CRA_a	OS=Homo	sapiens	GN=C1orf24	PE=4	SV=1 29.6336 24 52 24 103.07 1.587
P09543 2',3'-cyclic-nucleotide	3'-phosphodiesterase	OS=Homo	sapiens	GN=CNP	PE=1	SV=2 50.5938 22 44 22 47.549 1.569
P20339 Ras-related	protein	Rab-5A	OS=Homo	sapiens	GN=RAB5A	PE=1	SV=2 73.9535 15 95 9 23.644 1.566
Q8N9N7 Leucine-rich	repeat-containing	protein	57	OS=Homo	sapiens	GN=LRRC57	PE=1	SV=1 48.1172 9 21 9 26.737 1.564
O95466 Formin-like	protein	1	OS=Homo	sapiens	GN=FMNL1	PE=1	SV=3 19.3636 23 36 7 121.777 1.564
B4E2S3 cDNA	FLJ56561	OS=Homo	sapiens	PE=2	SV=1 8.71212 5 6 1 86.651 1.554
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P61026 Ras-related	protein	Rab-10	OS=Homo	sapiens	GN=RAB10	PE=1	SV=1 86.5 22 138 16 22.527 1.552
Q9UKW4 Guanine	nucleotide	exchange	factor	VAV3	OS=Homo	sapiens	GN=VAV3	PE=1	SV=1 3.42385 3 5 2 97.713 1.55
J9JID7 Lamin	B2,	isoform	CRA_a	OS=Homo	sapiens	GN=LMNB2	PE=1	SV=1 8.06452 4 9 4 69.906 1.548
P51148 Ras-related	protein	Rab-5C	OS=Homo	sapiens	GN=RAB5C	PE=1	SV=2 73.6111 15 194 10 23.468 1.547
A4D2P1 Ras-related	C3	botulinum	toxin	substrate	1	(Rho	family,	small	GTP	binding	protein	Rac1)	OS=Homo	sapiens	GN=RAC1	PE=2	SV=161.9792 13 143 4 21.436 1.543
P49006 MARCKS-related	protein	OS=Homo	sapiens	GN=MARCKSL1	PE=1	SV=2 24.1026 2 2 2 19.517 1.531
P82909 28S	ribosomal	protein	S36,	mitochondrial	OS=Homo	sapiens	GN=MRPS36	PE=1	SV=2 24.2718 2 2 2 11.459 1.525
B4E1U9 cDNA	FLJ54776,	highly	similar	to	Cell	division	control	protein	42	homolog	OS=Homo	sapiens	PE=2	SV=1 52.9661 13 160 12 26.511 1.518
Q59EG8 Proteasome	26S	non-ATPase	subunit	2	variant	(Fragment)	OS=Homo	sapiens	PE=2	SV=1 41.2924 30 48 30 100.524 1.516
Q9NQE9 Histidine	triad	nucleotide-binding	protein	3	OS=Homo	sapiens	GN=HINT3	PE=1	SV=1 18.6813 3 4 3 20.348 1.491
Q8TCU6 Phosphatidylinositol	3,4,5-trisphosphate-dependent	Rac	exchanger	1	protein	OS=Homo	sapiens	GN=PREX1	PE=1	SV=3 1.14527 2 2 2 186.085 1.476
Q15286 Ras-related	protein	Rab-35	OS=Homo	sapiens	GN=RAB35	PE=1	SV=1 85.5721 18 103 14 23.011 1.472
P61204 ADP-ribosylation	factor	3	OS=Homo	sapiens	GN=ARF3	PE=1	SV=2 67.4033 12 55 7 20.588 1.454
H0YKY3 Proline-serine-threonine	phosphatase-interacting	protein	1	OS=Homo	sapiens	GN=PSTPIP1	PE=1	SV=1 2.8777 1 1 1 47.602 1.443
Q5TC84 Opioid	growth	factor	receptor-like	protein	1	OS=Homo	sapiens	GN=OGFRL1	PE=2	SV=1 1.99557 1 2 1 51.22 1.434
P38117 Electron	transfer	flavoprotein	subunit	beta	OS=Homo	sapiens	GN=ETFB	PE=1	SV=3 14.5098 3 4 3 27.826 1.423
A0A024RB87 RAP1B,	member	of	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAP1B	PE=4	SV=1 84.2391 18 216 8 20.812 1.42
Q9UL26 Ras-related	protein	Rab-22A	OS=Homo	sapiens	GN=RAB22A	PE=1	SV=2 54.1237 7 26 5 21.841 1.415
D7RF68 AGTRAP-BRAF	fusion	protein	OS=Homo	sapiens	PE=2	SV=1 6.53266 2 2 2 66.164 1.402
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	THP1	sample	(repeat)
Accession Description Coverage #	Peptides #	PSMs
#	Unique	
Peptides MW	[kDa]
Abundance	
Ratio:	(129)	/	
(128)
A0A024R324 Ras	homolog	gene	family,	member	A,	isoform	CRA_a	OS=Homo	sapiens	GN=RHOA	PE=3	SV=1 81.34715026 19 201 8 21.754 2.452
B1AH77 Ras-related	C3	botulinum	toxin	substrate	2	OS=Homo	sapiens	GN=RAC2	PE=1	SV=1 85.13513514 11 75 7 16.765 2.214
Q15907 Ras-related	protein	Rab-11B	OS=Homo	sapiens	GN=RAB11B	PE=1	SV=4 71.10091743 21 294 3 24.473 2.001
Q504R6 RAB13	protein	(Fragment)	OS=Homo	sapiens	GN=RAB13	PE=2	SV=1 45.90163934 11 88 8 27.182 1.965
A0A090N8Y8 Zinc	and	ring	finger	2,	isoform	CRA_b	OS=Homo	sapiens	GN=ZNRF2	PE=4	SV=1 23.55371901 3 6 3 24.1 1.927
Q9Y3L5 Ras-related	protein	Rap-2c	OS=Homo	sapiens	GN=RAP2C	PE=1	SV=1 27.32240437 3 5 2 20.731 1.927
I6L9I9 FMNL1	protein	OS=Homo	sapiens	GN=FMNL1	PE=2	SV=1 27.79552716 17 40 1 69.416 1.909
B3KY04 cDNA	FLJ46506	fis,	clone	THYMU3030752,	highly	similar	to	BTB/POZ	domain-containing	protein	KCTD12	OS=Homo	sapiens	PE=2	SV=138.76923077 11 30 11 35.709 1.819
O95466 Formin-like	protein	1	OS=Homo	sapiens	GN=FMNL1	PE=1	SV=3 29.72727273 30 74 11 121.777 1.813
Q6ICQ8 ARHG	protein	(Fragment)	OS=Homo	sapiens	GN=ARHG	PE=2	SV=1 70.15706806 14 98 13 21.295 1.803
B2R9K4 cDNA,	FLJ94434,	highly	similar	to	Homo	sapiens	platelet-activating	factor	acetylhydrolase	2,	40kDa	(PAFAH2),	mRNA	OS=Homo	sapiens	PE=2	SV=146.42857143 15 9 15 44.037 1.789
P29966 Myristoylated	alanine-rich	C-kinase	substrate	OS=Homo	sapiens	GN=MARCKS	PE=1	SV=4 30.12048193 7 33 7 31.536 1.767
P35527 Keratin,	type	I	cytoskeletal	9	OS=Homo	sapiens	GN=KRT9	PE=1	SV=3 44.94382022 23 72 22 62.027 1.766
A0A087X0V5 2'-5'-oligoadenylate	synthase	2	OS=Homo	sapiens	GN=OAS2	PE=1	SV=1 8.67768595 8 14 8 83.183 1.702
P02649 Apolipoprotein	E	OS=Homo	sapiens	GN=APOE	PE=1	SV=1 68.76971609 24 86 24 36.132 1.698
P61026 Ras-related	protein	Rab-10	OS=Homo	sapiens	GN=RAB10	PE=1	SV=1 83.5 23 168 19 22.527 1.679
P62745 Rho-related	GTP-binding	protein	RhoB	OS=Homo	sapiens	GN=RHOB	PE=1	SV=1 28.57142857 3 32 1 22.109 1.678
P80723 Brain	acid	soluble	protein	1	OS=Homo	sapiens	GN=BASP1	PE=1	SV=2 60.35242291 8 20 8 22.68 1.663
P10644 cAMP-dependent	protein	kinase	type	I-alpha	regulatory	subunit	OS=Homo	sapiens	GN=PRKAR1A	PE=1	SV=113.38582677 6 11 6 42.955 1.648
A0A0A1HAV9 H.sapiens	ras-related	Hrab4	protein	OS=Homo	sapiens	PE=2	SV=1 78.40375587 13 59 1 23.887 1.645
A0A024RB09 RAB5B,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB5B	PE=3	SV=1 53.48837209 8 121 5 23.692 1.607
A0A024R5Z8 RAB11A,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAB11A	PE=3	SV=1 82.87037037 20 291 2 24.378 1.606
Q9BRT3 Migration	and	invasion	enhancer	1	OS=Homo	sapiens	GN=MIEN1	PE=1	SV=1 24.34782609 3 6 3 12.395 1.592
P63218 Guanine	nucleotide-binding	protein	G(I)/G(S)/G(O)	subunit	gamma-5	OS=Homo	sapiens	GN=GNG5	PE=1	SV=348.52941176 5 20 5 7.314 1.59
Q709C8 Vacuolar	protein	sorting-associated	protein	13C	OS=Homo	sapiens	GN=VPS13C	PE=1	SV=1 18.91819877 57 107 57 422.124 1.578
P51148 Ras-related	protein	Rab-5C	OS=Homo	sapiens	GN=RAB5C	PE=1	SV=2 70.37037037 15 266 12 23.468 1.568
B4DRL5 cDNA	FLJ60834,	highly	similar	to	Engulfment	and	cell	motility	protein	2	(CED-12	homolog	A)	OS=Homo	sapiens	PE=2	SV=127.18579235 17 32 13 83.905 1.563
A8K5J7 cDNA	FLJ77290,	highly	similar	to	Homo	sapiens	BCL2-associated	athanogene	5	(BAG5),	mRNA	OS=Homo	sapiens	PE=2	SV=118.56823266 6 7 6 51.209 1.556
A0A024R6C9 Dihydrolipoamide	S-succinyltransferase	(E2	component	of	2-oxo-glutarate	complex),	isoform	CRA_a	OS=Homo	sapiens	GN=DLST	PE=3	SV=110.59602649 6 13 6 48.724 1.543
P37235 Hippocalcin-like	protein	1	OS=Homo	sapiens	GN=HPCAL1	PE=1	SV=3 57.51295337 11 36 11 22.299 1.541
J9JID7 Lamin	B2,	isoform	CRA_a	OS=Homo	sapiens	GN=LMNB2	PE=1	SV=1 6.129032258 3 6 3 69.906 1.54
Q9UJ68 Mitochondrial	peptide	methionine	sulfoxide	reductase	OS=Homo	sapiens	GN=MSRA	PE=1	SV=1 7.234042553 2 3 2 26.116 1.536
P09917 Arachidonate	5-lipoxygenase	OS=Homo	sapiens	GN=ALOX5	PE=1	SV=2 61.8694362 50 234 50 77.933 1.535
P35580 Myosin-10	OS=Homo	sapiens	GN=MYH10	PE=1	SV=3 10.37449393 22 94 1 228.858 1.532
Q5TC84 Opioid	growth	factor	receptor-like	protein	1	OS=Homo	sapiens	GN=OGFRL1	PE=2	SV=1 2.43902439 1 1 1 51.22 1.509
P20339 Ras-related	protein	Rab-5A	OS=Homo	sapiens	GN=RAB5A	PE=1	SV=2 65.11627907 10 134 7 23.644 1.504
Q59EG8 Proteasome	26S	non-ATPase	subunit	2	variant	(Fragment)	OS=Homo	sapiens	PE=2	SV=1 27.92990142 21 47 21 100.524 1.503
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A0A024RB87 RAP1B,	member	of	RAS	oncogene	family,	isoform	CRA_a	OS=Homo	sapiens	GN=RAP1B	PE=4	SV=1 79.89130435 16 156 7 20.812 1.492
H6VRG1 Keratin	1	OS=Homo	sapiens	GN=KRT1	PE=3	SV=1 46.97674419 37 150 32 66.086 1.491
Q9H8Y8 Golgi	reassembly-stacking	protein	2	OS=Homo	sapiens	GN=GORASP2	PE=1	SV=3 4.203539823 2 4 2 47.116 1.487
Q9NRW4 Dual	specificity	protein	phosphatase	22	OS=Homo	sapiens	GN=DUSP22	PE=1	SV=1 5.97826087 1 1 1 20.897 1.48
Q92608 Dedicator	of	cytokinesis	protein	2	OS=Homo	sapiens	GN=DOCK2	PE=1	SV=2 37.15846995 55 136 55 211.812 1.475
Q01546 Keratin,	type	II	cytoskeletal	2	oral	OS=Homo	sapiens	GN=KRT76	PE=1	SV=2 7.836990596 6 10 1 65.8 1.47
O14980 Exportin-1	OS=Homo	sapiens	GN=XPO1	PE=1	SV=1 1.774042951 1 1 1 123.306 1.457
P04350 Tubulin	beta-4A	chain	OS=Homo	sapiens	GN=TUBB4A	PE=1	SV=2 49.77477477 17 110 1 49.554 1.434
P20338 Ras-related	protein	Rab-4A	OS=Homo	sapiens	GN=RAB4A	PE=1	SV=3 83.02752294 14 66 2 24.374 1.433
Q9UL26 Ras-related	protein	Rab-22A	OS=Homo	sapiens	GN=RAB22A	PE=1	SV=2 46.39175258 8 27 6 21.841 1.43
Q92556 Engulfment	and	cell	motility	protein	1	OS=Homo	sapiens	GN=ELMO1	PE=1	SV=2 37.82668501 22 39 18 83.776 1.428
K7EK60 Formin-like	protein	1	OS=Homo	sapiens	GN=FMNL1	PE=1	SV=1 28.0058651 17 42 2 74.555 1.426
P04259 Keratin,	type	II	cytoskeletal	6B	OS=Homo	sapiens	GN=KRT6B	PE=1	SV=5 21.45390071 12 31 4 60.03 1.414
O95721 Synaptosomal-associated	protein	29	OS=Homo	sapiens	GN=SNAP29	PE=1	SV=1 12.01550388 2 3 2 28.953 1.407
P62834 Ras-related	protein	Rap-1A	OS=Homo	sapiens	GN=RAP1A	PE=1	SV=1 76.08695652 13 126 4 20.974 1.403
E9PCR7 2-oxoglutarate	dehydrogenase,	mitochondrial	OS=Homo	sapiens	GN=OGDH	PE=1	SV=1 1.637764933 2 4 2 117.59 1.403
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Proteins	with	an	abundance	ratio	above	1.4	in	TMT	labelled	MEF	sample.	
Accession Description Coverage
#	
Peptides
#	
PSMs
#	
Unique	
Peptides MW	[kDa]
Abundance	
Ratio:	(127)	
/	(126)
E9Q0B5 Protein	Fcgbp	OS=Mus	musculus	GN=Fcgbp	PE=1	SV=1 0.348432056 1 3 1 275.043 2.799
Q6ZPF4 Formin-like	protein	3	OS=Mus	musculus	GN=Fmnl3	PE=1	SV=2 30.15564202 29 94 22 117.095 2.207
Q8BU31 Ras-related	protein	Rap-2c	OS=Mus	musculus	GN=Rap2c	PE=1	SV=1 19.67213115 2 5 2 20.731 2.106
Q9CWF2 Tubulin	beta-2B	chain	OS=Mus	musculus	GN=Tubb2b	PE=1	SV=1 67.86516854 24 168 1 49.921 2.101
Q9D2G2 Dihydrolipoyllysine-residue	succinyltransferase	component	of	2-oxoglutarate	dehydrogenase	complex,	mitochondrial	OS=Mus	musculus	GN=Dlst	PE=1	SV=122.46696035 8 16 8 48.963 2.027
G3UW70 MCG21719	OS=Mus	musculus	GN=Lamtor5	PE=1	SV=1 20.68965517 2 4 2 15.345 2.012
Q99J83 Autophagy	protein	5	OS=Mus	musculus	GN=Atg5	PE=1	SV=1 17.09090909 3 5 3 32.381 1.99
A0A068BFR3 RAS	oncogene	family	protein	OS=Mus	musculus	GN=Rab11b	PE=2	SV=1 69.72477064 21 261 21 24.473 1.946
A0A0A1HAM8 80K	protein	OS=Mus	musculus	GN=Marcks	PE=2	SV=1 31.39158576 8 53 8 29.704 1.741
Q50HX4 RAB14	protein	OS=Mus	musculus	GN=Rab14	PE=2	SV=1 92.55813953 24 228 2 23.882 1.741
Q62159 Rho-related	GTP-binding	protein	RhoC	OS=Mus	musculus	GN=Rhoc	PE=1	SV=2 50.77720207 10 42 2 21.992 1.738
Q3U9P7 Succinyl-CoA:3-ketoacid-coenzyme	A	transferase	OS=Mus	musculus	GN=Oxct1	PE=2	SV=14.807692308 2 3 2 56.013 1.733
P61211 ADP-ribosylation	factor-like	protein	1	OS=Mus	musculus	GN=Arl1	PE=1	SV=1 7.73480663 1 1 1 20.398 1.697
A2APV2 Formin-like	protein	2	OS=Mus	musculus	GN=Fmnl2	PE=1	SV=2 24.03314917 22 69 15 123.024 1.697
O54734 Dolichyl-diphosphooligosaccharide--protein	glycosyltransferase	48	kDa	subunit	OS=Mus	musculus	GN=Ddost	PE=1	SV=22.494331066 1 2 1 48.997 1.653
Q9D6F9 Tubulin	beta-4A	chain	OS=Mus	musculus	GN=Tubb4a	PE=1	SV=3 54.72972973 18 134 1 49.554 1.61
Q8BFZ3 Beta-actin-like	protein	2	OS=Mus	musculus	GN=Actbl2	PE=1	SV=1 28.19148936 10 106 1 41.977 1.582
Q3TSQ1 Putative	uncharacterized	protein	OS=Mus	musculus	GN=Atp1b1	PE=2	SV=1 4.605263158 1 2 1 35.188 1.568
Q9CQD1 Ras-related	protein	Rab-5A	OS=Mus	musculus	GN=Rab5a	PE=1	SV=1 70.23255814 13 201 10 23.584 1.543
O88456 Calpain	small	subunit	1	OS=Mus	musculus	GN=Capns1	PE=1	SV=1 3.345724907 1 2 1 28.445 1.532
Q3TJG6 Putative	uncharacterized	protein	OS=Mus	musculus	GN=Ptges3	PE=2	SV=1 10.625 2 3 2 18.735 1.525
Q3TJ39 RAB5C,	member	RAS	oncogene	family,	isoform	CRA_a	OS=Mus	musculus	GN=Rab5c	PE=2	SV=171.2962963 15 246 12 23.398 1.511
Q0PD56 Rab5B	OS=Mus	musculus	GN=Rab5b	PE=2	SV=1 53.27510917 9 159 6 25.259 1.501
P40124 Adenylyl	cyclase-associated	protein	1	OS=Mus	musculus	GN=Cap1	PE=1	SV=4 2.320675105 1 1 1 51.532 1.494
Q99LC5 Electron	transfer	flavoprotein	subunit	alpha,	mitochondrial	OS=Mus	musculus	GN=Etfa	PE=1	SV=27.807807808 2 3 2 34.988 1.485
P63168 Dynein	light	chain	1,	cytoplasmic	OS=Mus	musculus	GN=Dynll1	PE=1	SV=1 24.71910112 1 2 1 10.359 1.483
B2RRE0 A	kinase	(PRKA)	anchor	protein	(Gravin)	12	OS=Mus	musculus	GN=Akap12	PE=2	SV=1 26.54394299 38 120 38 180.586 1.48
Q9CYN2 Signal	peptidase	complex	subunit	2	OS=Mus	musculus	GN=Spcs2	PE=1	SV=1 8.407079646 1 1 1 24.962 1.471
P05132 cAMP-dependent	protein	kinase	catalytic	subunit	alpha	OS=Mus	musculus	GN=Prkaca	PE=1	SV=32.564102564 1 2 1 40.545 1.469
Q4FJP3 Nras	protein	OS=Mus	musculus	GN=Nras	PE=2	SV=1 45.07772021 7 29 2 21.675 1.448
Q9QUI0 Transforming	protein	RhoA	OS=Mus	musculus	GN=Rhoa	PE=1	SV=1 61.65803109 13 62 5 21.768 1.425
Q80VP0 Tectonin	beta-propeller	repeat-containing	protein	1	OS=Mus	musculus	GN=Tecpr1	PE=1	SV=118.35334477 16 41 16 130.184 1.416
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New Danger Signals in Anti-Bacterial Immunity 
Cara Ellison and Felix Randow 
MRC Laboratory of Molecular Biology ∙ Francis Crick Avenue ∙ 
Cambridge Biomedical Campus ∙ Cambridge ∙ CB2 0QH
The Immune System 
Our immune system is constantly roaming our bodies 
searching for harmful pathogens (e.g. bacteria & viruses) to 
eradicate. However, pathogens have found ways to avoid 
being detected by our immune system: they can hide inside 
cells. 
How does a cell know it’s been invaded?
• Or the cell detects its own external molecules that enter 
the cell with the pathogen:
Identifying a new danger signal: Lipids 
(fats)
My method of investigation:
1. Using a lipid-specic protein from earthworms
2. Engineer human cells to express the protein
3. Infect these cells with Salmonella (a cause of food poisoning)
Identifying lipid detectors:
Method:
Scale bar = 10µm
Confocal microscopy Super-resolution microscopy
Scale bar = 1µm
• Lipid-specic protein co-localises with Galectin on 
Salmonella-containing vacuoles:
Results:
- 49 candidate proteins identied
- 12 of these are recruited to Salmonella in cells
- Currently further analysing each candidate 
1. Model cell membrane 2. Add cell proteins 3. Pull-out proteins 
bound to membrane
Thurston T. et al. Nature, 2012
Conclusions & Future work 
• Cell lipids are exposed to the inside of cells upon bacterial  
invasion.
• Investigate if lipid danger signal is exposed during invasion 
by viruses.
• Further investigate candidate lipid detectors and identify 
new sigalling pathways in anti-bacterial immunity.
• Identify, in patients, genetic mutations in this lipid danger 
signal detection pathway. 
• Either the cell detects parts of the pathogen:
MergeLipid-specic protein Galectin 
Galectin
Sugars act as a danger signal and are detected by the 
danger receptor, Galectin. 
Bacterium
Virus
Pathogen hidden 
in a vacuoleCell 
membrane
Introduction
• Lipid-specic protein is recruited to vacuoles containing 
other bacterial 
 species:
Shigella Listeria
Cell proteins
e.g.
Cell sugars
Other cell 
molecules
?
?
?
Galectin
Killing of the bacterium 
(Autophagy)
?
Vacuole ruptures : 
Hidden molecules are 
exposed & detected by 
danger receptors (e.g. 
Galectin) 
Host molecules 
(e.g. sugars) are 
hidden in the 
pathogen-containing 
vacuole.
Results: 
• Lipid-specific protein is recruited to Salmonella:
Antibiotic resistance poses an increasing threat to public 
health. It is therefore important to understand how cells 
detect and destroy bacteria. My research aim has been to 
identify new danger signals that inform the cell of bacterial 
invasion. 
Individual cells that are not part of the immune system can 
also destroy invading pathogens using a mechanism 
known as Autophagy. To achieve this, the cell must rst 
detect the invasion.
Inside cell 
R
R
Cell receptor
Lipid
specic 
protein
Lipid
specic 
protein
Cell nucleus
Green 
lipid-
specic 
protein
Salmonella
